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Abstract 
This thesis details the discovery and development of several novel gold-catalysed reactions for 
the synthesis of nitrogen containing carbo- and heterocyclic frameworks from carbon-carbon 
triple bonds. The realisation of a 1,1-carboalkoxylation strategy to generate gold carbenes from 
ynamides is described. This novel skeletal rearrangement proceeds with a previously 
unreported nitrogen migration onto a gold carbene for the synthesis of highly functionalised 
indenes. The mechanism has been investigated using isotopic labelling which confirms the 
predicted mode of cyclisation, enforced by the electronic properties of ynamides.  
This work led to the discovery of a gold-catalysed polycyclisation reaction to generate complex 
three-dimensional tetracyclic products. The scope and limitations of this method are described, 
and the mechanism has been probed using isotopic labelling. A novel copper-catalysed cascade 
reaction has also been demonstrated towards the synthesis of valuable nitrogen heterocycles.  
Finally a gold-catalysed rearrangement of electron deficient alkynes under oxidative conditions 
is detailed along with the reaction optimisation and difficulties encountered. 
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Chapter 1: Generation of Gold Carbenes from C-C Triple 
Bonds 
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1.1 Gold Catalysis in Organic Synthesis 
The use of gold catalysis in organic synthesis has seen a dramatic increase over the past decade 
and has led to the discovery of a wide range of new transformations through the 
functionalisation of carbon-carbon multiple bonds. Gold (as well as platinum) is termed a π-acid 
and its chemistry has been extensively reviewed in recent years.1,2 The Lewis acidic character of 
gold complexes derives from relativistic effects, which are more pronounced for gold than for 
any other metal, leading to a shorter and stronger metal-to-ligand bond as well as large and 
diffuse d-orbitals.3 This makes gold complexes more susceptible to orbital interactions over 
charge interactions and therefore they activate ‘soft’ nucleophilic π-systems such as alkenes, 
alkynes and allenes towards inter- and intramolecular nucleophilic attack. 
Gold catalysts exhibit remarkable functional group tolerance and allow for the rapid generation 
of complex molecules from simple starting materials. One of the most appealing aspects of gold 
catalysts, and the main theme behind my PhD research is the formation of gold carbene 
intermediates and their subsequent utility (Scheme 1).  
 
Scheme 1: Formation of gold carbenes from gold-activated C-C triple bonds 
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Coordination of a gold species to a triple bond (1) promotes nucleophilic attack to form vinyl 
gold species 2.4 This now nucleophilic π-system can undergo addition of an electrophile to 
positions α- or β-to the metal. In the first case, addition to the α-position gives 1,2-addition 
products 3. This reactivity is exemplified in 1,2-carbofunctionalisation processes as described in 
detail in Chapter 2 (Section 2.2). Alternatively, addition to the β-position generates a gold 
carbene 4. Computational models show that on formation of a gold carbene from a vinyl gold 
species, there is an increase in π-bonding and a decrease in σ-bonding, however the overall 
bond order is close to or less than one.5 The exact structure of these intermediates is still a 
matter of debate amongst the scientific community with the exact structure probably lying 
closer to a metal-stabilised carbocation than a metal-carbon double bond.6 The nature of these 
intermediates is also expected to be influenced by the gold ligands as well as the substitution 
around the carbene centre.7 These intermediates are known to possess a highly electrophilic 
carbon atom which is stabilised by back-donation of electron density from the metal to the 
vacant p-orbital. Throughout the following chapters, gold carbenes are depicted as a classical 
metal carbene for simplicity. A small number of relevant aspects of gold carbene chemistry are 
detailed below. 
α-Oxo gold carbenes have been identified as potent reactive intermediates in the last several 
years allowing access to highly valuable transformations, such as CH-functionalisation, 
cyclopropanation and ylide formation.8,9 In these cases, the nucleophile shown in Scheme 1 is 
oxygen, and the α-oxo gold carbene is formed on expulsion of a leaving group from the vinyl 
gold intermediate 5. A simplified mechanism is shown in Scheme 2. Subsequent attack of a 
14 
 
nucleophile onto the gold-bound metal centre may occur from carbene 6 or prior to the 
expulsion of the leaving group (5) and so the term carbenoid is often used to describe the 
reactive intermediate. The tolerance of gold catalysts to aqueous media is demonstrated by the 
ability to carry out these reactions in water.10 
 
Scheme 2: Formation of an α-oxo gold carbene through oxidation of a C-C triple bond 
The formation of gold carbenes through these pathways is highly attractive as it avoids the use 
of diazo compounds, which have traditionally been employed to access these intermediates 
through transition metal-catalysed decomposition processes.11 The use of diazo compounds 
requires extra synthetic steps and therefore reduces efficiency. Furthermore, the explosive and 
toxic nature of these compounds limits large scale use.12 
Development of gold-catalysed processes has led to the realisation of cascade reactions which 
combine several distinct transformations in a single step. 1,2-Migrations of adjacent groups 
onto gold carbenes are often involved in these reactions and represent a fundamental process 
for these intermediates. When available, 1,2-hydrogen migration usually prevails, however 
when the adjacent centre is fully substituted, 1,2-alkyl and aryl migrations are commonly 
observed to generate a diverse range of products (Scheme 3, see Chapter 2 for 1,2-N and 1,2-O 
migrations).13,14 
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Scheme 3: 1,2-R migration onto a gold carbene 
Gold carbenes can also undergo reaction with olefins to generate products of cyclopropanation 
(Scheme 4). This can occur in an inter- or intramolecular fashion.15 The latter case is illustrated 
in the cycloisomerisations of enynes and represents a key strategy for the rapid build-up of 
molecular complexity.16 The formation of a distorted gold carbene is proposed for these 
transformations2d where the formation of the 3-membered ring is thought to occur in a 
concerted fashion (see Chapter 3 for examples of cyclopropanation onto gold carbenes).17 
 
Scheme 4: Formation of cyclopropanes from gold carbenes 
Whilst well reported for alkyne activation, the use of gold catalysis for the activation of 
electron-rich ynamides is much less explored, however the number of available transformations 
is beginning to grow rapidly.18 Ynamides readily coordinate to gold species and the relative 
electron deficiency of the α-carbon, as depicted in the keteniminium resonance form below 
(Scheme 5), leads to highly predictable nucleophilic attack. As well as alkynes, ynamides have 
been shown to allow access to gold carbene intermediates.19  
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Scheme 5: Keteniminium resonance form of a gold-bound ynamide 
The following chapters will detail the use of ynamides and alkynes in gold-catalysed reactions, 
with introductions addressing the relevant literature context. The overall goal of this research 
programme has been to develop efficient means to access and employ gold carbene 
intermediates in a novel manner and / or in a unique environment.  
Chapter 2 details an ynamide carboalkoxylation approach for the formation of functionalised 
indenes. This work later led to the discovery and development of a gold-catalysed cascade 
reaction of N-allyl ynamides, initiated by [1,5]-hydride transfer, which is discussed in Chapter 3. 
Chapter 4 details a copper-catalysed cascade reaction for isoquinoline synthesis, again involving 
a [1,5]-hydride shift. Finally, formation and rearrangement of ammonium ylides via α-oxo gold 
carbene intermediates is discussed in Chapter 5. 
These investigations have resulted in the discovery of four novel, complexity increasing 
catalysis-based transformations which generate valuable nitrogen containing carbo- and 
heterocycles. Furthermore, several examples are described where Derivatisation of products 
has been achieved, expanding the scope of materials that can be accessed through these 
methodologies. 
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Chapter 2: 1,2-N-Migration in a Gold-Catalysed 
Synthesis of Functionalised Indenes by the 1,1-
Carboalkoxylation of Ynamides 
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2.1 Introduction 
Interest within the Davies group in the generation of gold carbenes directly from triple 
bonds19a,20 led to the exploration of ynamides in order to access reactivity pathways divergent 
to those available for alkyne equivalents, in a regioselective manner. This chapter details how an 
ynamide 1,1-carboalkoxylation strategy has been developed to synthesise highly functionalised 
indenes through the intermediacy of a unique gold carbene environment (Scheme 6).21  
 
Scheme 6: Formation of a gold carbene through the 1,1-carboalkoxylation of an ynamide 
Carboalkoxylation refers to the formal insertion of a C-C multiple bond into a C-O σ-bond. These 
processes are typified by attack of an oxygen nucleophile onto a C-C multiple bond to generate 
a charged oxonium species, which can evolve through migration of a suitable group with overall 
C-O addition.22 These types of carbofunctionalisations are not limited to C-O bonds (vide infra) 
and a diverse range of transformations can be accessed through the application of these 
reactivity principles to different heteroatoms. Variation in the connectivity between the 
heteroatom, the C-C multiple bond and the migrating group will dictate the mode of cyclisation 
and the evolution of the reactive intermediate.  
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During my PhD studies I was able to co-author a detailed review in which we categorised the 
area of π-acid mediated C-X insertion into C-C triple bonds as outlined in Scheme 7.22b 
 
Scheme 7: Outline of π-acid mediated C-X insertion into C-C triple bonds 
Path a shows 1,2-carbofunctionalisation where external migration occurs, i.e. with loss of 
connectivity between the migrating group (Y) and the triple bond. When allyl groups are 
involved, sigmatropic or cationic migrations are possible. Path b shows 1,2-
carbofunctionalisation with alternative internal migration, i.e. no loss of connectivity between 
the migrating group and the alkyne. Path c demonstrates 1,1-carbofunctionalisation of the triple 
bond, shown here for both internal and external migrations. Finally, path d shows the 1,5-
external migration mode available for benzoic acid derived substrates. The examples shown 
next to each pathway are taken from the following introductory sections. 
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From the overall reactivity picture we developed, it was proposed that the use of an ynamide 
instead of an alkyne could provide sufficient control over regioselectivity to provide access to a 
relatively unexplored but valuable mode of carboalkoxylation. Despite the number of examples 
of this chemistry in the literature, there were no studies employing ynamides at the outset of 
my investigation. The following sections outline literature examples and key aspects of reactivity 
and applicability within this area, before detailing the discovery of an ynamide 1,1-
carboalkoxylation.21 
2.2 [1,2]-Addition of Carbon-Heteroatom Bonds Across Alkynes 
The most common transformations in this field involve an overall 1,2-addition of a carbon-
heteroatom σ-bond across an alkyne (see above, Scheme 7, path a). Nucleophilic attack of the 
heteroatom (X) into the π-acid activated alkyne (18) generates charged intermediate 19, which 
evolves through a 1,3-migration of tethered group Y to the metallated centre to give products of 
type 20 with overall 1,2-X-Y addition (Scheme 8). 
 
Scheme 8: π-Acid catalysed 1,2-addition of an X-Y σ-bond across an alkyne, shown here for exo-mode cyclisation 
2.2.1 Heteroatom to Carbon Allyl Migration (Cationic Pathway) 
π-Acid mediated carboalkoxylations involving alkynes were first realised by Fürstner and co-
workers in the synthesis of tetrahydrofuran derivatives (Scheme 9).23,24,25,26 Conjugated 
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electron-deficient alkynes with a tethered allyl ether moiety, such as 21, underwent PtCl2-
catalysed exo-cyclisation to generate oxonium intermediate 25 which evolves to form the most 
stable cation with cleavage of the O-C bond. Migration of the unsymmetrical allylic cation to the 
metallated position generates a mixture of branched and linear isomers 22 and 23 with an O→C 
allyl migration. The formation of these isomers eliminates the possibility of a fully concerted 
migration. 
 
Scheme 9: Synthesis of tetrahydrofuran derivatives by PtCl2-catalysed carboalkoxylation of an alkyne with a 
tethered allyl ether moiety 
Endo-mode cyclisation of ortho-alkynyl phenol allyl ethers such as 27 was also achieved by 
Fürstner and Davies in the synthesis of substituted benzofurans 28 (Scheme 10).27 Again, it was 
proposed that an allylic cation is formed which migrates to the metallated position.  
As well as insertion into C-O σ-bonds, analogous carboamination processes are also well known, 
whereby the alkyne inserts into a C-N σ-bond. Aniline derivatives 30 were shown to undergo 
similar endo-cyclisation and 1,3-N→C allyl migration in the preparation of 2,3-disubstituted 
indoles 31 (Scheme 10). For both transformations, a carbon monoxide atmosphere was 
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employed alongside a platinum catalyst which led to a significant increase in reaction rate. This 
was attributed to the potential of π-acidic CO ligands to increase the electrophilicity of the 
metal.28 
 
Scheme 10: Synthesis of benzofurans and indoles by platinum-catalysed carboalkoxylation and carboamination, 
with endo-mode cyclisation 
The first example of 1,2-carbothiolation (C-S addition) across an alkyne was demonstrated by 
Nakamura and co-workers. Endo-mode cyclisation of ortho-alkynyl thiophenol derivatives 32 
was achieved using simple AuCl as the catalyst to give benzothiophenes 13 in excellent yields 
(Scheme 11).29 
 
Scheme 11: Synthesis of benzothiophenes by 1,2-carbothiolation 
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Davies and Albrecht demonstrated the 1,2-carbothiolation of a non-aromatic system in a 
cascade reaction (Scheme 12).30 Cycloisomerisation precursor 36 was formed in situ in this case, 
through the intermolecular gold-mediated coupling of propargylic carboxylate 33 and allyl 
propargyl sulfide 34. Gold-catalysed carbothiolation then afforded dihydrothiophene 35 by 1,3-
S→C allyl migration. 
 
Scheme 12: Gold-catalysed cascade reaction with 1,2-carbothiolation 
2.2.2 Heteroatom to Carbon Allyl Migration by Sigmatropic Rearrangement 
The examples discussed so far have involved the 1,2-carbofunctionalisation of triple bonds by 
1,3-heteroatom-to-carbon migration through formation of an allylic cation which adds to the 
metallated position. In the case of unsymmetrical allylic cations, mixtures of branched and 
linear isomers can be formed (Scheme 13, path a). Intermediates such as 42 may also evolve in a 
concerted fashion by [3,3]-sigmatropic rearrangement (Scheme 13, path b). In these cases, a 
single product 44 is formed with allylic inversion. 
24 
 
 
Scheme 13: Possible allyl migration modes from onium intermediate 43 
This reaction type was first identified by Gagosz and co-workers in the formation of N-tosyl 
pyrroles 48 (Scheme 14).31 Activation of the alkyne moiety of 45 by a cationic gold complex 
triggers an exo-mode cyclisation to generate intermediate 46 which undergoes an aza-Claisen-
type rearrangement to give 47. Demetallation and double bond isomerisation afford the 
aromatic product 48. The concerted nature of the allyl migration was confirmed by complete 
inversion of the prenyl substituent. Acyclic alkynyl allyl ethers 49 afforded analogous furan 
products 50 through the related reaction.32 
 
Scheme 14: Formation of pyrroles and furans via a cyclisation-triggered concerted aza-Claisen-type 
rearrangement 
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The synthesis of trisubstituted isoxazoles by cyclisation of alkynyl oxime ethers has been 
reported by Miyata and co-workers (Scheme 15).33 The same Claisen-type rearrangement is 
invoked here and crossover reactions confirmed that the process is intramolecular. In this case 
however, incomplete allylic inversion of the migrating crotyl group was observed in the reaction 
of 53, suggested that a potential cationic mechanism cannot be ignored. 
 
Scheme 15: Formation of trisubstituted isoxazoles through Claisen-type rearrangement and with incomplete 
allylic inversion 
Computational studies into related cycloisomerisations showed that a gold species was integral 
for the formation of the charged intermediate required for sigmatropic rearrangement. 
However, the presence of a gold phosphine substituent had only a small effect on the energy 
barrier for the subsequent Claisen-type rearrangement.34 
In these reactions, the role of the metal catalyst can be considered to be acting predominantly 
as an electron sink to trigger [3,3]-sigmatropic rearrangements. This was supported in work by 
Fensterbank, Malacria and co-workers in the generation of substituted indoles such as 57 
(Scheme 16).35 The charge-accelerated aza-Claisen rearrangement was observed to proceed 
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under both platinum catalysis (conditions A) and metal-free conditions (conditions B) by protic 
activation of the triple bond using silica.  
 
Scheme 16: Indole formation using platinum catalysis and metal-free conditions with mechanism shown for 
protic activation 
2.2.3 Migration of Benzyl Groups 
1,2-Carbofunctionalisations are not limited to allylic systems, so long as the migrating group is 
able to stabilise the developing positive charge in the X→C migration step. Benzyl groups have 
been successfully employed independently by Fürstner and Davies, and Nakamura and co-
workers in the platinum or gold-catalysed syntheses of benzofurans (62 and 66, Scheme 17).27,29 
In both reports, a p-methoxybenzyl derivative was observed to be more amenable to migration 
than a simple benzyl group. This observation is consistent with the methoxy group being able to 
add extra stabilisation to the migrating cation (64). 
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Scheme 17: Migration of benzyl groups to generate benzofurans and benzothiophenes 
Transfer of the benzylic group as a cationic fragment in such X→C migrations was supported in 
crossover studies for the platinum-catalysed cycloisomerisation of ortho-alkynyl phenyl 
selenides in the formation of benzoselenophenes by Nakamura and co-workers (Scheme 18).36 
Reaction of a 1:1 mixture of 67 and 68, with 68 containing deuterium labels on both the 
migrating group and alkyne substituent, resulted in the predominant formation of products 69 
and 70 from intramolecular reaction, alongside small amounts of products 71 and 72 from 
intermolecular reaction. 
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Scheme 18: Formation of crossover products through intra- and intermolecular cationic benzyl migration 
When ortho-alkynyl phenyl selenide 73 was subjected to gold catalysis, the sole formation of 
benzoselenophene 74 was observed from the expected Se→C 1,3-migration of the 
p-methoxybenzyl group (Scheme 19, path a). When a platinum catalyst was employed, 
regioisomer 75 was also observed from a competing migration pathway (Scheme 19, path b). 
This isomer was proposed to arise from an alternative 1,2-migration of the p-methoxybenzyl 
group β- to the metal to form a metal carbene 78. Evolution of this intermediate can occur 
through a second 1,2-shift either of the same group, leading to the expected product 74, or of 
the p-methoxybenzene group, quenching the carbene and generating regioisomer 75. Vinyl 
metal species are known to display nucleophilic character at both the α- and β-positions,3,37 
which helps to rationalise this competing 1,2-shift pathway. The formation of a single product 
under gold catalysis can be attributed to the reduced susceptibility of gold chloride to form a 
metal carbene in this system, thus favouring path a.5,6c 
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Scheme 19: Divergent pathways available in the gold- and platinum-catalysed formation of benzoselenophenes 
Nakamura and co-workers observed an interesting transfer of chirality in a direct 1,3-X→C 
migration process in the synthesis of benzothiophenes such as 82 (Scheme 20).38 Single 
enantiomers of sulfides such as 81, incorporating a stereogenic centre at the migrating benzylic 
position, were employed in a gold-catalysed carbothiolation. The transfer of stereochemical 
information was then monitored across the migration step. Depending on the substitution at 
the alkyne, retention of stereochemical information was observed to varying degrees. This 
indicates the migration proceeds through a close contact ion pair 85 and rules out a [1,3]-
sigmatropic rearrangement (83) as the required suprafacial migration would result in inversion 
of the stereogenic centre. 
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Scheme 20: Intermediates arising from close contact ion pair and [1,3]-sigmatropic pathways 
The formation of a close contact ion pair was further supported by the observation that chirality 
was less effectively preserved when conditions were employed that would be expected to 
increase separation of the ion pair, such as the use of higher temperatures and more polar 
solvents. Finally, deuterium labelling was used to confirm a direct 1,3-migration over two 
sequential 1,2-migrations. 
2.2.4 Migration of Acetal groups 
Besides allyl and benzyl groups, heteroatom-stabilised groups such as acetals can also undergo 
efficient 1,3-X→C migration. This was first demonstrated independently by the groups of 
Fürstner and Nakamura in platinum-catalysed preparations of highly functionalised benzofuran 
derivatives (Scheme 21).27,39 In-keeping with the mechanisms discussed so far, activation of 
ortho-alkynyl phenol derived acetals 86 and 90 led to endo-mode cyclisation and transfer of an 
oxonium species to the metallated, nucleophilic C-3 position of the newly-formed benzofuran 
ring.  
31 
 
 
Scheme 21: Carboalkoxylation with migration of oxygenated carbon units under platinum catalysis. (cod = 
cyclooctadiene) 
The transformation of substrates of type 86 was significantly accelerated on addition of 
substoichiometric quantities of cyclooctadiene (cod) to the reaction.39 Interestingly, PtCl2(cod) 
did not promote the reaction at all. This effect was tentatively assigned to the generation of a 
more reactive platinum species by aiding the disaggregation of polymeric PtCl2. In contrast to 
the use of olefin additives, a CO atmosphere in the reaction of substrate 90 proved beneficial 
once again (vide supra) allowing for the formation of functionalised benzofuran 91 in high 
yield.27 
Acetal migrations in benzofuran synthesis are particularly useful transformations as they install 
a protected alkoxy group at the C-3 position. A protected form of vibsanol, an inhibitor of lipid 
peroxidation, was prepared in a platinum-catalysed 1,2-carboalkoxylation by Nakamura and co-
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workers (Scheme 22).40 In the presence of the PtCl2 / cod catalyst system, functionalised mixed 
acetal 92 underwent smooth transformation to the desired benzofuran 93. 
 
Scheme 22: 1,2-Carboalkoxylation strategy towards the synthesis of vibsanol 
The first total synthesis of erypoegin H, which shows activity against various MRSA strains and 
vancomycin-resistant enterococci,41 was synthesised using a similar strategy by Fürstner and co-
workers. A range of natural products based around the pterocarpene skeleton were synthesised 
through platinum-catalysed 1,2-carboalkoxylation of acetal 94 on a multigram scale (Scheme 
23).42 Smooth cycloisomerisation occurred to generate the desired benzofuran 95 in high yield, 
importantly leaving the reactive C-I bond intact for further manipulation. The benzofuran core 
was then elaborated in four steps to the natural product.  
 
Scheme 23: 1,2-Carboalkoxylation towards the total synthesis of erypoegin H 
Acetal migrations have also been reported by Nakamura and co-workers where the oxonium 
intermediate is formed through exo-mode cyclisation using an electronically biased alkyne 
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(Scheme 24).43 Platinum catalysis was employed to promote carboalkoxylation with oxonium 
migration to form multisubstituted dihydrofuran derivatives 12. Substitution of the ester at the 
alkyne terminus was observed to influence the stereoselectivity of these reactions. Electron-
deficient substituents promoted a rapid [1,3]-migration from oxonium (Z)-97 to give the (Z)-
alkene products. When an electron-rich substituent was employed however, the (E)-alkenes 
were formed. This was attributed to a slower rate of reaction, presumably due to increased 
electron density at the metallated C-3 position, allowing interconversion of (Z)-97 into (E)-97. 
Interestingly, the stereochemical outcome of the reaction with these substrates was also 
influenced by the choice of olefin additive. The use of 1,5-hexadiene gave rise to near complete 
(E)-selectivity from 99, whilst the use of cyclooctadiene favoured the formation of the (Z)-
isomer.44 
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Scheme 24: Influence of the ester group on E / Z selectivity for acetal migration 
The first examples of intermolecular carboalkoxylation of terminal alkynes have recently been 
reported. Hu and co-workers developed a novel gold-catalysed reaction between a terminal 
alkyne 101 and a dimethyl acetal 102 with a formal addition of C-O across the alkyne and 
subsequent hydrolysis of the enol ether to afford the ketone 103 (Scheme 25).45 
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Scheme 25: Gold-catalysed formal intermolecular carboalkoxylation of an alkyne 
Shortly after, Schultz and co-workers reported the related transformation with aldehydes, in the 
presence of a range of alcohol coupling partners, removing the requirement for a pre-formed 
acetal (Scheme 26).46 In the proposed mechanism, ketone 110 is formed through gold-catalysed 
hydration of the alkyne 101. Acetal 111 is also formed under the reaction conditions from the 
aldehyde 108, which on fragmentation to the oxonium 112, gives rise to the aldol addition 
product through coupling with tautomer 113. 
 
Scheme 26: Gold-catalysed 3-component coupling of an aldehyde, alkyne and alcohol 
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2.2.5 [1,2]-Carboalkoxylation of Ynamides 
During the preparation of our own manuscript,21 Hashmi and co-workers reported the first 
example of carboalkoxylation using ynamides in the synthesis of benzofurans (Scheme 27).47 
Following the generally accepted mechanism discussed so far for 1,2-carbofunctionalisations, 
and previous reports on carboalkoxylation of o-alkynylphenol derivatives, cationic migration of 
unsymmetrical allyl groups to the metallated position was observed in the formation of 
branched and linear isomers 115 and 116. Due to the connectivity of the substrates employed, 
the same regioselectivity was observed as with alkyne substrates. The goal of my own work was 
to override this cyclisation bias to access an alternative 1,1-carboalkoxylation pathway (see 
Scheme 7, path c) in a regioselective manner (vide infra). 
 
Scheme 27: 1,2-Carboalkoxylation of ynamides (IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) 
2.2.6 Migrating Centres at Higher Oxidation Levels 
An early example of π-acid mediated 1,2-carboamination was demonstrated by Nakamura and 
co-workers in the formation of 2,3-disubstituted indoles 122-124 by the platinum-catalysed 
intramolecular amino-acylation of alkynes (Scheme 28).48 Migration of the acyl moiety through 
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an acylium cation demonstrates the migration of a carbon centre at the ketone oxidation level. 
When the acyl group was substituted with an electron withdrawing CF3 group, complete 
transfer was observed to give 3-substituted indole 122. In certain cases, for example, when a 
simple acyl group was employed, small amounts of 3-H indole 125 were observed from 
incomplete acyl transfer, allowing protodemetallation of the organo-platinum intermediate. 
 
Scheme 28: Intramolecular amino acylation of alkynes under platinum catalysis 
Nakamura and co-workers went on to demonstrate the migration of alkoxycarbonyl and 
carbamoyl groups where the carbon is at the carboxylic acid oxidation level, in the platinum-
catalysed formation of functionalised indoles (Scheme 29).49 No 3-H products were observed for 
alkoxycarbonyl migration (128-129, Scheme 29, Eq. [1]), however carbamoyl migration appears 
less efficient allowing some protodemetallation to occur to give 136 (Scheme 29, Eq. [2]). The 
use of molecular sieves in the reaction did not affect the levels of 136 generated. Furthermore, 
when the reactions were carried out in deuterated solvent, 3-deuterated indoles were not 
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observed, indicating the proton involved in protodemetallation originates from the migrating 
group. 
 
Scheme 29: Migration of alkoxycarbonyl and carbamoyl groups 
2.2.7 Migration of Heteroatoms 
As well as carbon-based units, Nakamura and co-workers have shown that sulfonyl groups are 
able to participate in related [1,3]-migration processes.50 The gold-catalysed cycloisomerisations 
of ortho-alkynyl-N-sulfonyl anilines 137-139 afforded sulfonylated indole products 140-142 
(Scheme 30). Whilst the sulfonyl group predominantly migrated to the C-3 position, some 
substitution onto C-5 and C-7 was also observed with the formation of isomeric indoles 145-
148. 
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Scheme 30: Competitive migrations of sulfonyl groups 
1,3-S→C Silyl migration has also been reported in the preparation of 3-silyl benzothiophenes 150 
by Nakamura and co-workers (Scheme 31).51 No substitution onto the benzene ring was 
observed in this case, however the formation of crossover products, arising from intermolecular 
transfer of the silyl group, was observed.  
 
Scheme 31: 1,3-S→C silyl migration to give 3-silyl benzothiophenes 
2.2.8 [1,5]-HeteroatomCarbon Migrations  
In the examples discussed so far, the migrating group has been directly bound to the 
nucleophilic heteroatom. This does not need to be the case, however, as demonstrated by 
Fürstner and co-workers in the synthesis of isochromenone 17 from ortho-alkynyl benzoate 151 
(Scheme 32).27 The carbonyl oxygen attacks the π-acid activated triple bond to generate 
charged intermediate 153. The connectivity of the benzoic acid derived substrates allows for an 
alternative 1,5-O→C migration of the oxymethylene unit to yield isochromenone 17. Small 
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quantities of the protonated isochromenone 152 were also isolated as a result of incomplete 
migration of the benzyl ether. 
 
Scheme 32: Carboalkoxylation of alkynyl benzoates through [1,5]-benzyl ether migration 
Related allyl and benzyl migrations have also been reported under cationic gold(I) catalysis by 
Hashmi and co-workers in the generation of isochromenones such as 156 (Scheme 33).52 
Crossover experiments in this case demonstrated an intramolecular delivery of the migrating 
group. 
 
Scheme 33 Gold-catalysed formation of isochromenones by [1,5]-allyl migration. 
2.2.9 Internal vs. External Migrations 
All of the carbofunctionalisations discussed so far can be classified as external migration 
processes. The migrating group is tethered to the alkyne through the nucleophilic heteroatom, 
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and so the connectivity between the migrating group and the alkyne is broken over the course 
of the transformation (Scheme 34, path a).22 Internal migration processes can therefore also be 
classified where the connectivity between the migrating group and the alkyne is maintained 
from starting material to product (Scheme 34, path b). 
 
Scheme 34: External (path a) and internal (path b) migration pathways 
The first example of this type of reaction pathway was demonstrated in the synthesis of indenyl 
ethers 14 under cationic gold(I) catalysis by Toste and co-workers (Scheme 35).53 Oxonium 
species 160 is generated through 5-exo-dig cyclisation, initiated by nucleophilic attack of the 
methoxy oxygen onto the gold-activated triple bond. Evolution of this intermediate by external 
migration is not feasible as this would require formation of a methyl cation. Instead, C-O bond 
cleavage occurs to generate the most stable cation at the dibenzylic position (161), maintaining 
connectivity between the migrating methoxy unit and the alkyne. Following bond rotation, the 
benzylic cation is trapped by the newly-formed nucleophilic vinyl gold species to complete an 
overall 1,2-carboalkoxylation reaction.  
42 
 
 
Scheme 35: Access to indenyl ethers through internal migration under gold catalysis 
This reactivity was also applied to the synthesis of substituted cyclohexenes 163 and protected 
1-indenones 165 (Scheme 36). In the same manner, C-O bond cleavage occurs to form the most 
stable carbocation. The use of activated molecular sieves was required to minimize hydrolysis of 
the resulting enol ether or acetal products. 
 
Scheme 36: Access to cyclohexenes and indenones through internal migration under gold catalysis 
Interestingly, when enantioenriched substrates were employed, no racemisation of the starting 
material was observed over the course of the reaction. When substrate 166 was subjected to 
the reaction conditions, indene 167 was isolated with near complete transfer of chirality 
(Scheme 37). 
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Scheme 37: Transfer of chirality across a 1,2-carboalkoxylation reaction. 
Despite the mechanism invoking planarisation at the benzylic position, it was proposed that a 
helical transition state for the ionisation of the C-O bond was responsible for the observed 
‘memory of chirality’ effect (171, 172, Scheme 38). Maximising overlap between the cation and 
the aromatic π-system, the resulting intermediate (173, 174) is primed for facially selective C-C 
bond formation on minimal bond rotation about the sp2-sp2 centre. This hypothesis was 
supported by a subsequent computational study54 which highlights how small energy 
differences associated with conformational changes in gold-catalysed transformations can be 
product determining (Scheme 38). 
 
Scheme 38: Computed pathways for the intramolecular carboalkoxylation with ‘memory of chirality’ 
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As well as the transfer of chiral information,55 recently Toste and co-workers reported their 
development of an enantioselective method where chirality was imparted on alkynyl acetal 
substrates by the use of a single enantiomer of a chiral gold catalyst (Scheme 39).56 
3-Methoxycyclopentenones such as 180 were synthesised with high enantioselectivity following 
hydrolysis of the corresponding enol ethers (179). The enantiodetermining step was thought to 
be cyclisation of planar vinyl gold species 182 where the gold ligands are positioned close to the 
stereogenic centre being formed. 
 
Scheme 39: Enantioselective carboalkoxylation of alkynyl acetals 
During the course of our study, Liu and co-workers observed interesting catalyst-dependent 
chemoselective carboalkoxylations in the synthesis of indanones 186 and 188 (Scheme 40).57 
When an electron deficient acidic gold species in ‘wet’ nitromethane was employed (conditions 
A), selective formation of 1-indanone 186 was observed in most cases following in situ 
hydrolysis of the enol ether. When an electron-rich gold species was employed in a less polar 
solvent (conditions B), selective formation of 2-indanone 188 was instead observed. In certain 
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cases, erosion of the selectivity occurred. For example when methoxy substituted alkyne 185 
was employed under conditions B, a 1:1 mixture of the two isomers 187 and 189 was obtained.  
 
Scheme 40: Chemoselective carboalkoxylations to generate isomeric indanones 
The observed selectivity was tentatively assigned to the potential of an electron deficient 
catalyst to generate a positive charge at the internal carbon of the alkyne, promoting the 
5-exo-dig cyclisation which has been previously observed for these substrates (vide supra). An 
electron-rich catalyst may cause development of a positive charge at the terminal carbon of the 
alkyne, promoting a 6-endo-dig cyclisation of the methoxy onto the alkyne (190). This may 
provide an alternative pathway with the formation of a gold carbene 192 (vide infra). 
[1,2]-H-shift followed by hydrolysis of the enol ether 193 would generate 2-indanones 188 and 
189 with an alternative 1,1-carboalkoxylation of the alkyne (vide infra). 
Finally the same group very recently reported further interesting product divergence in the 
reactions of the same substrates when gold or Brønsted acid catalysts were employed to 
generate 1- and 3-substituted 2-methoxy-1-H-indenes.58 
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2.2.10 1,1-Carbofunctionalisations 
Alongside the direct formation of the C-C and C-heteroatom bonds in a 1,2 fashion across the 
starting alkyne, it is also possible to form these bonds in a 1,1 fashion, as seen in the final 
example above by Lui and co-workers. Aside the competing 1,1- and 1,2-carbofunctionalisations 
that were observed in the synthesises of benzoselenophenes (vide supra, Scheme 19), all other 
transformations described have involved an overall 1,2-alkyne carbofunctionalisation. This has, 
in most cases, been realised by [1,3]-external migration from the heteroatom to the metallated 
carbon (194-195, Scheme 41, path a). 
 
Scheme 41: Pathways arising from nucleophilic attack onto an activated alkyne for endo-cyclisation with external 
migration 
As mentioned previously, vinyl-gold or platinum intermediates 194 are capable of displaying 
nucleophilic character at the β-carbon as well as the α-carbon. The migrating group can in 
certain cases undergo initial 1,2-shift onto the β-carbon to generate a gold carbene 196. This 
valuable intermediate, which will be discussed further in section 2.4, can then be quenched by 
1,2-insertion of a neighbouring group (196-197, Scheme 41, path c).13,59 The outcome of this 
second step will be dictated by the relative migratory aptitude of the groups adjacent to the 
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metal carbene (196). It seems reasonable to assume that [1,3]-migrations may in some cases 
arise through an initial 1,2-shift followed by 1,2-insertion of the same group to quench the 
newly formed carbenoid (196-195, cf. Scheme 19). 
Though the 1,2-carboamination of alkynes with amides has been clearly demonstrated (Scheme 
41, path a, vide supra), this pathway can be blocked when the amide bond is constrained within 
a lactam, allowing access to 1,1-carboamination products (Scheme 41, path c) as demonstrated 
by Zhang and co-workers.60 Useful polycyclic amines 201, 16 and 202 were generated from 
readily prepared precursors 198-200 using PtCl4 as a catalyst under an O2 atmosphere (Scheme 
42). Hydrogen, alkyl and aryl substituents at the alkyne terminus underwent [1,2]-migration 
onto the metal carbene 209 formed in the initial 1,1-carboamination process (206-209). 
Isomeric side products 203 and 204 were identified in certain cases in small quantities as a 
result of the migrating acylium cation being trapped by the adjacent benzene ring, in a similar 
way to that observed with sulfonyl migration (c.f. Scheme 30). 
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Scheme 42: Formation of fused indoles through 1,1-carboamination 
This platinum-catalysed 1,1-carboamination strategy was the recently applied to the formation 
of the tricyclic core of the natural product 7-methoxymitosene,61 effective against Gram positive 
bacteria.62 Despite the hindered nature of substrate 210, cycloisomerisation occurred efficiently 
to form the fused indole 211 which was readily converted into the target molecule in four steps 
(Scheme 43).  
 
Scheme 43: Platinum-catalysed 1,1-carbofunctionalisation in the synthesis of 7-methoxymitosene. 
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In a related process, Iwasawa and co-workers reported the generation of N-fused tricyclic 
indoles with overall 1,1-carboamination of an alkyne (Scheme 44).63 Though the presence of the 
amine proved incompatible with gold and platinum in this case, the use of a tungsten or 
rhenium catalyst allowed for effective reaction of pyrolidine derivatives such as 213. Alkyne 
activation and cyclisation results in the formation of metal containing ammonium ylide 215/216 
which undergoes sequential [1,2]-Stevens-type rearrangement, then [1,2]-alkyl shift to quench 
the metal carbene 217.  
 
Scheme 44: Indole formation through sequential [1,2]-Stevens rearrangement and [1,2]-alkyl shift 
The 1,1-carbofunctionalisation reactivity pattern was observed in one of the earliest studies on 
transition metal-catalysed reactions of aryl alkynes bearing ortho-acetals by Nakamura and co-
workers.25 Palladium-catalysed carboalkoxylation of alkyne 218 gave indenol ether 219 with 
cleavage of the sp-sp3 C-C bond at the alkyne terminus, following an internal migration of a 
methoxy group (Scheme 45, Eq. [1]). Employment of PtCl2 as the catalyst led to a significant 
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increase in yield when the substrate contained a tethered alkene.26 A number of olefin additives 
were therefore explored alongside PtCl2, with β-pinene producing the best results to give 15 in 
excellent yield (Scheme 45, Eq. [2]). The positive influence of an alkene additive was later 
exploited in related 1,2-carboalkoxylations (vide supra). The formation of a metal carbene is 
invoked, which is quenched by a [1,2]-alkyl shift of the alkyne substituent. 
 
Scheme 45: 1,1-Carboalkoxylation of ortho-acetal aryl alkynes under palladium and platinum catalysis 
2.3 Summary  
Whilst many of the examples discussed above have featured a 1,2-carbofunctionalisation of a 
triple bond, the 1,1-pathway is much less explored. Specifically, the only example of the 1,1-
carboalkoxylation of an alkyne at the outset of my work was that reported by Nakamura and co-
workers (Scheme 45).The use of a 1,1-carboalkoxylation strategy to generate metal carbenes 
directly from alkynes is an attractive proposal which avoids the use of hazardous diazo 
compounds (Scheme 46, path b). The next sections detail the realisation of the use of ynamides 
to enforce a 1,1-carboalkoxylation pathway in order to generate gold carbenes 224.21 
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Scheme 46: 1,1- and 1,2-carboalkoxylation pathways 
2.4 Results and Discussion 
Ynamides of type 225 were chosen for study to allow direct comparison with the alkyne 1,2-
carboalkoxylations reported by Toste and co-workers (vide supra, Scheme 35).53 It was proposed 
that the electronic influence of an ynamide would lead to an alternative 6-endo-cyclisation 
pathway (225-226, Scheme 47) over the 5-exo-pathway previously described. On formation of 
intermediate 226, ring-opening to form the more stable dibenzylic cation would generate a vinyl 
gold intermediate 227, with migration of the methoxy group to the alkyne in an internal fashion. 
On ring closure, a gold carbene 228 would be formed in a unique environment bearing an 
adjacent hemiaminal ether, with a 1,1-carboalkoxylation of the ynamide. 
On formation of such a carbene, there are several possible outcomes that could be envisaged 
such as insertion or migration of adjacent groups to form functionalised indenes. These 
carbocyclic cores are synthetically important and serve as core structures in many natural 
products64 and pharmaceuticals,65 as well as being useful ligands for transition metals.66  
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Scheme 47: Proposed ynamide-dictated gold-catalysed carboalkoxylation 
2.4.1 Initial Results 
Many of the ynamides employed in this study were accessed through copper-catalysed coupling 
of a sulfonamide with terminal alkyne 232, which was synthesised in four steps from 2-
bromobenzaldehyde 229 (Scheme 48). Trimethylsilyl-protected alkyne 230 was prepared in high 
yield by Sonagashira coupling under standard conditions.67 Grignard addition to the aldehyde 
gave the alcohol 231 in excellent yield following the procedure reported by Toste and co-
workers.53 All Grignard reagents used in this work were freshly prepared from the relevant aryl 
bromide. Alkylation of the alcohol with methyl iodide was carried out, again according to Toste’s 
procedures, with purification conducted only after the deprotection of the terminal alkyne. 
 
Scheme 48: Synthesis of terminal alkyne 232 
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Ynamide 234, was synthesised directly from alkyne 232 using the copper-catalysed amidation 
procedure reported by Stahl and co-workers (Scheme 49).68 This coupling reaction represents a 
very general route to a variety of differently functionalised ynamides from terminal alkynes and 
is therefore an attractive option. Five equivalents of the sulfonamide are required to achieve 
good yields, however, the unreacted sulfonamide can be recouped on purification (85% 
recovery of 233 based on four remaining equivalents in this example). Slow addition of a 
solution of the alkyne to the reaction vessel is required to minimize formation of the alkyne 
dimer and was carried out using a syringe pump. When using sterically bulky ortho-substituted 
arylalkynes, as in this work, the yields tend to be modest as a result of dimer formation even 
when the concentration of alkyne relative to sulfonamide is kept low by slow addition. 
 
Scheme 49: Copper-catalysed amidation of terminal alkyne 232 to form ynamide 234 
An alternative method via formation of a bromoalkyne was used to prepare several of the 
ynamides (vide infra) however, this approach was found to be ineffective when aniline-derived 
sulfonamides were used. 
With ynamide 234 in hand, its reactivity in the presence of a range of gold catalysts was 
investigated (Table 1). On reaction with AuCl at room temperature, a novel skeletal 
rearrangement of ynamide 234 was observed with the sole formation of N-indenyl sulfonamide 
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235 in 27% yield alongside a substantial amount of unreacted starting material (Table 1, Entry 
1). PtCl2 did not promote the reaction at all, with only starting material observed by 
1H-NMR 
spectroscopy (Entry 2).  
Table 1: Survey of reaction conditions
[a] 
 
Entry Catalyst Time / h 234 / %[b] 235 / %[b] 
1 AuCl 24 53 27 
2 PtCl2 24 >95 33 
3 AuLCl2
[c] 24 17 63 
4 PPh3AuCl / AgNTf2 6 -- 79 
5 (t-Bu)2(o-biphenyl)PAuCl / AgNTf2 20 -- 73 
6 (p-CF3C6H4)3PAuCl / AgNTf2 2 -- 89 
7 (p-CF3C6H4)3PAuCl / AgBF4 2 -- 88 
8 (p-CF3C6H4)3PAuCl / AgOTs 6 -- 78 
9 (p-CF3C6H4)3PAuCl 24 >95% -- 
10 (p-CF3C6H4)3PAuNTf2 2 -- 88 
11 AgNTf2 24 >95% -- 
12 HNTf2 24 66 -- 
13 BF3∙OEt2 24 31 -- 
14 SiO2 24 80 -- 
[a] Reaction conditions: 234 (0.1 mmol, 1.0 equiv.), CH2Cl2 (0.1 M), time as indicated 
[b] Yields calculated 
by 1H-NMR spectroscopy against a known quantity of internal standard (1,2,4,5-tetramethylbenzene). 
[c] L=Picolinate.  
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Dichloro(picolinate)gold(III) gave a much higher conversion than AuCl after 24 hours, although 
unreacted starting material still remained (Entry 3). Greater conversion to the desired product 
was achieved using cationic gold(I) phosphine complexes (Entries 4-8). The PPh3AuCl / AgNTf2 
catalyst system led to complete consumption of starting material after 6 hours to give 235 in 
high yield (Entry 4). 
A more electron-rich biphenyl phosphine ligand gave a similar result in terms of yield, although 
the reaction rate was greatly reduced (Entry 5). The use of a phosphine ligand with an electron 
withdrawing substituent led to improvement in both the yield and rate of the 
cycloisomerisation (Entry 6). Changing the silver salt was found not to be beneficial (Entries 7 
and 8).  
The use of AgBF4 gave an identical result to AgNTf2 (Entry 7) however, its sensitivity to heat and 
moisture rendered it less appealing as compared to bench-stable AgNTf2. The requirement for 
activation of the gold complex with a poorly-coordinating counterion was demonstrated by the 
absence of reaction when the silver salt was omitted (Entry 9).  
When preformed (p-CF3C6H4)3PAuNTf2 was used as the catalyst for formation of 235, an 
identical result was obtained as with the in situ formed catalyst (Entry 10 vs. 6), and so this was 
used for the remainder of the work. Clearly silver species are not required to promote the 
reaction, nevertheless AgNTf2 was tested for activity and, as anticipated, failed to catalyse the 
reaction (Entry 11). Brønsted or σ-Lewis-acid activation was also ineffective with only 
degradation of the starting material observed (Entries 12-14). 
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The formation of indene 235 is thought to arise from the proposed α-hemiaminal ether gold 
carbene 228 (Scheme 47). Selective 1,2-N migration from the adjacent quaternary centre onto 
gold carbene 236 would generate the observed product (Scheme 50).  
 
Scheme 50: Selective 1,2-N migration from α-hemi aminal ether gold carbene 236 
Nitrogen migrations onto carbenes are not well known,69 and to the best of our knowledge, this 
transformation represents the first example of nitrogen migration onto a gold carbene. A rare 
example of nitrogen migration onto copper carbenes generated from the metal-catalysed 
decomposition of β-methylene-β-silyloxy-β-amido-α-diazoacetates 237 was recently reported 
by Doyle and co-workers detailing competing O-,C-, and N-migrations (Scheme 51).70  
 
Scheme 51: Catalyst dependant migrations onto rhodium and copper carbenes 
When using a rhodium catalyst, mixtures of 238 and 239 were obtained from competitive [1,2]-
C- or [1,2]-O-migrations onto the carbene centre. When a copper catalyst was used however, 
exclusive formation of 240 was observed arising from an selective [1,2]-N migration. This 
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catalyst dependant pathway was attributed to the vacant coordination sites available for copper 
which allow coordination to the pyrazolidinone carbonyl (241), providing a directing effect for 
N-migration. In contrast, the coordinatively saturated dirhodium complex is unlikely to form 
such an interaction. 
In contrast to this system, where the adjacent substitution pattern is installed prior to carbene 
formation, the ynamide carboalkoxylation approach sees this system formed concurrently with 
the gold carbene, without need for sacrificial functionality such as a diazo group. Overall, the 
process is highly efficient with new C-C, C-O and C-N bonds formed in a single step. In addition, 
this reaction proceeds through a rare example of C-N bond cleavage of an ynamide. 
2.4.2 Reaction Scope 
2.4.2.1 Modification of the Nitrogen Migrating Group 
In order to further develop and understand this novel reaction, a series of ynamides were 
synthesised from terminal alkyne 232 to assess the migratory aptitude of different amides. In 
the cases of aniline derived sulfonamides, conditions reported by Stahl and co-workers were 
employed (Scheme 52).68 
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Scheme 52: Synthesis of ynamides 244 and 245 
As mentioned previously, this method presents certain limitations in terms of product yield, due 
the formation of the undesired alkyne dimer. For the remaining substrates, which did not 
contain an aniline-derived sulfonamide, the method reported by Hsung and co-workers was 
instead employed.71 Whilst adding an extra synthetic step to form the bromoalkyne coupling 
partner, purification was not required at this stage and the crude bromoalkyne could be used 
directly in the copper-catalysed amidation reactions (Scheme 53). This method employs the 
sulfonamide as the limiting reagent, with a slight excess of the bromoalkyne (1.2 equiv.). The 
resulting ynamides 252-257 were isolated in good to excellent yields following flash column 
chromatography.  
 
Scheme 53: Synthesis of ynamides incorporating different migrating groups 
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The ynamides were then subjected to the optimised reaction conditions, with isolated yields 
given following flash column chromatography or recrystallisation (Table 2). 
Table 2: Study of the N-migrating group
[a] 
 
Entry NR1R2 Time / h A / %[b] B / %[b] 
1 234 NPhTs 1 235 / 78 -- 
2 244 NPhSO2Ph 1 258 / 68
[c],[d] -- 
3 245 NPhNs 0.75 259 / 76 -- 
4 252 NBnMs 3 260 / 72[c] -- 
5 253 NMeMs 48 261 / 23 262 / 20[e] 
6 254 NMeNs 24 263 / 29 264 / 23 
7 255 N-AllylMs 1 265 / 74 266 / 9 
8[f] 255 N-AllylMs 24 265 / 58 266 / 10 
9[g] 255 N-AllylMs 24 265 / 64 266 / 5 
10 256 N(Ox)[h] 2 267 / 78 -- 
11 257 N(5-(S)Bn-Ox) 24 --[i] -- 
[a] Reaction conditions: ynamide (0.2 mmol, 1.0 equiv.), [b] Isolated yields after flash column 
chromatography unless otherwise stated. [c] Isolated yield after recrystallisation without 
chromatography. [d] 3.0 mmol, 1.4 g scale.[e] Yield calculated by 1H-NMR spectroscopy: present as an 
inseparable mixture with 253. [f] Catalyst: (C5F5)3PAuCl / AgNTf2. 
[g] Catalyst: [AuLCl2] L = picolinate.
[h] Ox 
= 2-oxazolidinone. [i] 37% of 257 remaining. 
Aniline-derived sulfonamide groups underwent the reaction smoothly to give the expected 
regioisomer from 1,2-N-migration (Table 2, Entries 1-3). The scalability of the reaction was 
demonstrated by the formation of indene 258 in good yield from 1.4 grams (3.0 mmol) of 
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ynamide 244 (Entry 2). Column chromatography was not required in this case, and pure 258 was 
obtained after filtration to remove metal residues, evaporation and subsequent 
recrystallisation. Reaction of the corresponding nosyl-substituted ynamide 254 was also slow. 
Whilst starting material was consumed after 24 hours, the isolated yields of the two 
regioisomers were modest (Entry 6). The erosion of regioselectivity observed with these 
substrates is proposed to arise from competitive 1,2-O-migration onto the gold carbene 288 
(Scheme 54, vide infra). 
 
Scheme 54: Competitive [1,2]-N and [1,2]-O-migrations onto the gold carbene 
Regioisomer 266 was also isolated in small quantities when N-allyl substituted ynamide 255 was 
employed (Entries 7-9), although a high yield of the major regioisomer 265 was obtained (Entry 
7). The use of a more electron deficient catalyst system (C6F5)3PAuCl / AgNTf2, and a gold(III) 
complex had no dramatic effect on the ratio of the regioisomers. It is important to note that no 
cyclopropanation between the proposed gold carbene and the tethered alkene was observed, 
indicating the 1,2-migration is rapid in this system.  
Oxazolidinone substituted ynamide 256 underwent smooth reaction to give the expected 
regioisomer in 78% yield (Entry 10). The use of a more hindered chiral benzyl substituted 
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oxazolidinone derivative, however, led to a complex mixture including unreacted ynamide 
(Entry 11). 
It was possible to grow single crystals of 235 and 265 that were suitable for X-ray analysis using 
a pentane / dichloromethane solvent system. Confirmation of these structures, which had 
previously been assigned based on 1H- and 13C-NMR data, was therefore obtained (Figure 1). 
 
Figure 1: Crystal structures of 235 (left) and 265 (right) with ellipsoids drawn at the 50% probability level. X-Ray 
crystallography was carried out and data solved by Dr Louise Male (University of Birmingham). 
2.4.2.2 Modification at the Benzylic Position 
The impact of modifications elsewhere on the substrates was then investigated, initially by 
varying the groups at the benzylic position. According to the proposed mechanism, the benzylic 
position requires a substituent capable of stabilising positive charge. Therefore substituted aryl 
groups, ferrocene and furan groups were chosen for investigation. Ynamides 278-282 were 
synthesised through addition of the relevant freshly prepared organolithium or Grignard 
reagent to aldehyde 230 (Scheme 55). Alcohols 268-272 were methylated and the silyl group 
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cleaved using the conditions previously described to give terminal alkynes 273-277. Copper-
catalysed coupling with N-tosyl benzenesulfonamide 233 gave the desired ynamides in modest 
to good yields. 
 
Scheme 55: Synthesis of ynamides 272-282 from aldehyde 230 
Substrates substituted with electron-donating and electron-withdrawing aryl groups (278 and 
279) underwent the desired reaction smoothly to give indenes 283 and 284 in good yields 
(Scheme 56). An electron-rich ferrocene-substituent was also tolerated to give indene 285 as a 
single regioisomer in moderate yield.  
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Scheme 56: Exploration of various benzylic substituents in the gold-catalysed indene formation 
A p-methoxybenzyl substituent was not compatible for the cycloisomerisation. Whilst ynamide 
281 was consumed, a complex mixture was obtained following column chromatography. In the 
proposed mechanism, methoxy migration precedes formation of the more stable benzyl cation 
(vide supra, Scheme 47). As the oxygen lone pair of p-methoxybenzene can be delocalised onto 
the benzylic position, it is possible that the benzylic cation is sufficiently long-lived to undergo 
side reactions. It was not possible however to isolate and characterise any products from this 
reaction due to the complexity of the mixture. A furan substituent gave a similar result. A 
surprising loss of regioselectivity was observed when certain ynamides bearing larger 
substituents at the benzylic position were employed. 1-Naphthyl, o-tolyl and o-anisole derived 
substrates 292-294 were synthesised as previously described using the relevant Grignard 
reagent (Scheme 57). 
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Scheme 57: Synthesis of ynamides with larger substituents at the benzylic position. Conditions A: CuCl2, py., 
Na2CO3, O2 (1 atm), 233 (5.0 equiv.), toluene, 70 °C, Conditions B = (i) NBS, AgNO3, acetone, RT, (ii) CuSO4∙5H2O, 
1,10-phenanthroline, K2CO3, 249 (1.0 equiv), toluene, 65 °C 
When ynamide 292 was subjected to the reaction conditions, only 40% of the expected indene 
296 was isolated (Scheme 58). It was not possible to isolate what appeared to be the indene (B) 
resulting from 1,2-O-migration, based on 1H-NMR analysis of the crude reaction mixture. An o-
tolyl substituted system 293 reacted in a similar fashion, although it was possible to isolate and 
characterise the two regioisomers 297 and 298 in this case in good yield. A naphthyl substituted 
system 294 gave the same loss of selectivity to give indenes 299 and 300 as a separable mixture 
in high yield. It was supposed that the reduced selectivity might be a result of π-stacking and 
through-space interactions72 between the benzylic and aromatic nitrogen substituents, 
therefore stabilising the intermediate for O-migration (vide infra). To test this, ynamide 295 
bearing NMsAllyl substituents was prepared, where these stabilising interactions are 
unavailable. The sole formation of indene 301 in high yield from selective N-migration is 
consistent with this hypothesis. 
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Scheme 58: Erosion of regioselectivity with larger benzylic substituents 
2.4.2.3 Modification of the Benzene Backbone 
Some electronic effects on the reaction were then tested by modifying the benzene backbone 
(Scheme 59). Methoxy- and fluorine-substituted 2-bromobenzaldehydes 302-304 were 
converted in three steps to the terminal alkynes 308-310 using previously discussed procedures. 
Coupling of the alkynes with N-mesyl-N-allyl sulfonamide 249 or oxazolidinone 250 were carried 
from the relevant bromoalkynes, to yield ynamides 311-313. 
 
Scheme 59: Synthesis of ynamides 311-313 incorporating substituents on the benzene backbone 
These functionalities were well-tolerated in the gold-catalysed transformation and indenes 314 
and 315, with electron-rich benzene rings were formed in good yields (Scheme 60). 4-Fluoro-
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substituted ynamide 313 required a longer reaction time and an increased catalyst loading 
however, a good yield of 316 was achieved alongside expected regioisomeric indene 317. This 
lower reactivity could be attributed to the destabilisation of the benzyl cation following 
methoxy migration. 
 
Scheme 60: Synthesis of functionalised indenes with modification of the benzene backbone. 
[a]
 10 mol% catalyst 
required 
2.4.2.4 Modification of the Oxygen Migrating Group 
Variation of the oxygen migrating group was also explored with the synthesis of benzyl, allyl and 
BOM ethers. Following literature procedures,53,73 O-alkylation was carried out prior to alkyne 
deprotection to give terminal alkynes 318-320 in moderate to high yields over two steps. 
Depending on the sulfonamide required, different conditions were employed in the final stages 
to yield ynamides 321-324 in moderate to good yields (Scheme 61). An O-allyl protected 
ynamide 327 with a vinyl group at the benzylic position was also synthesised in the same way, 
with alternative employment of vinylmagnesium bromide to give alcohol 325 in high yield. 
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Scheme 61: Synthesis of ynamides 321-324 and 327 with variation of the O-protecting group: Conditions A: CuCl2, 
py., Na2CO3, O2 (1 atm), 233 (5.0 equiv.), toluene, 70 °C. Conditions B: (i) NBS, AgNO3, acetone, RT, (ii) 
CuSO4∙5H2O, 1,10-phenanthroline, K2CO3, 249 (1.0 equiv), toluene, 65 °C 
O-Benzyl and O-allyl protected ynamides 321 and 322 underwent the desired skeletal 
rearrangement to give the indenes 328 and 329 in moderate to good yields (Scheme 62, Eq. [1]). 
Allyl and benzyl groups, among others, are well known to be capable of [1,3]-migration to the 
metallated centre in 1,2-carbofunctionalisations, following initial nucleophilic attack of the 
heteroatom (vide supra). Pleasingly, no traces of this competing pathway were observed. (331-
331, Scheme 61, Eq. [2]). Bis-allylated indene 330 was also generated in good yield as a single 
regioisomer on reaction of ynamide 323, which allowed for further derivatisation by ring closing 
metathesis (vide infra). 
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Scheme 62: Incorporation of different O-substituents (Eq. [1]) and potential competing 1,3-migration pathway 
(Eq.[2]) 
BOM-ether substituted ynamide 324 did not undergo the desired reaction, with only starting 
material observed by 1H-NMR spectroscopy. A 5-membered cyclic acetal was also not 
compatible under the reaction conditions, with only cleavage of the acetal in low levels 
observed after 6 hours by 1H-NMR spectroscopy. The synthesis of this type of ynamide is 
described in Chapter 3. Whilst an O-allyl substituted ynamide 327 bearing a vinyl group at the 
benzylic position was consumed under the reaction conditions, complex mixtures were obtained 
following column chromatography. 
2.4.3 Mechanistic Studies 
A crossover-study was conducted in order to confirm that the proposed 1,2-N-migration is an 
intramolecular process. A 1:1 mixture of ynamides 245 and 322, bearing different nitrogen and 
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oxygen substituents, reacted to give the expected indenes 259 and 329 as the only observed 
products by 1H-NMR spectroscopy. No crossover products resulting from intermolecular 
pathways were detected (Scheme 63).  
 
Scheme 63: Crossover study 
In the proposed mechanism (Scheme 64, path a), ynamide-controlled endo-mode cyclisation 
occurs onto the gold-activated triple bond to give 6-membered oxonium intermediate 226. 
Fragmentation to form the most stable carbocation would then generate a benzylic cation 
tethered to form vinyl gold species 227. Gold carbene 228 would then result on ring closure. 
The major indene product A in most cases would result from selective 1,2-N-migration whereas 
regioisomeric indene B would arise from competitive 1,2-O-migration onto the same carbene 
intermediate. An alternative pathway could also be envisaged, initiated by an exo-mode 
cyclisation onto the triple bond as proposed by Toste and co-workers for alkyne substrates 
(Scheme 64, path b).53 Fragmentation of the 5-membered oxonium intermediate 333 would 
generate an alternative vinyl gold species 334 which could then, on ring closure, potentially 
form exo-gold carbene 335. Migration of one of the carbon-carbon bonds of the cyclobutene 
ring would then generate the same observed products.  
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Scheme 64: Possible endo- and exo-mode cyclisations for the formation of regioisomeric indenes 
A 13C-labelling study was therefore designed to confirm an endo-mode cyclisation. In the 
proposed 1,2-N-migration pathway, connectivity between the alkyne and the aryl group is 
maintained over the transformation (Scheme 64, path a). In contrast, if the alternative 
mechanism was in operation, this connectivity would be broken and, for the major isomer A2, 
these two carbons would become switched (Scheme 64, path b). 13C-Labelling of one of the 
carbons of the triple bond would therefore allow analysis of the connectivity in the indene 
products. N-Allyl ynamide 255 was chosen for this study as both regioisomers are formed on 
cycloisomerisation. The structures of both isomers have been thoroughly analysed by 1H- and 
13C-2D NMR spectroscopy (see Appendix) and the structure of the major indene confirmed by X-
ray crystal diffraction (vide supra, Figure 1). Following analysis of several possible routes and 
options in terms of the source of the 13C-label, a synthesis from 13C-labelled benzoic acid was 
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designed and implemented (Scheme 65). A 1:4 mixture of 13C- and 12C-benzoic acid 336 was 
converted to the diethyl benzamide 337 via the acid chloride in excellent yield over two steps. 
This functionality was then employed as a directing group for ortho-lithiation, following a 
modified literature procedure.74,75 The metallated intermediate was trapped in-situ using freshly 
distilled benzaldehyde. Initially, a diisopropylamide was employed to direct the lithiation, 
however inefficient trapping was observed, presumably due to the larger alkyl groups blocking 
the ortho-position. With alcohol 338 in hand, alkylation was conducted using MeI to give 339 in 
excellent yield.  
 
Scheme 65: Synthesis of 
13
C-labelled ynamide 
13
C-255 from benzoic acid. (TMEDA: tetramethylenediamine, 
DIBAL: diisobutylaluminium hydride, DMEDA: dimethylethylenediamine) 
Attempts were then made to reduce the amide directly to the aldehyde 341. Unfortunately 
suitable conditions could not be found, with mixtures of aldehyde 341 and alcohol 340 always 
generated. It was decided to force the reduction through to the alcohol and re-oxidise it back to 
the aldehyde, despite the addition of an extra synthetic step. An excess of DIBAL was activated 
with n-BuLi to form an ‘ate’ complex which afforded effective reduction. Crude alcohol 340 was 
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subjected to Swern oxidation conditions to give aldehyde 341 in excellent yield over two steps. 
The aldehyde was readily converted using a Corey-Fuchs olefination to dibromoolefin 342 under 
standard conditions.76 Finally, the copper-catalysed amidation conditions reported by Evano and 
co-workers77 were employed alongside N-mesyl-N-allyl sulfonamide 249 to form the desired 
ynamide 13C-255 in moderate yield.  
 
Scheme 66: Reaction of 
13
C-labelled ynamide 
13
C-255 with no scrambling of the carbons of the triple bond 
On subjecting ynamide 13C-255 to the standard reaction conditions, isomeric indenes 13C-265 
and 13C-266 were isolated in an identical ratio and yield to that observed for the non-labelled 
substrate (Scheme 66). The maintenance of connectivity of the starting triple bond was 
confirmed as well as the cleavage of the C-N (13C-265, Figure 2) or C-O (13C-266, Figure 3) bonds 
with the migrated group connected to the labelled carbon. 
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Figure 2: 
13
C-NMR spectra of 265 and 
13
C-265 
 
 
Figure 3: 
13
C-NMR spectra of 266 and 
13
C-266 
While no intramolecular cyclopropanation had been seen, attempts to trap the gold carbene in 
an intramolecular fashion with an external olefin were similarly unsuccessful (Scheme 67). The 
rapid [1,2]-migrations can be attributed to the sterically congested nature of the gold carbene 
* * 
* * 
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intermediate, and perhaps more importantly the neighbouring group aided migration step (see 
below). 
 
Scheme 67: Intra- and intermolecular cyclopropanation pathways from gold carbene 343 
2.4.4 Origin of Selectivity for [1,2]-N-Migration 
Whilst a clearer understanding of the mechanism had been obtained, the regioselectivity of 
nitrogen migration had not been addressed. As mentioned previously, the alternative 
regioisomer was proposed to arise from competitive 1,2-O-migration from the same gold 
carbene. When ynamides were employed with smaller nitrogen substituents, mixtures of 
isomers were observed (Figure 4). In the case of methyl substituted systems, there was almost 
no selectivity. 
 
Figure 4: Loss of selectivity with smaller nitrogen substituents 
These observations can begin to be rationalised by considering the gold carbene prior to 
migration (Scheme 68). [1,2]-Migration must proceed with planarisation of the non-migrating 
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group as sp2-character at the α-carbon develops. If [1,2]-N-migration occurs, steric strain is 
minimised by formation of oxonium 348 (Scheme 68, path a). In contrast, if [1,2]-O-migration 
occurs, substantial steric strain would arise as the larger nitrogen substituents are forced into 
the plane (349, Scheme 68, path b). This pathway is therefore largely disfavoured due to the 
high energy intermediates involved.  
This model can therefore be used to explain why erosion of selectivity is observed for substrates 
containing smaller N-substituents. A planar configuration 349 can be more easily adopted in 
these cases meaning pathway b is less disfavoured. Regioisomers B could potentially result from 
an initial exo-mode cyclisation, however, this pathway seems an unlikely scenario for smaller 
substituents when it is not observed with larger groups. 
 
 
Scheme 68: Rationalisation of regioselectivity 
Larger aromatic substituents at the benzylic position were also observed to reduce the 
selectivity when aromatic nitrogen substituents were also employed (vide supra, Scheme 58). π-
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Stacking and through-space interactions with the N-phenyl-tolyl sulfonamide may help to 
stabilise the intermediate 349/351, therefore lowering the energy barrier for O-migration 
(Scheme 69).  
 
Scheme 69: Possible π- and through-space interactions behind the formation of regioisomer 300  
As well as a model based purely on the development steric strain, the greater ability of nitrogen 
to stabilise the build up of positive charge during migration, as compared to oxygen, would also 
expect to contribute to the observed selectivity (346 versus 347). 
2.4.5 Derivatisation of Products 
The functionalised indene products were found to be sensitive to basic conditions. On 
purification of the product arising from cycloisomerisation of ynamide 245, triethylamine was 
added to the eluent in order to improve chromatographic separation. Instead of the expected 
indene 259, novel C-sulfonylated indene 352 was instead isolated in good yield (Scheme 70). 
352 Could be deliberately prepared in comparable yield on isolation of 259 and treatment with 
triethylamine. 
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Scheme 70 Synthesis of C-sulfonylated indene 352 
Interestingly, the tosylated variant 235 did not undergo rearrangement in the presence of 
triethylamine. When a stronger base, (DBU) was used however, α-alkoxy conjugated imine 353 
was isolated in high yield from expulsion of the sulfonyl group, (Scheme 71). For the nosyl 
protected indene 259, the same elimination mechanism is thought to occur, likely assisted by 
the adjacent methoxy group, although the electron poor sulfonyl should act as a better leaving 
group and so a milder base is sufficient. Formation of C-sulfonylated indene 352 likely occurs 
though attack of the sulfonyl anion onto the electrophilic centre of the imine.  
 
Scheme 71: Formation of α-alkoxy conjugated imine 353. (DBU: 1,8-Diazabicyclo[5.4.0]undec-7-ene) 
The reason behind the difference in reactivity between the two substrates is not completely 
clear, as we might expect the more electron-rich tosyl group to behave as a better nucleophile 
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for the imine. Coordination of the tosyl anion to the conjugate acid of DBU may hinder this 
second step. The X-ray crystal structure of 235 (Figure 1) shows the N-S bond of the sulfonyl 
aligned with the enol π-system, which may help to explain the ready elimination of this group. 
Similar base lability was observed when oxazolidinone-substituted indene 314, generated from 
ynamide 311 was exposed to triethylamine on purification by column chromatography (Scheme 
72). Indene 354 arising from double bond migration was isolated in good yield.  
 
Scheme 72: Formation of indene 354 arising from base-mediated double bond migration 
Bis-allylated indene 330 was subjected to ring closing metathesis to generate the unusual, not 
previously reported tricylic oxazocine core 355 (Scheme 73). Only one isomer was formed in the 
ring closing reaction, and while the (E)/(Z) stereochemistry could not be unequivocally 
confirmed due to broadened and overlapping signals in the 1H-NMR spectrum, it seems 
reasonable to assume that this would be the (Z)-isomer, based on previous reports of formation 
of 8-membered rings by ring closing metathesis reactions.78 
On standing in chloroform at room temperature, clean rearrangement of the 8-membered ring 
was observed over the course of one week to give synthetically valuable vinyl azetidine 356 as a 
1:1.4 mixture of diastereoisomers in 75% yield. When 355 was heated in toluene for 5.5 hours, 
the vinyl azetidine 356 was isolated in 71% yield, however in this case the ratio of 
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diastereoisomers was 1.5:1. The actual reaction time required for conversion at this 
temperature is uncertain as it was not possible to follow the reaction by TLC. 
 
Scheme 73: Ring closing metathesis reaction to form oxazocine 335 and subsequent rearrangement. Grubbs(II) = 
(1,3-Bis(2,4,6-trimethylphenyl)-2-
imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium 
This unusual transformation is thought to proceed through a [3,3]-Claisen rearrangement which 
sets the relative stereochemistry of the two stereogenic centres of the azetidine ring (Scheme 
74). Providing the assumption of a (Z)-double bond is correct, the oxazocine ring of 335 is 
expected to adopt a boat-type conformation with alignment of the two double bonds (355-a or 
355-b) (Shown in an untwisted form for simplicity, following Hedberg’s analysis of 
cyclooctadiene).79 This conformation would bring the reactive molecular orbitals into alignment, 
allowing carbon-carbon bond formation to occur. As the benzylic carbon is also stereogenic, two 
diastereoisomers are formed with a cis-relationship between the vinyl group and the C-O 
σ-bond. Formation of 356-a or 356-b would arise from reaction through one of the two boat 
conformations 355-a or 355-b shown in Scheme 74. Unfortunately, it was not possible to assign 
the two isomers by nOe experiment due to overlapping resonances. 
This analysis assumes that the formation of a boat-like conformation can be adopted with a 
formally sp2-nitrogen centre in the ring. Based on the X-ray crystal structures of related indene 
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precursors (Figure 1), this centre does not appear to be planar, with the nitrogen resonance-
decoupled from the C-C π-system. The ready elimination of the sulfonyl group of 259 under 
mildly basic conditions was also attributed to this observation (Scheme 70).  
 
Scheme 74: Formation of vinyl azetidine 356 from oxazocine 355 
This transformation would be expected to be irreversible due to the formation of a strong 
carbonyl-oxygen double bond and so discussion into the formation of kinetic and 
thermodynamic products is inappropriate. The difference in selectivity observed when a polar 
solvent is employed at room temperature as compared to the use of a non-polar solvent at high 
temperature might suggest different mechanisms are in operation. Optimisation of reaction 
conditions could potentially lead to selective access to either diastereoisomer. 
Azetidines are valuable N-heterocyclic cores due to their valuable biological properties and use 
as synthetic intermediates.80,81 Routes towards these motifs are somewhat limited however, as 
ring strain makes synthesis more challenging. The ability to access these rare motifs through 
rearrangement of 8-membered oxazocines could potentially lead to new and exciting 
methodologies. 
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2.5 Summary and Conclusions 
The generation of gold carbene intermediates directly from ynamides through a 1,1-
carboalkylation process has been realised. Adding a valuable contribution to a field dominated 
by alkyne carbofunctionalisations, a novel series of ynamides have been successfully 
implemented to control the regioselectivity of initial cyclisation, thereby forcing an alternative 
reaction pathway (Scheme 75). 
 
Scheme 75: Formation of functionalised indenes via a gold carbene generated from an ynamide 
This work represents a novel skeletal rearrangement, invoking a unique α-hemiaminal ether 
gold carbene and previously unknown, regioselective [1,2]-nitrogen migration onto a gold 
carbene. The [1,2]-shift pathway has been confirmed by isotopic labelling. Generally high 
selectivity has been observed for nitrogen migration and a model has been proposed to 
rationalise this based on developing steric congestion of the carbene intermediate. Several of 
the indene products have been further elaborated to generate interesting carbo- and 
heterocyclic cores. 
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Chapter 3: Gold-Catalysed Polycyclisation of N-Allyl 
Ynamides Initiated by [1,5]-Hydride Transfer 
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3.1 Introduction 
As mentioned in Chapter 2, attempts to trap gold carbene 343, generated from the 1,1-
carboalkoxylation of ynamide 255 in an intermolecular fashion were unsuccessful. Similarly, 
intramolecular trapping of the carbene with a tethered N-allyl moiety to generate cyclopropane 
345 was not observed (Scheme 76, path b), indicating that the 1,2-N-migration is a favourable 
and rapid process under these conditions (Scheme 76, path a). 
Scheme 76: Potential pathways for gold carbene 343 
Reaction conditions were therefore explored to promote intramolecular cyclopropanation using 
N-allyl ynamide 255. After some study (vide infra) it was discovered that when the Au(III) 
precatalyst AuLCl2 (L = picolinate) was employed at high temperature, a new tetracyclic product 
357 was generated in good yield as a mixture of diastereisomers, alongside small quantities of 
the carboalkoxylation products 265 and 266 (Scheme 77). On analysis of 1H- and 13C-2D-NMR 
spectroscopic data and later, of X-ray crystallographic data, it became clear that the new 
tetracycle observed was not the product predicted from a carboalkoxylation-based process 
(345). 
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Scheme 77: Formation of novel tetracycle 357 through a [1,5]-hydride transfer / cyclisation cascade 
It was proposed that the tetracyclic product 357 was generated through an alternative gold 
carbene 361, formed through a [1,5]-sigmatropic hydride transfer onto the gold-keteneiminium 
ion 358 and 4π-electrocyclisation (360→361). Subsequent cyclopropanation of the tethered 
alkene would provide the observed tetracyclic product. 
This transformation is distinct from previous examples of [1,5]-hydride transfer / cyclisation 
methodologies and generates a complex 3D structure from a relatively simple ynamide. Three 
new carbon-carbon bonds and four contiguous stereocentres (shown by *), two of which are 
quaternary carbon centres, are formed in a single step. The scope and mechanism of this novel 
transformation will be discussed alongside relevant examples from the literature. 
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3.2 [1,5]-Hydride Transfer / Cyclisation Reactions 
Hydride transfer reactions provide powerful and flexible methods for the activation of sp3-CH 
bonds.82 These types of reactions provide a valuable contribution to the rapidly emerging field 
of CH-activation and are complementary to methods whereby a transition metal inserts directly 
into a C-H σ-bond. The ability to activate CH bonds allows new retrosynthetic disconnections to 
be realised and while progress in the field is beginning to gather pace, selective 
functionalisation of ‘inert’ sp3-CH bonds remains one of the greatest challenges in modern 
synthetic organic chemistry.83 
Generally accepted proposals for [1,5]-migration / cyclisation mechanisms are depicted below 
(Scheme 78). Zwitterionic intermediate 365 may be generated by [1,5]-through-space migration 
of a hydride anion (path a). Alternatively, charge separated resonance form 364 may be invoked 
which can undergo [1,5]-sigmatropic hydrogen shift (path b). Cyclisation of 365 in a 6-endo-trig 
fashion generates the 6-membered heterocycles 366 (Scheme 78, Eq. [1]). 
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Scheme 78: Modes of [1,5]-hydride shift and subsequent cyclisation pathways 
[1,5]-Sigmatropic hydride migration can also be envisaged (Scheme 78, Eq. [2]) as shown for 
allenic system 367. In this case, there is no formation of charges and cyclisation of the 
conjugated intermediate 368 occurs though a 6π-electrocyclic ring closure (ERC) to give 369. 
The reactions discussed below generally follow one of these proposed reaction pathways. 
Intramolecular hydride transfer reactions generally involve Lewis acid, π-acid or thermal 
activation and evolve along different pathways depending on the connectivity of the hydride 
donor and acceptor components of the substrate. An extensive review in the area of [1,n]-
hydrogen transfer / cyclisation processes was very recently published by Wang and Xiao.84 
Various hydride acceptors such as activated alkenes, alkynes and allenes have been explored in 
recent years, as well as variations of the hydride donor. The examples described in this section 
are ordered based upon the type of acceptor employed and only focus on selected, relevant 
examples. Whilst [1,4]-85,[1,6]-86 and other modes of hydride shift have been reported, the 
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examples here will focus on reactions involving the most commonly encountered [1,5]-hydride 
shift, and subsequent cyclisation for the generation of hetero- and carbocycles. 
3.2.1 Hydride Donors 
In order to increase hydride donating ability, the carbon donor will usually contain an α-
heteroatom which can stabilise developing cationic character at the migrating centre through p-
orbital overlap. Historically, this has been realised in ring closing reactions using aniline 
substrates, taking advantage of the so called ‘tert-amino effect.’87 The second purpose of the 
heteroatom is to increase hydridic character by polarising and weakening the C-H bond, a factor 
important in both cationic and sigmatropic mechanisms.84,88,89 A number of examples have also 
been described in which an α-aryl group was sufficient to promote the migration. In fact, the 
use of a sterically restricted aliphatic system has been recently reported to undergo hydride 
transfer under gold catalysis (vide infra). Figure 5 shows the relative efficiencies of heteroatoms, 
aryl and tert-alkyl groups to stabilise adjacent carbocations.84 
 
Figure 5: Stabilisation of α-carbocations on hydride migration 
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Whether the migration step is sigmatropic or through-space depends on the type of the 
substrate. A suitable distance between the donor and acceptor moieties is crucial for efficient 
hydride transfer. Popular substrates are therefore ortho-substituted aromatics.  
3.2.2 Hydride Acceptors 
3.2.2.1 Electron Deficient Alkenes 
Sames reported the first example of through-space [1,5]-hydride transfer of non-conjugated 
systems with activated alkenes through a Lewis acid-catalysed hydroalkylation (Scheme 79).90 
α,β-Unsaturated aldehyde acceptors were tethered to tetrahydropyran, -furan and -pyrrole 
donors by an alkyl chain. Spirocyclic ethers 372 and amides were accessed in high yields through 
[1,5]-hydride transfer and 6-endo-trig cyclisation of intermediates such as 371. A range of Lewis 
acid catalysts were found to be active for this transformation and the reactions were conducted 
at room temperature. Sames also demonstrated the use of alkylidene malonate 373 with a 
benzylic C-H donor to generate cyclohexene derivative 374, although in this case, a Pt catalyst 
and an elevated temperature were essential. 
 
Scheme 79: Synthesis of spirocyclic ethers and cyclohexanes by through-space [1,5]-hydride shift 
89 
 
Several years later Tu and co-workers developed an enantioselective variant of Sames’ seminal 
work in the synthesis of spiroethers with high enantiopurity (Scheme 80).91 α,β-Unsaturated 
aldehydes such as 375 were converted in situ into iminium ion-activated hydride acceptors 
(377) using a chiral organocatalyst 376. In order to measure the ee values, the aldehyde 
products were converted directly to the corresponding unsaturated ethyl esters 378 using a 
Wittig reaction. 
 
Scheme 80: Use of a chiral organocatalyst to generate enantiopure spiroethers 
In related work, Kim and co-workers recently reported enantioselective oxidative enamine 
catalysis for the synthesis of tetrahydroquinolines 381 (Scheme 81).92 α,β-Unsaturated iminium 
species 383 were generated from aldehydes such as 379 through in situ reaction with the amine 
organocatalyst 380 and subsequent oxidation using IBX. Following [1,5]-hydride transfer, the 
enantioselectivity was determined upon ring closure, controlled by the bulky amine catalyst. 
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Scheme 81: Enantioselective organocatalytic synthesis of tetrahydroquinolines from aldehydes (IBX: 2-
Iodoxybenzoic acid, DNBS: 2,4-dinitrobenzene sulfonic acid) 
Alkylidene and benzylidine malonates are highly activated systems towards [1,5]-hydride 
transfer due to the polarisation of the olefin. Seidel and co-workers reported the synthesis of a 
range of polycyclic tetrahydroquinolines such as 387 using Gd(OTf)3 as a chelating Lewis acid 
catalyst, without the need for harsh conditions (Scheme 82).87,93 The tertiary amine stabilises 
the carbocation 386 formed on [1,5]-hydride transfer and the dipolar intermediate undergoes 
ready cyclisation. Luo and co-workers recently developed an enantioselective version of this 
reaction in which magnesium salts were employed alongside a chiral phosphoric acid.94 
 
Scheme 82: [1,5]-Hydride shift using a chelating Lewis acid catalyst 
A later report by Sames and co-workers detailed the synthesis of benzopyrans in a similar 
fashion from benzylidene malonates using catalytic Sc(OTf)3 (Scheme 83).
95 The substitution 
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pattern around the benzene ring was found to greatly influence the reactivity. When a methoxy 
group was installed para- to the donor group (388), resonance stabilisation of the developing 
oxocarbenium ion accelerated the reaction. In contrast, a methoxy substituent para- to the 
acceptor group (389) reduced the rate and yield of the reaction and required a higher catalyst 
loading. This is in agreement with the decreased ability of a more electron rich alkene to accept 
a hydride. Bromide substitution meta- to the hydride acceptor had no effect on the yield of 394, 
however no reaction took place when bromide was incorporated meta- to the donor (391). 
 
Scheme 83: Effect of electron donating and electron withdrawing substituents on the [1,5]-hydride shift 
Akiyama and co-workers observed an interesting steric effect in their synthesis of benzopyrans 
from benzylic ethers catalysed by SnCl4 (Scheme 84).
96 On installation of substituents ortho- to 
the benzyl ether donor (395-397), reactivity was greatly enhanced compared to unsubstituted 
systems. This can be rationalised by the donor and acceptor reactive partners being forced into 
closer spatial proximity, reducing the energy barrier for migration. The effect was most 
pronounced for tert-butyl substituents (398-400). 
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Scheme 84: Effect of ortho-substituents on [1,5]-hydride transfer 
3.2.2.2 Alkynes as Hydride Acceptors 
Barluenga and co-workers published the first example of a [1,5]-hydride transfer / cyclisation 
reaction using carbon-carbon triple bonds in their work on alkynyl Fischer carbenes.97 A range of 
stable 1,2-dihydroquinolinyl carbene complexes such as 406 were synthesised in high yields 
(Scheme 85). The addition of alkynes to the reaction mixture gave rise to the Dötz 
benzannulation products 402, adding a further dimension of complexity to the one-pot cascade. 
The strongly electron-withdrawing properties of the chromium carbene 401, (403→404) 
overcame the high energy barrier associated with 1,5-hydride transfer.82 Furthermore, DFT 
calculations confirmed the cleavage of the C-H bond as the rate determining step (404→405), 
with the subsequent cyclisation being of low energy. 
 
Scheme 85: Use of 1,2-dihydroquinolinyl chromium carbenes to promote a [1,5]-hydride shift 
93 
 
Sulfonylated alkynyl ethers 407 have been employed in the synthesis of dihydropyrans 408 
using rhodium catalysis by Urabe and co-workers (Scheme 86).98 The sulfonyl substitution was 
found to be crucial as terminal, internal and even α,β-unsaturated carboxylic ester substituted 
alkynes did not undergo the desired transformation. The intramolecular migration of a benzylic 
proton was confirmed by deuterium labelling. 
 
Scheme 86: Use of sulfonylated alkynes to promote a [1,5]-hydride shift 
The use of electronically unbiased alkynes as hydride acceptors was found to require a 
transition metal catalyst for sufficient activation of the system. The first examples of the use of 
unactivated alkynes as hydride acceptors focussed on aromatic substrates, generating 
substituted indenes through the [1,5]-hydride transfer / cyclisation of ethynyl substituted 
benzenes. 
Examples of Pt- and Ru-catalysed reactions have been reported which generally invoke the 
formation of a metal vinylidene species. These species could potentially evolve through 
insertion of the vinylidene into the benzylic CH-bond99 or through a [1,5]-hydride transfer / 
cyclisation pathway.100,101 In the latter case (Scheme 87), a likely mechanism would involve the 
formation of a metallocycle 414, formed by electrocyclisation of the metal carbene 413, which 
then demetallates to give the indene product 415. The metal carbene 413 could also be 
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envisaged as a metal stabilised carbocation which might undergo 4π-electrocyclic ring closure to 
give the 5-membered indene directly.  
 
Scheme 87: [1,5]-Hydride shift invoking a metal vinylidene intermediate by Chatini and co-workers 
Having been previously limited to aromatic alkynyl substrates, Sames and co-workers reported 
α-alkenylation of cyclic ethers and amides linked to terminal alkynes at the C-3 position (416, 
Scheme 88).102 This work was the first to demonstrate through-space [1,5]-hydride transfer 
using terminal alkynes and gave exclusively 5-exo-alkenylation products such as 417. PtI4 was 
found to be superior to other platinum halide catalysts due to its higher Lewis acidity, whilst 
gold salts did not promote the reaction effectively. A [1,6]-hydride transfer mechanism, 
following formation of a Pt vinylidene species 419, was also suggested. Deuterium labelling 
studies with a related substrate provided evidence for an intramolecular hydride shift but could 
not distinguish between the formation of the two possible intermediates 418 and 419. Amides 
linked at the C-2 position of the ring also underwent reaction, however the tetrahydrofuran 
equivalents required the less active K2PtCl4 as a catalyst to prevent decomposition of starting 
material. 
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Scheme 88: Formation of 5-exo-alkenylation products by α-alkylation of a cyclic amide 
Soon after this Gagosz and co-workers reported their work on these substrates with the use of 
electron rich gold(I) catalysts (Scheme 89).103 They found that cyclisation of tetrahydrofurans 
and dioxolanes linked at the 2-position was selective for 6-membered ring formation (423), with 
only traces of the isomeric 5-membered ring that was reported by Sames.  
 
Scheme 89: Formation of alternative 6-membered rings in spiroether synthesis 
Deuterium labelling studies supported the mechanism where [1,5]-hydride transfer occurs 
directly onto the activated alkyne instead of via formation of a gold vinylidene intermediate. 
Tricyclic compound 424 was also formed as the minor product by formal [3+2]-cycloaddition of 
the alkyne onto the tetrahydrofuran ring. The proposed mechanism is shown above whereby 
[1,5]-hydride transfer onto the gold-activated alkyne 425 generates a 5-membered ring 426 
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with an exocyclic gold carbene which might then undergo [1,5]-hydride transfer to generate 
oxonium 427, cyclisation then forms the second ring of the tricycle 424. 
A very recent contribution employing internal unactivated alkynes as hydride acceptors was 
reported by Gong and co-workers (Scheme 90).104 N-Cinnamylisoindole 429, which was 
generated by a [1,5]-hydride transfer onto the gold-activated alkyne of 428 could be trapped in 
an intermolecular fashion with a variety of dienophiles to access complex polycyclic scaffolds 
such as 430 under mild reaction conditions. 
 
Scheme 90: [1,5]-Hydride shift / Diels-Alder cascade 
The examples discussed so far have involved transfer of a hydride which is assisted 
electronically by a neighbouring heteroatom or aryl substituent. Barluenga, Ballesteros and co-
workers recently showed that this migration could also be promoted from a non-benzylic, 
aliphatic position by employing sterically restricted alkynylspirocyclopropanes such as 431 
(Scheme 91), which brings together the reacting centres and helps to stabilise the carbocation 
formed on hydride migration.105  
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Scheme 91: [1,5]-Deuteride transfer in an aliphatic system 
In the proposed mechanism, [1,5]-hydride / deuteride migration onto the gold-activated alkyne 
occurs with cleavage of the cyclopropane ring to give intermediate allene 432. Cyclisation and 
1,2-hydride insertion onto the gold carbene 433 gave tricycles 434. As shown, complete 
deuterium incorporation was observed, demonstrating an intramolecular process. Under 
harsher conditions, tricycles such as 434 could be transformed into divergent products through 
gold-assisted ring opening of the newly formed cyclopropane.  
3.2.3.3 Allenes as Hydride Acceptors 
Propargylic esters provide useful substrates for [1,5]-hydride shift / cyclisation. On exposure to a 
π-acid catalyst, such as gold and platinum, they undergo facile rearrangement,106 generating 
allenyl-metal complexes which can act as hydride acceptors. Liang and co-workers were the first 
to describe a [1,5]-sigmatropic hydride shift using propagylic esters 435 under platinum catalysis 
(Scheme 92).107 The resulting intermediate 438 underwent 6π-electrocyclic ring closure to 
generate 439. Elimination of methanol was observed in most cases, generating aromatic 
naphthalenes (436). 
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Scheme 92: Rearrangement of propagylic esters to generate in situ allene acceptors 
Due to the ready elimination of the heteroatom substituents used to aid hydride shift, this 
methodology is limited to the formation of naphthalene acetates. In a complementary study, 
the same group went on to develop a synthesis of naphthylamine derivatives under Pd catalysis 
(Scheme 93).108 An N-acyl or N-sulfonyl group was essential for activation of the adjacent sp3-CH 
bond, with a simple dimethylamine substituted system leading to complete decomposition of 
starting material. The addition of a methyl group to the benzene ring of 449 gave an excellent 
yield of naphthylamine 442, however when a mildly electron withdrawing substituent was 
introduced (441), the yield dropped dramatically. 
 
Scheme 93: Synthesis of naphthylamines using palladium catalysis (dba: dibenzylideneacetone) 
The use of a tetrahydrofuran moiety as a hydride donor has previously been discussed with 
activated alkene and alkyne acceptors (vide supra). Gagosz and co-workers have also explored 
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the application of these systems alongside allene acceptors to generate fused- and spiro-
tetrahydrofurans and –pyrans (Scheme 94).109 When optimising the reaction conditions for 
allenes of type 444, interesting product divergence was observed depending on whether a 
Brønsted acid or gold catalyst was used. Whilst both products 445 and 446 arose following [1,5]-
hydride transfer onto the proton- or gold-activated allene, the gold bound intermediate 448 
could evolve through a number of stepwise processes giving rise to both 445 and 446. Under 
Brønsted acid catalysis however, the regioselective loss of a proton from 448 gave rise 
selectively to the isopropenyl compound 445. 
 
Scheme 94: Product divergence under gold- or Brønsted acid-catalysis 
Recently, Bandini and co-workers reported the gold-catalysed synthesis of substituted 
naphthalenes through the activation of benzhydryl sp3-CH bonds (Scheme 95).110 A [1,5]-hydride 
shift was proposed following gold-mediated rearrangement of the propagylic ester which then 
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underwent cyclisation and aromatisation. As well as biaryl systems 452, allylbenzene substrates 
454 underwent the same reaction in moderate yield. Following deuterium labelling studies, the 
primary kinetic isotope effect was measured as kH/kD = 1.94 by 
1H-NMR spectroscopy, indicating 
that cleavage of the benzylic sp3-CH bond is the turnover limiting step. 
 
Scheme 95: [1,5]-Hydride transfer from benzhydryl sp
3
-CH bonds 
While the examples above feature [1,5]-hydride transfer onto the C-2 carbon of the allene, 
Liang and co-workers reported [1,5]-hydride transfer onto the C-1 carbon in the 
platinum-catalysed synthesis of ring-fused tetrahydroquinolines (Scheme 96).111  
Hydride transfer onto the in situ formed allenyl acetate 458, and subsequent cyclisation of 
iminium 459 is followed by deacylation to give stable products. LiCl as an additive was found to 
increase the yield and molecular sieves or CaO were also beneficial, presumably in order to 
reduce side products from hydrolysis of the acetate. 
 
101 
 
 
Scheme 96: Hydride transfer to the C-1 position of allene 456 
Alajarin, Vidal and Sánchez-Andrada recently showed that allenes could be sufficiently activated 
by electron withdrawing groups to participate in [1,5]-hydride shift reactions under thermal 
conditions (Scheme 97).112 The proposed mechanism is in line with the group’s previous work 
which will be discussed in the next section. In most cases the spirocycle 461 was not isolated 
due to favourable aromatisation and opening of the acetal to give naphthalenes such as 462. 
Sulfonyl- and alkoxycarbonyl substituted allenes also could be generated in situ on exposure of 
the relevant alkynes to catalytic triethylamine in refluxing toluene, which then participated 
smoothly in the cascade reaction.  
 
Scheme 97: Electron withdrawing group activation of allenes for [1,5]-hydride transfer 
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3.2.3.4 Ketenimines as Hydride Acceptors 
Alajarin and Vidal have made significant contributions to the field using ketenimine (463, 464) 
and carbodiimide (468) acceptors, both possessing an electrophilic central carbon.89,113 They 
found that acetals and thioacetals promoted [1,5]-hydride shifts by behaving as hydride 
releasing fragments, allowing ready access to isoquinolines (466, 467) using only thermal 
activation (Scheme 98). They proposed a [1,5]-sigmatropic hydride shift / 6π-electrocyclic ring 
closure mechanism throughout their work, where the hydride migration was the rate 
determining step. This was supported by detailed computational studies. Although carbodiimide 
substrates such as 468 required more forcing thermal conditions, the acetal system cleanly 
cyclised to give quinazoline 469 (Scheme 98). The corresponding dithioacetal did not react 
under these conditions. Triaryl methane units were also found to be suitable hydride donors, 
undergoing the cascade reaction in refluxing ortho-xylene.114 In this work, the beneficial effect 
of a substituent ortho- to the donor group was also observed. 
 
Scheme 98: Ketenimine and carbodiimide hydride acceptors 
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The synthesis of oxyisoquinolines 473 and 475 from ortho-ethynyl benzacetals 470 by the 
copper-catalysed in situ formation of C-aryl ketenimines 471 was recently published by Lu and 
Wang (Scheme 99).115 When acyclic acetals were employed, a [1,5]-O shift of a methoxy group 
onto the C-aryl keteniminium was observed to give intermediate 472 (path a). With cyclic 
acetals however, a [1,5]-hydride shift prevailed to give imine intermediate 474 (path b). In both 
cases, 6π-electrocyclic ring closure was proposed to generate the oxyisoquinolines 473 and 475 
in moderate to good yields. 
 
Scheme 99: In situ formation of C-aryl ketenimine hydride acceptors 
3.2.3.5 Keteniminium Ion Acceptors 
During the final stages of our own study, Evano and co-workers published the first example of 
keteniminium ion acceptors which were generated from treatment of simple ynamides using 
strong acids and resulted in a rapid polycyclisation (Scheme 100).116 The mechanistic rationale 
behind this work draws several parallels to our own in which keteniminium formation is 
promoted by a gold catalyst (vide infra).  
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Scheme 100: Acid promoted polycyclisation of ynamides via a keteniminium ion 
In this study, triflic acid or bistriflimide were employed to initiate the formation of the 
keteniminium intermediate 478 which is proposed to undergo a [1,5]-sigmatropic hydride shift 
to generate intermediate 479. A Nazarov-type 4π-electrocyclisation from 480 would then give 
the first carbocycle. The resulting carbocation 481 could then react with the tethered benzyl 
group selectively on the lower face, giving the tetracyclic product 477 upon loss of a proton. In a 
deuterium labelling study, the preferential migration of hydride over deuteride suggested the 
presence of a kinetic isotope effect for this step. 
Whilst high yields and complete diastereoselectivity were achieved, the strongly acidic reaction 
conditions limited the scope to simple aromatics. Some success was however achieved with allyl 
substituted ynamides. As expected, no reaction was observed with simple allyl groups (484), but 
polycyclisation took place when a substituted allyl group was employed (482, 483, Scheme 101). 
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Scheme 101: Polycyclisation using N-allyl ynamides 
3.2.4 Summary 
[1,5]-Hydride transfer / cyclisation reactions have been demonstrated to be powerful processes, 
allowing functionalisation of ‘inert’ sp3-CH bonds for the formation of pharmaceutically valuable 
carbo- and heterocycles. The formation of multiple new bonds is often achieved in a single step 
which allows for the rapid development of complexity from simple starting materials in an 
atom-economical fashion. The following section details the discovery and optimisation of a 
novel gold-catalysed [1,5]-hydride shift initiated polycyclisation to generate complex three-
dimensional structures from simple ynamides. 
3.3 Results and Discussion 
3.3.1 Reaction Discovery and Optimisation 
Following the initial discovery of the gold-catalysed [1,5]-hydride shift cascade reaction, a 
survey of reaction conditions was conducted to promote this pathway for ynamide 255 (Table 
3). When phosphines bearing neutral or electron-deficient aryl groups were employed, only 
products of carboalkoxylation were observed (Table 3, Entries 1 and 2). The electron-rich biaryl 
phosphine ligand XPhos provided poor conversion of starting material, however resonances 
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typical of a cyclopropane ring system were visible in the 1H-NMR spectrum (Table 3, Entry 3). 
Commercially available catalyst dichloro(picolinate)gold(III) (AuLCl2) gave full consumption of 
starting material, although only trace amounts of tetracycle 357 were observed, alongside 
indenes 265 and 266 from competing carboalkoxylation pathways (Table 3, Entry 4). The yield of 
357 was not particularly influenced by the solvent used with this catalyst (Table 3, Entries 5-7). 
N-Heterocyclic carbene ligated IPrAuCl also failed to promote the desired reaction (Table 3, 
Entry 8). When ynamide 255 was heated with AuLCl2 in toluene however, the competing 
pathways were suppressed (Table 3, Entry 9). The choice of a less polar solvent appeared 
important at this temperature as the ratio of 357 to indenes 256 and 266 was eroded on using 
MeNO2 under otherwise identical conditions (Table 3, Entry 10).  
The formation of the undesired indenes could be reduced to low levels on heating in m-xylene 
at 120 °C to give tetracycle 357 in 75% as a 1:2.3 mixture of diastereoisomers (Table 3, Entry 
13). Whilst the major diastereomer was isolated by column chromatography, the minor isomer 
could not be separated from indene 266.  
An alternative gold(III) source promoted the desired reaction at high temperature but less 
cleanly (Table 3, Entry 14). To ensure the gold catalyst was responsible for promoting the 
cascade, a test reaction was conducted in the absence of catalyst, at high temperature (Table 3, 
Entry 15). Starting material remained after 6 hours with the only product observed being a new 
isoquinoline product in 16% yield. The formation of this compound will be discussed in Chapter 
4. Finally, the use of an alternative σ-Lewis acid led to complete degradation of the starting 
material (Table 3, Entry 16). 
107 
 
Table 3: Optimisation of reaction conditions
[a] 
 
Entry Catalyst Temp/°C Solvent 255/%[b] 265/%[b] 266/%[b] 357/%[b] 
1 (p-CF3C6H4)AuCl/AgNTf2 RT CH2Cl2 -- 74 9 -- 
2 PPh3AuCl/AgBF4 RT CH2Cl2 13 16 -- -- 
3 XPhosAuCl/AgNTf2 RT CH2Cl2 54 -- 13 7 
4 AuLCl2
[c] RT CH2Cl2 -- 67 25 4 
5 AuLCl2 RT MeCN -- 52 21 6 
6 AuLCl2 RT THF -- 50 12 8 
7 AuLCl2 RT toluene -- 54 32 9 
8 IPrAuCl/AgNTf2 RT toluene -- 60 30 trace 
9 AuLCl2 80 toluene -- 21 7 61 
10 AuLCl2 80 MeNO2 -- 45 19 9 
11 AuLCl2 100 p-xylene -- 8 4 56 
12 AuLCl2 100 toluene -- 11 6 66 
13 AuLCl2 120 p-xylene -- 7 5 75 
14 AuBr3 120 p-xylene -- 8 4 48 
15 None 120 p-xylene 23[d] -- -- -- 
16 BF3·OEt2 80 toluene -- -- -- -- 
[a] Reaction conditions: 255 (0.1 mmol, 1.0 equiv.), catalyst (5 mol%), solvent (0.1 M), all reactions were 
stirred for 6 hours at the temperature indicated. [b] Yields calculated by 1H-NMR spectroscopy against a 
known quantity of internal standard (1,2,4,5-tetramethylbenzene). [c] L=Picolinate. [d] 16% isoquinoline 
product observed. XPhos = 2-Dicyclohexylphosphino-2,4,6-triisopropylbiphenyl. IPr = 1,3-bis(2,6-
diisopropylphenyl)imidazol-2-ylidene. 
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A single crystal of the major diastereoisomer of tetracycle 357, suitable for X-ray analysis was 
grown using a pentane / dichloromethane solvent system. The resulting structure shows that 
the migrated hydrogen is syn to the methylene group of the cyclopropane ring at the [5,5]-ring 
junction (Figure 6), with both groups also on the same face as the phenyl substituent at the 
benzylic position. 
 
Figure 6: Crystal structure of 357 with ellipsoids drawn at the 50% probability level. X-Ray crystallography was 
carried out and data solved by Dr Louise Male (University of Birmingham) 
3.3.2 Reaction Scope 
3.3.2.1 Modification of the Nitrogen Protecting Group 
With conditions optimised for the [1,5]-hydride shift / cyclisation cascade for ynamide 255, the 
effect of varying the nitrogen protecting group was then investigated. Many of the substrates 
discussed in this section were synthesised using methods presented in Chapter 2 from the 
appropriate, freshly prepared bromoalkyne (Scheme 102).71 
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Scheme 102: Formation of ynamides with variation of the protecting group (TIPBS = triisopropylbenzenesulfonyl, 
DEP = diethylphosphonate) 
Under the standard conditions, nosyl substituted ynamide 493 produced the desired tetracycle 
497, however, the yield was reduced and unidentified contaminants could not be removed. The 
use of a more sterically bulky sulfonyl group in 495 led to a complex mixture, including starting 
material, with no desired product generated. A similar result was obtained with a 
phosphoramidate substituted system 496.  
 
Scheme 103: Modification of the N-protecting group 
N-Tosyl allyl substituted ynamide 494 had previously proved to be a poor substrate for 
carboalkoxylation and therefore had not been investigated for the initial optimisation studies 
for the present reaction, which had been based upon the idea that carboalkoxylation was 
required. However, when 494 was subjected to the optimised reaction conditions, tetracycle 
498 was formed exclusively in high yield (Scheme 104). The major diastereoisomer was 
confirmed to be the same as the N-mesyl tetracycle (Figure 6) by nOe experiment. 
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Scheme 104: Use of the tosyl nitrogen protecting group 
Pleasingly, while the reaction rate was greatly decreased at room temperature, only traces of 
indene side products were observed in the 1H-NMR spectrum of the crude reaction mixture, 
which were easily removed by column chromatography. The ratio of diastereoisomers was also 
improved at this temperature. Note that only two of the possible four diastereoisomers were 
generated in this transformation, due to a favoured syn-configuration at the [5,5]-ring junction. 
This was confirmed by nOe experiment (vide infra). 
3.3.2.2 Modification at the Benzylic position 
Further elaboration of the benzylic position was then explored. As a heteroatom is generally 
required to stabilise the developing carbocationic character on hydride transfer, the methoxy 
substituent was maintained. Terminal alkyne 499, was synthesised in three steps from 2-
iodobenzyl alcohol.  
Terminal alkynes 289-291 and 326 were prepared as described in Chapter 2 using the 
appropriate freshly prepared Grignard reagent (vide supra). Ynamides 500-504 were then 
synthesised in good to excellent yields via the bromoalkyne (Scheme 105). 
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Scheme 105: Synthesis of ynamides with variation at the benzylic position 
Without the additional substitution of an aryl group, a simple methyl ether 500 group did not 
provide the desired product (Scheme 106). This is potentially due to the phenyl group assisting 
with adoption of the required conformation for [1,5]-hydride transfer. Alternatively in a direct 
hydride transfer mechanism, the phenyl substituent would assist in cation stabilisation. Larger 
aryl groups with ortho-substitution (501 and 502) were not suitable, leading to complex 
mixtures.  
 
Scheme 106: Attempts to modify benzylic position 
While naphthyl substituted ynamide 503 gave the desired tetracyclic product 505 in 50% yield 
(determined by 1H-NMR spectroscopy), attempts to isolate the product by column 
chromatography were unsuccessful due to co-elution of unidentified side products. A vinyl 
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substituted system was also unsuitable, generating a highly complex mixture, although weak 
resonances characteristic of cyclopropane rings could be observed in the 1H-NMR spectrum. 
 
Figure 7: 
1
H-
1
H NOSEY experiment showing the through-space relationship of the migrated hydrogen, 
cyclopropane ring and phenyl substituent 
Modifications to the O-protecting group were conducted using the same methods described in 
Chapter 2 (vide supra, Scheme 61) employing instead the tosyl sulfonamide 490 for the ynamide 
formation. Bis-allylated system 506 reacted cleanly when heated to 60 °C to give the tetracyclic 
Hf Hc Ha Hd He 
Hb 
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product 507 in high yield as a mixture of diastereoisomers (Scheme 107). The major 
diastereoisomer was isolated by recrystallisation and the relative stereochemistry confirmed by 
nOe experiment (Figure 7).  
The temperature required for the cascade reaction to proceed appears to be highly substrate 
dependant since no reaction was observed at room temperature in this case. BOM-ether 
substituted ynamide 508 was not reactive under the reaction conditions even at 80 °C with only 
starting material and degradation observed by 1H-NMR spectroscopy (Scheme 107). 
 
Scheme 107: Modification of the O-protecting group 
As discussed in the introduction, the acetal functionality is reported to increase the ‘hydricity’ of 
the migrating hydrogen, weakening the C-H bond and stabilising the resulting intermediate (vide 
supra).89,112,113,114 The incorporation of an acetal also provides a synthetic handle for further 
functionalisation of products. A number of ortho-acetal substrates were therefore synthesised 
with 517 and 518 incorporating electron donating and electron withdrawing substituents 
respectively (Scheme 108). Ortho-ethynyl benzaldehydes 509-511 were converted to the 
corresponding cyclic acetals under acid-catalysed condensation conditions. Unsubstituted and 
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electron deficient aldehydes underwent acetal formation smoothly, however the electron rich 
system 510 proved prone to degradation under the reaction conditions. A poor yield was 
obtained in this case as a result, whether the alkyne was protected with SiMe3 or not. 
Regardless, 2-(2-ethynylphenyl)-1,3-dioxolanes 512–514 were converted into the corresponding 
ynamides 515-518 under standard conditions in high yields. 
 
Scheme 108: Synthesis of ortho-acetal substituted ynamides 
Pleasingly, ortho-acetal functionalised ynamide 515 reacted cleanly at room temperature to give 
tetracycle 519 in excellent yield and as a single diastereoisomer (Scheme 109). Again, the syn-
relationship between the migrated hydrogen and the cyclopropane ring was confirmed by nOe 
experiment (Figure 8). 
 
Scheme 109: Generation of tetracycles with ortho-acetal functionality 
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Figure 8: 
1
H-
1
H NOSEY experiment showing the through-space relationship of the migrated hydrogen and the 
cyclopropane ring 
Furthermore, it was possible to obtain nosyl protected tetracycle 520 in good yield. No reaction 
took place at room temperature and was sluggish at 50 °C, however when heated to 80 °C, 
ynamide 516 was consumed within one hour. A phosphoramidate substituted system was also 
prepared, however unacceptable levels of impurities meant that it could not be used in the 
catalysis. 
Hb 
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He 
116 
 
The ability to bring acid-labile acetal groups through this transformation untouched, serves to 
demonstrate the high functional group tolerance of gold catalysts and the mild conditions 
required. Conditions employed by Evano and co-workers for the polycyclisation of ynamides 
using strong acids were tested with ynamide 515 (TfOH, 5.0 equiv., CH2Cl2, 0 °C, 5 minutes).
116 
Unsurprisingly, while 515 was consumed, no traces of a cyclisation product could be identified 
from the crude mixture by 1H-NMR spectroscopy.  
3.3.2.3 Modification of the Alkyne-Acetal Linker 
When the substrates 517 and 518 bearing electron-donating and withdrawing-substituents on 
the benzene backbone, were subjected to gold catalysis at 80 °C, a significant effect on the rate 
of conversion was observed (Scheme 110). 
 
Scheme 110: Effect of electron withdrawing and donating substituents on the rate of reaction 
The fluoro-substituted ynamide 518 went to completion at 80 °C in 24 hours to give the 
tetracycle 522 in excellent yield. Poor reactivity was observed at lower temperatures. In 
contrast, dimethoxy-substituted ynamide 517 was consumed in just 20 minutes to give 521, 
again in excellent yield. The reduced rate of reaction for ynamide 518 can be rationalised by the 
inductively withdrawing effect of the fluorine atom, removing electron density from the benzylic 
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position and thereby reducing hydridic character of the migrating group. The methoxy in the 4-
position can stabilise cationic character, helping to activate the hydride donor and increasing 
the rate of the reaction. The significant electronic effect is consistent with the turnover-limiting 
step involving development of carbocationic character at the benzylic position as the CH bond is 
cleaved. The methoxy in the 5-position could be expected to reduce the reaction rate by 
pushing electron density into the keteneiminium ion, decreasing its hydride accepting ability. 
However, it seems the effect on the hydride donor group is the more important factor in this 
case. These results are in line with those observed by Sames and co-workers in their benzopyran 
synthesis.95  
To further study this new transformation, a non-aromatic cyclohexene and heteroaromatic 
pyridine and thiophene substrates were chosen as important target substrates, not only to 
evaluate the limits of the reaction but also to provide synthetically valuable fused systems. An 
ortho-vanillin derived system was also synthesised. In order to access the common bromo-
aldehyde motif, aldehydes 523–526 were synthesised from commercially available materials 
using known procedures (Scheme 111).122,117,118,119 Whilst generally straightforward 
transformations, the Vilsmeier-Haack haloformylation of cyclohexene to form 523 was 
problematic. 
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Scheme 111: Synthesis of 2-bromoaldehydes 
Despite numerous procedures in the literature reporting yields of 80-85%,120 the yield obtained 
in our case was always close to 20%, despite consumption of starting material by TLC. Every 
component of the reaction was investigated, with fresh bottles of anhydrous DMF and PBr3. The 
water content of the dichloromethane from the solvent purification system was checked by Karl 
Fischer titration, and undried solvent was also used as supplied. The cyclohexanone was 
checked for purity by TLC and 1H- and 13C-NMR spectroscopy. Variation of the reaction duration 
was tested and the work up method was modified several times in terms of quenching and 
number of extractions. The result, however, was frustratingly, always the same. Further 
investigation by a colleague (Elli Chatzopoulou) indicated that the use of diethyl ether instead of 
dichloromethane in the extraction process, increased the yield with certain substrates, however 
this was not the general case. 
Nevertheless, enough material was obtained to continue with the ynamide synthesis. 
Sonagashira couplings of the bromides gave the ortho-ethynyl aldehydes 527–530 which were 
then converted to acetals 531-534 following deprotection to the alkynes in high yields (Scheme 
112).  
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Scheme 112: Synthesis of ynamides 535-538 from ortho-ethynyl aldehydes 527-530 
In the case of cyclohexene 531, some loss of product through degradation was observed on the 
walls of the reaction flask during acetal formation. N-Allyl ynamides 535-538 were synthesised 
via formation of the bromoalkyne under standard conditions. The formation of ynamide 538 
with a methoxy substituent ortho- to the triple bond was slow and gave a reduced yield due to 
congestion around the reacting centre. 
Ynamides 535-538 were then subjected to the catalysis conditions (Scheme 113). Cyclohexene 
derivative 535 did not undergo reaction at all at room temperature after 5 hours. When the 
reaction was repeated at 50 °C however, consumption of starting material was complete in 20 
minutes and tetracycle 539 was isolated in 80% yield. When the reaction was scaled up to 0.6 
mmol (usually 0.2 mmol scale), a quantitative yield of 539 was obtained. 
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Scheme 113: Results from catalysis using ynamides 535-538 
Ynamides 536-538 however, did not participate in the reaction. In the case of the pyridine 
substituted ynamide 536, the lack of reactivity can be rationalised in two possible ways. Firstly, 
deactivation of the aromatic ring by the electronegative nitrogen atom would increase the pKa 
at the benzylic position and so make CH bond cleavage more difficult. The other factor to 
consider is that the pyridine nitrogen can bind to gold (as evident in the precatalyst employed 
throughout this work), and so competition for binding of gold between the triple bond and 
pyridine nitrogen may shut down the reaction. 
The thiophene based ynamide 537 was also unreactive and only degradation was observed by 
1H-NMR spectroscopy. A potential rationale for this could be the greater bond angle associated 
with a 5-membered thiophene ring, which may create too great a distance between the hydride 
donor and acceptor for migration to occur. Methoxy substituted ynamide 538 did not undergo 
reaction after 8 hours at 80 °C and raising the temperature to 100 °C had no effect. This lack of 
reactivity is unlikely to be a result of the methoxy blocking the triple bond towards activation as 
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ortho-methoxy substituted aryl ynamides and alkynes have been reported to undergo gold-
catalysed transformations.121 A smaller gold(I) species Me2SAuCl, was also tested against this 
substrate under otherwise identical conditions by a colleague (Elli Chatzopoulou) but again, no 
consumption of starting material was observed. A possible explanation is that the position of 
the methoxy group prevents the keteniminium from adopting the required conformation for 
[1,5]-hydride transfer. Deactivation of the keteniminium ion through donation of electron 
density could also be invisaged. Me2SAuCl, which has seen success in related systems, was also 
tested against 537 and 538 (Elli Chatzopoulou), however the same results were observed.  
Pleasingly, it was possible to cleave the acetal of cyclohexene 539 to give the enone 540 in good 
yield (Scheme 114). A very preliminary study of reactivity saw no conversion when 540 was 
exposed to organo-copper reagents. 
 
Scheme 114: Hydrolysis of acetal 539 
3.3.2.4 Variation of the Acetal 
Attention was next turned to modification of the acetal. Dimethyl acetal substituted ynamide 
542 was prepared readily under standard conditions in high yield (Scheme 115).122 When 
subjected to gold catalysis, no consumption of starting maternal was observed at room 
temperature. At 50 °C the ynamide was consumed in 5 hours, however, a complex mixture was 
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obtained. A number of aldehyde peaks were visible in the crude 1H-NMR spectrum arising from 
acetal hydrolysis in the presence of a Lewis acid. 
 
Scheme 115: Synthesis of ortho-dimethylacetal ynamide 542 
The preparation of different cyclic acetal derivatives was readily achieved using propane 1,3-diol 
or propane 1,2-diol to generate the precursor for ynamides 545 and 546 (Scheme 116). When 
ynamide 545, substituted with a 6-membered ring acetal was heated at 80 °C under gold 
catalysis, no consumption of starting material was observed.  
 
Scheme 116: Synthesis of methyl substituted and 6-membered ring acetal containing ynamides 
Alajarin and co-workers have reported successful [1,5]-hydride transfer / cyclisation with these 
donors under thermal conditions,113 although higher temperatures were required, as compared 
to the 5-membered ring acetal series (refluxing o-xylene, 22-24 hours). For this reason, the 
reaction was repeated at 120 °C in p-xylene. Complete consumption of starting material was 
observed after 3 hours, however, the 1H-NMR spectrum of the crude reaction mixture showed 
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complete acetal degradation, with a number of aldehyde peaks visible, and no desired 
tetracycle. When ynamide 546, with a methyl-substituted 5-membered ring acetal was 
subjected to gold catalysis at 50 °C for 45 minutes, tetracycle 547 was isolated in good yield as a 
mixture of four diastereoisomers (Scheme 117).  
 
Scheme 117: Formation of tetracycle 547 under gold catalysis 
Due to the number of overlapping resonances in the 1H-NMR spectrum, it was not possible to 
accurately assign a ratio to the full mixture of diastereoisomers. Four resonances corresponding 
to the methyl group of the acetal, split onto distinctive doublets were observed, however, 
overlap with cyclopropane ring resonances limited interpretation. There does appear to be two 
major diastereoisomers in a 1:1 proportion, alongside two minor diastereoisomers. The reaction 
of ynamide 546 leads to products with five stereocentres, which could potentially generate 32 
diastereoisomers. As the relative stereochemistry of three of these centres is set, this number is 
limited to just four. 
The diastereoisomers which would arise from reaction of ynamide 546, are shown below (Figure 
9). The complexity of the 1H-NMR spectra however, meant it was not possible to assign 
structures of the major products. The stereoselectivity observed in systems with unsymmetrical 
groups at the benzylic position is discussed in section 3.3.3 (c.f. Scheme 136). 
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Figure 9: Diastereoisomers arising from reaction of ynamide 546 
The use of a dithioacetal hydride donor was next explored. The dithiolane ring of 549 was 
constructed using 1,2-ethane dithiol with an acid catalyst in good yield (Scheme 118).123 
Bromination of the alkyne, prior to ynamide formation failed due to incompatibility, therefore 
copper-catalysed amidation conditions using terminal alkynes reported by Stahl and co-
workers68 were employed. As mentioned in Chapter 2, the yields for this method, with ortho-
substituted alkynes tend to be modest, with dimer formation leading to significant consumption 
of the starting alkyne. This strategy has however been necessary to synthesise certain 
substrates.  
 
Scheme 118: Synthesis of ynamide 550 with an ortho-thioacetal functionality 
When dithioacetal substituted ynamide 550 was subjected to gold catalysis, only traces of the 
desired product were seen in the 1H-NMR spectrum. The crude mixture contained starting 
material alongside significant degradation products after heating to 80 °C for 9 hours. The 
position of the methoxy group on the benzene ring may also play a role as mesomeric effects 
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might be expected to decrease the ability of the triple bond to accept a hydride.95 This was 
however, later investigated by a colleague (Elli Chatzopoulou), who found the equivalent 
substrate without methoxy substitution was similarly unreactive when heated to 90 °C for 6 
hours, with only degradation observed by 1H-NMR spectroscopy. Repeating the reaction of this 
S,S-acetal at even higher temperature might be a useful follow-up, as Alajarin and co-workers 
reported successful [1,5]-hydride transfer / cyclisation with these donors in related systems, 
although harsher conditions were required.89,113 
3.3.2.5 Modification of N-Substituents 
Modifications of the N-allyl group was then investigated, initially with homoallyl substituted 
ynamide 552. The required N-homoallyl sulfonamide 551, readily prepared from reaction of 
commercially available 4-bromobut-1-ene with tosylamine,124 was coupled with alkyne 512 
under standard conditions (Scheme 119).71 
 
Scheme 119: Synthesis of N-homoallyl substituted ynamide 552 
In the desired reaction, substrate such 552 would give rise to formation of a 6,3-ring system. 
However, 1,6-eneynamides have previously been shown to undergo cycloisomerisation 
reactions such as the formation of 1,3-dienes in the presence of π-acids.125 A possible 
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mechanism for occurrence of this pathway in the present work is shown below (Scheme 120) 
which is based upon the cationic manifold originally proposed by Fürstner and co-workers for 
platinum catalysed enyne cycloisomerisations.24 Due to the longer tether, the alkene is now 
able to cyclise onto the triple bond and so activation of ynamide 552 by gold may alternatively 
precede formation of α-amido carbene 555. The carbene can undergo ring expansion to form 
the cyclobutyl cation 556, stabilised by the adjacent heteroatom. Demetallation and 
cyclobutene ring opening would lead to 1,3-diene 553. 
 
Scheme 120: Proposed mechanism for the formation of 1,3-diene 553 
In order to test this, 552 was subjected to gold catalysis initially at 50 °C (Scheme 121). 
Diastereomeric tetracycles 558-a and 558-b were isolated in a 2:1 ratio. The formation of the 
diastereoisomer 558-a, with an anti-relationship between the hydrogen and the cyclopropane 
ring not observed with allylic systems, was attributed to the greater flexibility associated with a 
larger ring size. The relative stereochemistry was confirmed by nOe experiments, with the major 
diastereoisomer having the cyclopropane ring and the migrated hydrogen on opposite faces. 
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Scheme 121: Reactivity of homoallyl ynamide 552 (
1
H-NMR yields with isolated yields shown in brackets) 
In all other examples, when allyl groups are employed, the cyclopropane and the migrated 
hydrogen are on the same face due to the steric requirements of ring formation. It was 
surprising to observe that with a 6-membered ring, derived from a homoallyl group, the major 
isomer had the opposite configuration around this ring junction.  
This modest selectivity should arise from difference in the relative energies of the transition 
states on formation on the 6,3-ring system through reaction of the alkene onto the gold 
carbene (Scheme 122). Based on the use of molecular models, a possible explanation can be 
suggested. In order to generate the major diastereoisomer 558-a, a chair conformation for the 
approach of the alkene appears feasible. To achieve the opposite selectivity, where the 
cyclopropane ring is formed on the same face as the migrated hydrogen 558-b, a higher energy 
twist-boat conformation is required to achieve the correct alignment between the gold carbene 
and the alkene. 
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Scheme 122: Possible rationale for the migrated hydrogen and the cyclopropane ring to occupy opposite faces 
when a homoallyl substituted system is employed 
Alongside the formation of the two diastereomeric tetracycles, the 1,3-diene 553 was observed 
by 1H-NMR spectroscopy of the crude reaction mixture in low levels. Although isolation was not 
possible in this case, the likely structure is drawn above. The reaction of ynamide 552 was then 
repeated at higher temperature, resulting in an improved yield of 558 and a cleaner reaction, 
although this had no effect on the ratio of diastereoisomers. At both temperatures, formation 
of the enyne cycloisomerisation side product 553 was observed.  
In order to investigate the effects of substituents adjacent to the ynamide nitrogen, α-
substituted allyl- and homoallyl sulfonamides were prepared by reaction of freshly prepared 
vinyl or allyl magnesium bromide with the relevant imine. 
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Scheme 123: Formation of α-substituted allyl- and homoallyl sulfonamides 
Ynamides 566-569 were then synthesised from freshly prepared bromoalkynes under standard 
conditions in moderate to good yields (Figure 10).71 When the bulky isopropyl substituted 
sulfonamide 565 was employed however, no coupling was observed. 
 
Figure 10: Substituted N-allyl-and N-homoallyl ynamides 
α-Methyl substituted N-allyl ynamide 566 underwent smooth gold-catalysed polycyclisation at 
80 °C in one hour to give tetracycle 570 in a good yield as a 1:4 mixture of diastereoisomers 
(Scheme 124). The major diastereoisomer was isolated by recrystallisation and its structure 
confirmed by nOe experiment. Rationalisation for this selectivity is discussed later (see Scheme 
136). α-Phenyl substituted N-homoallyl ynamide 567 was unreactive towards the reaction 
conditions and only degradation of starting material was observed. 
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Scheme 124: α-Methyl and α-phenyl substituted ynamides 
Allyl and homoallyl ynamides 545 and 568 containing a 6-membered ring acetal were prepared 
simultaneously as it was not known that this functionality was unsuitable for the 
transformation. When α-methyl substituted N-homoallyl ynamide 568 was subjected to the 
reaction conditions, complete consumption of starting material was observed after 45 minutes 
at 80 °C, however, the single product was not the desired tetracycle. Instead, the enyne 
cycloisomerisation pathway, previously detected with homoallyl ynamide 552, was favoured 
giving 1,3-diene 571 in good yield (Scheme 125). The structure of 571 was assigned using 1H- 
and 13C-NMR spectroscopy. 
In parallel, α-methyl N-homoallyl ynamide 569, substituted with a 5-membered ring acetal in 
the benzylic position was subjected to identical reaction conditions. The corresponding 1,3-
diene 572 was again formed as the sole product, as observed by 1H-NMR spectroscopy, 
although isolation of an acceptably pure compound was not possible in this case. 
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Scheme 125: Formation of 1,3-dienes with α-methyl substituted N-homoallyl ynamides 
As mentioned previously (Scheme 121), small amounts of the 1,3-diene were observed for the 
non-substituted homoallyl ynamide 552, though the major product was the desired tetracycle 
558. The α-methyl group appears to play a critical role in orientating the ene component, 
increasing the rate of the undesired enyne cycloisomerisation pathway, which is consistent with 
a reactive rotomer effect. 
Substitution around the double bond of the allyl group was also investigated. Methyl-
substituted sulfonamides were kindly donated by colleagues and coupled with alkynes 223 or 
512 via the bromoalkyne under standard conditions (Scheme 126). 
 
Scheme 126: Synthesis of ynamides 576-578 with methyl substituted N-allyl groups 
Ynamide 576 was heated at 120 °C for 24 hours in an attempt to generate the tetracyclic 
product 579 with methyl substitution at the [5,3]-ring junction (Scheme 127). A complex 
132 
 
mixture was generated which included unreacted starting material, an isoquinoline side product 
(this pathway is discussed in Chapter 4) and what appeared to be the desired product based on 
1H-NMR spectroscopy of the crude reaction mixture. The complexity of the mixture however 
meant it was not possible to isolate and characterise the tetracycle 579.  
 
Scheme 127: Substitution of the alkene 
This reaction was followed up with the acetal substituted ynamide 577 with a Ns protecting 
group, also known to undergo smooth polycyclisation when the allyl is unsubstituted. After 
subjecting 577 to gold catalysis, however, only degradation alongside unreacted starting 
material was observed by 1H-NMR spectroscopy. A gem-dimethyl substitution pattern was 
similarly unsuccessful with only unreacted starting material 578 and degradation visible by 1H-
NMR spectroscopy. This type of substitution might be expected to affect the cyclopropanation 
step in the proposed mechanism, however, the lack of conversion of starting ynamides is less 
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readily explained. Due to the presence of inductively donating methyl groups, the electron rich 
alkene may become a better ligand for the gold catalyst rendering ynamide activation for [1,5]-
hydride shift unproductive.  
3.3.2.7 Alternative Carbene Traps 
While an N-mesyl N-benzyl substituted system gave high yields of N-migration product in the 
previously described carboalkoxylation chemistry (vide supra), an N-tosyl N-benzyl system, 
generated from sulfonamide 580 gave a mixture of isomeric products which could be separated 
by column chromatography and characterised (Scheme 128). Alongside the expected indene 
582 arising from a 1,2-N migration (47%) and the minor regioisomer from 1,2-O migration 583 
(19%), a third indene product 584 was also isolated in a 15% yield. The structure of 584 was 
assigned based on 1H- and 13C-NMR spectroscopy. 
 
Scheme 128: Formation of isomeric indenes through competing carboalkoxylation and [1,5]-hydride shift / 
cyclisation pathways 
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Indene 584 was proposed to arise from a 1,2-hydride shift into gold carbene 585, generated 
through the [1,5]-hydride migration / cyclisation pathway. Electrophilic aromatic substitution of 
the benzyl substituent onto the gold carbene was not observed (cf. Evano’s polycyclisations).116 
The difference in reactivity as compared to the mesyl substituted system could be due to the 
larger size of the nitrogen substituents of 581, slightly hindering nucleophilic attack by oxygen 
onto the gold-activated triple bond, providing opportunity for [1,5]-hydride migration to occur, 
due to the smaller size of the hydride. Ynamide 581 was also subjected to conditions established 
for the [1,5]-hydride transfer cascade (Scheme 128). While reaction at room temperature and at 
50 °C gave little consumption of starting material after 24 hours, when heated to 80 °C, 
formation of 584 was observed, albeit in a 27% yield. No other isomeric products were observed 
in the 1H-NMR spectrum of the crude reaction mixture although degradation was apparent. A 
through-space interaction between the tolyl and phenyl groups could be envisaged, preventing 
adoption of the required reactive conformation for [1,5]-hydride transfer. 
The formation of two regioisomeric carboalkoxylation products seems counter-intuitive based 
on the model proposed to explain the usually observed regioselectivity (Scheme 68, Chapter 2). 
This result could be rationalised by invoking π- and through-space interactions between the 
benzyl and tosyl substituents, stabilising the intermediate required for methoxy migration 
(Scheme 129). 
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Scheme 129: Possible rationalisation for observance of methoxy migration product 583 by π- and through-space 
interactions 
In order to favour electrophilic aromatic substitution onto the gold carbene in benzylic systems, 
substrate 587 was synthesised from sulfonamide 586 (Scheme 130). It was proposed that 
incorporation of an election donating methoxy substituent in the 3-position of the benzene ring 
would promote an electrophilic aromatic substitution pathway by providing additional 
stabilisation of the carbocation generated on cyclisation onto the gold carbene to generate 
fused system 588 (Scheme 130). It was known that the ortho-acetal substrates did not undergo 
carboalkoxylation so competition from this pathway would not be an issue.  
 
Scheme 130: Electrophilic aromatic substitution pathway for the gold carbene 
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When subjected to gold catalysis under standard conditions, ynamide 587 showed little 
reactivity and when the reaction was conducted at even higher temperatures, complex mixtures 
were obtained. A variety of different gold catalysts and solvents were therefore tested, however 
in many cases, very little reactivity was observed. Whilst for a number of phosphine gold(I) 
catalyst systems, complete consumption of ynamide was observed however, the complexity of 
the reaction mixture prevented the isolation of any single product.  
3.3.3 Mechanistic Considerations: Deuterium Labelling Studies 
In order to gain insight into the mechanism of this reaction, deuterated ynamides d-494 and d-
515 were prepared (Scheme 131).  
 
Scheme 131: Synthesis of deuterated ynamides d-494 and d-515 
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The common deuterated aldehyde precursor d-230 was prepared by reduction of methyl 2-
iodobenzoate 589 with LiAlD4 to give the alcohol 590 which was converted to the deuterated 
aldehyde 591 by a Swern oxidation.126 Sonagashira coupling with trimethylsilyl acetylene gave d-
230. The dibenzylether and cyclic acetal substituted ynamides were then synthesised using 
previously described procedures.  
The first experiment employed ynamide d-494 which, in contrast to its protonated counterpart, 
did not react at room temperature after 24 hours. The reaction was repeated at 80 °C and the 
tetracycle d-498 was isolated as a mixture of diastereoisomers in good yield (Scheme 132). Full 
deuterium incorporation was observed in the product, confirming that the hydride migration is 
an intramolecular process. The reluctance of d-494 to undergo reaction at room temperature 
also indicated a kinetic isotope effect with the CH/CD bond cleavage involved in the turnover-
limiting step. This is in line with observations in previous studies.110,116 
 
Scheme 132: Complete transfer of deuterium through intramolecular [1,5]-hydride migration  
It was decided to investigate the kinetic isotope effect further by comparing the rates of 
reaction of labelled and unlabeled substrates by 1H-NMR spectroscopy. As the ortho-acetal 
substituted systems displayed superior reactivity to give single diastereoisomers in high yields, 
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the study was performed using ynamide d-515 (Scheme 131). Reactions of ynamides 515 and d-
515 under gold catalysis were run side-by-side at 50 °C to ensure both had suitable reaction 
times at a moderate temperature. It was important to ensure the reaction temperature was 
relatively mild, so as not to hold the NMR machine at high temperature for extended periods, 
avoiding potential damage. As expected, the deuterated ynamide reacted more slowly. 
Unlabelled ynamide 515 was consumed in one hour whereas ynamide d-515 was consumed 
over 5.5 hours (Scheme 133) with complete deuterium incorporation (See Appendix). 
 
Scheme 133: Comparison of reaction times for labelled and non labelled ynamides (
1
H-NMR yields) 
The reactions were then repeated separately in NMR tubes at 50 °C, with 20 mol% of 1,2,4,5-
tetramethylbenzene as an internal standard (Scheme 134). In the case of ynamide 515 1H-NMR 
spectra were recorded every five minutes for a total of 70 minutes, over which time the 
reaction was complete (Graph 1).  
 
Scheme 134: 
1
H-NMR experiment with ynamides 519 and d-519 at 50 °C 
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Due to the slower rate of reaction for ynamide d-515, spectra were recorded every ten minutes 
over a six hour period. Surprisingly, the reaction only reached 72% conversion in this time 
(Graph 2), however, it was not possible to run the reaction for a longer time period. Fluctuations 
above the set temperature of the oil bath and stirrer hotplate, used in the first case (Scheme 
132) may be the cause of the increased reaction rate as compared to the 1H-NMR experiment. 
Also, the reactions conducted in NMR tubes were almost three times as concentrated as the 
standard conditions, which may also play a factor. As both 1H-NMR studies were conducted 
under identical conditions this discrepancy was not a concern.  
The rate of reaction in both cases is essentially zero for the first 5-10 minutes which 
corresponds to the induction period whereby the active gold catalyst is formed from the 
picolinate-ligated gold precatalyst, first developed by Hashmi and co-workers.127 The rate of 
reaction then increases sharply before decreasing steadily over time (Graph 1 and Graph 2). It 
was not possible to deduce the rate constants, which are required to calculate the primary 
kinetic isotope effect for this type of experiment,128 from the 1H-NMR data of these catalytic 
reactions. Rate laws could not be determined as they did not remain constant over time. 
Furthermore, calculating rate constants from the initial rates is prevented due the induction 
period of the catalyst. 
In order to gain this information, the use of a catalyst which does not require an induction 
period is required. Alternatively, the catalyst could be pre-activated by first adding a small, 
known quantity of ynamide (or an alternative substrate). Upon consumption of this initial 
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material, the required quantity of ynamide could be added to the same reaction tube containing 
the now activated catalyst.  
 
Graph 1: Complete consumption of ynamide 515 in 70 minutes at 50 °C 
 
Graph 2: 72% Consumption of ynamide d-515 in 6 hours at 50 °C 
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Whilst it is difficult to quantify accurately, there is clearly a kinetic isotope effect in operation, 
whereby the rate of reaction is greatly reduced on substitution with a deuterium atom, due to 
the cleavage of the CH/CD bond being involved in the turnover-limiting step. Based on this 
information, observations made throughout the project, and relevant examples in the literature, 
a mechanism for the [1,5]-hydride transfer cascade is proposed below (Scheme 135). 
 
Scheme 135: Proposed mechanism for the formation of tetracycles from N-allyl ynamides 
Upon activation of the triple bond by the gold catalyst, a [1,5]-sigmatropic hydride shift occurs, 
as proposed in systems such as those reported by Evano,116 Liang107 and Alajarin.89,113 This step 
is high energy and turnover-limiting, as proven by isotopic labelling. The resulting highly 
conjugated iminium ion 359 is in resonance with carbocation 360 which undergoes 
4π-electrocyclisation in a conrotatory fashion to give gold carbene 361. Whilst a sigmatropic 
142 
 
hydride shift is proposed above, a through-space [1,5] hydride transfer mechanism, as initially 
proposed by Sames for aliphatic systems, should not be ignored.90 In this case, hydride transfer 
would occur with formation of oxonium A with subsequent ring closure leading to the same 
gold carbene 361. 
As previously discussed, this mechanism draws parallels to work by Evano and co-workers 
whereby keteniminium formation from an ynamide is promoted by a strong acid (vide supra).116 
In Evano’s studies however, only a small number of substituted allyl groups could be trapped to 
generate cyclohexenes as mixtures of isomers in moderate yields. In the present work, 
unsubstituted allyl groups react with the gold carbene smoothly to generate the observed 
tetracycles. Pleasingly, when an N-allyl ynamide is employed, only the syn-relationship between 
the cyclopropane ring and the migrated hydrogen is observed, as confirmed by 1H-NMR 
spectroscopy. When an N-homoallyl ynamide is employed, a mixture of diastereoisomers arise 
from formation of the opposite configuration around the [5,6]-ring junction (Scheme 121).  
Mixtures of diastereoisomers were generated when the substrate contained a stereogenic 
centre at the benzylic position. According to the mechanism, this position becomes planarised 
with developing sp2 character. Selectivity must therefore arise prior to the 4π-conrotatory ring 
closure which forms the first ring (360–361, Scheme 135).  
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Scheme 136: Rationalisation of regioselectivity for polycyclisation of N-allyl ynamides 
[1,5]-Sigmatropic hydride transfer generates a planar, conjugated intermediate. Bond rotation 
around the C-O bond can occur as some resonance forms have more single bond character 
(Scheme 136, 593) which would allow the larger substituents, i.e. the phenyl and N-allyl groups 
in this example to move away from each other, reducing steric strain. The enamine component 
has always been drawn in one geometry, however rotation around the gold-bound C-C bond 
would also be possible. Nazarov-type conrotatory cyclisation of carbocation 594 sets the relative 
stereochemistry at the benzylic and adjacent positions. Note that only one of the possible 
stereochemical outcomes is shown (Scheme 136). 
Formation of the final two stereocentres through cyclopropanation onto the carbene is 
stereospecific when an allyl group is employed, adopting the favoured syn-configuration around 
the [5,5]-ring junction. Based on this analysis, we might expect the major diastereoisomer to be 
that which has the phenyl ring and the nitrogen heterocycle on opposite faces. This is indeed 
the case based upon the X-ray crystal structure of the major isomer of 357 and is also apparent 
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from nOe experiments of O-allyl substituted tetracycle 507 which shows the phenyl ring and the 
migrated hydrogen to be on the same face (vide supra). The ratio of isomers is affected by 
temperature with selectivity improved at lower temperatures. 
When an acetal was employed at the benzylic position, a single diastereoisomer was obtained in 
most cases. With ynamides 546 and 566 with methyl substitution on the acetal and allyl groups 
respectively, mixtures of diastereoisomers were generated. The same model described above is 
tentatively invoked to rationalise the formation of major and minor diastereoisomers in these 
cases based on steric repulsion between the amide and the acetal groups (Scheme 137). In the 
case of 566, this effect is thought to be more pronounced with the conformation adopted prior 
to conrotatory cyclisation presumed to be similar to that shown below, with the amide group 
positioned away from the acetal. The formation of diastereoisomers in this case is attributed to 
the clockwise or anticlockwise formation of the new σ-bond. 
 
Scheme 137: Rationalisation for the formation of diastereoisomers for reaction of ynamides 546 and 566 
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3.4 Conclusions 
A novel gold-catalysed cascade has been discovered and developed, initiated by a [1,5]-hydride 
shift onto an ynamide. This transformation generates two new carbocycles and a nitrogen 
heterocycle in a single step by formation of three new carbon-carbon bonds and three 
contiguous stereocentres, two of which are quaternary carbons. 
 
Scheme 138: Summary of the [1,5]-hydride transfer cascade 
The mechanism of this reaction has been explored through by deuterium labelling studies which 
indicate that cleavage of the CH bond is turnover limiting. Finally, the diastereoselectivity 
observed for ynamides containing a stereogenic carbon at the benzylic position has been 
rationalised based on reduction of steric strain prior to a conrotatory 4π-electrocyclisation. 
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Chapter 4: Isoquinoline Synthesis through a Novel 
Copper-Catalysed Cascade of N-Allyl Ynamides 
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4.1 Introduction 
During studies into the cycloisomerisation of N-allyl ynamides (Chapter 3), a novel 
copper-catalysed [1,5]-hydride transfer cascade was discovered leading to the generation of 
valuable isoquinoline cores. In addition to the discussion of literature concerning the 
mechanistic details of this type of transformation, a selection of recent contributions towards 
the transition metal catalysed synthesis of isoquinolines are detailed below. 
4.1.1 Traditional Syntheses 
Isoquinolines are privileged motifs, abundant in biologically active natural products129 such as 
imerubrine130 and annocherine,131 as well as pharmaceuticals132 such as the opium alkaloid 
papaverine (Figure 11).133 The development of novel and efficient routes for their synthesis 
therefore continues to be an important goal in modern synthetic chemistry. 
 
Figure 11: Natural products and pharmaceuticals containing the isoquinoline motif 
Traditionally, methods based on Friedel Crafts-type acylation such as the Bischler-Napieralski,134 
Pomeranz-Fritsch135 and Pictet-Spengler136 syntheses have been used to generate these 
heteroaromatic cores. These methods, initially developed in the late 1800s and early 1900s, 
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require strongly acidic conditions to generate an imine or a nitrile which then cyclises onto an 
aromatic ring. These procedures tend to be limited by the need for electron rich carbocycles and 
the functional group incompatibility inherent to the use of acidic conditions. 
More recent methods have therefore been developed to widen the scope of isoquinoline 
syntheses by developing milder conditions and multi-component strategies. Some selected 
approaches towards this goal are shown below. 
4.1.2 sp2-CH Activation Approaches 
A significant number of modern methods have focused on the use of transition metal-catalysed 
multi-component annulations to assemble the isoquinoline ring system. Such approaches allow 
minimal prefunctionalisation of substrates and offer high atom- and step-economy. Rh, Ru and 
Mn catalysts, among others, have been employed to mediate sp2-CH activation / annulations 
employing internal alkynes.137,138 A simplified general mechanism is shown below (Scheme 139). 
Nitrogen sources such as N-substituted and N-H imines, oximes, oxime ethers and amines (595) 
have been employed to direct insertion of a metal into the ortho-sp2-CH bond, generating a 5-
membered metallocycle 598. Alkyne insertion then occurs into the carbon-metal bond, forming 
a 7-membered metallocycle 600. Reductive elimination regenerates the catalyst and gives 
substituted isoquinolines of type 596. Whilst an impressive range of isoquinolines have been 
generated through these methods, drawbacks include restrictions in the substituents possible 
when using internal alkynes and limited regioselectivity for unsymmetrical alkynes in certain 
cases.  
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Scheme 139: sp
2
-CH Activation / annulation using internal alkynes 
Different substitution patterns can be accessed using coupling partners other than alkynes. 
Glorius and co-workers recently reported the first example of the use of 1,3-dienes in a sp2-
Rh(III) catalysed CH-activation / annulation strategy (Scheme 140).139 Nitrogen directed 
insertion of Rh generates a 5-membered rhodacycle 603 as proposed in the general mechanism 
above. Insertion of a 1,3-diene generates 7-membered rhodacycle 604 which undergoes C-N 
bond formation and N-O bond cleavage to give intermediate 606 where Rh is co-ordinated to 
the alkene. β-Hydride abstraction and acid mediated isomerisation gives the observed 
isoquinoline. A range of 1,3-dienes were employed with complete regioselectivity to generate 3-
alkyl substituted isoquinolines such as 602. A silver additive was required to abstract chloride 
from the Rh pre-catalyst and form the active catalyst alongside AgCl.  
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Scheme 140: Use of 1,3-dienes and aryl oximes as coupling partners (Cp = cyclopentadienyl) 
Under Pd-catalysis, Yang and co-workers successfully employed aryloxime pivolates 607 without 
the need for an external oxidant, generating 3-aryl substituted isoquinolines 608 (Scheme 
141).140  
 
Scheme 141: Isoquinoline synthesis by Pd-catalysed self coupling of acetophenone oxime acetate 
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In the proposed mechanism, palladacycle 609 undergoes ligand exchange with a second 
molecule of aryloxime pivolate. Loss of acetic acid and equilibration of enamine 611 generates 
612 which undergoes reductive elimination, forming the required C-C bond in the ortho 
position. Regeneration of the catalyst and condensation generates isoquinoline 608. It was also 
possible to access products of cross coupling, when a non-acetophenone partner was used and 
607 was employed in excess.  
As well as functionalisation of ‘inert’ sp2-CH bonds, Cheng and co-workers developed a Ni-
catalysed annulation method for the synthesis of isoquinolines and isoquinolinium salts using 
prefunctionalised ortho-halo ketoximines (616) (Scheme 142).141 1,3,4-Trisubstituted 
isoquinolines 618 were accessed in a highly regioselective manner using unsymmetrical aryl 
alkynes such as 617 with the aryl group of the alkyne preferentially adding to the position 
adjacent to nitrogen. The proposed mechanism follows the general scheme shown above 
(Scheme 139) with oxidative addition of Ni(II) into the C-I bond preceding formation of a 
7-membered metallocycle on insertion of the alkyne.  
 
Scheme 142: Ni-catalysed annulation of ortho-halo ketoximines with unsymmetrical alkynes 
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4.1.3 Imine Cyclisation onto ortho-Alkynes 
Larock and co-workers have developed several methodologies towards the synthesis of 
isoquinolines, including the copper-catalysed cyclisation of ortho-alkynyl imines 619 (Scheme 
143).142 Following palladium / copper co-catalysed Sonagashira coupling, the crude ortho-
alkynyl imines were used directly to generate 1,4-unsubstituted isoquinolines 620 through 
cyclisation, elimination of iso-butene and protodemetallation. 
 
Scheme 143: Cu-Catalysed cyclisation of ortho-alkynyl imines 
3,4-Substitution patterns were also achieved by a Pd-catalysed cyclisation / Heck coupling 
cascade for the synthesis of highly functionalised isoquinolines 622 (Scheme 144).143 Following 
cyclisation of the imine onto the palladium activated alkyne (623), the external olefin is added 
to the metallated position to give 625. β-Hydride elimination reinstates the double bond and 
isoquinolium 626 fragments to give the product. Optimum conditions were found to require a 
copper-co-catalyst, an excess of base and O2 as an oxidant. The group also demonstrated 
cyclisation of related substrates using electophiles such as sulfides and halogens under mild 
conditions.144 An earlier contribution from the same group described the generation of 
dihydroisoquinolines from ortho-halo acylated benzylamines and alkynes using Pd catalysis.145 
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Scheme 144: Pd-catalysed cyclisation / Heck coupling methodology 
Valuable 4-carboxylated isoquinolines could also be accessed through cyclisation of 2-alkynyl 
benzaldoximes by a Ag / Cu co-catalysed annulation reported by Yu and co-workers.146 In a 
contrasting approach, AuCl3 catalysed room-temperature benzannulation of oxo-alkyne 
substituted pyridines and electron deficient alkynes was reported by Sarkar and co-workers in 
the synthesis of quinolines and isoquinolines.147 
4.1.4 Copper-Catalysed Cascade Reactions 
Fujii and Ohno reported a 4-component, one-pot synthesis of isoquinolines148 and fused 
isoquinolines149 (Scheme 145). Simple 2-ethynyl benzaldehydes such as 511 underwent a 
Mannich-type reaction alongside imine formation from the condensation of the aldehyde and 
primary amine to give 628 which subsequently cyclised to give isoquinolinium ion 629. The 
tethered nucleophile can then attack the charged species, and following oxidation, polycyclic 
isoquinolines such as 627 can be accessed with high atom economy. Whilst an air atmosphere 
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was sufficient in many cases, the use of pure O2 atmosphere was found to accelerate product 
formation. 
 
Scheme 145: Cu-catalysed 4 component synthesis of fused isoquinolines 
In an alternative approach, Ma and co-workers found that 1,3-diketones and β-keto esters (631) 
underwent copper-catalysed coupling with ortho-halo benzylamines 630 (Scheme 146).150 
Subsequent cyclisation by condensation occurred smoothly in the presence of a mild base and 
the resulting dihydroisoquinolines 625 were oxidised in the presence of air to give 3,4-
difunctionalised isoquinolines such as 632. 
 
Scheme 146: Cu-catalysed coupling of β-keto esters and ortho-halo benzylamines 
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Wu and co-workers also recently described the synthesis of 1,2-dihydroisoquinolin-1-
ylphosphonates 638 by a copper-catalysed 3-component cascade reaction between aromatic 
aldehydes 636, anilines 637 and diethyl phosphate (Scheme 147).151 
 
Scheme 147: Synthesis of 1,2-dihydroisoquinolin-1-ylphosphonates 638 
4.1.5 Non-Metal Approaches 
As well as the use of transition metals to promote isoquinoline formation, metal free examples 
have also been reported.152,144 An elegant example of this was demonstrated by Stoltz and co-
workers for the synthesis of isoquinolines and indolines through the annulation of benzynes 
with enamines (Scheme 148).153 Silyl aryl triflates 639 were treated with a fluoride source to 
generate benzyne 642 which undergoes formal [4+2]-cycloaddition with enamine 640. 
Aromatisation with loss of water gave isoquinolines such as 641 with a range of substitution 
patterns. It was also possible to apply this approach to the synthesis of the pharmaceutical 
papaverine (see Figure 11). 
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Scheme 148: Isoquinoline formation through benzyne annulation (TBAT = Tetrabutylammonium 
difluorotriphenylsilicate) 
4.1.6 [1,5]-Hydride Transfer / Cyclisation  
It is proposed that the isoquinoline synthesis described in section 4.2.2 occurs through a [1,5]-
hydride shift / electrocyclisation mechanism (vide supra/infra). As discussed in Chapter 3, Lu and 
Wang recently described a copper-catalysed cascade for the synthesis of dihydroisoquinolines 
(see Scheme 99).115 In this work, a ketenimine hydride acceptor was generated in situ which 
underwent cyclisation initiated by a [1,5]-hydride migration.  
[1,5]-Hydride transfer / cyclisation of ortho-ketenimine benzacetals, reported by Alajarin, Vidal 
and co-workers for the synthesis of quinolines was also described. (Scheme 97 and Scheme 
98).89,112,113 The work of these two groups most closely resembles our own cascade reaction and 
the mechanistic similarities will be discussed in Section 4.2. 
4.1.7 Ynamides in Isoquinoline Synthesis 
During the course of our work, Skrydstrup and co-workers reported the gold-catalysed formal 
[4+2]-cycloaddition between ynamides and imines in the synthesis of highly functionalised 
dihydroisoquinolines (Scheme 149).154 As exploited throughout our own work, regiocontrol is 
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ensured by the electronic properties of the ynamide (vide infra). Nucleophilic attack by imine 
646 occurs at the α-carbon of the ynamide 645. The imine intermediate 649 could then be 
trapped directly by the electron rich aryl group to give 650 which provides the observed product 
647 on protodemetallation. An alternative mechanism through formation of an α-aziridine gold 
carbene was also suggested. The mechanism does not allow for 4-substitution of the 
isoquinoline and electron rich aromatics were required on the ynamide terminus. The 
isoquinolines obtained were highly functionalised however, and this work represents the first 
use of ynamides in the synthesis of isoquinolines. 
 
Scheme 149: The use of ynamides in a gold-catalysed synthesis of isoquinolines. 
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4.2 Results and Discussion 
4.2.1 Reaction Discovery and Optimisation 
Whilst the optimisation of reaction conditions for the gold-catalysed [1,5]-hydride transfer 
cascade were being investigated for N-allyl ynamide 255, a new pathway was observed. At high 
temperature with PPh3AuCl/AgNTf2 as the catalyst system a new, structurally distinct product 
was observed by 1H-NMR spectroscopy. Isolation of the new structure was possible by column 
chromatography and it was assigned as isoquinoline 651 (Table 4).  
1H-NMR spectra of a side product which was isolated following column chromatography of the 
crude reaction mixture of a copper-catalysed ynamide formation68 to generate the N-allyl 
ynamide 255 was subsequently reanalysed. It appeared that the new isoquinoline 651 product 
had been previously observed in trace quantities. This observation led to a later short 
optimisation study focusing on the use of inexpensive copper salts (Table 4).  
Several other Au(I) complexes were also tested at high temperature, and low yields of the 
isoquinoline product 651 were observed, alongside mixtures of other cycloisomerisation 
products reported in previous chapters (Table 4, Entries 1-4). Au(III) complex AuLCl2 (L = 
picolinate), used for the polycyclisation described in the previous chapter did not lead to any 
observable traces of isoquinoline 651 in the 1H-NMR spectrum of the crude reaction mixture 
(Table 4, Entry 5). AuCl3 however gave 22% yield of 651 (Table 4, Entry 6) at high temperature. 
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Table 4: Optimisation of reaction conditions
[a]
 
 
Entry Catalyst T/°C Time/h 255 
/%[b] 
265 
/%[b] 
266 
/%[b] 
357 
/%[b] 
651 
/%[b] 
1 IPrAuCl/AgNTf2 120 6 -- 14 9 traces 8 
2 XPhosAuCl/AgNTf2 120 3 -- traces traces traces 25 
3 PPh3AuCl/AgNTf2 120 3 -- -- -- -- 41 (37) 
4 JohnPhosAuCNMeSbF6 120 5 -- -- -- traces 27 
5 AuLCl2
[c] 120 6 -- 7 5 75 -- 
6 AuCl3 120 4 -- 7 3 32 22 
7 CuCl2 120 4 -- -- -- -- 40 
8 CuOTf2 120 4 -- -- -- -- 34 
9 Cu(MeCN)4BF4 120 4 traces -- -- -- 18 
10 CuI 120 4 -- -- -- -- 58 (50) 
11 CuI[d] 100 8 -- -- -- -- 68 (65) 
12 CuI[d] 80 24 40 -- -- -- 32 
13 None 120 24 23 -- -- -- 16 
[a] Reaction conditions: 255 (0.1 mmol, 1.0 equiv.), catalyst (5 mol%), solvent (0.1 M). [b] Yields 
calculated by 1H-NMR spectroscopy against a known quantity of internal standard (1,2,4,5-
tetramethylbenzene). Isolated yields shown in brackets. [c] L = picolinate. [d] solvent = toluene. 
Simple copper salts CuI, CuOTf2, Cu(MeCN)4BF4 and CuCl2 were all found to promote the 
reaction generating isoquinoline 651 as the sole product in moderate yields (Table 4, Entries 7-
10). Whilst in all cases the starting ynamide 255 was consumed, CuI gave the best yield of 58% 
(Table 4, Entry 10). High temperatures are necessary to promote this transformation, however 
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they also lead to product degradation. It was found that on reduction of the reaction 
temperature to 100 °C over a reaction time of 8 hours, a good yield of isoquinoline 651 could be 
isolated by column chromatography (Table 4, Entry 11). Even at the reduced temperature, care 
must be taken with the reaction time as degradation of the products begins to become 
significant after 8 hours. This could be clearly observed when the reaction was sampled every 30 
minutes, and the samples analysed by HPLC (Graph 3).  
 
Graph 3: Formation and degradation of isoquinoline 651 at 100 °C using CuI (5 mol%) in toluene (0.1 M) 
When the temperature was reduced to 80 °C, only 32% of 651 was formed, with significant 
starting material remaining after 24 hours (Table 4, Entry 12). Finally, as a control reaction, 
ynamide 255 was subjected purely to thermal conditions (Table 4, Entry 13). Whilst the 
isoquinoline was observed in 16% yield, unreacted starting material remained after 24 hours at 
120 °C. 
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4.2.2 Reaction Mechanism 
A mechanism is proposed below to account for the formation of the observed isoquinoline 651 
(Scheme 150). The first step is an aza-Claisen rearrangement of the N-allyl ynamide 255, to 
generate the sulfonyl ketene imine species 652. 
 
Scheme 150: Proposed mechanism for isoquinoline formation from ynamide 255 
Hsung and co-workers have contributed a substantial amount of research to the formation of 
allyl ketenimines from rearrangement of N-allyl ynamides, promoted thermally or by palladium 
salts.155 Ketenimine intermediate 657 is generated on heating ynamide 656 in toluene which 
evolves in this case through a 1,3-sulfonyl shift to generate nitriles such as 658 in excellent 
yields (Scheme 151). 
 
Scheme 151: Nitrile formation through aza-Claisen rearrangement / 1,3-sulfonyl shift 
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Following the formation on the sulfonyl ketene imine 652, subsequent [1,5]-sigmatropic hydride 
migration occurs with dearomatisation of the benzene ring, generating imine 653. The 
sulfonylated imine intermediate likely evolves through a 6π-electrocyclic ring closure with 
rearomatisation of the benzene ring, forming dihydroisoquinoline 654, a mechanism supported 
by the work of Alajarin, Lu and Wang, and Liang in the synthesis of quinoline, isoquinoline and 
napthalene derivatives (vide infra). 
Formation of isoquinolinium 655 should then proceed through the nitrogen-assisted expulsion 
of the methoxy group, gaining aromaticity in the second ring. In the final step, the formation of 
isoquinoline 651 could be envisaged in two ways. Substitution of the sulfonamide by the 
released methoxide may occur followed by release of the isoquinoline, a mechanism potentially 
valid for both mesyl and tosyl substituted systems (vide supra). Alternatively, deprotonation of 
the mesyl group by the released methoxide, generating methanol may precede release of the 
isoquinoline 651 by formation of a sulfonylmethane fragment. 
Whilst ketenimine acceptors have been reported for [1,5]-hydride migration,89,113,114 the only 
example of C-aryl ketenimines functioning as hydride acceptors was that recently published by 
Lu and Wang in the generation of isoquinolines (Scheme 152).115 
 
Scheme 152: In situ formed C-aryl ketenimine hydride acceptors 
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It was possible to probe the proposed mechanism through intermediate trapping, substrate 
design and deuterium labelling (vide supra). It should be noted that the exact role of the copper 
catalyst is not included in the reaction mechanism. As observed (Table 4, Entry 13) the reaction 
proceeds at a reduced rate in the absence of catalyst. As the ynamide substrate 255 is formed 
under copper catalysis, traces of copper species in the reaction mixture cannot be ruled out 
entirely, however, each step is readily envisaged and supported by thermal activation. The 
catalyst may accelerate the reaction through binding to (a) the ketenimine, thereby promoting 
[1,5]-hydride shift, (b) the resulting imine, promoting 6π-electrocyclic ring closure (although 
these processes are generally expected to be thermally activated), or (c) the methoxy group, 
assisting aromatisation. 
4.2.3 Reaction Scope 
4.2.3.1 Modification of the Nitrogen Protecting Group 
The use of the mesyl nitrogen protecting group on the ynamide was found to be crucial for the 
formation of isoquinoline 651 in high yield, reflecting the relative ease of removal in the final 
stage of the mechanism (Table 5). Ynamides 493, 494 and 496 incorporating different N-
protecting groups were prepared as described in chapter 3. Reaction of nosyl protected 
ynamide 493 failed to generate any isoquinoline 651 and the reaction appeared to stop at the 
dihydroisoquinoline stage (c.f. 654, Scheme 150). Isolation was impossible in this case due to 
the complexity of the mixture (Entry 1). Tosyl and diethylphosphoramidate substituted 
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ynamides 494 and 496 underwent the reaction but afforded the isoquinoline in low yields 
alongside unreacted starting material and degradation (Entries 2 and 3).  
Table 5: Effect of different nitrogen protecting groups
[a]
 
 
Entry R Ynamide / %[b] 651 / %[b] 
1 493 R = Ns 9 --[c] 
2 494 R = Ts 25 20 
3 496 R = P(O)(OEt)2 19 9 
[a]
 Reaction conditions: ynamide (0.1 mmol, 1.0 equiv.), solvent (0.1 M). 
[b]
 Yields calculated by 1H-NMR 
spectroscopy against a known quantity of internal standard (1,2,4,5-tetramethylbenzene). 
[c]
 Dihydroisoquinoline 
product observed by 
1
H-NMR spectroscopy but isolation not possible.  
4.2.3.2 Trapping of Dihydroisoquinoline Intermediates 
It was postulated that the breakdown of dihydroisoquinoline 654 (Scheme 150) may be 
promoted by a proton from adventitious water or from traces of acid present in the reaction 
mixture. To eliminate this pathway and potentially observe this intermediate, the reaction was 
conducted in the presence of a slight excess of K2CO3. It was indeed possible to isolate 654 in 
high yield following column chromatography with triethylamine-treated silica (Scheme 153). To 
further support the intermediacy of 654, on standing in toluene at room temperature, slow 
conversion was observed over 3 days to yield the isoquinoline 651 in 96% yield (based on 654). 
It was also possible to access dihydroisoquinoline 662 in good yield by reaction of bis-allylated 
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ynamide 323. In both cases, the products are stable under the basic reaction conditions, even 
after 24 hours, making their synthesis more attractive as degradation is not observed. 
 
Scheme 153: Isolation of dihydroisoquinolines by addition of K2CO3 to the reaction 
A BOM-ether protected ynamide 663 was also prepared and subjected to the same conditions 
(Scheme 154). The labile functionality however was eliminated and 633 was converted directly 
to isoquinoline 651, which was isolated as the sole product in moderate yield. 
 
Scheme 154: Attempt to incorporate a BOM-ether functionality 
4.2.3.3 Deuterium Labelling Studies 
In order to confirm the intramolecular nature of this reaction, deuterium labelled ynamide d-
255 was synthesised in the same manner as that as described in Chapter 3 for the tosylated 
variant (Compound d-494, Scheme 131) and subjected to the reaction conditions (Scheme 155). 
Complete Deuterium incorporation at the C-3 position was observed in the dihydroisoquinoline 
product d-651 (see Apendix) which is in line with the proposed mechanism whereby 
166 
 
protonation of the sulfonyl ketene imine occurs via intramolecular [1,5]-hydride migration from 
the benzylic position. A kinetic isotope effect was indicated with the reaction rate of d-255 
being approximately half that observed for the non-deuterated example (Scheme 153). As 
mentioned previously, computational,97,113 and isotopic labelling studies in our own work 
(Chapter 3, Section 3.5) and the work of others,110,116 have indicated that for [1,5]-hydride 
migration processes, cleavage of the C-H bond is the rate determining step (or the turnover-
limiting step for catalytic reactions). 
 
Scheme 155: Complete deuterium incorporation for the Cu-catalysed cascade 
4.2.3.4 ortho-Benzacetals as Hydride Donors 
Based on the previous work of Alajarin and co-workers89,112,113,114 and previous success in my 
own work, employing acetals to increase the ‘hydricity’ of the donor, a series of ynamides were 
synthesised incorporating a cyclic acetal at the benzylic position. Copper catalysed amidation 
reactions were again employed as described in Chapters 2 and 3.71 The addition of K2CO3 was 
initially maintained due to the stability of the dihydroisoquinolines 654 and 662 under the 
reaction conditions (Scheme 153). It was anticipated that in the absence of a base the 
isoquinoline 667 would be formed through aromatisation and ring opening of the acetal 
(Scheme 156). When ynamide 664 was subjected to the reaction conditions however, no 
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consumption of starting material was observed after 24 hours. When this was repeated, 
omitting the K2CO3 additive, the protected oxyisoquinoline derivative 665 was isolated in high 
yield. No degradation or traces of 667 in the reaction mixture were observed by 1H-NMR, 
indicating these products are stable even over long reaction times at high temperature.  
 
Scheme 156: Formation of dioxyoisoquinolines 665 and 666 
The reason behind the lack of reactivity of ynamide 664 in the presence of K2CO3 is unclear at 
this stage. In the case of benzyl ether substituted ynamide 255, under basic conditions, the 
reaction rate was reduced, although consumption of starting material was complete in 24 
hours. In contrast, when base was omitted, the formation of isoquinoline 651 was observed 
after just 8 hours (Table 4, Entry 11 vs. Scheme 153). K2CO3 could be preventing the copper 
catalyst from binding, which might be a more important factor in the present case as benzyl 
ether substrate 255 was shown to undergo slow reaction in the absence of copper. Another 
possibility is that the base eliminates any traces of acid, which may act as the catalyst in this 
system.  
It was possible to incorporate a larger tosyl protecting group in this type of substrate, to 
generate 666 in good yield (Scheme 156). Unfortunately, the reaction rate was doubled as 
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compared to the mesyl substituted system 665 and so for this reason, it was not practical to 
subject the N-allyl-N-tosyl ynamides synthesised in Chapter 3 to the present chemistry. Acetal-
derived mesyl protected ynamides were synthesised for the remainder of the study, and K2CO3 
was omitted from the reaction conditions. In a preliminary study, deprotection of the 
dioxyisoquinoline 665 was demonstrated in the presence of a mild acid. Aromatisation with 
cleavage of the acetal ring to give 668 was observed by 1H-NMR (Scheme 157). 
 
Scheme 157: Deprotection of dioxyisoquinoline 665 
4.2.3.5 Modification of the Benzene Backbone 
In light of these promising results incorporating the acetal functionality, the scope of this 
intriguing transformation was explored. A fluorine substituent on the benzene backbone was 
well tolerated (Scheme 158) with no observable effect on the reaction rate, compared to the 
non-substituted system 664. Dihydroisoquinoline 672 was isolated in high yield after 24 hours 
and no degradation was observed by TLC or 1H-NMR spectroscopy. 
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Scheme 158 Substitution of the benzene ring with F and OMe substituents 
In the gold-catalysed cascade described in Chapter 3, a methoxy group ortho to the triple bond 
completely suppressed the reaction. This was assigned to the gold-bound keteniminium 
acceptor not being able to adopt the required conformation for 1,5-hydride transfer. In the 
present case, the first step in the proposed mechanism is an aza-Claisen rearrangement of the 
N-allyl ynamide, which generates an alternative ketenimine hydride acceptor which appears not 
to be restricted by the neighbouring group in terms of adopting the required conformation. A 
moderate yield of oxyisoquinoline 673 was isolated. Whilst the ynamide 670 was consumed, the 
reduced yield is attributed to product degradation. 
When the more electron-rich dimethoxy substituted ynamide 671 was left to react for 16 hours, 
all of the product 674 (the formation of which was observed by TLC) was lost through 
degradation pathways and a complex mixture was observed by 1H-NMR spectroscopy. The 
reaction was repeated with careful monitoring, and consumption of starting ynamide 670 was 
complete after 11 hours. The desired dihydroisoquinoline 674 was then isolated following 
column chromatography, however, the sample was contaminated by traces of grease (only a 1H-
NMR spectrum was obtained). Several attempts to recrystallise the product were subsequently 
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made and on repeating the 1H-NMR experiment, a new product 675 had been isolated. For this 
electron rich system, aromatisation and opening of the acetal ring occurred spontaneously on 
standing in solvent to give alcohol 675 in good yield (based on conversion from 674). 
Whilst the pyridine and thiophene based ynamides were not reactive under gold-catalysed 
conditions, the mesylated equivalents 676 and 677 did react in the current transformation 
(Scheme 159). This demonstrates differences in the nature of the hydride acceptors in the two 
transformations. Deactivation of the gold catalyst by competing coordination to sulfur or 
nitrogen may also be a factor. The 2,6-naphthyridine ring system 678 was generated smoothly 
in good yield although some degradation was visible on the walls of the reaction tube. The 
thiophene equivalent 677 also underwent the desired reaction, however, degradation was more 
substantial in this case and only 25% of the thieno-pyridine fused system 679 was isolated after 
two independent reactions.  
 
Scheme 159: Reactions of pyridine and thiophene systems 
Finally, cyclohexane derived ynamide 680 was prepared and subjected to the reaction 
conditions, however, none of the expected tetrahydroxyisoquinoline product was observed 
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(Scheme 160). As seen with the dimethoxy substituted system 671 (Scheme 158), aromatisation 
alongside opening of the acetal ring appears facile after cyclisation. The alcohol 681 could only 
be isolated in approximately 21% yield and the purity was not of an acceptable level to report. 
As discussed in Chapter 3, a similar elimination pathway was observed by Alajarin and co-
workers where a series of spironapthalenes were converted into the corresponding 1-(2-
hydroxy)ethoxy-2-substituted napthalenes in situ through a β-elimination pathway (vide supra, 
Scheme 97).112 In the dimethoxybenzene and cyclohexene derived substrates 675 and 681, the 
driving force for aromatisation appears stronger than for unsubstituted or fluorine substituted 
benzenes. Presumably in the dimethoxy example, the more electron rich nature of the π-system 
drives aromatisation. In the case of the cyclohexene, transformation from a fully non-aromatic 
system to an aromatic one, should be a stronger driving force than for the benzenoid systems.  
 
Scheme 160: Reaction of cyclohexane derived ynamide 680 
4.2.3.6 Support for an Aza-Claisen Mechanism 
In order to test our proposed mechanism, whereby the ketenimine hydride acceptor is 
generated through a concerted aza-Claisen rearrangement, ynamide 683 was prepared 
incorporating a methyl substituted N-allyl substituent (Scheme 161). The proposed 
rearrangement of this group was confirmed by isolation of a single isomer 684 in excellent yield, 
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with inversion of the allyl group. If a cationic, step-wise mechanism was in operation, we would 
expect a mixture of branched and linear isomers.  
 
Scheme 161: Confirmation of a concerted rearrangement of the N-allyl group (L = picolinate) 
Interestingly, when ynamide 683 was subjected to the gold-catalysed conditions reported in 
Chapter 3, no tetracycle was formed at 80 °C. However, oxyisoquinoline 684 was isolated in 60% 
yield when the temperature was increased to 100 °C. As described in the previous chapter, 
methyl substitution of the N-allyl group for the gold-catalysed transformation was met with 
failure in all cases. This was assigned to the possibility of the more electron-rich alkene 
providing a better ligand for gold than the triple bond, therefore ynamide activation was 
unavailable. Whilst the yield of 684 is reduced, gold is clearly capable of promoting the reaction. 
With the gold-bound keteniminium not accessible, the competing isoquinoline formation can 
occur. This is in agreement with the initial optimisation studies where certain gold catalysts 
were found to promote isoquinoline formation (Table 4). 
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4.3 Conclusions 
The first synthesis of valuable isoquinolines and oxyisoquinolines directly from N-allyl ynamides 
has been demonstrated using an inexpensive copper catalyst through a [1,5]-hydride transfer / 
cyclisation cascade. The intriguing mechanism of this transformation has been probed and the 
intermediacy of a dihydroisoquinoline has been proven. A range of 1,4-disubstituted 
isoquinolines have been generated in moderate to excellent yields. Acetal substituted products 
are readily accessed, including pyridine and thiophene fused systems. 
Deuterium labelling has confirmed the intramolecular nature of the hydride transfer, as well as 
suggesting a kinetic isotope effect, with cleavage of the CH / CD bond being involved in the 
turnover limiting step. The concerted nature of the initial aza-Claisen rearrangement of the N-
allyl ynamide has also been demonstrated through substitution of the allyl group. 
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Chapter 5: Generation of Ammonium Ylides Directly 
from Alkynes and Ynamides 
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5.1 Introduction 
As discussed in Chapter 1, α-oxo gold carbenes are highly valuable intermediates and the ability 
to generate these species directly from alkynes has been a highly active area of research in 
recent years. Generated through a π-acid catalysed redox reaction between an alkyne and a 
nucleophilic oxidant (1→6), it was proposed an α-oxo gold carbene could be trapped by attack 
of a suitable nitrogen nucleophile, to generate an ammonium ylide such as 686. There is still 
debate about the order of steps for this type of process.8,9 The vinyl gold intermediate 5 is also 
electrophilic and so attack of the nitrogen nucleophile may occur prior to elimination of the 
leaving group, to give the same outcome. Throughout this chapter, formation of a distinct α-oxo 
gold carbenoid is drawn for simplicity. Shown here for an allyl containing system, [2,3]-
sigmatropic rearrangement of 686 could be exploited to access a range of functionalised 
nitrogen heterocycles (Scheme 162). 
 
Scheme 162: Formation of an α-oxo gold carbene and intramolecular trapping with a nitrogen nucleophile to 
generate an ammonium ylide 
Nitrogen heterocycles are widespread throughout nature and pharmaceuticals and so their 
efficient generation from simple starting materials is highly attractive and is an ongoing target in 
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organic chemistry. Traditional methods for the generation of ylides involve sacrificial 
functionality9c which reduces synthetic efficiency by increasing the number of manipulations 
required. In contrast, mechanisms such as that shown above (Scheme 162), lead to more step- 
and process- efficient transformations and are therefore an interesting target area for 
research.156 This methodology would mean alkynes could be employed as ‘masked’ ammonium 
ylides and therefore a direct precursor to this highly reactive intermediate could be introduced 
earlier in a target synthesis, allowing greater flexibility when designing retrosyntheses. This 
chapter will detail work towards the realisation of this goal using gold catalysis. 
5.1.1 Rearrangements of Ammonium Ylides 
5.1.1.1 [1,2]-Rearrangements 
In 1928, Stevens and co-workers were the first to observe the rearrangement of a benzyl group 
as a result of the formation of an ammonium ylide.157,158 The rearrangement of 2-
(benzyldimethyl)ammonium acetophenone 688 into 2-benzyl-2-dimethylamino acetophenone 
689 was observed in the presence of aqueous sodium hydroxide at high temperature (Scheme 
163). Stevens deduced that the reaction was intramolecular based on crossover studies.159 A 
concerted electrocyclic mechanism is stereoelectronically unfeasible due to orbital symmetry 
requirements, and would lead to a highly strained transition state. The reaction likely involves 
diradical intermediates (690-692).160,161 
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Scheme 163: Discovery of the Stevens rearrangement 
Radical recombination reactions are usually inefficient processes, which contrasts with the high 
yields observed here. It was proposed that the two reactive components are held together by a 
solvent cage, the diffusion from which is slower than the reaction steps, giving the radical 
recombination step intramolecular efficiency.  
5.1.1.2 [2,3]-Rearrangements 
[2,3]-Sigmatropic rearrangements can also occur for benzylic ammonium ylides (694). They 
produce stable, neutral tertiary amines and are therefore favourable processes. This is reflected 
in the observation that even aromatic ring systems can participate in such processes, despite 
the reduced thermodynamic favourability associated with dearomatisation. Such benzylic 
rearrangements are known as Sommelet-Hauser rearrangements (Scheme 164)162 and are 
initiated by deprotonation of ammonium salt 693 with a suitable base.  
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Scheme 164: The Sommelet-Hauser Rearrangement 
There is often competition between the [1,2]- and [2,3]-rearrangement mechanisms for benzylic 
ammonium ylides with the distribution of products depending on the reaction conditions and 
substrate structure. When favourable allylic [2,3]-rearrangement is possible however, [1,2]- and 
[2,3]-benzyl rearrangement mechanisms are not usually observed.160 
[2,3]-Rearrangements of acyclic allyl sulfonium ylides were first reported by Baldwin and co-
workers in 1968.163 Ollis and co-workers subsequently published their work in this area, which 
they extended to include ammonium ylide rearrangements.164 
5.1.2 Formation of Ammonium Ylides 
5.1.2.1 Non-Metal Approaches to Ammonium Ylides 
Ammonium ylides are traditionally prepared via alkylation of an amine and subsequent 
deprotonation of the ammonium salt using a suitable base, a method first reported by Stevens 
and co-workers.157 Desilylation of α-silylammonium salts using a fluoride source represents 
another method.165 
[2,3]-Sigmatropic rearrangements of acyclic ammonium ylides can proceed with low 
stereoselectivity and the formation of a tertiary amine also requires that a protecting group is 
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installed to allow for further Derivatisation. To improve on these limitations, Lewis acids can be 
employed. For example, Blid and Somfai demonstrated that complexation of a Lewis acid to an 
acyclic amine, such as 697 prior to ylide formation by deprotonation (698), can lead to an allylic 
[2,3]-sigmatropic rearrangement. Following work-up, a secondary amine 699 is formed, with 
good control of diastereoselectivity (Scheme 165).166 
 
Scheme 165: Lewis acid mediated [2,3]-sigmatropic rearrangement 
Nitrile substituted ammonium ylides have also been reported, where the nitrile group provides 
additional stabilisation for the ylide and also acts as a traceless protecting group. The nitrile is 
readily removed following rearrangement of the ylide, which is generally formed in the 
presence of base. 167 
5.1.2.2 Decomposition of Diazo Compounds 
Ammonium ylides can be formed by the direct reaction of carbenes with a suitable nitrogen 
nucleophile, however, the high reactivity of carbenes renders this method of limited use.160 
Carbene precursors, such as diazo compounds, can be employed which allow the in situ 
generation of metal carbenes in the presence of substoichiometric quantities of transition 
metals such as copper or rhodium, generally under mild reaction conditions.168 Attack of a 
neutral nitrogen nucleophile onto the carbene centre displaces the metal to generate an ylide. 
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This methodology was first reported by Doyle169 and co-workers although its development has 
been somewhat hindered by competing carbene reaction pathways such as C-H insertion, 
dimerisation and cyclopropanation, or by the deactivation of the metal catalyst by 
heteroatoms.170 
West and co-workers have reported the formation of cyclic ammonium ylides from the metal-
catalysed decomposition of α-oxo diazo compounds (Scheme 166). The tertiary amine 701 
cyclises onto an in situ formed metal carbene to generate cyclic ylide 702 which can evolve 
through an exo-[1,2]-Stevens rearrangement.171,172 Using rhodium catalysis at room 
temperature, substituted piperizines 703 and 704 were formed as the sole products in excellent 
yields, with catalyst deactivation through amine coordination not apparent. High-dilution and 
slow addition techniques, usually employed to minimize side products, were not required. 
When substituted benzyl migrating groups were used, some formation of the homocoupled 
dimer 706 was observed which was rationalised by a greater tendency for the aryl radical to be 
displaced from the proposed solvent cage. 
 
Scheme 166: [1,2]-Stevens rearrangement of cyclic ammonium ylides 
Ammonium ylide chemistry lends itself well to the formation of synthetically important fused 
nitrogen heterocycles. West and co-workers also reported the generation of spirocyclic 
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ammonium ylides through the copper-catalysed decomposition of (S)-proline derived α-oxo 
diazo compound 707 (Scheme 167).173 Quinolizidine core 712 was generated in high 
diastereoselectivity from the preferential formation of ylide 710. Ring expansion through a 1,2-
Stevens shift occurred with stereochemical retention and the major diastereoisomer 712a was 
formed in 75% ee. The transfer of chiral information was thought to occur due to rapid 
recombination of radicals, occurring faster than bond rotation. The major diastereoisomer 712a 
was then converted to the alkaloid (-)-epilupinine in three steps. 
 
Scheme 167: Diastereo- and enantioselective formation of the quinolizidine core from a proline derivative 
A ring expansion strategy was also employed for the synthesis of bicyclic alkaloids from 
spirocyclic azetidinium ylides such as 715 by West and co-workers (Scheme 168).174 Using 
copper catalysis, α-oxo diazo 714 was converted into an inseparable mixture of bicyclic 
diastereoisomers 716a and 716b in high yield. The ketones were then reduced to give a 
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separable mixture of 717 and 718 which were then treated with LiAlH4 to give the racemic 
alkaloids (±)-turneforcidine and (±)-platynecine in 5 steps from commercially available materials. 
Yu, Che and co-workers have also reported the total synthesis of (±)-platynecine in 8 steps, 
including a [2,3]-sigmatropic rearrangement of an cyclic ammonium ylide.175 
 
Scheme 168: [1,2]-Rearrangement of a spirocyclic ammonium ylide in the synthesis of bicyclic alkaloids 
Clark and co-workers reported the intramolecular [2,3]-sigmatropic rearrangement of cyclic 
allylic ammonium ylides 720, generated by the Cu(acac)2-catalysed decomposition of α-oxo 
diazo compounds such as 719 (Scheme 169).176 The formation of five- to eight-membered N-
heterocycles was achieved in modest to good yields. 
 
Scheme 169: Preparation of cyclic amines by the [2,3]-sigmatropic rearrangement of ammonium ylides 
Substrates were then explored where the allyl group was incorporated as part of the cyclic 
amine and so [2,3]-sigmatropic rearrangements lead to fused bicycles such as 724 (Scheme 
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170).177 Enantiopure α-oxo diazo compound 722, derived from (S)-prolinol was subjected to 
copper catalysis to generate spirocyclic ammonium ylide 723. Using a similar model to that 
proposed by West, one of the diastereomers available from nitrogen inversion is favoured, 
generating a spirocyclic ylide where the vinyl group is positioned endo- to the newly formed 
ring. Cyclisation of the ylide generates the observed product with high enantioselectivity. Similar 
transformations have been reported by McMills, using (S)-proline derived α-diazo esters to 
generate azacene rings.178 
 
Scheme 170: Enantioselective synthesis of the core of manzamine-type alkaloids 
5.1.2.3 Ylides Directly From Alkynes 
As discussed in Chapter 1, there is a demand to replace the use of diazo compounds as carbene 
precursors due to the potentially explosive nature of these compounds, alongside the need to 
incorporate extra synthetic steps.12 Therefore the prospect of the generation of carbenes 
directly from alkynes is an attractive one. 
As described in Chapter 2 for a 1,1-carboamination strategy, metal-containing ammonium ylides 
727 were invoked as important intermediates in the formation of polycyclic indoles 729 by 
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Iwasawa and co-workers (Scheme 171, Eq. [1]).63 Activation of ortho-alkynylphenyl pyrrolidine 
or piperidine derivatives with an electrophilic transition metal catalyst leads to nucleophilic 
attack of the alkyne by nitrogen. The ammonium ylide 727 then undergoes ring expansion 
through a [1,2]-Stevens-type rearrangement to give metal carbene 728. 1,2-alkyl migration to 
quench the carbene affords the observed N-fused tricyclic indole derivatives with an overall 1,1-
carboamination of the alkyne (vide supra, Chapter 2). Whilst gold and platinum catalysts failed 
to give the desired product, tungsten and rhenium catalysts promoted the reaction efficiently. 
The intermediacy of the metal carbene was proven by trapping with triethylsilane to afford 
observable quantities of 731 (Scheme 171, Eq. [2]). 
 
Scheme 171: [1,2]-Stevens-type rearrangement of metal-containing ammonium ylides 
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5.1.2 Rearrangements of Sulfonium Ylides 
α-Oxo gold carbenoids can be generated by the reaction of a gold-activated alkyne with an 
oxygen-delivering oxidant in an inter- or intramolecular fashion (vide supra, Chapter 1). Attack 
of a suitable nucleophile onto the carbene centre has the potential to generate ylides. This 
reactivity was initially proposed independently by the research groups of Toste9a and Zhang179 in 
some of the earliest reports of α-oxo gold carbenoid formation directly from alkynes. Both 
groups aimed to determine whether these intermediates could be generated via a gold-
catalysed rearrangement whereby a sulfoxide acts as the nucleophile and also as the leaving 
group (Scheme 172). In both cases, formation of tetrahydrobenzothiepinones such as 734 was 
observed in excellent yields. The initially proposed mechanism is detailed below, whereby α-oxo 
gold carbene formation (737) precedes Freidel-Crafts-type cyclisation to form products 734 in 
excellent yields. The potential reversible formation of gold-containing sulfur ylide 738 was also 
proposed by Zhang as a means of assisting stabilisation of the gold carbene. 
 
Scheme 172: Proposed mechanism for the formation of tetrahydrobenzothiepinone. IMes = 1,3-bis(2,4,6-
trimethylphenyl)-imidazolium 
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In order to confirm the transfer of oxygen from the sulfoxide gave the ketone in the final 
product, a sulfimine 739 was subjected to the same cyclisation conditions by Toste and co-
workers to give the N-tosyl enamine 740 (Scheme 173). 
 
Scheme 173: Formation of an N-tosyl enamine 
This mechanism was recently further investigated by Zhang and co-workers who expanded the 
reaction scope and carried out computational studies.180 As a result, a high energy barrier for 
the proposed Friedel-Crafts type cyclisation was calculated for this system (737–734, Scheme 
172). Instead, an alternative [3,3]-sigmatropic rearrangement of 736 was proposed following 
initial cyclisation, without the formation of a gold carbene or sulfur ylide (Scheme 174). 
 
Scheme 174: Alternative [3,3]-sigmatropic rearrangement of intermediate 736 
This pathway had previously been reported by Asensio, Ujaque and co-workers in a related 
intermolecular sulfoxide addition to an alkyne. Experimental and computational studies ruled 
out a Friedel-Crafts type reaction.181 
In an alternative system, Davies and Albrecht reported the generation of sulfur ylides directly 
from alkynes, via the gold catalysed rearrangement of a propargylic carboxylate (Scheme 175).30  
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Scheme 175: Gold-catalysed rearrangement of a propargylic carboxylate and subsequent cascade reaction 
Gold carbene 741, generated from such a rearrangement, can undergo attack by a low valent 
sulfur nucleophile to generate a sulfur ylide 742 without poisoning of the catalyst. Following 
rearrangement of the ylide to give 743, gold-catalysed 1,2-carbothiolation occurs to give 35 
(vide supra, Chapter 2, Scheme 12). In these initial studies, the concept for the formation of 
sulfur ylides from gold carbenes was proved. Building on this work, Davies and Albrecht 
explored the generation of functionalised sulfur heterocycles directly from sulfoxide tethered 
alkynes under π-acid catalysis (Scheme 176).20 In the proposed mechanism, an α-oxo gold 
carbenoid is generated alongside a sulfide (747) via an internal redox process, providing the 
moieties needed for ylide formation. Attack of the carbenoid by the sulfide generates the ylide 
intermediate 748 and subsequent [2,3]-sigmatropic rearrangement of the allyl group gives 
sulfur heterocycles such as 749 with formation of new carbon-carbon, carbon-oxygen, and 
carbon-sulfur bonds in a single step. This methodology was successfully applied to the 
generation of a wide range of monocyclic and fused bicyclic sulfur heterocycles. 
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Scheme 176: Ylide formation via gold-catalysed rearrangement of alkynyl sulfoxides 
The desired ylide formation and rearrangement was observed when functionalised sulfoxide 
substrates were treated with platinum or gold π-acids (Scheme 177). The use of PtCl2 in 
dichloroethane with mild heating was found to be the most effective conditions for terminal 
alkynes such as 750 (Scheme 177, Eq. [1]). Lower yields were observed for those substrates 
containing an internal alkyne when subjected to platinum catalysis however, this was greatly 
improved by the use of dichloro(picolinate)gold(III) (Scheme 177, Eq. [2]) 
 
Scheme 177: Gold and platinum catalysed synthesis of sulfur heterocycles  
The cyclisation reactions proceed with complete allylic inversion owing to a concerted [2,3]-
sigmatropic rearrangement of the sulfur ylide. Synthetic flexibility was achieved by the 
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incorporation of a range of functionality in the sulfoxide precursors, including a vinyl bromide 
substituent which remained intact under the mild reaction conditions. 
Recently, Davies and Dos Santos reported their work on the formation of sulfur ylides using 
ynamides (Scheme 178).20 Under gold catalysis, ynamides such as 754 underwent regioselective 
addition of a nucleophilic oxidant to generate electrophilic vinyl gold species 757. As mentioned 
previously for ammonium ylide generation (vide supra, Scheme 162), addition of the allyl sulfide 
nucleophile may occur directly onto this species, prior to elimination of the pyridine leaving 
group or onto α-oxo gold carbenoid 758 following an internal redox process (the latter case is 
again drawn for simplicity). On formation of sulfur ylide 759, [2,3]-sigmatropic rearrangement of 
the allyl group occurs to generate structurally complex thioethers such as 756. This is a 
challenging intermolecular transformation with all reagents added at the beginning of the 
reaction. Diketone 760 was observed in all cases from competing attack of a second molecule of 
oxidant onto the carbenoid, however, good selectivity was achieved for the desired pathway. 
 
Scheme 178: Formation of sulfur ylides through formation of an α-oxo gold carbenoid from an ynamide. L2 = 
tris(2,4-di-tert-butylphenyl) phosphite 
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5.2 Results and Discussion 
5.2.1 Aniline-Based Substrates 
With the concept of sulfur ylide generation directly from alkynes, and later ynamides, already 
established within the Davies group, the next goal was to expand this methodology to include 
ammonium ylide formation. Due to the ease of synthesis and handling, aniline-derived 
substrates were chosen for investigation. N,N-Diallyl-2-ethynylaniline 764 was synthesised 
according to literature procedures over three steps (Scheme 179) in a 90% overall yield.182 
 
Scheme 179: Synthesis of terminal alkyne 764 from 2-iodoaniline 
In keeping with work ongoing within the Davies research group, and the work of others,8,19a,20 
employing pyridine N-oxides as intermolecular nucleophilic oxidants, it was decided to pursue a 
similar approach using substrate 764. It was anticipated that pyridine N-oxide would attack the 
gold-activated triple bond to generate vinyl gold species 766 (Scheme 180). An internal redox 
process would then generate the required α-oxo gold carbenoid 767 with expulsion of the 
pyridine leaving group. Nucleophilic attack of the tertiary amine onto the electrophilic metal 
centre would yield ammonium ylide 768, which could evolve through a [2,3]-sigmatropic 
rearrangement of one of the allyl substituents to generate isooxindole 765.  
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Scheme 180: Gold-catalysed isooxindole formation using an external oxidant 
This is an inherently challenging transformation, with competing intra- and intermolecular 
pathways available. In the first case, direct attack of the aniline nitrogen onto the gold activated 
triple bond would generate substituted indole 769 (Scheme 180, path b) through the 
intramolecular 1,2-carboamination pathway discussed in Chapter 2. 
The second issue is the double oxidation of the triple bond to yield diketone 780. In this case, a 
second molecule of oxidant attacks the α-oxo gold carbenoid (Scheme 180, path c). In line with 
these potential issues, the nucleophilicity of both the aniline nitrogen and the pyridine based 
oxidant would be crucial. N,N-Diallyl-2-ethynylaniline 764 was subjected to three different gold 
catalysts using standard pyridine N-oxide as the external oxidant (Scheme 181). In all cases, no 
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formation of the desired isooxindole 765 was detected and clean conversion to the 1,3-diallyl 
indole 769 was observed by 1H-NMR spectroscopy. 
 
Scheme 181: Rearrangement of 764 under gold catalysis. L = picolinate 
The intramolecular formation of 769 from 764 has previously been reported by Lin and co-
workers who reported a concerted aza-Claisen rearrangement of the allyl group under both gold 
and ruthenium catalysis.182 Whilst no desired product 765 was observed, neither was the 
diketone product 780 arising from double oxidation of the triple bond (Scheme 180, path c). It 
was supposed that the competing intramolecular reaction was too rapid to allow other 
pathways to occur due to the high reactivity of the aniline nitrogen of 764. It was decided to 
reduce the nucleophilicity at this centre by substitution with an electron withdrawing group. 
Consequently, tosyl-substituted aniline derivative 783 was synthesised in three steps from 2-
((trimethylsilyl)ethynyl)aniline 762 (Scheme 182) according to literature procedures.183 
 
Scheme 182: Synthesis of tosylated substrate 783 (DMAP = dimethylamino pyridine) 
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With the N-deactivated substrate in hand, a variety of gold catalysts, solvents and oxidants were 
explored. The use of standard pyridine N-oxide at room temperature with gold(I) and gold(III) 
catalysts was unproductive with no consumption of starting material observed (Entries 1-3). It 
was thought that traces of basic pyridine may be competitively binding to the gold catalyst and 
prevent the reaction proceeding. Acid additives have been employed successfully by several 
groups in gold-catalysed reactions to counteract basic pyridine by-products. For example, Zhang 
and co-workers observed significant improvement in yield and reaction rate in their synthesis of 
dihydrofuran-3-ones and oxetan-3-ones in the presence of strong acids. Based on this 
observation, methanesulfonic acid was added to the reaction, however, a complex mixture was 
observed by 1H-NMR spectroscopy with no clear indication of product formation (Entry 4). 
Methyl picolinate N-oxide O-1, the use of which has seen previous success in our laboratory,20 
had no effect on the reactivity of the system, although it was only tested at room temperature 
(Entry 5). Heating the reaction in dichloroethane with PPh3AuNTf2 as the catalyst also gave no 
consumption of starting material (Entry 6). Diphenyl sulfoxide was also tested as an oxidant. 
When heated to 80 °C in either dichloroethane or nitromethane low levels of conversion of 
starting material were observed (Entries 7 and 8). 
While isolation of a new product was not possible, analysis by 1H- and 13C-NMR spectroscopy 
and mass spectrometry indicated that the undesired 1,2-carboamination product 784 had been 
formed with no oxidation of the alkyne. The in situ formation of an N-oxide by m-CPBA 
oxidation prior to addition of the gold catalyst had already been reported by Zhang and co-
workers in the gold-catalysed synthesis of bicyclic piperidin-4-ones and related systems.184 
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Table 6: Exploration of rearrangement conditions for 783
[a] 
 
Entry Catalyst Oxidant Temp/°C Solvent 783/%[b] 784/%[b] 
1 IPrAuCl[c]/AgOTs py. N-oxide RT CH2Cl2 -- -- 
2 AuLCl2
[d] py. N-oxide RT CH2Cl2 -- -- 
3 PPh3AuNTf2 py. N-oxide RT CH2Cl2 -- -- 
4 PPh3AuNTf2
[e] py. N-oxide RT CH2Cl2 --
[f] --[f] 
5 PPh3AuNTf2 O-1 RT CH2Cl2 -- -- 
6 PPh3AuNTf2 py. N-oxide 70 ClCH2CH2Cl -- -- 
7 IPrAuCl / AgOTs Ph2SO 80 MeNO2 -- 10 
8 IPrAuCl / AgSbF6 Ph2SO 80 ClCH2CH2Cl  -- 10 
9 PPh3AuNTf2 m-CPBA
[g] RT CH2Cl2 -- 32 
10 IPrAuCl / AgOTs none 80 MeNO2 -- 50 
[a]
 Reaction conditions: 783 (0.1 mmol, 1.0 equiv.), oxidant (1.1 equiv.), solvent (0.1 M). 
[b]
 Yields calculated by 
1
H-
NMR spectroscopy against a known quantity of internal standard (1,2,4,5-tetramethylbenzene). 
[c]
 IPr = 1,3-
bis(2,6-diisopropylphenyl)imidazol-2-ylidene. 
[d]
 L=Picolinate. 
[e]
 1.1 equiv. MsOH added at beginning of reaction. 
[f]
 Complex mixture observed by 
1
H-NMR. 
[g]
 m-CPBA (1.1 equiv) added at 0 °C and stirred for 16 hours before 
addition of catalyst at room temperature. 
It was hoped that an intramolecular oxidation pathway could be accessed analogous to that 
reported by Davies and Albrecht for the formation of sulfur ylides (vide supra, Scheme 176). 
However, using conditions reported by Zhang, no oxidation of the aniline nitrogen was observed 
by TLC and addition of a gold catalyst led to undesired carboamination product 784 alongside 
remaining starting material (c.f. Entries 3 and 9). The increased yield of 784 may be due to the 
traces of acid from the oxidant which assist in promoting the rearrangement. As a control 
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reaction, 783 was heated in nitromethane in the absence of an oxidant Table 6, Entry 10), 
leading to a 50% yield of rearranged product 784. More forceful conditions are certainly 
required to effect the 1,2-carboamination pathway than observed previously with the diallyl 
system. In all cases, however, no oxidation of the triple bond was observed, indicating the 
alkyne moiety is not sufficiently activated to undergo nucleophilic oxidation. 
5.2.2 Use of Electron Deficient Alkynes 
Consequently, it was decided to try and favour the desired process using an alkyne substituted 
with an electron withdrawing ester group. 786 was synthesised in one step from 764 by 
deprotonation of the alkyne with n-BuLi and trapping with methyl chloroformate (Scheme 183). 
Electronically-biasing the alkyne in this manner was intended to increase the reactivity at the β-
position toward the external oxidant while decreasing competing cyclisation of the nitrogen 
directly onto the alkyne at the α-position. 
 
Scheme 183: Synthesis of methyl ester substituted alkyne 786 
When alkyne 764 was subjected to gold catalysis using an IPrAuCl / AgOTs catalyst system in the 
presence of pyridine N-oxide, over 40% conversion of starting material was observed (Scheme 
184). Chromatographic separation was possible in this case and three new products were 
isolated and characterised.  
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Scheme 184: Initial results from catalysis with 786 indicating ylide formation 
As well as the expected undesired indole product 788 from 1,2-carboamination of the alkyne, 
diketone 789 (vide supra, Scheme 180, path c) was also isolated, demonstrating the increased 
reactivity of the triple bond. Pleasingly, desired isooxindole 787 was also isolated, arising from 
the proposed oxidation of the triple bond, ammonium ylide formation and [2,3]-sigmatropic 
rearrangement of an allyl group. Encouraged by these promising initial results, a thorough 
optimisation study was conducted and selected entries are detailed below. 
Variation of the counterion had a negative effect on the desired pathway with this gold catalyst 
(Table 7, Entries 1 and 2). When an excess of oxidant was employed, diketone 789 was observed 
at the major product, with no formation of isooxindole 787 (Entry 3). 
Unsurprisingly, in the absence oxidant, 788 was formed in excellent yield (Entry 4). A phosphite-
ligated gold complex also led to sole formation of 788 in the presence of oxidant (Entry 5). 
Simple gold(I) and gold(III) catalysts promoted the reaction, although starting material remained 
in both cases (Entries 6 and 7). 
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Table 7: Investigation of catalysts for ammonium ylide formation
[a] 
 
Entry Catalyst 786 / %[b] Yield 787 / %[b] Yield 788 / %[b] 789 / %[b] 
1 IPrAuCl / AgSbF6 -- trace 51 23 
2 IPrAuCl / AgNTf2 -- -- 68 34 
3 IPrAuCl / AgNTf2 -- --
[e] 29 71 
4 IPrAuCl[c] / AgOTs -- --[d] 95 -- 
5 L2AuCl / AgNTf2 23 -- 76 -- 
6 AuCl 31 8 56 15 
7 AuCl3 6 7 41 7 
8 AuLCl2
[f] trace 20 66 12 
[a]
 Reaction conditions: 786 (0.1 mmol, 1.0 equiv.), py. N-oxide (1.1 equiv.), all reactions were run for 16 hours. 
[b]
 
Yields calculated by 
1
H-NMR spectroscopy against a known quantity of internal standard (1,2,4,5-
tetramethylbenzene). 
[c]
 IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]. 
[d]
 No oxidant used. 
[e] 
4 
equivalents of oxidant used. 
[e]
 L=Picolinate. 
[f]
 L2 = tris(2,4-di-tert-butylphenyl) phosphite. 
The gold(III) precatalyst dichloro(picolinate)gold gave more promising results with near 
complete consumption of starting material and 20% of the desired product observed (Entry 8). 
This commercially available, air-stable catalyst was therefore used for the remainder of the 
study. A wide variety of oxidants and solvents were then tested for this transformation, with 
selected examples detailed below (Table 8). 
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Table 8: Investigation of oxidants and solvents for ammonium ylide formation
[a] 
 
Entry Solvent Oxidant 786 / %[b] 787 / %[b] 788 / %[b] 789 / %[b] 
1 CH2Cl2 O-2 -- 23 39 4 
2 CH2Cl2 O-1 7 11 54 14 
3 MeNO2 O-1 trace 21 50 27 
4 toluene O-1 trace 6 68 17 
5 H2O O-1 -- -- 85 5 
6 THF[c] O-1 trace 42 (41) 41 (39) 7 (7) 
7 THF[d] O-1  41 42 6 
8 THF O-3 -- 45 31 16 
9 THF O-3[e] -- 32 67 3 
10 THF O-3[f] 15 29 23 19 
11 DMF O-1 -- 46 21 6 
12 DMF O-3 -- 46 36 5 
13 DMF O-3[g] -- 50 50 -- 
[a]
 Reaction conditions: 786 (0.1 mmol, 1.0 equiv.), oxidant (1.1 equiv.), all reactions run for 16 hours. 
[b]
 Yields 
calculated by 
1
H-NMR spectroscopy against a known quantity of internal standard (1,2,4,5-tetramethylbenzene). 
[c]
 50 ppm water already present in solvent. 
[d]
 4 Å MS used. 
[e]
 Reaction conducted at 50 °C. 
[f]
 Reaction 
conducted at 0 °C. 
[g]
 Reaction conducted at 80 °C, using 4.0 equiv. of oxidant. 
4- and 2-(Methoxycarbonyl)pyridine N-oxides (O-2 and O-1) did not improve the yield of desired 
product in dichloromethane. The ratio of 787 to 788 was improved, although overall recovery 
was decreased (Entries 1 and 2). The use of a more polar solvent, nitromethane, had a positive 
effect on oxidation, although the yield of diketone 789 was also higher (27%, Entry 3). A less 
polar solvent such as toluene was not beneficial (Entry 4). Impressively, the 1,2-carboamination 
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pathway was promoted when water was used as the solvent (Entry 5), demonstrating the 
practical advantages of gold catalysts. The use of THF as the solvent gave a large improvement 
in terms of yield of desired product 787 and reduced over oxidation (Entries 6 and 7). Traces of 
water in the reaction solvent were found not to affect the outcome. In the first case (Entry 6), 
the THF used was found by Karl Fisher titrations to have a water content of 50 ppm. In the 
second case (Entry 7), activated molecular sieves were used in the reaction tube. 8-Ethyl 
quinoline N-oxide also performed well, to yield 45% of the desired product, although diketone 
789 was observed in higher yield (16%, Entry 8). Heating the reaction to 50 °C reduced the level 
of diketone but led to a large increase of the rearranged product 788 (Entry 9). Conducting the 
reaction at 0 °C led to much lower selectivity, with 19% diketone observed and starting material 
remaining after 16 hours (Entry 10). 
The use of DMF as the solvent gave very promising initial results (Entries 11-13). When the 
reaction was heated to 80 °C in the presence of four equivalents of O-1, no diketone was 
formed. Only a 1:1 mixture of the desired product 787 and rearranged product 788 were 
observed by 1H-NMR (Entry 13). Unfortunately, these results were not readily repeated, with 
the yields of products varying when a new bottle of solvent was used. Whilst similar results 
between runs could be obtained when reactions were repeated using a single batch of solvent, 
the initial results shown above could not be matched. This could be attributed to fluctuations in 
organic and inorganic impurities introduced during manufacture between batches of the solvent 
purchased, and also variations between different suppliers. Distillation of the solvent prior to 
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use did not improve matters. As a result of these investigations, the most effective system was 
deemed to be 2-(methoxycarbonyl)pyridine N-oxide (O-1) in THF at room temperature (Entry 6).  
During time spent at AstraZeneca (Macclesfield, UK), further attempts were made to optimise 
the desired pathway, taking advantage of the automated equipment available in a process 
chemistry laboratory. The first step was to perform a scaled-up synthesis of alkyne 768 starting 
from 50 g of 2-iodoaniline 761 (Scheme 185) which was successfully carried out in 91% yield 
over four steps to afford 38 g of 768.  
 
Scheme 185: Large scale synthesis of alkyne 768 
A Design of Experiment (DoE) was conducted using a factorial experimental design approach in 
order to optimise the desired pathway. It was decided to look at four experimental factors: 
temperature, concentration, catalyst loading and the equivalents of oxidant. Each factor was 
expected to have an effect on the product yield and rate of reaction. The advantage of 
investigating multiple factors at the same time is that information can be gained about which 
experimental factors, if any, are influenced by each other. The use of a high concentration may 
only be beneficial at low temperature, for example, a relationship that may be missed when 
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employing the more traditional ‘one factor at a time’ approach. This also limits the number of 
required experiments, saving time and resources.185 Using Modde software, an experimental 
design was generated (see Appendix), which suggested a series of 19 experiments based upon 
ranges input into the program, over which each factor would be tested. Ranges were chosen as 
follows: Oxidant: 1-5 equivalents, concentration: 0.05-0.2 M, temperature: 10-40 °C, catalyst 
loading: 2.5-7.5 mol%. The run order or experiments was randomised to reduce operator errors. 
The 19 reactions were carried out over two days, using an Integrity 10 Stem reaction block 
which allowed each reaction (up to 10) to be held at a different temperature whilst stirring, 
under a nitrogen atmosphere. An Amigo workstation auto-sampler was used to take 10 samples 
from each reaction over a 24 hour period. Once taken, each 40 µL sample was automatically 
diluted with 1200 µL of a MeCN / H2O mixture. The high dilution was sufficient to halt further 
reaction, which was later proven by HPLC analysis of samples taken several days previously. The 
samples (190 in total) were analysed by HPLC and the % area was used to generate a graph for 
each reaction. Three of the resulting graphs are shown below with the reaction number 
referring to the run order (see Appendix for all graphs). Reaction 10 (Figure 12) was conducted 
at the highest temperature employed in this study, also with the highest catalyst loading. The 
rate of reaction is therefore unsurprisingly rapid with the starting alkyne 786 consumed after 3 
hours. Because of this, and the restrictions on the frequency of sampling, little information can 
be obtained about the early stages of the reaction. As previously observed, the use of higher 
temperatures tends to promote the formation of undesired 1,3-diallyl indole 788. 
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Figure 12: Relative formations of products 787-789 as determined by HPLC analysis. Reaction conducted at high 
temperature, high concentration, with low oxidant loading and high catalyst loading 
When the same conditions were employed at low temperature (10 °C), the formation of 
undesired indole 788 was slightly suppressed, and diketone 789 was only detected in low levels 
(Figure 13). 
 
Figure 13: Reaction conducted at low temperature, high concentration with low oxidant loading and high catalyst 
loading  
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When these conditions were repeated employing a high oxidant loading, the formation of the 
desired product 787 was further increased. Interestingly, the level of formation of the diketone 
789 remained low at this temperature despite the large excess of oxidant. The reaction rate was 
much slower in this case and the starting material was consumed only after 40 hours at 10 °C. A 
trend observed throughout this study is clearly visible in this example. The formation of 788, 
arising from 1,2-carboamination of the alkyne is rapid at the beginning of the reaction, after 
which, the concentration remains reasonably constant. In contrast, the rate of formation of 
desired product 786 is slow in the initial stages of the reaction and then the rate steadily 
increases. This suggests that the catalytic species which promotes 1,2-carboamination, is 
distinct from that which catalyses ammonium ylide formation. 
 
Figure 14: Reaction conducted at low temperature, high concentration with high oxidant loading and high 
catalyst loading  
This catalyst, first reported by Hashmi,127 is known to require an induction period where the 
active catalytic species is formed, although it is not known what that actual active catalyst is. 
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This induction period was clearly observed in 1H-NMR studies conducted in Chapter 2. The 
reason behind the changing rates of reaction for the formation of 787 and 788 is unclear at 
present. Unfortunately, due to time constraints and preferential focus on other projects, it was 
not possible to further investigate this interesting reaction. 
Following my own work in this area, Yang, Tang and co-workers published their studies on the 
synthesis and rearrangement of oxonium ylides through formation of an α-oxo gold carbenoid 
from an alkyne under oxidative gold catalysis (Scheme 186).186 Interestingly, formation of 1,2-
carboalkoxylation or double oxidation products were not observed in this system, highlighting 
the inherent difficulties of ammonium ylide formation in related systems. In initial optimisation 
studies for reaction of phenol derived alkyne 790, the only side product observed was that 
arising from deallylation.  
 
Scheme 186: Synthesis of dihydrofuran-3-ones through gold catalysed oxoinium ylide formation 
The use of a stoichiometric rare-earth Lewis acid was required for high conversion alongside 
molecular sieves or anhydrous MgSO4. For aromatic substrates of type 790, the oxonium ylide 
(analogous to the proposed ammonium ylide in the above work) evolves through 1,4-migration 
of the allyl group to form O-allyl ether 791 which would then undergo a Claisen rearrangement 
to give the observed dihydrofuran-3-one 792. The intermediacy of 791 was confirmed by its 
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isolation in a related system. Depending on the substrate employed, different migration 
mechanisms, including direct allylic [2,3]-sigmatropic rearrangement, were invoked. 
5.2.2 Ynamide Substrates 
Building on work ongoing at the time in the Davies group into the generation of sulfur ylides 
from ynamides, via an α-oxo-gold carbenoid (vide supra, Scheme 178), the use of ynamides to 
access ammonium ylides was also briefly explored (prior to the research carried out at 
AstraZeneca discussed in the previous section). It was proposed that if an ynamide with a 
tethered N-allyl nitrogen nucleophile was employed, under oxidative gold-catalysis, ammonium 
ylides could be accessed which could then evolve through a [2,3]-sigmatropic rearrangement to 
generate valuable nitrogen heterocycles (Scheme 187). In principle, the allylamine moiety could 
be tethered to either the N or C terminus of the ynamide. 
 
Scheme 187: Proposed formation of ammonium ylides from ynamides 
To test this hypothesis, ynamide 800 was designed and synthesised to potentially access 
substituted piperizines (Scheme 188). Readily available ethylene diamine 797 was sulfonylated 
and mono-allylated according to literature procedures.187,188 The allylation step gave only a 
moderate yield of 799 due to some formation of the bis-allylated product, which was easily 
removed by column chromatography. The sulfonamide was then coupled with 
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bromophenylacetylene under standard conditions71 to give functionalised ynamide 800 in high 
yield. 
 
Scheme 188: Synthesis of acyclic ynamide 800 
Based on the general mechanism above, it was proposed that, on exposure to a gold catalyst 
and pyridine N-oxide, the triple bond of ynamide 800 would undergo regioselective oxidation 
and internal redox, with expulsion of pyridine to form 803. Formation of ammonium ylide 804 
would precede allylic [2,3]-sigmatropic rearrangement to generate the oxygenated piperizines 
805 (Scheme 189). Competing against this would, as before, be direct carboamination as well as 
over oxidation. 
 
Scheme 189: Proposed formation of piperizine 805 
In order to test this hypothesis, initial screening reactions of ynamide 800 were carried out 
using standard pyridine N-oxide and a variety of gold(I) and gold(III) catalysts, in 
dichloromethane ( 
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Table 9). Encouragingly, all catalysts tested led to some activation of the triple bond. IPrAuCl 
showed poor reactivity and the starting ynamide was largely untouched (Entries 1 and 2). Over-
oxidation to diketone 806, which was an expected side product, was observed in all cases by 1H-
NMR spectroscopy.  
Table 9: Initial screening of ynamide 800[a] 
 
Entry Catalyst 800 / %[b] 805 / %[b] 806 / %[b] 
1 IPrAuCl / AgOTs 91 -- 5 
2 IPrAuCl / AgSbF6 87 traces 5 
3 PPh3AuNTf2 44 12 41 
4 AuCl3 44 8 36 
5 AuCl 34 -- 58 
6 AuLCl2
[c] 41 14 44 
7 AuLCl2
[d] -- 5 88 
8 none 98%   
[a]
 Reaction conditions: 800 (0.1 mmol, 1.0 equiv.), py. N-oxide (1.1 equiv.). 
[b]
 Yields calculated by 
1
H-NMR 
spectroscopy against a known quantity of internal standard (1,2,4,5-tetramethylbenzene). 
[c]
 L=Picolinate. 
[d]
 5.0 
equivalents of oxidant used. IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene. 
Several catalysts promoted the generation of a new product in low yields, the mass of which 
was in agreement with the desired mono-oxidised rearrangement product 805. The most 
promising results were those using PPh3AuNTf2 (Entry 3) and AuLCl2 (Entry 6). An experiment 
was carried out using five equivalents of pyridine N-oxide (Entry 7) in order to obtain solely the 
over oxidised product 806. While 806 was formed in 88% yield, full characterisation was not 
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possible due to co-elution with 805 and other unidentified impurities on purification by column 
chromatography. The Rf values of the three species are nearly identical and so clean isolation 
was not possible, although analysis of crude 1H- and 13-C-NMR spectra, as well as mass 
spectrometry, supported the formation of the desired product 805 and the diketone 806. In this 
system, the 1,2-carboamination pathway was not observed to compete with either the 
oxidation pathways.  
Table 10: Survey of solvents and oxidants[a] 
 
Entry Solvent Oxidant Temp / °C 800 / %[b] 805 / %[b] 806 / %[b] 
1 MeNO2 py. N-oxide RT 40 traces 38 
2 THF py. N-oxide RT 61 5 33 
3 toluene py. N-oxide RT 38 15 47 
4 toluene py. N-oxide 80 37 -- 37 
5 MeCN py. N-oxide RT 54 4 31 
6 MeCN py. N-oxide 70 54 16 34 
7 CH2Cl2 Ph2SO RT 43 4 30 
8 CH2Cl2 O-1 RT 46 -- 42 
9 CH2Cl2 O-2 RT 31 3 41 
10 CH2Cl2 O-3 RT 44 -- 52 
11 CH2Cl2 O-4 RT 42 3 41 
12 CH2Cl2 py. N-oxide RT 41 14 44 
[a]
 Reaction conditions: 800 (0.1 mmol, 1.0 equiv.), oxidant (1.1 equiv.). 
[b]
 Yields calculated by 
1
H-NMR 
spectroscopy against a known quantity of internal standard (1,2,4,5-tetramethylbenzene). 
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The function of the gold catalyst in promoting consumption of ynamide 800 was confirmed 
when no reaction was observed in the absence of catalyst (Entry 8).A variety of different 
solvents were next screened using the gold(III) pre-catalyst AuLCl2 (L = picolinate, 
Table 10).  
Variation of the polarity of the solvent and the use of an increased temperature did not offer 
any improvement as compared to the use of dichloromethane at room temperature (Entries 1-
6). A number of different N-oxides were also tested (Entries 8-11) however, none gave any real 
improvement on the consumption of starting material or formation of the desired product. 
Despite the success of methyl picolinate N-oxide O-1 in the previous oxidation chemistry, no 
desired product was detected by 1H-NMR spectroscopy (Entry 8). 
It has been shown that the triple bond of ynamide 800 is sufficiently activated by a gold catalyst 
to undergo oxidation by an external nucleophilic oxidant. Oxygenated piperizine 805 and 
diketone 806 had been observed by 1H- and 13C-NMR as well as by mass spectrometry, although 
isolation was not possible. Due to the high levels of diketone formation, alongside poor 
conversion of starting material, it was decided not to continue the optimisation of this system.  
Finally, the synthesis of the benzene-derived ynamide was attempted (Scheme 190). It was 
thought that a more rigid system would help to bring the desired reactive components together 
in space and reduce the levels of over-oxidation by favouring the desired ylide formation. 2-
Nitroaniline 807 was reduced under acidic conditions to give the diamine 808 which was 
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sulfonylated in moderate yield to give 809 (Scheme 190). Using the same conditions as for the 
acyclic substrate (Scheme 188), monoallylated sulfonamide 810 was prepared. 
 
Scheme 190: Attempted synthesis of benzene derivative 811 
Unfortunately, the final step in the synthesis, copper-catalysed coupling with 
bromophenylacetylene,71 failed to generate the desired ynamide, with only starting material 
visible in the 1H-NMR spectrum of the crude reaction mixture. This might be explained by 
chelate complexation of the diamine derivative with the copper catalyst, as well as 
intramolecular hydrogen bonding between the secondary and tertiary amides, made possible by 
the reduced flexibility of this system. Evidence for the latter can be seen in the 1H-NMR 
spectrum where two distinct resonances are observed for the allylic protons which suggests 
restricted rotation.  
5.3 Summary 
Several systems have been prepared and investigated towards the realisation of gold-catalysed 
ammonium ylide generation directly from triple bonds. Despite terminal alkynes being used 
successfully in other oxidative gold-catalysed transformations,9a,179 ortho-ethynyl aniline-derived 
substrates were not suitable in this case due to lack of reactivity towards oxidation, and 
competing intramolecular 1,2-carboamination processes. Substitution of the alkyne terminus 
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with an electron withdrawing ester group, however, led to the formation of the desired 
isooxindole product which is expected to arise from formation of the proposed ammonium ylide 
intermediate. The formation of the diketone side product supports the intermediacy of an α-
oxo-gold carbenoid.  
Extensive optimisation studies have been carried out for aniline-derived systems, with the 
formation of the desired product maximised at low temperature with high catalyst loading. 
Intriguingly, formation of the desired product and the indole arising from competitive 1,2-
carboamination, appear to be promoted by distinct catalytic species. Preliminary work has also 
been conducted into the formation of ammonium ylides from ynamides. Future work would 
seek to modify the reactivity of the nitrogen nucleophile to promote ylide formation. 
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6 Outlook and Future Work 
Throughout the course of this research, I have discovered and developed four novel 
transformations for the synthesis of valuable nitrogen heterocycles and carbocycles from C-C 
triple bonds using gold and copper catalysis.  
 
Scheme 191: Summary of motifs accessed from gold- and copper-catalysed transformations of triple bonds 
The concept of ammonium ylide generation directly from alkynes has been demonstrated in the 
synthesis of an isoxindole using gold catalysis under oxidative conditions (Scheme 191). This 
proved to be a very challenging transformation due to competing inter- and intramolecular 
pathways. Whilst this chemistry has been established for sulfonium and oxonium ylides, 
examples of the ammonium equivalent remain unreported. Future work should aim to develop 
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an understanding of the catalytic species involved in the promotion of the observed pathways. 
This would assist in the further optimisation and exploitation of the potential of this highly 
valuable reaction. The power of π-acid catalysed insertion of C-C triple bonds into C-X σ-bonds 
has been demonstrated in the first reported example of the 1,1-carboalkoxylation of ynamides 
(Scheme 191, path a). A novel range of functionalised indenes have been generated, with 
formation of new C-C, C-O and C-N bonds in a single step. By controlling the initial cyclisation, a 
novel gold carbene intermediate has been accessed which evolves through a selective [1,2]-N-
migration, previously unreported in gold catalysis. The observed selectivity has been 
rationalised based on developing steric strain adjacent to the gold carbene. 13C-Labelling studies 
have confirmed the proposed endo-mode cyclisation, with cleavage of the C-N bond of the 
ynamide. Furthermore, by derivatising the functionalised indene products a novel 8-membered 
oxazocine core was prepared and observed to undergo ready conversion into a valuable vinyl 
azetidine motif. This 6-π electrocyclisation of the 8-membered ring potentially offers a powerful 
new route into functionalised azetidines. Future work should aim to explore whether this 
chemistry can be more widely used on systems other than the indene support and realise a 
more general route to these cores (Scheme 192). 
 
Scheme 192: A general rearrangement of an oxazocine ring to give functionalised vinyl azetidines 
The generation of an alternative gold carbene has also been realised through a [1,5]-hydride 
shift onto a gold-bound keteneiminium acceptor. N-allyl substituted ynamides were employed 
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to access a novel polycylisation cascade to form functionalised tetracyclic products through 
cyclopropanation onto the carbene (Scheme 191, path b). The scope and limitations of this 
reaction have been investigated to include the incorporation of acid sensitive acetal groups, 
which makes this transformation highly appealing. Further Derivatisation of the products, 
through carbonyl addition in a 1,2-, 1,4- or a 1,7-sense, would add considerable value to this 
chemistry. Deuterium labelling studies have confirmed the intramolecular nature of the hydride 
shift and a primary kinetic isotope effect has been observed, indicating the cleavage of the C-H / 
C-D bond is involved in the turnover-limiting step. Work on the further development of this 
fascinating transformation is ongoing in our laboratory (Elli Chatzopoulou) and the substrate 
scope has already been expanded considerably as a result. 
Finally, using related N-allyl ynamide substrates, a novel copper-catalysed cascade has been 
realised for the synthesis of range of functionalised isoquinoline derivatives, through an rare 
[1,5]-shift pathway onto a sulfonyl ketene imine (Scheme 191, path c). Deuterium labelling has 
again confirmed the intramolecular nature of the hydride transfer and indicated cleavage of the 
C-H / C-D is involved in the turnover limiting step. 
This work has demonstrated the wide utility of ynamides, and the use of these motifs to control 
regioselectivity and therefore, reaction outcomes. The use of ynamides in gold catalysis is still a 
relatively undiscovered area and I have demonstrated how it can be used to effect a rapid 
development of complexity in processes. As these processes inherently involve nitrogen 
incorporation into hetero- and carbocyclic products, they, and related reactions should lend 
themselves well to the synthesis of natural products and biologically active target molecules. 
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7 Experimental Section 
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General Experimental 
Flash column chromatography: Fluorochem silica gel 60 (0.043-0.063 mm). Thin layer 
chromatography (TLC): Merck silica gel 60F254 analytical plates which were developed using 
standard visualizing agents: UV fluorescence (254 and 366 nm), potassium permanganate /Δ 
and vanillin /Δ. IR: Perkin–Elmer Spectrum 100 FTIR spectrometer. Only selected absorbencies 
(νmax) are reported in cm
-1. MS and HRMS (EI): VG ProSpec or VG-ZabSpec at 70 eV. High 
resolution EI spectra were measured using perfluorokerosene (PFK) as an internal calibrant. MS 
and HRMS (ES): Micromass LCT using a methanol mobile phase. HRMS was obtained using a 
lock-mass to adjust the calibrated mass scale. MS data are reported as m/z (relative intensity). 
Commercially available chemicals/reagents were purchased from Sigma Aldrich, Acros, Alfa 
Aesar and used without further purification unless reported. All Grignard reagents were freshly 
prepared according to GP2. All catalysis reactions were carried out under argon in heat gun-
dried glassware. The solvents used were purified using a Pure Solv-MD solvent purification 
system and were transferred under argon. The following cooling baths were used: 0 °C 
(ice/water), -10 °C (NaCl/ice/water) and -78 °C (dry ice/acetone). Paraffin oil baths on stirrer 
hotplates were employed for reactions with temperature controlled via an external probe. 
NMR: Spectra were recorded on Bruker AVIII300 (1H = 300 MHz) and Bruker AVIII400 (1H = 400 
MHz, 13C = 101 MHz) and Bruker AVIII500 (1H = 500 MHz, 13C = 126 MHz) in the solvents 
indicated; CDCl3, d6-DMSO and d7-toluene were purchased from Sigma Aldrich. High 
temperature NMR were recorded on Brucker AV400 (1H = 400 MHz, 13C = 101 MHz). Chemical 
shifts (δ) are given in ppm relative to TMS. The solvent signals were used as references and the 
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chemical shifts converted to the TMS scale (CDCl3: δC ≡ 77.16 ppm; residual CHCl3 in CDCl3: δH ≡ 
7.26 ppm). Coupling constants (J) are reported in Hz. Multiplicity is denoted in 1H-NMR by: m 
(multiplet), d (doublet), t (triplet) and q (quartet) and 13C-NMR by: C (quaternary) CH (tertiary), 
CH2 (secondary) and CH3 (primary). 1D 
13C-NMR spectra were recorded using the UDEFT or 
PENDANT pulse sequences from the Bruker standard pulse program library. 2D 13C-NMR HSQC 
and HMBC spectra were recorded using the Bruker standard pulse program library. 2D 1H-NMR 
spectra were recorded using the Bruker standard pulse program library. Spectra were processed 
using MestReNova version 6.0.2 or Topspin version 2.1. 
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General Procedures 
General Procedure 1 (GP1): Preparation of 2-Ethynyl Aldehydes 
 
The required bromide (1.0 equiv.) was dissolved in Et3N (0.25 M) at room temperature. 
Pd(PPh3)Cl2 (2 mol%), CuI (1 mol%) and trimethylsilyl acetylene were added and the resulting 
mixture was stirred at 50 °C until complete by TLC. After cooling to room temperature, the 
solids were removed by filtration through a pad of celite (ca. 3 cm) and the solvent removed 
under reduced pressure. The crude residue was purified by flash column chromatography to 
give the desired 2-ethynyl aldehydes. 
General Procedure 2 (GP2): Preparation of Benzhydric Alcohols 
 
Procedure is based on that reported by Dubé and Toste,53 using freshly prepared Grignard 
reagents: Magnesium turnings (3.0 equiv.) were added to a 2-neck flask fitted with a reflux 
condenser. THF or Et2O (1 M) was then added followed by a catalytic quantity of iodine (5-50 
mg). The aryl bromide (3.0 equiv.) was added slowly and the reaction stirred for 0.5-1 hour until 
the magnesium turnings had been consumed. Once the flask had cooled to room temperature, 
stirring was stopped and the solution was used directly. The alcohol (1.0 equiv.), was dissolved 
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in THF (0.2 M) and cooled to -78 °C. The relevant Grignard solution (1 M in THF or Et2O, 2.0 
equiv.) was added dropwise and the resulting solution stirred at this temperature for 10 
minutes. The solution was then warmed to room temperature and stirred for 1 hour before the 
addition of saturated NH4Cl solution. The aqueous layer was extracted with Et2O (× 2) and 
washed with brine before drying over Na2SO4, filtering and concentrating under reduced 
pressure. Purification using flash column chromatography afforded the desired alcohols. 
General Procedure 3 (GP3): Preparation of Terminal Alkynes 
 
Following the procedure described by Dubé and Toste,Error! Bookmark not defined. the required 
benzhydric alcohol (1 equiv.) was dissolved in THF (0.2 M) and cooled using an ice bath. NaH 
(60% dispersion in mineral oil, 1.2 equiv.) was added in one portion and the resulting mixture 
stirred for 30 minutes at this temperature. The relevant alkyl halide (1.5 equiv.) was added and 
the mixture stirred at room temperature for 2 hours. Saturated NH4Cl solution was added, and 
the aqueous phase extracted with Et2O (× 2), washed with brine and dried over Na2SO4. The 
solid was filtered off and the solvent removed under reduced pressure. The crude residue was 
dissolved in MeOH (0.2 M) and stirred at room temperature with K2CO3 (0.5 equiv.) for 1 hour. 
The inorganic salt was removed by filtration through a pad of silica (1 cm), eluting with CH2Cl2, 
and the solvent was removed under reduced pressure. Purification by flash column 
chromatography gave the desired terminal alkynes. 
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General Procedure 4 (GP4): Preparation of Terminal Alkynes 
 
The required 2-((trimethylsilyl)ethynyl)benzaldehyde derivative (1.0 equiv.) was dissolved in 
MeOH (0.2 M), K2CO3 (0.5 equiv.) was added and the mixture was stirred at room temperature 
for up to 1 hour, until complete by TLC. Saturated NaHCO3 solution was added and the aqueous 
phase was extracted with EtOAc (× 2) and dried over Na2SO4. The solid was filtered off and the 
solvent removed under reduced pressure to give the terminal alkynes which were used without 
further purification. 
General Procedure 5 (GP5): Preparation of Acetals from Ethynyl Aldehydes 
 
The required aldehyde (1.0 equiv.), diol (1.2 equiv.) and p-TsOH·H2O (5 mol%) were dissolved in 
toluene (0.2 M) and heated at reflux with azeotropic removal of water using Dean Stark 
apparatus. Once complete by TLC (generally between 30 minutes and 4 hours), the reaction 
mixture was cooled to room temperature and saturated NaHCO3 solution was added. The 
aqueous layer was extracted with EtOAc (× 3), dried over Na2SO4, filtered and the solvent 
removed under reduced pressure. The crude acetals were purified by flash column 
chromatography. 
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General Procedure 6 (GP6): Preparation of N-Tosyl Alkyl Imines 
 
The required alkyl aldehyde (1.0 equiv.), p-methylbenzene sulfonamide (1.0 equiv.) and sodium 
p-methylbenzene sulfinate (1.0 equiv.) were dissolved in a 1:1 mixture of formic acid and H2O 
(0.3 M) and the resulting solution was stirred at room temperature for 16 hours. The precipitate 
was filtered under vacuum and the filter bed was washed with H2O (× 3), and pentane. The solid 
was dissolved in CH2Cl2 and washed rapidly with saturated NaHCO3 solution (ca. 45 seconds). 
The aqueous layer was extracted with CH2Cl2 (× 3), dried over Na2SO4, filtered and the solvent 
was removed under reduced pressure to give the pure imines. 
General Procedure 7 (GP7): Preparation of Sulfonamides 
 
The required amine (1.2 equiv.) and pyridine (3.0 equiv.) were dissolved in CH2Cl2 (0.3 M) and 
cooled to 0 °C. The required sulfonyl chloride (1.0 equiv.) was added in small portions and the 
resulting mixture was stirred at room temperature for 16 hours. 1.0 M HCl solution was added 
and the aqueous layer was extracted with CH2Cl2 (× 3). The combined organic extracts were 
washed with H2O (× 2), brine, dried over Na2SO4, filtered and the solvent was removed under 
reduced pressure. The resulting sulfonamides did not usually require further purification. 
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General Procedure 8 (GP8): Preparation of Substituted N-Allyl and N-Homoallyl Sulfonamides  
 
Vinyl and allyl Grignard reagents were freshly prepared as described in GP2. The sulfonyl imine 
(1.0 equiv.) was dissolved in THF (0.2 M) and cooled to -10 °C. The Grignard solution (1.0 M, 2.0 
equiv.) was added dropwise. The solution was allowed to warm to room temperature and 
stirred for 1 hour. Saturated NH4Cl solution was added and the aqueous layer was extracted 
with Et2O (× 2) and washed with brine before drying over Na2SO4, filtering and concentrating 
under reduced pressure. Purification by flash column chromatography afforded the substituted 
N-allyl- or N-homoallyl sulfonamides. 
General Procedure 9 (GP9): Preparation of Bromoalkynes using n-BuLi / Br2 
 
The terminal alkyne (1.0 equiv.) was dissolved in THF (0.6 M) and cooled to -78 °C. n-BuLi (2.5 M 
in hexane, 1.2 equiv.) was added dropwise and the resulting solution stirred for 10 minutes. Br2 
(1.4 equiv.) was added dropwise and the solution was warmed to room temperature. Saturated 
NH4Cl solution was added and the product extracted with Et2O (× 2). The combined organic 
fractions were washed with brine, dried over NaSO4 and filtered. The solvent was removed 
under reduced pressure to give the bromoalkynes which were used immediately in the next 
step without further purification. 
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General Procedure 10 (GP10): Preparation of Bromoalkynes using NBS/AgNO3 
 
N-Bromosuccinimide (1.1 equiv.) and AgNO3 (0.1 equiv) were added to a solution of the 
terminal alkyne (1.0 equiv.) in acetone (0.2 M) at room temperature and the solution was 
stirred for 1 hour. 2-3 spatulas of silica were added to the flask and the solvent removed under 
reduced pressure. The resulting solid was loaded onto a pad (ca. 2 cm) of silica and the product 
was eluted [hexane:EtOAc (95:5)] into a receiving flask. The solvent was removed under 
reduced pressure to give the bromoalkynes which were used immediately in the next step 
without further purification. 
General Procedure 11 (GP11): Preparation of Ynamides from Bromoalkynes  
 
Following the procedure described by Hsung,71 sulfonamide (1.0 equiv.), 1,10-phenanthroline 
(0.4 equiv.), CuSO4∙5H2O (0.2 equiv.), K2CO3 (2.0 equiv.) and the bromoalkyne (1.2 equiv.) were 
combined in a flask which was purged with argon for 5 minutes. Toluene (1.0 M) was added and 
the resulting solution was heated to 65 °C and stirred for 16 hours unless specified. The 
resulting mixture was diluted with CH2Cl2 and filtered through a short pad (ca. 1 cm) of silica, 
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eluting with CH2Cl2. The solvent was removed under reduced pressure and the crude residue 
was purified by flash column chromatography to give the desired ynamides. 
General Procedure 12 (GP12): Preparation of Ynamides from Terminal Alkynes 
 
Following the procedure reported by Stahl,68 sulfonamide (5.0 equiv.), Na2CO3 (2.0 equiv.) and 
CuCl2 (0.2 equiv.) were added to a 500 mL 3-necked flask which was purged with O2 for 15 
minutes. Toluene (1.0 M with respect to sulfonamide) and then pyridine (2.0 equiv.) were added 
and the mixture heated to 70 °C. 2 large balloons were filled with O2 and attached to the flask 
using needles. A solution of alkyne (1.0 equiv.) in toluene (0.2 M with respect to alkyne) was 
added over 8 hours using a syringe pump and stirring was continued for 16 hours. The solvent 
was removed under reduced pressure and the crude residue was purified by flash column 
chromatography to give the desired ynamides. The unreacted amide is recoverable by column 
chromatography. 
General procedure 13 (GP13): Preparation of Functionalised Indenes 
 
The relevant ynamide (1.0 equiv.) was dissolved in CH2Cl2 (0.1 M), (p-CF3C6H4)3PAuNTf2 (5 mol%) 
was added and the reaction was stirred at room temperature until complete by TLC. The 
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reaction mixture was filtered through a pipette containing a short silica pad (ca. 1 cm), eluting 
with EtOAc (15 mL) and the solvent removed under reduced pressure. Purification by flash 
column chromatography or recrystallisation gave the desired indene derivatives. 
General Procedure 14 (GP14): Preparation of Functionalised Tetracycles 
 
The relevant ynamide (1.0 equiv.) was dissolved in toluene (0.1 M) and if required, the reaction 
tube was placed in a preheated oil bath at the specified temperature. Dichloro(2-
pyridinecarboxylato)gold (5 mol%) was added and the reaction stirred until complete by TLC. 
The reaction mixture was cooled to room temperature as necessary and filtered through a 
pipette containing a short (ca. 1 cm) pad of silica, eluting with EtOAc (15 mL). In the case of 
acetal protected substrates, Et3N (0.1 mL, 1%) was added to the eluent. The solvent was 
removed under reduced pressure and purification by flash column chromatography gave the 
desired functionalised tetracycles. 
General procedure 15 (GP15): Preparation of Functionalised Isoquinolines (I) 
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The required N-allyl ynamide (1.0 equiv.) was dissolved in toluene (0.1 M) before the addition of 
CuI (5 mol%) and K2CO3 (1.2 equiv.). The reaction tube was placed in an oil bath, preheated to 
100 °C and stirred until complete by TLC. The reaction mixture was cooled to room temperature 
and filtered through a pipette containing a short (ca. 1 cm) pad of silica, eluting with a mixture 
of EtOAc (15 mL) and Et3N (0.2 mL, 1%). The solvent was removed under reduced pressure and 
purification by flash column chromatography gave the desired functionalised isoquinolines. 
General procedure 16 (GP16): Preparation of Functionalised Isoquinolines (II) 
GP14 was followed without the addition on K2CO3. 
Preparation of 2-Bromo Aldehydes 
2-Bromocyclohex-1-ene-1-carbaldehyde 523 
 
DMF (3.5 mL, 45.0 mmol, 3.0 equivs.) was dissolved in CH2Cl2 (50 mL, 0.3 M) and cooled to 0 °C. 
PBr3 (3.8 mL, 40.5 mmol, 2.7 equiv.) was added dropwise and the resulting solution was stirred 
for 1 hour at this temperature. Cyclohexanone (1.6 mL, 15.0 mmol, 1.0 equiv.) was added 
dropwise and stirring was continued for 16 hours at room temperature. The reaction mixture 
was poured slowly into an ice-cooled, saturated solution of NaHCO3 (150 mL). The organic 
phase was extracted with CH2Cl2 (3 × 100 mL), washed with water (100 mL), dried over Na2SO4, 
filtered and the solvent removed was under reduced pressure. Purification by flash column 
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chromatography [hexane:EtOAc (95:5)] gave the 2-bromo aldehyde 523 (624 mg, 22%) as a clear 
oil; 1H-NMR (300 MHz, CDCl3): δ 10.01 (s, 1H), 2.79 – 2.69 (m, 2H), 2.30 – 2.23 (m, 2H), 1.81 – 
1.64 (m, 4H); IR: νmax (cm
-1) 2968, 2955, 2945, 2855, 2821, 1680, 1210, 947. Data matches that 
reported in the literature.120a 
Note: Employment of reduced reaction time and increased number of extractions made little 
difference to the yield of isolated product. 
3-Bromoisonicotinaldehyde 524 
 
n-BuLi (4.2 mL, 2.4 M solution in hexane, 10.0 mmol, 1.0 equiv.) was added dropwise to a 
solution of diisopropylamine (1.4 mL, 10.0 mmol, 1.0 equiv) in THF (17 mL, 0.6 M) at room 
temperature. After 10 minutes, the solution was cooled to -78 °C and 3-bromopyridine (1.0 mL, 
10.0 mmol, 1.0 equiv) was added dropwise. After a further 10 minutes, DMF (0.8 mL, 10.0 
mmol, 1.0 equiv.) was added slowly and the resulting solution was stirred for 30 minutes. The 
reaction mixture was warmed to room temperature and water (20 mL) was added. The organic 
layer was extraced with EtOAc (3 × 20 mL), dried over Na2SO4, filtered and the solvent was 
removed under reduced pressure to give the aldehyde 524 (1.3 g, 73%) as a white solid which 
was used without further purification; mp: 79-81 °C; 1H-NMR (300 MHz, CDCl3): δ 10.35 (s, 1H), 
8.90 (s, 1H), 8.70 (d, J = 4.9 Hz, 1H), 7.69 (d, J = 4.9 Hz, 1H); IR: νmax (cm
-1) 3080, 3045, 3008, 
2899, 1692, 1276, 1012, 764, 750. Data matches that reported in the literature.189 
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3-Bromothiophene-2-carbaldehyde 525 
 
n-BuLi (6.2 mL, 2.4 M solution in hexane, 15.0 mmol, 1.0 equiv.) was added dropwise to a 
solution of diisopropylamine (2.1 mL, 15.0 mmol, 1.0 equiv) in THF (26 mL, 0.6 M) at room 
temperature. After 10 minutes, the solution was cooled to 0 °C and 3-bromothiophene (1.4 mL, 
15.0 mmol, 1.0 equiv.) was added dropwise. After strirring for 1 hour, DMF (1.2 mL, 10.0 mmol, 
1.0 equiv.) was added slowly and the resulting solution was stirred for a further 4 hours. Water 
(30 mL) was added and the mixture was warmed to room temperature. The organic layer was 
extraced with Et2O (3 × 30 mL), washed with brine (30 mL), dried over Na2SO4, filtered and the 
solvent was removed under reduced pressure to give aldehyde 525 (2.8 g, 97%) as a brown oil 
which was used without further purification; 1H-NMR (300 MHz, CDCl3): δ 9.97 (d, J = 1.4 Hz, 
1H), 7.71 (dd, J = 5.1, 1.4 Hz, 1H), 7.14 (d, J = 5.1 Hz, 1H); IR: νmax (cm
-1) 3105, 2844, 2816, 2776, 
1658, 1496, 1415, 1371, 1342, 886, 730, 661. Data matches that reported in the literature.118 
2-Formyl-6-methoxyphenyl trifluoromethanesulfonate 526 
 
A solution of o-vanillin (1.0 g, 6.6 mmol, 1.0 equiv.) and pyridine (1.1 mL, 13.1 mmol, 2.0 equiv.) 
in CH2Cl2 (25 mL, 0.3 M) was cooled to 0 °C and  Tf2O (1.4 mL, 8.5 mmol, 1.3 equiv.) was added 
over 1 hour. The resulting solution was warmed to room temperature and filtered through a 
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short pad (ca. 2 cm) of silica, eluting with CH2Cl2 (50 mL). The solvent was removed under 
reduced pressure to give the triflate XX (1.8 g,98%) as a yellow oil which was used without 
further purification; 1H-NMR (300 MHz, CDCl3): δ 10.23 (s, 1H), 7.52 (dd, J = 7.8, 1.9 Hz, 1H), 7.46 
(app. t, J = 7.8 Hz, 1H), 7.31 (dd, J = 7.8, 1.9 Hz, 1H), 3.96 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
186.9 (CH), 151.8 (C), 139.4 (C), 129.7 (C), 129.2 (CH), 123.8 (q, JC-F = 320.7 Hz, C), 121.3 (CH), 
118.8 (CH), 56.7 (CH3); IR: νmax (cm
-1) 3083, 2966, 2875, 2767, 1701, 1480, 1418, 1408, 1129, 
882. Data matches that reported in the literature.119a 
Preparation of 2-Ethynyl Aldehydes 
2-((Trimethylsilyl)ethynyl)benzaldehyde 230 
Prepared according to GP1 from 2-bromobenzaldehyde (2.0 g, 10.8 mmol). 
Purification by flash column chromatography [hexane:EtOAc (92:8)] gave the 
protected alkyne 230 (2.1 g, 97%) as a pale brown solid; mp: 49-51 °C; 1H-NMR (300 MHz, 
CDCl3): δ 10.56 (d, J = 0.8 Hz, 1H), 7.94 – 7.88 (m, 1H), 7.61 – 7.51 (m, 2H), 7.48 – 7.39 (m, 1H), 
0.28 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 192.0 (CH), 136.3 (C), 133.8 (CH), 133.6 (CH), 129.0 
(CH), 127.0 (CH), 126.9 (C), 102.6 (C), 100.2 (C), -0.1 (3 × CH3); MS (EI): m/z 202 [M]
+ (10 %), 187 
(100). Data matches that reported in the literature.190 
4,5-Dimethoxy-2-((trimethylsilyl)ethynyl)benzaldehyde 302 
Prepared according to GP1 from 6-bromoveratraldehyde (2.45 g, 10.0 mmol) 
using 5 mol% Pd and Cu catalysts. Purification by flash column 
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chromatography [hexane:EtOAc (92.5:7.5)] gave the protected alkyne 302 (2.5 g, 96%) as a 
yellow solid; mp: 113-115 °C; 1H-NMR (400 MHz, CDCl3): δ 10.38 (d, J = 0.6 Hz, 1H), 7.36 (s, 1H), 
6.97 (s, 1H), 3.95 (s, 3H), 3.92 (s, 3H), 0.27 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 190.7 (CH), 
153.6 (C), 150.0 (C), 130.8 (C), 121.5 (C), 114.7 (CH), 108.2 (CH), 100.9 (C), 100.2 (C), 56.4 (CH3), 
56.2 (CH3), -0.05 (3 × CH3). Data matches that reported in the literature.
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5-Methoxy-2-((trimethylsilyl)ethynyl)benzaldehyde 303 
Prepared according to GP1 from 2-bromo-5-methoxybenzaldehyde (2.0 g, 9.2 
mmol). Purification by flash column chromatography [hexane:EtOAc (95:5)] 
gave the protected alkyne 303 (2.0 g, 94%) as a white solid; 1H-NMR (300 
MHz, CDCl3): δ 10.50 (s, 1H), 7.47 (d, J = 8.6 Hz, 1H), 7.36 (d, J = 2.8 Hz, 1H), 7.07 (dd, J = 8.6, 2.8 
Hz, 1H), 3.85 (s, 3H), 0.26 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 191.8 (CH), 160.0 (C), 137.7 (C), 
135.0 (CH), 121.6 (CH), 120.0 (C), 109.7 (CH), 100.6 (C), 100.3 (C), 55.72 (CH3), -0.02 (3 × CH3); IR: 
νmax (cm
-1) 2998, 2971, 2965, 2846, 2151, 1695, 1599, 1489, 1387, 1314, 1076, 1028. Data 
matches that reported in the literature.192  
5-Fluoro-2-((trimethylsilyl)ethynyl) benzaldehyde 304 
Prepared according to GP1 from 2-bromo-5-fluorobenzaldehyde (1.5 g, 7.5 
mmol) using 5 mol% Pd and Cu catalysts. Purification by flash column 
chromatography [hexane:EtOAc (90:10)] gave the protected alkyne 304 (1.6 g, 
96%) as a yellow oil;  1H-NMR (400 MHz, CDCl3): δ 10.49 (d, J = 3.2 Hz, 1H), 7.57 (dd, J = 8.6, 1.5 
Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H), 7.24 (ddd, J = 8.6, 7.9, 2.7 Hz, 1H), 0.27 (s, 9H); 13C NMR (101 
MHz, CDCl3) δ 190.7 (CH), 162.6 (d, JC-F = 252.9 Hz, C), 138.4 (d, JC-F = 6.7 Hz, C), 135.7 (d, JC-F = 
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7.7 Hz, CH), 123.0 (d, JC-F = 3.4 Hz, C), 121.3 (d, JC-F = 22.8 Hz, CH), 113.6 (d, JC-F = 23.0 Hz, 
CH),102.3 (C), 99.15 (C), -0.13 (3 × CH3); IR: νmax (cm
-1) 2961, 2158, 1707, 1695, 1601, 1485, 
1421, 1188, 1149, 887, 737. Data matches that reported in the literature.191 
2-((Trimethylsilyl)ethynyl)cyclohex-1-ene-1-carbaldehyde 527 
Prepared according to GP1 from 2-bromocyclohex-1-ene-1-carbaldehyde 523 
(1.2 g, 6.1 mmol), using 5 mol% Pd and Cu catalysts. Purification by flash column 
chromatography [hexane:EtOAc (98:2)] gave the protected alkyne 527 (691 mg, 55%) as a 
brown oil; 1H-NMR (300 MHz, CDCl3): δ 10.20 (s, 1H), 2.44 – 2.35 (m, 2H), 2.28 – 2.19 (m, 2H), 
1.71 – 1.58 (m, 4H), 0.21 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 193.2 (CH), 143.7 (C), 139.9 (C), 
104.8 (C), 101.6 (C), 32.3 (CH2), 22.1 (CH2), 21.9 (CH2), 21.1 (CH2), -0.1 (3 × CH3); IR: νmax (cm
-1) 
3052, 2987, 2947, 2849, 2843, 1670, 1598, 1485, 1265. Data matches that reported in the 
literature.193 
3-((Trimethylsilyl)ethynyl)isonicotinaldehyde 528 
Prepared according to GP1 from 3-(bromoethynyl)isonicotinaldehyde 524 (600 
mg, 3.3 mmol). Purification by flash column chromatography [hexane:EtOAc 
(95:5)] gave the protected alkyne 528 (467 mg, 74%) as an orange solid; mp: 162-164 °C; 1H 
NMR (300 MHz, CDCl3) δ 10.52 (d, J = 0.7 Hz, 1H), 8.88 (d, J = 0.7 Hz, 1H), 8.72 – 8.68 (m, 1H), 
7.67 (dd, J = 5.1, 0.8 Hz, 1H), 0.29 (s, 9H); IR: νmax (cm
-1) 2955, 2934, 2880, 2836, 1705, 1345, 
1159, 809, 663. Data matches that reported in the literature.194 
3-((Trimethylsilyl)ethynyl)thiophene-2-carbaldehyde 529 
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Prepared according to GP1 from 3-(bromoethynyl)thiophene-2-carbaldehyde 525 
(1.0 g, 5.0 mmol). Purification by flash column chromatography [hexane:EtOAc 
(97:3)] gave the protected alkyne 529 (512 mg, 49%) as an orange oil; 1H-NMR (300 MHz, CDCl3): 
δ 10.12 (d, J = 1.3 Hz, 1H), 7.64 (dd, J = 5.0, 1.3 Hz, 1H), 7.17 (d, J = 5.0 Hz, 1H), 0.27 (s, 9H); 13C-
NMR (101 MHz, CDCl3): δ 183.3 (CH), 144.7 (C), 133.8 (CH), 131.9 (CH), 131.1 (C), 102.7 (C), 96.5 
(C), -0.2 (3 × CH3); IR: νmax (cm
-1) 2960, 2900, 2842, 2812, 2154, 1666, 1415, 1250, 997, 835.Data 
matches that reported in the literature.195 
3-Methoxy-2-((trimethylsilyl)ethynyl)benzaldehyde 530 was prepared according to the following 
procedure: 
 
Triflate 526 (1.7 g, 6.0 mmol, 1.0 equiv.), was dissolved in DMF (18 mL, 0.3 M). Pd(PPh3)Cl2 (126 
mg, 0.2 mmol, 3 mol%), Et3N (3.7 mL, 26.5 mmol, 4.4 equiv.) and trimethylsilylacetylene (1.2 mL, 
8.9 mmol, 1.5 equiv.) were added and the mixture heated at 90 °C for 4 hours. Once cooled to 
room temperature, the resulting mixture was diluted with water (50 mL) and extracted with 
Et2O (3 × 30 mL). The combined organic layers were washed with water (30 mL), brine (30 mL) 
and then dried over Na2SO4. The solids were filtered off and the solvent removed under reduced 
pressure. Purification by flash column chromatography [hexane:Et2O (95:5)] gave the desired 
alkyne (969 mg, 70%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 10.55 (d, J = 0.8 Hz, 1H), 
7.50 (dd, J = 7.8, 1.1 Hz, 1H), 7.41 – 7.33 (m, 1H), 7.09 (dd, J = 8.2, 0.8 Hz, 1H), 3.92 (s, 3H), 0.28 
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(s, 9H); 13C-NMR (101 MHz, CDCl3): δ 192.3 (CH), 161.1 (C), 137.8 (C), 129.7 (CH), 119.0 (CH), 
116.4 (C), 115.9 (CH), 107.4 (C), 96.2 (C), 56.5 (CH3), 0.1 (3 × CH3); IR: νmax (cm
-1) 2960, 2905, 
2843, 2744, 2154, 1699, 1269, 1244, 859, 839; HRMS (ES) m/z calculated for C13H16O2NaSi 
(M+Na)+ 255.0817, found 255.0823. 
Preparation of Benzhydric Alcohols 
Phenyl(2-((trimethylsilyl)ethynyl)phenyl)methanol 231 
Prepared according to GP2 from aldehyde 230 (1.0 mg, 5.0 mmol). Purification by 
flash column chromatography [hexane:EtOAc (95:5)] gave the alcohol 231 (1.1 g, 
79%) as an off-white solid; mp: 47-49 °C; 1H-NMR (300 MHz, CDCl3): δ 7.54 – 7.40 
(m, 4H), 7.40 – 7.17 (m, 5H), 6.28 (s, 1H), 0.23 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 146.1 (C), 
143.1 (C), 132.9 (CH), 129.1 (CH), 128.4 (2 × CH), 127.6 (CH), 127.4 (CH), 126.8 (2 × CH), 126.5 
(CH), 121.2 (C), 103.3 (C), 100.3 (C), 74.2 (CH), -0.0 (3 × CH3); MS (ES): m/z 303 [M+Na]
+ (100 
%).Data matches that reported in the literature.53 
(4-(t-Butyl)phenyl)(2-((trimethylsilyl)ethynyl)phenyl)methanol 268 
Prepared according to GP2 using aldehyde 230 (1.20 g, 5.9 mmol) and (4-t-
butylphenyl)magnesium bromide (1 M in THF, 11.9 mL, 11.9 mmol). Purification 
by flash column chromatography [hexane:EtOAc (95:5)] gave the alcohol 268 
(1.41 g, 71%) as a white solid; mp: 74-78 °C;  1H-NMR (300 MHz, CDCl3) δ 7.57 (d, J = 7.8 Hz, 1H), 
7.46 (dd, J = 7.6, 1.1 Hz, 1H), 7.39 – 7.32 (m, 4H), 7.22 (app. td, J = 7.5, 1.3 Hz, 1H), 6.25 (s, 1H), 
2.60 (s, 1H), 1.30 (s, 9H), 0.22 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 150.6 (C), 146.5 (C), 140.5 
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(C), 133.1 (CH), 129.3 (CH), 127.5 (CH), 126.8 (2 × CH), 126.6 (CH), 125.6 (2 × CH), 121.3 (C), 
103.5 (C), 100.4 (C), 74.3 (CH), 34.8 (C), 31.7 (3 × CH3), 0.20 (3 × CH3); IR: νmax (cm
-1) 3379, 3068, 
2960, 2903, 2867, 2153, 1246, 1010, 828, 839; HRMS (ES) m/z calculated for C22H28ONaSi 
(M+Na)+ 359.1807 found 359.1801. 
(3,5-Difluorophenyl)(2-((trimethylsilyl)ethynyl)phenyl)methanol 269 
Prepared according to GP2 using aldehyde 230 (1.20 g, 5.9 mmol) and (3,5-
difluorophenyl)magnesium bromide (1 M in THF, 11.9 mL, 11.9 mmol). 
Purification by flash column chromatography [hexane:EtOAc (93:7)] gave the 
alcohol 269 (1.79 g, 95%) as an orange oil; 1H-NMR (300 MHz, CDCl3) δ 7.51 – 7.42 (m, 2H), 7.35 
(app. td, J = 7.6, 1.4 Hz, 1H), 7.25 (app. td, J = 7.5, 1.4 Hz, 1H), 6.99 (dd, J = 8.3, 1.7 Hz, 2H), 6.68 
(tt, J = 8.9, 2.4 Hz, 1H), 6.22 (d, J = 4.4 Hz, 1H), 2.80 (br s, 1H), 0.25 (s, 9H); 13C-NMR (101 MHz, 
CDCl3) δ 163.3 (dd, JC-F = 248.2, 12.5 Hz, 2 × C), 147.5 (C), 145.2 (C), 133.3 (CH), 129.6 (CH), 128.2 
(CH), 126.7 (CH), 121.3 (C), 109.7 (d, JC-F = 25.7 Hz, 2 × CH), 103.0 (t, JC-F = 25.4 Hz, CH), 103.1 (C), 
101.1 (C), 73.5 (CH), 0.12 (3 × CH3);  IR: νmax (cm
-1) 3331, 3068, 2961, 2900, 2156, 1623, 1597, 
1454, 1250, 1117; HRMS (ES) m/z calculated for C18H17F2Si (M-OCH3)
+ 299.1068 found 299.1078. 
(Ferrocene)(2-((trimethylsilyl)ethynyl)phenyl)methanol 270 
Ferrocene (1.08 g, 5.8 mmol, 1.0 equiv.) was dissolved in THF (7.3 mL, 0.8 M) and 
cooled to -20 °C. t-BuLi (1.9 M in pentane, 2.5 mL, 4.7 mmol, 0.8 equiv.) was 
added dropwise and the mixture was stirred for 30 minutes at this temperature. 
Aldehyde 230 (1.20 g, 5.9 mmol) was then added in one portion and the mixture stirred 
overnight at room temperature. Saturated NH4Cl solution (20 mL) was added and the aqueous 
235 
 
layer was extracted with Et2O (2 × 20 mL). The combined organic phases were washed with 
brine (50 mL), dried over Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography gave the alcohol 270 (0.58 g, 26%) as an orange oil;  1H-NMR (300 
MHz, CDCl3) δ 7.55 (d, J = 7.8 Hz, 1H), 7.41 (dd, J = 7.7, 1.1 Hz, 1H), 7.32 (app. td, J = 7.7, 1.3 Hz, 
1H), 7.18 (app. td, J = 7.6, 1.3 Hz, 1H), 5.97 (d, J = 3.6 Hz, 1H), 4.35 (app. dt, J = 2.4, 1.2 Hz, 1H), 
4.27 – 4.23 (m, 1H), 4.22 (s, 5H), 4.17 – 4.12 (m, 2H), 2.63 (d, J = 3.6 Hz, 1H), 0.28 (s, 9H); 13C-
NMR (101 MHz, CDCl3) δ 146.2 (C), 132.6 (CH), 129.1 (CH), 127.3 (CH), 125.8 (CH), 121.0 (C), 
103.7 (C), 99.8 (C), 94.2 (C), 70.0 (CH), 68.7 (5 × CH), 68.3 (CH), 68.0 (CH), 67.6 (CH), 66.1 (CH), 
0.39 (3 × CH3); IR: νmax (cm
-1) 3530, 3094, 2957, 2897, 2154, 1478, 1446, 1248, 864, 837, 756; 
HRMS (ES) m/z calculated for C22H24OSiFe (M+H)
+ 388.0946 found 388.0950. 
(4-Methoxyphenyl)(2-((trimethylsilyl)ethynyl)phenyl)methanol 271 
Prepared according to GP2 from aldehyde 230 (1.0 g, 4.9 mmol). Purification by 
flash column chromatography [hexane:EtOAc (85:15)] gave the alcohol 271 (1.3 
g, 83%) as a clear oil; 1H-NMR (500 MHz, CDCl3): δ 7.55 (dd, J = 8.1, 0.9 Hz, 1H), 
7.45 (dd, J = 7.7, 0.9 Hz, 1H), 7.38 – 7.32 (m, 3H), 7.21 (td, J = 7.5, 1.2 Hz, 1H), 6.85 (d, J = 8.8 Hz, 
2H), 6.23 (d, J = 4.1 Hz, 1H), 3.78 (s, 3H), 2.58 (d, J = 4.1 Hz, 1H), 0.24 (s, 9H); 13C-NMR (126 MHz, 
CDCl3): δ 159.1 (C), 146.4 (C), 135.4 (C), 132.9 (CH), 129.1 (CH), 128.2 (2 × CH), 127.2 (CH), 126.1 
(CH), 121.0 (C), 113.8 (2 × CH), 103.3 (C), 100.2 (C), 73.8 (CH), 55.4 (CH3), 0.0 (3 × CH3); IR: νmax 
(cm-1) 3320, 2958, 2154, 1612, 1511, 1250, 1172, 1035, 842, 760; HRMS (ES) m/z calculated for 
C19H22O2NaSi (M+Na)
+ 333.1287, found 333.1279. 
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Furan-2-yl(2-((trimethylsilyl)ethynyl)phenyl)methanol 272 
Furan (0.33 mL, 4.5 mmol, 1.0 equiv) was dissolved in THF (22 mL, 0.2 M) and 
cooled to -10 °C. n-BuLi (2.5 M solution in hexane, 1.8 mL, 4.5 mmol, 1.0 equiv.) 
was added dropwise and the resulting solution stirred for 2 hours at this 
temperature. Aldehyde 230 (1.0 g, 4.9 mmol, 1.1 equiv.) was added in small portions and the 
reaction was stirred at room temperature for 16 hours. Water (15 mL) was added and the 
organic layer was extracted with EtOAc (3 × 15 mL), dried over Na2SO4, filtered and the solvent 
removed under reduced pressure. Purification by flash column chromatography [hexane:Et2O 
(90:10), then hexane:EtOAc (90:10)] gave the alcohol 272 (947 mg, 71%) as a yellow oil; 1H-NMR 
(400 MHz, CDCl3): δ 7.59 (d, J = 7.7 Hz, 1H), 7.46 (dd, J = 7.7, 1.2 Hz, 1H), 7.41 – 7.35 (m, 2H), 
7.26 (td, J = 7.5, 1.2 Hz, 1H), 6.30 (dd, J = 3.2, 1.8 Hz, 1H), 6.23 (s, 1H), 6.06 (d, J = 3.2 Hz, 1H), 
2.78 (br. s, 1H), 0.20 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 155.3 (C), 143.1 (C), 142.5 (CH), 132.6 
(CH), 129.0 (CH), 127.8 (CH), 126.5 (CH), 121.3 (C), 110.4 (CH), 107.8 (CH), 102.5 (C), 100.6 (C), 
68.5 (CH), 0.0 (3 × CH3); IR: νmax (cm
-1) 3340, 2960, 2989, 2157, 1500, 1479, 1448, 1249, 1009, 
864, 837; HRMS (ES) m/z calculated for C16H18O2NaSi (M+Na)
+ 293.0974, found 293.0960. 
(2-Methoxyphenyl)(2-((trimethylsilyl)ethynyl)phenyl)methanol 286 
Prepared according to GP2 using aldehyde 230 (1.2 g, 5.9 mmol) and o-anisole 
magnesium bromide (1 M in THF, 11.9 mL, 11.9 mmol). Purification by flash 
column chromatography [hexane:EtOAc (90:10)] gave the alcohol 286 (1.76 g, 
95%) as a yellow oil; 1H-NMR (300 MHz, CDCl3) δ 7.52 (dd, J = 7.8, 1.3 Hz, 1H), 7.47 (dd, J = 7.6, 
1.1 Hz, 1H), 7.35 (app. td, J = 7.6, 1.4 Hz, 1H), 7.30 – 7.19 (m, 2H), 7.09 – 7.03 (m, 1H), 6.93 – 
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6.85 (m, 2H), 6.51 (s, 1H), 3.86 (s, 3H), 0.14 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 157.4 (C), 145.2 
(C), 132.6 (CH), 131.4 (C), 129.0 (CH), 129.0 (CH), 128.2 (CH), 127.3 (CH), 127.0 (CH), 121.9 (C), 
120.9 (CH), 110.6 (CH), 103.4 (C), 100.0 (C), 70.2 (CH), 55.7 (CH3), 0.1 (3 × CH3); IR: νmax (cm
-1) 
3447, 3066, 2959, 2900, 2837, 2156, 1589, 1600, 1490, 1462, 1244, 1024, 839; HRMS (ES) m/z 
calculated for C19H22O2NaSi (M+Na)
+ 333.1287 found 333.1300. 
o-Tolyl(2-((trimethylsilyl)ethynyl)phenyl)methanol 287 
Prepared according to GP2 using aldehyde 230 (1.20 g, 5.9 mmol) and o-
toluene magnesium bromide (1 M in THF, 11.9 mL, 11.9 mmol). Purification by 
flash column chromatography [hexane:EtOAc (92.5:7.5)] gave the alcohol 287 
(1.72 g, 98%) as a white solid; mp: 111-113 °C; 1H-NMR (300 MHz, CDCl3) δ 7.53 (d, J = 7.1 Hz, 
1H), 7.46-7.42 (m, 1H), 7.36 – 7.15 (m, 6H), 6.46 (d, J = 4.0 Hz, 1H), 2.55 (d, J = 4.0 Hz, 1H), 2.31 
(s, 3H), 0.24 (s, 9H); 13C-NMR (101 MHz, CDCl3) δ 145.1 (C), 140.4 (C), 135.9 (C), 132.7 (CH), 
130.3 (CH), 129.0 (CH), 127.5 (CH), 127.2 (CH), 126.9 (CH), 126.3 (CH), 126.0 (CH), 122.0 (C), 
102.8 (C), 99.8 (C), 71.0 (CH), 19.4 (CH3), -0.11 (3 × CH3); IR: νmax (cm
-1) 3179, 3063, 3031, 2959, 
2154, 1492, 1477, 1462, 1249, 1036, 1020, 851; HRMS (ES) m/z calculated for C19H23OSi (M+H)
+ 
295.1518 found 295.1514. 
Naphthalen-1-yl(2-((trimethylsilyl)ethynyl)phenyl)methanol 288 
Prepared according to GP2 using aldehyde 230 (1.40 g, 6.9 mmol) and 1-
bromonaphthalene magnesium bromide (1 M in THF, 13.8 mL, 13.8 mmol). 
Purification by flash column chromatography [hexane:EtOAc (92.5:7.5)] gave the 
alcohol 288 (1.98 g, 87%) as a clear oil; 1H-NMR (300 MHz, CDCl3) δ 8.15 – 8.10 (m, 1H), 7.91 – 
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7.86 (m, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.58 – 7.44 (m, 5H), 7.36 – 7.21 (m, 3H), 7.03 (s, 1H), 2.65 
(s, 1H), 0.08 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 145.4 (C), 138.1 (C), 133.8 (C), 132.6 (CH), 
131.1 (C), 128.9 (CH), 128.7 (CH), 128.3 (CH), 127.5 (CH), 127.0 (CH), 126.2 (CH), 125.5 (CH), 
125.3 (CH), 124.2 (CH), 123.8 (CH), 121.8 (C), 102.7 (C), 100.4 (C), 70.8 (CH), -0.4 (3 × CH3); IR: 
νmax (cm
-1) 3298, 3056, 2957, 2897, 2155, 1248, 857, 839; HRMS (ES) m/z calculated for 
C22H22O2SiNa (M+Na)
+ 353.1338 found 353.1341. 
(4,5-Dimethoxy-2-((trimethylsilyl)ethynyl)phenyl)(phenyl)methanol 305 
Prepared according to GP2 using aldehyde 302 (1.15 g, 4.4 mmol) and phenyl 
magnesium bromide (1 M in THF, 8.8 mL, 8.8 mmol). Purification by flash 
column chromatography [hexane:EtOAc (80:20)] gave the alcohol 305 (1.46 g, 
99%) as a clear oil; 1H-NMR (300 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.32 (app. t, J = 7.3 Hz, 
2H), 7.25 (tt, J = 7.3, 1.9 Hz, 1H), 7.01 (s, 1H), 6.92 (s, 1H), 6.26 (s, 1H), 3.86 (s, 3H), 3.86 (s, 3H), 
2.55 (s, 1H), 0.23 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 149.9 (C), 147.8 (C), 143.3 (C), 139.8 (C), 
128.3 (2 × CH), 127.4 (CH), 126.4 (2 × CH), 114.7 (CH), 112.9 (C), 109.1 (CH), 103.3 (C), 98.2 (C), 
73.5 (CH), 56.0 (CH3), 55.9 (CH3), -0.1 (3 × CH3); IR: νmax (cm
-1) 3498, 3314, 3062, 3033, 3006, 
2958, 2900, 2851, 2147, 1605, 1505, 1245, 1195, 1104; HRMS (ES) m/z calculated for C20H25O3Si 
(M+H)+ 341.1567 found 341.1570. 
(5-Methoxy-2-((trimethylsilyl)ethynyl)phenyl)(phenyl)methanol 306 
Prepared according to GP2 using aldehyde 303 (1.0 g, 4.3 mmol) and phenyl 
magnesium bromide (1 M in Et2O, 8.6 mL, 8.6 mmol). Purification by flash 
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column chromatography [hexane (100%) then CH2Cl2 (100%)] gave the alcohol 306 (1.33 g, 99%) 
as a yellow oil; 1H-NMR (300 MHz, CDCl3) δ 7.35 – 7.10 (m, 6H), 6.96 (d, J = 2.7 Hz, 1H), 6.63 (dd, 
J = 8.5, 2.7 Hz, 1H), 6.12 (d, J = 3.9 Hz, 1H), 3.69 (s, 3H), 2.54 (d, J = 3.9 Hz, 1H), 0.10 (s, 9H); 13C-
NMR (101 MHz, CDCl3): δ 160.1 (C), 147.9 (C), 142.8 (C), 134.2 (CH), 128.3 (2 × CH), 127.5 (CH), 
126.7 (2 × CH), 113.2 (C), 112.9 (CH), 111.8 (CH), 103.3 (C), 98.3 (C), 74.0 (CH), 55.3 (CH3), -0.1 (3 
× CH3); IR: νmax (cm
-1) 3404, 2959, 2900, 2842, 2150, 1603, 1488, 1247, 1028, 836; HRMS (ES) 
m/z calculated for C19H22O2SiNa (M+Na)
+ 333.1287 found 333.1295. 
(5-Fluoro-2-((trimethylsilyl)ethynyl)phenyl)(phenyl)methanol 307 
Prepared according to GP2 using aldehyde 304 (1.50 g, 6.8 mmol) and phenyl 
magnesium bromide (1 M in THF, 13.6 mL, 13.6 mmol). Purification by flash 
column chromatography [hexane:EtOAc (95:5)] gave the alcohol 307 (1.91 g, 
94%) as a pale yellow oil; 1H-NMR (300 MHz, CDCl3) δ 7.42 – 7.37 (m, 3H), 7.33 – 7.22 (m, 4H), 
6.88 (ddd, J = 8.7, 8.3, 2.7 Hz, 1H), 6.21 (d, J = 3.6 Hz, 1H), 2.55 (d, J = 3.6 Hz, 1H), 0.21 (s, 9H); 
13C-NMR (101 MHz, CDCl3) 162.9 (d, JC-F = 250.5 Hz, C), 148.8 (d, JC-F = 7.3 Hz, C), 142.3 (C) 134.6 
(d, JC-F = 8.4 Hz, CH), 128.4 (2 × CH), 127.8 (CH), 126.8 (2 × CH), 117.0 (C), 114.5 (d, JC-F = 22.2 Hz, 
CH), 113.5 (d, JC-F = 23.4 Hz, CH), 102.1 (C), 99.7 (C), 73.6 (CH), -0.2 (3 × CH3); IR: νmax (cm
-1) 3326, 
3066, 3033, 2960, 2899, 2156, 1604, 1482, 1250; HRMS (ES) m/z calculated for C18H20FOSi 
(M+H)+ 299.1262 found 299.1274. 
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1-(2-((Trimethylsilyl)ethynyl)phenyl)prop-2-en-1-ol 325 
Prepared according to GP2 from aldehyde 230 (2.5 g, 12.4 mmol). Purification by 
flash column chromatography [hexane:EtOAc (94:6)] gave the alcohol 325 (2.4 g, 
84%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.49 – 7.43 (m, 2H), 7.38 – 7.31 (m, 1H), 7.22 
(td, J = 7.4, 1.4 Hz, 1H), 6.05 (ddd, J = 17.1, 10.4, 5.7 Hz, 1H), 5.69 – 5.60 (m, 1H), 5.39 (app. dt, J 
= 17.1, 1.5 Hz, 1H), 5.19 (dt, J = 10.4, 1.5 Hz, 1H), 2.39 (d, J = 4.6 Hz, 1H), 0.26 (s, 9H); IR: νmax 
(cm-1) 3352, 2954, 2865, 2832, 2141, 1562, 1433, 1412; MS (ES): m/z 230 [M]+ (60%), 185 (85), 
153 (100). Data matches that reported in the literature.196 
Preparation of Terminal Alkynes 
1-Ethynyl-2-(methoxy(phenyl)methyl)benzene 232 
Prepared according to GP3 from alcohol 231 (1.1 g, 3.7 mmol). Purification by flash 
column chromatography [hexane:EtOAc (95:5)] gave the terminal alkyne 232 (821 
mg, 72%) as a white solid; mp: 34-36 °C; 1H-NMR (300 MHz, CDCl3): δ 7.54 – 7.47 (m, 
2H), 7.47 – 7.41 (m, 2H), 7.40 – 7.17 (m, 5H), 5.83 (s, 1H), 3.40 (s, 3H), 3.35 (s, 1H); 13C-NMR (101 
MHz, CDCl3): δ 144.7 (C), 141.6 (C), 133.0 (CH), 129.5 (CH), 128.4 (2 × CH), 127.6 (CH), 127.3 
(CH), 127.0 (3 × CH), 126.4 (CH), 121.1 (C), 82.3 (CH), 82.1 (C), 57.2 (CH3);MS (EI): m/z 222 [M]
+ 
(20 %), 207 (100%). Data matches that reported in the literature.122 
1-((4-(t-Butyl)phenyl)(methoxy)methyl)-2-ethynylbenzene 273 
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Prepared according to GP3 using alcohol 268 (1.0 g, 3.0 mmol) and methyl iodide 
(0.28 mL, 4.5 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:Et2O (98:2)] gave the terminal alkyne 273 (384 mg, 46% 
over 2 steps) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.55 (d, J = 7.8 Hz, 1H), 7.49 (dd, J = 
7.7, 1.2 Hz, 1H), 7.36 (m, 5H), 7.22 (app. td, J = 7.5, 1.3 Hz, 1H), 5.82 (s, 1H), 3.40 (s, 3H), 3.36 (s, 
1H), 1.29 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 150.6 (C), 145.1 (C), 138.8 (C), 133.2 (CH), 129.7 
(CH), 127.5 (CH), 126.9 (2 × CH), 126.6 (CH), 125.5 (2 × CH), 121.3 (C), 82.4 (2 × CH), 82.3 (C), 
57.5 (3 × CH3), 34.8 (C), 31.7 (CH3); IR: νmax (cm
-1) 3290, 2962, 2904, 2869, 2823, 1463, 1099, 
1081,  759; HRMS (ES) m/z calculated for C19H19 (M(-OCH3)+H)
+ 247.1487 found 247.1501. 
1-((2-Ethynylphenyl)(methoxy)methyl)-3,5-difluorobenzene 274 
Prepared according to GP3 using alcohol 269 (1.0 g, 3.2 mmol) and methyl iodide 
(0.30 mL, 4.8 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:CH2Cl2 (95:5)] gave the terminal alkyne 274 (408 mg, 50% 
over 2 steps) as a pale yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.52 (dd, J = 7.7, 1.5 Hz, 1H), 7.44 
(dd, J = 7.9, 1.5 Hz, 1H) 7.38 (ddd, J = 7.9, 7.8, 1.5 Hz, 1H), 7.26 (app. td, J = 7.7, 7.6, 1.5 Hz, 1H), 
7.03 – 6.94 (m, 2H), 6.67 (tt, J = 8.9, 2.4 Hz, 1H), 5.80 (s, 1H), 3.40 (s, 1H), 3.39 (s, 1H); 13C-NMR 
(126 MHz, CDCl3): δ 163.3 (dd, JC-F = 248.2, 12.5 Hz, ipso-2 × C), 146.2 (t, JC-F = 8.3 Hz, meta-C), 
143.6 (C), 133.3 (CH), 129.9 (CH), 128.1 (CH), 126.6 (CH), 121.2 (C), 109.8 (d, JC-F = 25.7 Hz, ortho-
2 × CH), 103.1 (t, JC-F = 25.4 Hz, ortho-CH), 82.8 (CH), 82.0 (C), 81.3 (CH), 57.5 (CH3); IR: νmax (cm
-
1) 3298, 3068, 2994, 2994, 2934, 2827, 1624, 1596, 1454, 1437, 1116, 1102, 1083, 757; HRMS 
(ES) m/z calculated for C15H9F2 (M(-OCH3)+H)
+ 227.0672 found 227.0680. 
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1-Ethynyl-2-(methoxy(ferrocene)methyl)benzene 275 
Prepared according to GP3 using alcohol 270 (0.60 g, 1.4 mmol) and methyl iodide 
(0.13 mL, 2.1 mmol) as the alkyl halide. Purification by flash column chromatography 
[hexane:Et2O (97:3)] gave the terminal alkyne 275 (297 mg, 64% over 2 steps) as an 
orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.53 (dd, J = 7.8, 1.3 Hz, 2H), 7.39 (app. td, J = 7.8, 1.3 
Hz, 1H), 7.29-7.21 (m, 1H), 5.62 (s, 1H), 4.28 (app. dt, J = 2.5, 1.3 Hz, 1H), 4.16 (app. dt, J = 2.5, 
1.3 Hz, 1H), 4.14 – 4.07 (m, 2H), 4.10 (s, 5H), 3.40 (s, 1H), 3.31 (s, 3H); 13C-NMR (101 MHz, CDCl3) 
δ 143.9 (C), 132.0 (CH), 128.5 (CH), 126.6 (CH), 125.9 (CH), 120.5 (C), 89.6 (C), 81.4 (C), 81.2 
(CH), 78.4 (CH), 68.1 (5 × CH), 67.2 (CH), 66.8 (2 × CH), 65.8 (CH), 56.3 (CH3); IR: νmax (cm
-1) 3291, 
3102, 2982, 2931, 2819, 1478, 1446, 1105, 1079, 728; HRMS (ES) m/z calculated for C20H18OFe 
(M)+ 330.0707 found 330.0695. 
1-Ethynyl-2-(methoxy(4-methoxyphenyl)methyl)benzene 276 
Prepared according to GP3 using alcohol 271 (1.2 g, 3.9 mmol). Purification by flash 
column chromatography [hexane:EtOAc (95:5)] gave the alcohol 276 (590 mg, 60%) 
as a clear oil; 1H NMR-(400 MHz, CDCl3): δ 7.57 – 7.51 (m, 1H), 7.49 (dd, J = 7.7, 1.0 
Hz, 1H), 7.41 – 7.31 (m, 3H), 7.21 (td, J = 7.7, 1.3 Hz, 1H), 6.85 (d, J = 8.8 Hz, 2H), 5.77 (s, 1H), 
3.78 (s, 3H), 3.39 (s, 3H), 3.34 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 159.1 (2 × C), 144.9 (C), 
133.7 (C), 133.1 (CH), 129.4 (CH), 128.4 (2 × CH), 127.2 (CH), 126.2 (CH), 121.0 (C), 113.8 (2 × 
CH), 82.3 (CH), 82.1 (CH), 57.1 (CH3), 55.3 (CH3); HRMS (ES) m/z calculated for C17H16O2Na 
(M+Na)+ 275.1040, found 275.1043. Data matches that reported in the literature.  
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2-((2-Ethynylphenyl)(methoxy)methyl)furan 277 
Prepared according to GP3 using alcohol 272 (909 mg, 3.4 mmol) and methyl iodide 
(0.31 mL, 5.0 mmol) as the alkyl halide. Purification by flash column chromatography 
[hexane:EtOAc (95:5)] gave the terminal alkyne 277 (541 mg, 76% over 2 steps) as a 
yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.70 – 7.64 (m, 1H), 7.50 (dd, J = 7.6, 1.1 Hz, 1H), 7.47 – 
7.40 (m, 1H), 7.39 (dd, J = 1.8, 0.9 Hz, 1H), 7.32 – 7.25 (m, 1H), 6.30 (dd, J = 3.2, 1.8 Hz, 1H), 6.11 
(d, J = 3.2 Hz, 1H), 5.82 (s, 1H), 3.41 (s, 3H), 3.30 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 153.7 (C), 
142.9 (CH), 141.4 (C), 132.9 (CH), 129.4 (CH), 127.9 (CH), 126.8 (CH), 121.3 (C), 110.2 (CH), 108.8 
(CH), 82.4 (CH), 81.2 (C), 76.3 (CH), 57.3 (CH3); IR: νmax (cm
-1) 3290, 2989, 2935, 2823, 1480, 
1447, 1188, 1143, 1078, 1012, 761, 740; HRMS (ES) m/z calculated for C14H12O2 (M+H)
+ 
212.0837, found 212.0841. 
1-Ethynyl-2-(methoxy(2-methoxyphenyl)methyl)benzene 289 
Prepared according to GP3 using alcohol 286 (1.0 g, 3.2 mmol) and methyl iodide 
(0.30 mL, 4.8 mmol) as the alkyl halide. Purification by flash column chromatography 
[hexane:Et2O (95:5)] gave the terminal alkyne 289 (534 mg, 66% over 2 steps) as a 
yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.53 – 7.48 (m, 1H), 7.41 (dd, J = 7.6, 1.7 Hz, 1H), 7.34 – 
7.18 (m, 4H), 6.98 (app. td, J = 7.6, 0.9 Hz, 1H), 6.85 (dd, J = 8.2, 0.8 Hz, 1H), 6.13 (s, 1H), 3.76 (s, 
3H), 3.43 (s, 3H), 3.29 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 157.5 (C), 144.2 (C), 133.1 (CH), 
129.8 (C), 129.2 (CH), 128.9 (CH), 127.7 (CH), 127.4 (CH), 127.4 (CH), 122.3 (C), 120.8  (CH), 
110.9 (CH), 82.3 (C), 81.5 (CH), 77.2 (CH), 57.8 (CH3), 55.7 (CH3); IR: νmax (cm
-1) 3267, 3013, 2963, 
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2934, 2837, 2824, 1600, 1588, 1487, 1458, 1239, 1080, 1025; HRMS (ES) m/z calculated for 
C16H13O (M(-OCH4)+H)
 + 221.0966 found 221.0974. 
1-Ethynyl-2-(methoxy(o-tolyl)methyl)benzene 290 
Prepared according to GP3 using alcohol 287 (1.40 g, 4.8 mmol) and methyl iodide 
(0.44 mL, 7.1 mmol) as the alkyl halide. Purification by flash column chromatography 
[hexane:Et2O (95:5)] gave the terminal alkyne 290 (922 mg, 82% over 2 steps) as a 
clear oil; 1H-NMR (300 MHz, CDCl3): δ 7.57 – 7.52 (m, 1H), 7.42 – 7.11 (m, 7H), 5.94 (s, 1H), 3.45 
(s, 3H), 3.32 (s, 1H), 2.27 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.1 (C), 139.1 (C), 136.6 (C), 
133.1 (CH), 130.6 (CH), 129.3 (CH), 127.8 (CH), 127.7 (2 × CH), 126.7 (CH), 126.1 (CH), 122.5 (C), 
82.1 (C), 82.0 (CH), 79.8 (CH), 57.8 (CH3), 19.6 (CH3); IR: νmax (cm
-1) 3289, 3066, 3026, 2932, 
2822, 1479, 1461, 1447, 1077, 750; HRMS (ES) m/z calculated for C16H13 (M(-OCH3)+H)
+ 
205.1017 found 205.1025. 
1-((2-Ethynylphenyl)(methoxy)methyl)naphthalene 291 
Prepared according to GP3 using alcohol 288 (2.0 g, 5.9 mmol) and methyl iodide 
(0.59 mL, 8.9 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:Et2O (96.5:3.5)] gave the terminal alkyne 291 (1.34 g, 
84% over 2 steps) as a clear oil; 1H-NMR (300 MHz, CDCl3): δ 8.07 – 8.00 (m, 1H), 7.89 – 7.79 (m, 
2H), 7.67 – 7.57 (m, 2H), 7.54 – 7.42 (m, 3H), 7.28 – 7.23 (m, 3H), 6.53 (s, 1H), 3.55 (s, 3H), 3.37 
(s, 1H); 13C-NMR (101 MHz, CDCl3): δ 143.3 (C), 136.4 (C), 133.9 (C), 133.1 (CH), 131.4 (C), 129.3 
(CH), 128.8 (CH), 128.3 (CH), 127.7 (CH), 127.7 (CH), 126.2 (CH), 125.5 (CH), 125.4 (CH), 124.4 
(CH), 123.8 (CH), 122.1 (C), 82.2 (CH), 82.0 (C), 79.5 (CH), 57.9 (CH3); IR: νmax (cm
-1) 3284, 3058, 
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2929, 2821, 1597, 1509, 1478, 1446, 1086, 1071,757; HRMS (ES) m/z calculated for C20H16ONa 
(M+Na)+ 295.1099 found 295.1088. 
1-Ethynyl-4,5-dimethoxy-2-(methoxy(phenyl)methyl)benzene 308 
Prepared according to GP3 using alcohol 305 (1.40 g, 4.1 mmol) and methyl 
iodide (0.38 mL, 6.2 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:EtOAc (90:10)] gave the terminal alkyne 308 (640 mg, 
55% over 2 steps) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.37 – 7.33 (m, 2H), 7.28 – 7.23 
(m, 2H), 7.19 – 7.15 (m, 1H), 6.91 (s, 1H), 6.90 (s, 1H), 5.74 (s, 1H), 3.80 (s, 3H), 3.81 (s, 3H), 3.34 
(s, 3H), 3.22 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 150.3 (C), 147.9 (C), 141.8 (C), 138.1 (C), 128.2 
(2 × CH), 127.3 (CH), 126.5 (2 × CH), 114.6 (CH), 112.9 (C), 108.7 (CH), 82.0 (C), 81.8 (CH), 80.5 
(CH), 57.0 (CH3), 55.9 (CH3), 55.9 (CH3); IR: νmax (cm
-1) 3279, 2982, 2934, 2907, 2824, 1602, 1507, 
1462, 1451, 1395, 1356, 1258, 1212, 1185, 1096, 1082; HRMS (ES) m/z calculated for 
C18H18O3Na (M+Na)
+ 305.1154 found 305.1149. 
1-Ethynyl-4-methoxy-2-(methoxy(phenyl)methyl)benzene 309 
Prepared according to GP3 using alcohol 306 (1.39 g, 4.5 mmol) and methyl 
iodide (0.42 mL, 6.7 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:diethyl ether (95:5)] gave the terminal alkyne 309 (797 
mg, 70% over 2 steps) as a yellow solid; mp: 70-72 °C; 1H-NMR (300 MHz, CDCl3): δ 7.47 – 7.39 
(m, 3H), 7.36 – 7.20 (m, 3H), 7.06 (d, J = 2.7 Hz, 1H), 6.76 (dd, J = 8.5, 2.7 Hz, 1H), 5.80 (s, 1H), 
3.80 (s, 3H), 3.41 (s, 3H), 3.27 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 160.4 (C), 146.4 (C), 141.3 
(C), 134.2 (CH), 128.2 (2 × CH), 127.4 (CH), 126.8 (2 × CH), 113.3 (CH), 113.1 (C), 111.3 (CH), 82.1 
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(CH3), 82.0 (C), 80.7 (CH), 57.1 (CH), 55.3 (CH3); IR: νmax (cm
-1) 3294, 3067, 2982, 2928, 2889, 
2819, 2103, 1600, 1484, 1444, 1301, 1092, 1070, 1026; HRMS (ES) m/z calculated for C17H17O2 
(M+H)+ 253.1229 found 253.1231. 
1-Ethynyl-4-fluoro-2-(methoxy(phenyl)methyl)benzene 310 
Prepared according to GP3 using alcohol 307 (1.47 g, 4.9 mmol) and methyl 
iodide (0.46 mL, 7.4 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:CH2Cl2 (95:5)] gave the terminal alkyne 310 (847 mg, 
71% over 2 steps) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.44 – 7.31 (m, 3H), 7.29 – 7.16 
(m, 4H), 6.85 (app. td, J = 8.3, 2.7 Hz, 1H), 5.70 (s, 1H), 3.33 (s, 3H), 3.26 (s, 1H); 13C-NMR (101 
MHz, CDCl3): δ 163.2 (d, JC-F = 250.6 Hz, C), 147.7 (d, JC-F = 7.4 Hz, C), 140.8 (C), 134.8 (d, JC-F = 8.4 
Hz, CH), 128.4 (2 × CH), 127.8 (CH), 126.9 (2 × CH), 116.8 (d, JC-F = 3.3 Hz, C), 114.7 (d, JC-F = 22.4 
Hz, CH), 113.5 (d, JC-F = 23.2 Hz, CH), 81.9 (2 CH), 81.1 (C), 57.2 (CH3); IR: νmax (cm
-1) 3064, 3032, 
2988, 2933, 2824, 1605, 1487, 1453, 2100, 1077; HRMS (ES) m/z calculated for C16H13OFNa 
(M+Na)+ 263.0848 found 263.0839. 
1-((Benzyloxy)(phenyl)methyl)-2-ethynylbenzene 318 
Prepared according to GP3 using alcohol 231 (0.49 g, 1.7 mmol) and benzyl 
bromide (0.31 mL, 2.6 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:toluene (90:10) then hexane:EtOAc (98:2)] gave the 
terminal alkyne 318 (252 mg, 49% over 2 steps) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.59 
(dd, J = 7.9, 1.2 Hz, 1H), 7.53 – 7.44 (m, 3H), 7.41 – 7.20 (m, 10H), 6.06 (s, 1H), 4.58 (d, J = 11.7 
Hz, 1H), 4.53 (d, J = 11.7 Hz, 1H), 3.29 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 144.7 (C), 141.6 (C), 
247 
 
138.3 (C), 132.9 (CH), 129.4 (CH), 128.3 (4 × CH), 127.8 (2 × CH), 127.5 (CH), 127.4 (CH), 127.3 
(CH), 127.0 (CH), 126.8 (2 × CH), 121.0 (C), 82.2 (CH), 81.9 (C), 79.8 (CH), 70.89 (CH2); IR: νmax 
(cm-1) 3249, 3088, 3063, 3024, 2996, 2897, 1495, 1475, 1453, 1394, 1337, 1076, 1052, 1010, 
761, 742; HRMS (ES) m/z calculated for C22H18ONa (M+Na)
+ 321.1255 found 321.1258. 
1-((Allyloxy)(phenyl)methyl)-2-ethynylbenzene 319 
Prepared according to GP3 using alcohol 231 (1.0 g, 3.5 mmol) and allyl iodide 
(0.49 mL, 5.3 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:CH2Cl2 (95:5) then hexane:Et2O (95:5)] gave the 
terminal alkyne 319 (554 mg, 63% over 2 steps) as a pale yellow oil; 1H-NMR (300 MHz, CDCl3): δ 
7.56 (dd, J = 7.9, 1.2 Hz, 1H), 7.51 – 7.42 (m, 3H), 7.40 – 7.18 (m, 5H), 6.00 (s, 1H), 5.98 (ddt, J = 
17.2, 10.4, 5.3 Hz, 1H), 5.31 (ddt, J = 17.2, 3.0, 1.5 Hz, 1H), 5.19 (ddt, J = 10.4, 3.0, 1.5 Hz, 1H), 
4.03 (app. dt, J = 5.3, 1.5  Hz, 2H), 3.34 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 144.7 (C), 141.6 (C), 
134.6 (CH), 132.8 (CH), 129.3 (CH), 128.2 (2 × CH), 127.4 (CH), 127.2 (CH), 126.9 (2 × CH), 126.5 
(CH), 120.9 (C), 116.9 (CH2), 82.1 (CH), 81.9 (C), 79.6 (CH), 69.9 (CH2); IR: νmax (cm
-1) 3290, 3065, 
3029, 2859, 1494, 1478, 1449, 1060, 920; HRMS (ES) m/z calculated for C18H16ONa (M+Na)
+ 
271.1099, found 271.1082. 
1-(((Benzyloxy)methoxy)(phenyl)methyl)-2-ethynylbenzene 320 
Alcohol 231 (1.0 g, 3.6 mmol,1.0 equiv.) was dissolved in CH2Cl2 (18 mL, 
0.2M) and cooled to 0 °C. Benzyl chloromethyl ether (1.0 mL, 7.1 mmol, 2.0 
equiv.) and diisopropylethylamine (0.9 mL, 5.3 mmol, 1.5 equiv.) were 
added and the mixture stirred at 0 °C for 1 hour, before stirring at room temperature for 16 
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hours. The resulting solution was diluted with Et2O (20 mL) and washed with water (20 mL) and 
brine (20 mL). The organic layer was dried over Na2SO4, filtered and the solvent removed under 
reduced pressure. The crude residue was dissolved in MeOH (18 mL, 0.2 M), K2CO3 (246 mg, 0.5 
equiv.) was added and the mixture stirred at room temperature for one hour. Saturated 
NaHCO3 solution was added and the aqueous phase was extracted with EtOAc (× 2) and dried 
over Na2SO4. The solid was filtered off and the solvent removed under reduced pressure. 
Purification by flash column chromatography [hexane:toluene (50:50) gave the terminal alkyne 
320 (977 mg, 83%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.62 (d, J = 7.3 Hz, 1H), 7.53 – 
7.42 (m, 3H), 7.42 – 7.18 (m, 10H), 6.38 (s, 1H), 4.89 – 4.82 (m, 2H), 4.62 (s, 2H), 3.30 (s, 1H); 
13C-NMR (101 MHz, CDCl3): δ  144.5 (C), 141.4 (C), 137.9 (C), 133.0 (CH), 129.4 (CH), 128.4 (4 × 
CH), 128.1 (2 × CH), 127.8 (CH), 127.6 (CH), 127.4 (CH), 127.3 (2 × CH), 126.8 (CH), 121.0 (C), 
92.8 (CH2), 82.5 (CH), 81.9 (C), 76.7 (CH), 69.9 (CH2); IR: νmax (cm
-1) 3287, 3064, 3030, 2945, 
2886, 1453, 1035, 1023; HRMS (ES) m/z calculated for C23H19O2 (M+H)
+ 327.1385, found 
327.1382.  
1-(1-(Allyloxy)allyl)-2-ethynylbenzene 326 
Prepared according to GP3 using alcohol 325 (1.0 g, 4.3 mmol) and allyl iodide 
(0.6 mL, 6.5 mmol) as the alkyl halide. Purification by flash column 
chromatography [hexane:Et2O (90:10)] gave the terminal alkyne 326 (414 mg, 48% over 2 steps) 
as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.54 – 7.46 (m, 2H), 7.38 (app. td, J = 7.6, 1.2 Hz, 
1H), 7.24 (app. dt, J = 7.6, 1.4 Hz, 1H), 5.39-5.31 (m, 2H), 5.36 (app. t, J = 1.4 Hz, 1H), 5.29 (ddd, J 
= 17.2, 3.4, 1.7 Hz, 2H), 5.22-5.14 (m, 2H), 3.98 (ddt, J = 5.6, 2.9, 1.4 Hz, 2H), 3.30 (s, 1H); 13C-
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NMR (101 MHz, CDCl3): δ 143.6 (C), 137.9 (CH), 134.8 (CH), 133.0 (CH), 129.5 (CH), 127.4 (CH), 
126.5 (CH), 120.9 (C), 117.0 (CH2), 116.2 (CH2), 82.1 (CH), 81.6 (C), 79.3 (CH), 69.6 (CH2); IR: νmax 
(cm-1) 3070, 3023, 2993, 2860, 1479, 1446, 1414, 1064, 989, 925, 760; HRMS (ES) m/z calculated 
for C18H16ONa (M+Na)
+ 271.1099, found 271.1082. 
1-Ethynyl-2-(methoxymethyl)benzene 499 
 
NaH (60% dispersion in mineral oil, 615 mg, 15.3 mmol, 1.2 equiv.) was weighed into a flask and 
washed with hexane (2 × 10 mL). THF (25 mL, 0.5 M) was added and 2-iodobenzyl alcohol (3.0 g, 
12.9 mmol, 1.0 equiv.) was added in portions at room temperature. The mixture was heated to 
65 °C for 3 hours and cooled to 0 °C before the dropwise addition of MeI (1.2 mL, 19.2 mmol, 
1.5 equiv.). The resulting solution was stirred at room temperature for 3 hours and quenched by 
addition of saturated aqueous NH4Cl solution (20 mL). The aqueous phase was extracted with 
Et2O (3 × 20 mL) and dried over Na2SO4. The solid was filtered off and the solvent removed 
under reduced pressure. Purification by flash column chromatography [hexane:CH2Cl2 (80:20) 
gave the methyl ether 499a (2.0 g, 61%) as a clear oil.; 1H-NMR (300 MHz, CDCl3): δ 7.82 (dd, J = 
7.8, 1.1 Hz, 1H), 7.42 (dd, J = 7.8, 1.8 Hz, 1H), 7.35 (td, J = 7.6, 1.1 Hz, 1H), 6.99 (td, J = 7.6, 1.8 
Hz, 1H), 4.45 (s, 2H), 3.47 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 140.6 (C), 139.3 (CH), 129.3 (CH), 
128.8 (CH), 128.4 (CH), 97.9 (C), 78.5 (CH3), 58.7 (CH2); MS (EI): m/z 248 [M]
+ (10%), 217 (10), 
121 (100). Data matches that reported in the literature.197 
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Aryl iodide 499a (1.6 g, 6.5 mmol, 1.0 equiv.) was dissolved in Et3N (16 mL, 0.4 M). Pd(PPh3)Cl2 
(45.9 mg, 0.1 mmol, 1 mol%) and CuI (12.4 mg, 0.1 mmol, 1 mol%) were added and the solution 
stirred for 5 minutes. Trimethylsilylacetylene (1.1 mL, 7.8 mmol, 1.2 equiv.) was added slowly 
and the resulting solution stirred at room temperature for 14 hours. The solvent was removed 
under reduced pressure and the crude residue was purified by flash column chromatography 
[hexane:CH2Cl2 (80:20)] to give the protected alkyne 499b (1.3 g, 94%) as a yellow oil; 
1H-NMR 
(300 MHz, CDCl3): δ 7.49 – 7.41 (m, 2H), 7.33 (td, J = 7.5, 1.4 Hz, 1H), 7.22 (td, J = 7.5, 1.1 Hz, 
1H), 4.62 (s, 2H), 3.45 (s, 3H), 0.26 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 140.6 (C), 132.4 (CH), 
128.9 (CH), 127.5 (CH), 127.3 (CH), 121.9 (C), 102.8 (C), 99.1 (C), 72.7 (CH3), 58.7 (CH2), 0.1 (3 × 
CH3); MS (EI): m/z 218 [M]
+ (100%). Data matches that reported in the literature.198 
Alkyne 499b (1.3 g, 6.1 mmol, 1.0 equiv.) was dissolved in MeOH (30 mL, 0.2 M), K2CO3 (419 mg, 
0.5 equiv.) was added and the mixture stirred at room temperature for one hour. Saturated 
NaHCO3 solution (20 mL) was added and the aqueous phase was extracted with EtOAc (3 × 20 
mL) and dried over Na2SO4. The solid was filtered off and the solvent removed under reduced 
pressure to give the terminal alkyne 499 which did not require further purification; 1H-NMR 
(300 MHz, CDCl3): δ 7.50 (dd, J = 7.6, 1.0 Hz, 1H), 7.46 (dd, J = 7.6, 1.0 Hz, 1H), 7.37 (td, J = 7.6, 
1.3 Hz, 1H), 7.25 (td, J = 7.5, 1.3 Hz, 2H), 4.64 (s, 2H), 3.45 (s, 3H), 3.30 (s, 1H); 13C-NMR (101 
MHz, CDCl3): δ 140.8 (C), 132.9 (CH), 129.1 (CH), 127.6 (CH), 127.4 (CH), 120.8 (C), 81.8 (CH), 
81.1 (C), 72.7 (CH2), 58.7 (CH3); HRMS (ES) m/z calculated for C10H10O (M+H)
+ 146.0732, found 
146.0727. Data matches that reported in the literature.199 
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2-Ethynylbenzaldehyde 509 
Prepared according to GP4 using alkyne 230 (1.2 g, 3.9 mmol) to give the terminal 
alkyne 509 (1.4 g, 88%) as an off-white solid; mp: 65-67 °C; 1H-NMR (300 MHz, CDCl3): 
δ 10.54 (d, J = 0.8 Hz, 1H), 7.93 (dd, J = 7.7, 0.8 Hz, 1H), 7.62 (dd, J = 7.7, 1.4 Hz, 1H), 7.57 (td, J = 
7.4, 1.4Hz, 1H), 7.52 – 7.43 (m, 1H), 3.46 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 191.6 (CH) 136.7 
(C), 134.0 (CH), 133.9 (CH), 129.4 (CH), 127.4 (CH), 125.6 (C), 84.4 (CH), 79.3 (C); IR: νmax (cm
-1) 
3032, 3001, 2887, 2098, 1685, 1080, 768; Data matches that reported in the literature.149 
2-Ethynyl-4,5-dimethoxybenzaldehyde 510 
Prepared according to GP4 using alkyne 302 (2.6 g, 9.7 mmol) to give the terminal 
alkyne 510 (1.8 g, 98%) as a yellow solid; mp: 154-156 °C; 1H-NMR (300 MHz, 
CDCl3): δ 10.38 (s, 1H), 7.40 (s, 1H), 7.02 (s, 1H), 3.96 (s, 3H), 3.95 (s, 3H), 3.38 (s, 1H); MS (ES): 
m/z 191 [M+H]+ (20%), 190 (100). Data matches that reported in the literature.200 
2-Ethynyl-5-fluorobenzaldehyde 511 
Prepared according to GP4 using alkyne 304 (634 mg, 2.9 mmol) to give the terminal 
alkyne 511 (381 g, 89%) as an off-white solid; mp: 107-109 °C; 1H-NMR (300 MHz, 
CDCl3): δ 10.48 (d, J = 3.2 Hz, 1H), 7.66 – 7.56 (m, 2H), 7.28 (ddd, J = 8.5, 7.8, 2.8 Hz, 1H), 3.44 (d, 
J = 0.5 Hz, 1H); 13C-NMR (101 MHz, CDCl3): δ 190.3 (CH), 162.9 (d, JC-F = 253.4 Hz, C), 138.8 (d, JC-F 
= 6.7 Hz, C), 136.1 (d, JC-F = 7.7 Hz, CH), 121.7 (C), 121.4 (d, JC-F = 22.8 Hz, CH), 113.9 (d, JC-F 23.1 
Hz, CH), 84.2 (CH), 78.35 (C); IR: νmax (cm
-1) 3020, 2976, 2887, 2832, 2103, 1690, 976, 750. Data 
matches that reported in the literature.149  
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2-Ethynyl-3-methoxybenzaldehyde 534a 
Prepared according to GP4 using aldehyde 530 (928 mg, 4.0 mmol). Recrystallisation 
[CH2Cl2:hexane] gave the terminal alkyne 534a (415 mg, 65%) as a purple solid; mp: 
103-105 °C; 1H-NMR (300 MHz, CDCl3): δ 10.54 (d, J = 0.8 Hz, 1H), 7.53 (dd, J = 7.8, 1.1 Hz, 1H), 
7.47 – 7.39 (m, 1H), 7.14 (dd, J = 8.2, 0.8 Hz, 1H), 3.92 (s, 3H), 3.70 (s, 1H); 13C-NMR (101 MHz, 
CDCl3): δ 191.8 (CH), 161.5 (C), 138.1 (C), 130.2 (CH), 119.3 (CH), 115.9 (CH), 114.9 (C), 88.8 (CH), 
75.5 (C), 56.6 (CH3); IR: νmax (cm
-1) 3275, 3070, 3008, 2867, 1687, 1588, 1279, 1247, 795; HRMS 
(ES) m/z calculated for C10H8O2Na (M+Na)
+ 183.0422 found 183.0426. 
2-Ethynyl-5-methoxybenzaldehyde 548 
Prepared according to GP4 using alkyne 303 (907 mg, 3.9 mmol) to give the 
terminal alkyne 548 (631 g, >99%) as a pale yellow solid; mp: 95-97; 1H-NMR (300 
MHz, CDCl3): δ 10.49 (s, 1H), 7.53 (d, J = 8.5 Hz, 1H), 7.40 (d, J = 2.8 Hz, 1H), 7.10 (dd, J = 8.5, 2.8 
Hz, 1H), 3.86 (s, 3H), 3.37 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 191.5 (CH), 160.3 (C), 138.1 (C), 
135.3 (CH), 121.6 (CH), 118.2 (C), 110.1 (CH), 82.9 (CH), 79.3 (C), 55.8 (CH3); HRMS (ES) m/z 
calculated for C10H9O2 (M+H)
+ 161.0603, found 161.0605. Data matches that reported in the 
literature.149 
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Preparation of Acetals From 2-Ethynyl Aldehydes 
2-(2-Ethynylphenyl)-1,3-dioxolane 512 
Prepared according to GP5 using aldehyde 509 (1.2 g, 9.2 mmol) and ethylene glycol. 
Purification by flash column chromatography [hexane:EtOAc (95:5), 1% Et3N] gave 
the acetal 512 (1.4 g, 85%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.59 (dd, J = 7.6, 1.5 
Hz, 1H), 7.56 – 7.51 (m, 1H), 7.39 (app. td, J = 7.6, 1.6 Hz, 1H), 7.33 (app. td, J = 7.4, 1.6 Hz, 1H), 
6.22 (s, 1H), 4.22 – 4.12 (m, 2H), 4.13 – 4.01 (m, 2H), 3.33 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 
139.8, (C) 133.3 (CH), 129.1 (2 × CH), 126.1 (CH), 121.4 (C), 101.9 (CH), 82.0 (CH), 81.0 (C), 65.7 
(2 × CH2); MS (ES): m/z 175 [M+H]
+ (100%), 167 (40). Data matches that reported in the 
literature.201 
2-(2-Ethynyl-4,5-dimethoxyphenyl)-1,3-dioxolane 513 
Prepared according to GP5 using aldehyde 510 (1.9 g, 9.9 mmol) and ethylene 
glycol. Purification by flash column chromatography [hexane:EtOAc (90:10), 1% 
Et3N, then hexane:EtOAc (80:20) ] gave the acetal 513 (480 g, 21%) as an orange oil; 
1H NMR 
(300 MHz, CDCl3) δ 7.07 (s, 1H), 6.97 (s, 1H), 6.13 (s, 1H), 4.26 – 4.11 (m, 2H), 4.12 – 3.98 (m, 
2H), 3.91 (s, 3H), 3.87 (s, 3H), 3.24 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 150.0 (C), 149.4 (C), 
132.9 (C), 114.9 (CH), 113.8 (C), 108.7 (CH), 101.7 (CH), 81.0 (C), 80.5 (CH), 65.6 (2 × CH2), 56.1 
(CH3), 56.0 (CH3); HRMS (ES) m/z calculated for C13H14O4Na (M+Na)
+ 257.0789, found 257.0796. 
Data matches that reported in the literature.201 
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2-(2-Ethynyl-5-fluorophenyl)-1,3-dioxolane 514  
Prepared according to GP5 using aldehyde 511 (370 mg, 2.5 mmol) and ethylene 
glycol. Purification by flash column chromatography [hexane:Et2O (90:10), 1% 
Et3N] gave the acetal 514 (470 g, 98%) as an orange oil; 
1H NMR (300 MHz, CDCl3) δ 7.51 (dd, J = 
8.5, 5.5 Hz, 1H), 7.29 (dd, J = 9.4, 2.7 Hz, 1H), 7.02 (app. td, J = 8.5, 2.9 Hz, 1H), 6.18 (d, J = 1.5 
Hz, 1H), 4.25 – 4.11 (m, 2H), 4.11 – 4.00 (m, 2H), 3.30 (s, 1H); IR: νmax (cm
-1) 3293, 2956, 2921, 
2890, 2108, 1610, 1581, 1563, 1495, 1390, 1257, 1101, 1072, 856. Data matches that reported 
in the literature.201 
((2-(1,3-Dioxolan-2-yl)cyclohex-1-en-1-yl)ethynyl)trimethylsilane 531a 
Prepared according to GP5 using aldehyde 527 (1.0 g, 4.9 mmol) and ethylene 
glycol to give the crude acetal 531a which was used directly in the next step 
without purification.  
2-(2-Ethynylcyclohex-1-en-1-yl)-1,3-dioxolane 531 
Prepared according to GP4 from alkyne 531a to give the terminal alkyne 531 (523 
mg, 77% over 2 steps) as a brown oil; 1H-NMR (300 MHz, CDCl3): δ 5.90 (s, 1H), 4.05 – 
3.97 (m, 2H), 3.97 – 3.89 (m, 2H), 3.12 (s, 1H), 2.26 – 2.06 (m, 4H), 1.65 – 1.58 (m, 4H); IR: νmax 
(cm-1) 3260, 2933, 2884, 2085, 1386, 1274, 1224, 1143, 1102, 1054, 943. Data matches that 
reported in the literature.202 
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4-(1,3-Dioxolan-2-yl)-3-((trimethylsilyl)ethynyl)pyridine 532a 
Prepared according to GP5 using aldehyde 528 (450 mg, 2.2 mmol) and ethylene 
glycol. Purification by flash column chromatography [hexane:EtOAc (80:20), 1% 
Et3N] gave the acetal 532a (503 mg, 92%) as a clear oil; 
1H-NMR (300 MHz, CDCl3): δ 8.69 (d, J = 
0.6 Hz, 1H), 8.55 (d, J = 5.1 Hz, 1H), 7.42 (d, J = 5.1 Hz, 1H), 6.09 (s, 1H), 4.21 – 4.11 (m, 2H), 4.12 
– 4.01 (m, 2H), 0.27 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 153.5 (CH), 149.2 (CH), 147.6 (C), 120.1 
(CH), 119.2 (C), 103.2 (C), 100.9 (CH), 98.9 (C), 65.9 (2 × CH2), -0.07 (3 × CH3); IR: νmax (cm
-1) 
2959, 2891, 2159, 1587, 1481, 1399, 1249, 1089, 836, 758; HRMS (ES) m/z calculated for 
C13H18NO2Si (M+H)
+ 248.1107, found 248.1112. 
4-(1,3-Dioxolan-2-yl)-3-ethynylpyridine 532 
Prepared according to GP4 from alkyne 532a (463 mg, 1.9 mmol) to give terminal 
alkyne 532 (310 mg, 99%) as an orange oil; 1H-NMR (400 MHz, CDCl3): δ 8.73 (s, 1H), 
8.59 (d, J = 5.1 Hz, 1H), 7.47 (d, J = 5.1 Hz, 1H), 6.13 (s, 1H), 4.17 – 4.11 (m, 2H), 4.11 – 4.06 (m, 
2H), 3.45 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 153.8 (CH), 149.6 (CH), 148.1 (C), 120.0 (CH), 
118.1 (C), 100.6 (CH), 85.0 (CH), 78.0 (C), 65.9 (2 × CH2); IR: νmax (cm
-1) 1259, 2891, 2107, 1590, 
1482, 1401, 1234, 1161, 1091, 943, 836; HRMS (ES) m/z calculated for C10H10NO2 (M+H)
+ 
176.0712, found 176.0713. 
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((2-(1,3-Dioxolan-2-yl)thiophen-3-yl)ethynyl)trimethylsilane 533a 
Prepared according to GP5 using aldehyde 529 (491 mg, 2.4 mmol) and ethylene 
glycol. Purification by flash column chromatography [hexane:Et2O (95:5), 1% Et3N] 
gave the acetal 533a (171 mg, 72%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.22 (dd, J = 5.1, 
0.5 Hz, 1H), 7.02 (d, J = 5.1 Hz, 1H), 6.26 (s, 1H), 4.25 – 4.10 (m, 2H), 4.10 – 3.97 (m, 2H), 0.24 (s, 
9H); 13C-NMR (101 MHz, CDCl3): δ 145.0 (C), 130.3 (CH), 125.5 (CH), 122.0 (C), 99.2 (CH), 98.3 
(C), 98.0 (C), 65.55 (2 × CH2) 0.08 (3 × CH3); IR: νmax (cm
-1) 2959, 2894, 2154, 1671, 1249, 1073, 
834; HRMS (ES) m/z calculated for C12H16O2NaSSi (M+Na)
+ 275.0538, found 275.0543. 
2-(3-Ethynylthiophen-2-yl)-1,3-dioxolane 533 
Prepared according to GP4 from alkyne 533a (472 mg, 1.9 mmol) to give terminal 
alkyne 533 (324 mg, 96%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.25 (d, J = 5.1 
Hz, 1H), 7.05 (d, J = 5.1 Hz, 1H), 6.29 (s, 1H), 4.21 – 4.09 (m, 2H), 4.10 – 3.97 (m, 2H), 3.25 (s, 
1H); 13C-NMR (101 MHz, CDCl3): δ 145.7 (C), 130.4 (CH), 125.6 (CH), 120.6 (C), 99.1 (2 × CH2), 
81.0 (CH), 77.1 (C), 65.6 (CH3); IR: νmax (cm
-1) 3282, 3108, 2957, 2889, 2109, 1667, 1190, 1070, 
948, 935; HRMS (ES) m/z calculated for C9H9O2S (M+H)
+ 181.0323, found 181.0321. 
2-(2-Ethynyl-3-methoxyphenyl)-1,3-dioxolane 534 
Prepared according to GP5 using aldehyde 534a (400 mg, 2.5 mmol) and ethylene 
glycol (0.2 mL, 3.0 mmol). Purification by flash column chromatography 
[hexane:EtOAc (90:10), 1% Et3N] gave the acetal 534 (386 mg, 97%) as a yellow oil; 
1H-NMR (300 
MHz, CDCl3): δ 7.34 (app. t, J = 8.0 Hz, 1H), 7.20 (dd, J = 8.0, 0.8 Hz, 1H), 6.90 (dd, J = 8.0, 0.8 Hz, 
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1H), 6.23 (s, 1H), 4.18 – 4.10 (m, 2H), 4.10 – 4.02 (m, 2H), 3.90 (s, 3H), 3.58 (s, 1H); 13C-NMR (101 
MHz, CDCl3): δ 161.1 (C), 141.8 (C), 129.9 (CH), 118.1 (CH), 111.3 (CH), 110.7 (C), 101.8 (CH), 
86.4 (CH), 77.0 (C), 65.7 (2 × CH2), 56.2 (CH3); IR: νmax (cm
-1) 3006, 2947, 2900, 2868, 2842, 1686, 
1587, 1573, 1471, 1272, 1245, 1050, 738; HRMS (ES) m/z calculated for C12H13O3 (M+H)
+ 
205.0865, found 205.0863. 
2-(Dimethoxymethyl)-1-ethynyl-4-methoxybenzene 542 
5-Methoxy-2-((trimethylsilyl)ethynyl)benzaldehyde (181 mg, 0.8 mmol, 1.0 
equiv.), p-TsOH∙H2O (14.9 mg, 0.08 mmol, 0.1 equiv.) and trimethylorthoformate 
(0.4 mL, 3.9 mmol, 5.0 equiv.) were stirred in MeOH (4 mL, 0.2M) at room temperature for 1 
hour. NaHCO3 (10 mL) was added and the aqueous layer was extracted with EtOAc (3 × 10 mL), 
washed with brine (10 mL), dried over Na2SO4, filtered and the solvent removed under reduced 
pressure. The crude residue was dissolved redissolved in MeOH (4 mL) and stirred with K2CO3 
(10.8 mg, 0.08 mmol, 0.1 equiv.) for 1 hour. NaHCO3 (10 mL) was added and the aqueous layer 
was extracted with EtOAc (3 × 10 mL), washed with brine (10 mL), dried over Na2SO4, filtered 
and the solvent removed under reduced pressure. Purification by flash column chromatography 
[hexane:EtOAc (9:1), 1% Et3N] gave the acetal XX (141 mg, 88% over two steps) as a yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 7.44 (d, J = 8.5 Hz, 1H), 7.13 (d, J = 2.7 Hz, 1H), 6.83 (dd, J = 8.5, 2.7 
Hz, 1H), 5.68 (s, 1H), 3.83 (s, 3H), 3.40 (s, 6H), 3.24 (s, 1H); IR: νmax (cm
-1) 3292, 3066, 3002, 
2137, 1557, 1456, 1120, 758. Data matches that reported in the literature.122 
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((2-(1,3-Dioxan-2-yl)phenyl)ethynyl)trimethylsilane 543a 
Prepared according to GP5 using aldehyde 230 (607 mg, 3.0 mmol) and propane-
1,3-diol to give the crude acetal 543a which was used directly in the next step 
without purification.  
2-(2-Ethynylphenyl)-1,3-dioxane 543 
Prepared according to GP4 from alkyne 543a. Purification by flash column 
chromatography [hexane:Et2O (95:5), 1% Et3N] gave the acetal 543 (406 mg, 72%) as 
a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.71 (dd, J = 7.8, 1.2 Hz, 1H), 7.52 (dd, J = 7.8, 1.2 Hz, 
1H), 7.42 (td, J = 7.5, 1.4 Hz, 1H), 7.32 (td, J = 7.5, 1.4 Hz, 1H), 5.94 (s, 1H), 4.34 – 4.25 (m, 2H), 
4.05 (ddd, J = 12.3, 3.8, 2.5 Hz, 2H), 3.32 (s, 1H), 2.37 – 2.18 (m, 1H), 1.52 – 1.42 (m, 1H); IR: νmax 
(cm-1) 3246, 2981, 2960, 2863, 2105, 1394, 1381, 1277, 1109, 1087, 1006, 753. Data matches 
that reported in the literature.112 
Trimethyl((2-(4-methyl-1,3-dioxolan-2-yl)phenyl)ethynyl)silane 544a 
Prepared according to GP5 using aldehyde 230 (405 mg, 2.0 mmol). Purification 
by flash column chromatography [hexane:Et2O (98:2), 1% Et3N] gave the acetal 
543a (464 mg, 89%) as a yellow oil as a 1:1 mixture of diastereoisomers; 1H-NMR (300 MHz, 
CDCl3): δ 
1H NMR (300 MHz, CDCl3) δ 7.62 – 7.51 (m, 1H), 7.50 – 7.45 (m, 1H), 7.39 – 7.26 (m, 
2H), 6.30 and 6.21 (2 × s, 1H), 4.51 – 4.26 (m) and 4.14 (dd, J = 7.3, 6.5 Hz, 2H), 3.67 – 3.55 (m, 
1H), 1.43 (d, J = 6.1 Hz) and 1.37 (d, J = 6.1 Hz, 3H), 0.26 (2 × s, 9H); 13C-NMR (101 MHz, CDCl3): δ 
139.8 and 139.3 (C), 132.9 (CH), 129.0 and 128.9 (CH), 128.8 and 128.8 (CH), 126.5 and 126.2 
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(CH), 122.6 and 122.4 (C), 102.3 (C), 102.2 and 101.6 (CH), 99.4 and 99.3 (C), 73.8 and 72.8 (CH), 
72.5 and 71.6 (CH2), 18.6 and 18.5 (CH3), 0.1 (3 × CH3); IR: νmax (cm
-1) 2961, 2898, 2869, 2158, 
1699, 1249, 1064, 864, 839, 757; HRMS (ES) m/z calculated for C15H20O2SiNa (M+Na)
+ 283.1130, 
found 283.1136. 
2-(2-Ethynylphenyl)-4-methyl-1,3-dioxolane 544 
Prepared according to GP4 alkyne 544a (450 mg, 1.7 mmol) to give terminal alkyne 
544 (319 mg, 98%) as a yellow oil as a 1:1 mixture of diastereoisomers; 1H-NMR 
(300 MHz, CDCl3): δ 7.68 – 7.48 (m, 2H), 7.44 – 7.28 (m, 2H), 6.36 and 6.25 (2 × s, 1H), 4.45 – 
4.26 (m) and 4.15 (dd, J = 7.4, 6.4 Hz, 2H), 3.66 – 3.56 (m, 1H), 3.33 and  3.31 (2 × s, 1H), 1.42 
and 1.37 (2 × d, J = 6.1 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ 140.4 and 139.7 (C), 133.4 and 
133.2 (CH), 129.2 and 129.1 (CH), 129.1 and 129.0 (CH), 126.4 and 126.1 (CH), 121.5 and 121.3 
(C), 102.0 and 101.3 (CH), 82.1 and 82.0 (CH), 81.0 (C), 73.8 and 72.8 (CH), 72.4 and 71.6 (CH2), 
18.5 (CH3); IR: νmax (cm
-1) 2976, 2930, 2877, 1697, 1379, 1061, 759; HRMS (ES) m/z calculated for 
C12H12O2 (M+H)
+ 188.0837, found 188.0843.  
2-(2-Ethynyl-5-methoxyphenyl)-1,3-dithiolane 549 
Aldehyde 548 (300 mg, 1.9 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (15 mL, 0.1 
M) and silica gel (1.0 g), 1,2-ethanedithiol (0.4 mL, 4.1 mmol, 2.2 equiv.) and p-
TsOH·H2O (12.0 mg, 0.1 mmol, 3 mol%) were added. The mixture was heated at reflux for 1 hour 
before cooling to room temperature. The solution was filtered through a plug of cotton wool 
and the solvent was removed under reduced pressure. Purification by flash column 
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chromatography [hexane:EtOAc (96:4), 1% Et3N] gave the thioacetal 549 (281 mg, 63%) as a 
pale yellow solid; mp: 60-62 °C; 1H-NMR (300 MHz, CDCl3): δ 7.39 (d, J = 8.5 Hz, 1H), 7.35 (d, J = 
2.7 Hz, 1H), 6.75 (dd, J = 8.5, 2.7 Hz, 1H), 6.17 (s, 1H), 3.83 (s, 3H), 3.52 – 3.42 (m, 2H), 3.41 – 
3.30 (m, 3H), 3.34 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 160.3 (C), 145.5 (2 × C), 134.3 (CH), 
113.5 (CH), 113.3 (CH), 82.0 (CH), 81.4 (C), 55.5 (CH3), 53.4 (CH), 40.0 (2 × CH2); IR: νmax (cm
-1) 
3355, 3259, 1598, 1527, 1500, 1386, 1299, 1153, 1097, 901, 813; HRMS (ES) m/z calculated for 
C12H13OS2 (M+H)
+ 237.0408, found 237.0405. 
Preparation of Imines 
N-Ethylidene-4-methylbenzenesulfonamide 559 
Prepared according to GP6 using acetaldehyde (0.6 mL, 10.0 mmol) to give imine 
559 (1.3 g, 67%) as a white solid. mp: 114-116 °C; 1H-NMR (300 MHz, CDCl3): δ 
8.31 (q, J = 4.9 Hz, 1H), 8.01 (d, J = 8.2 Hz, 2H), 6.79 (d, J = 8.2 Hz, 2H), 1.90 (s, 3H), 1.33 (d, J = 
4.9 Hz, 3H); IR: νmax (cm
-1) 3277, 3060, 2988, 2922, 1630, 1595, 1427, 1314, 1290, 1155, 1089, 
146, 670. Data matches that reported in the literature.203 
N-Benzylidene-4-methylbenzenesulfonamide 560 
Benzaldehyde (1.0 mL, 10.0 mmol, 1.1 equiv.) and TsNH2 (1.5 g, 9.0 mmol, 1.0 
equiv.) were dissolved in toluene in a flask containing activated molecular 
sieves (1.0 g, 3 Å). Amberlyst 15 (1.0 g) was added and the mixture was heated to reflux for 4 
hours with azetropic removal of water using Dean Stark aparatus. Once cooled to room 
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temperature, the mixture was filtered through a cotton wool plug and the solvent was removed 
under reduced pressure. The resulting solid was triturated with hexane and the crystals were 
filtered and washed with pentane (30 mL) to give pure imine 560 (1.9 g, 72%) as a white solid; 
mp: 104-106 °C, 1H-NMR (300 MHz, CDCl3): δ 9.03 (s, 1H), 7.60 – 7.87 (m, 5H), 7.46 – 7.50 (m, 
2H), 7.34 (d, J = 8.2 Hz, 2H), 2.43 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.5 (C), 136.6 
(C),134.9(C), 132.3 (CH), 131.2 (2 × CH), 129.8 (2 × CH), 129.1 (2 × CH), 128.0 (2 × CH), 21.6 
(CH3); IR: νmax (cm
-1) 2932, 2864, 1650, 1570, 1414, 1380, 1322, 1280, 1064, 861, 753. Data 
matches that reported in the literature.204 
4-Methyl-N-(2-methylpropylidene)benzenesulfonamide 561 
Prepared according to GP6 using butyraldehyde (0.9 mL, 10.0 mmol) to give 
imine 561 (1.4 g, 64%) as a white solid; mp: 78-80 °C, 1H-NMR (300 MHz, 
CDCl3): δ 8.51 (d, J = 4.3 Hz, 1H), 7.80 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 2.72 (m, 1H), 
2.41 (s, 3H), 1.20 (d, J = 7.2 Hz, 6H); 13C-NMR (101 MHz, CDCl3): δ 181.8 (CH), 144.6 (C), 134.6 
(C), 129.7 (2 × CH), 128.0 (2 × CH), 34.6 (CH), 21.5 (CH3), 17.9 (2 × CH3); IR: νmax (cm
-1) 3305, 
3067, 2973, 1633, 1601, 1458, 1160, 1140, 1089, 750. Data matches that reported in the 
literature.203 
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Preparation of Sulfonamides 
4-Methyl-N-phenylbenzenesulfonamide 233 
Prepared according to GP7 using aniline (1.2 mL, 12.9 mmol) and p-
methylbenzenesufonyl chloride (1.7 g, 10.7 mmol). Purification by flash column 
chromatography [hexane:Et2O (90:10)] gave the sulfonamide XX (2.5 g, 94%) as a white solid; 
mp: 101-103 °C; 1H-NMR (300 MHz, CDCl3): δ 7.67 (d, J = 8.3 Hz, 2H), 7.26 – 7.20 (m, 4H), 7.12 – 
7.06 (m, 3H), 6.85 (br. s, 1H), 2.37 (s, 3H); IR: νmax (cm
-1) 3236, 3061, 2980, 2899, 1596, 1479, 
1414, 1319, 1290, 1223, 1186, 1153, 1089, 1031, 909, 754. Data matches that reported in the 
literature.205 
N-Phenylbenzenesulfonamide 242 
Prepared according to GP7 using aniline (6.0 mL, 65.8 mmol) and 
benzenesulfonyl chloride (3.0 mL, 54.9 mmol). Purification by flash column 
chromatography [hexane:Et2O (80:20)] gave the sulfonamide 242 (11.9 g, 93%) as a white solid; 
mp: 110-112 °C; 1H-NMR (400 MHz, CDCl3): δ 7.86 – 7.78 (m, 2H), 7.54 – 7.49 (m, 1H), 7.45 – 
7.39 (m, 2H), 7.26 – 7.17 (m, 2H), 7.14 – 7.07 (m, 3H); 13C-NMR (101 MHz, CDCl3): δ 139.0 (C), 
136.6 (C), 133.1 (CH), 129.4 (2 × CH), 129.2 (2 × CH), 127.4 (2 × CH), 125.5 (CH), 121.7 (2 × CH); 
MS (EI): m/z 256 [M+Na]+ (100 %). Data matches that reported in the literature.206  
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4-Nitro-N-phenylbenzenesulfonamide 243 
Prepared according to GP7 using aniline (2.0 mL, 21.9 mmol) and p-
nitrobenzenesulfonyl chloride (4.0 g, 18.3 mmol) to give sulfonamide 243 (4.6 
g, 90%) as an off-white solid; mp: 167-169 °C; 1H-NMR (300 MHz, CDCl3): δ 8.28 (d, J = 8.9 Hz, 
2H), 7.92 (d, J = 8.9 Hz, 2H), 7.33 – 7.24 (m, 2H), 7.23 – 7.15 (m, 1H), 7.14 – 7.02 (m, 2H), 6.72 
(br. s, 1H); 13C-NMR (101 MHz, CDCl3): δ 150.4 (C), 144.7 (C), 135.4 (C), 129.8 (2 × CH), 128.7 (2 × 
CH), 126.7 (CH), 124.4 (2 × CH), 122.6 (2 × CH); IR: νmax (cm
-1) 3284, 3236, 1596, 1517, 1340, 
1296, 1186, 1164, 909, 754. Data matches that reported in the literature.207 
N-Benzylmethanesulfonamide 246 
This sulfonamide was donated by a group member (Fernando Sanchez-Cantalejo). 
N-Methylmethanesulfonamide 247 
This sulfonamide was donated by a group member (Andrew Gillie). 
N-Methyl-4-nitrobenzenesulfonamide 248 
This sulfonamide was donated by a group member (Michel-Frank Boissennet). 
N-Allylmethanesulfonamide 249 
Prepared according to GP7 using allylamine (1.8 mL, 24.0 mmol) and 
methanesulfonyl chloride (1.5 mL, 20.0 mmol) to give sulfonamide 249 (2.1 g, 78%) 
as yellow oil;1H-NMR (300 MHz, CDCl3): δ 5.87 (ddt, J = 17.0, 10.2, 5.8 Hz, 1H), 5.31 (ddd, J = 
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17.0, 2.8, 1.6 Hz, 1H), 5.23 (ddd, J = 10.2, 2.8, 1.2 Hz, 1H), 4.48 (br. s, 1H), 3.78 (app. tt, J = 5.8, 
1.6 Hz, 2H), 2.97 (s, 3H); IR: νmax (cm
-1) 3286, 3019, 2933, 1434, 1412, 1308, 1141, 1062, 1141, 
967, 754; MS (EI): m/z 136 [M+H]+ (10 %), 135 (50), 134 (100). Data matches that reported in 
the literature.208 
N-Allyl-4-nitrobenzenesulfonamide 489 
Prepared according to GP7 using allylamine (1.8 mL, 24.0 mmol) and p-
nitrobenzenesulfonyl chloride (4.4 g, 20.0 mmol) to give sulfonamide 489 
(4.6 g, 95%) as white solid; mp: 110-112 °C; 1H-NMR (300 MHz, CDCl3): δ 8.37 (d, J = 9.0 Hz, 1H), 
8.06 (d, J = 9.0 Hz, 1H), 5.71 (ddt, J = 17.0, 10.2, 5.8 Hz, 1H), 5.19 (app. ddd, J = 17.0, 2.6, 1.5 Hz, 
1H), 5.13 (d, J = 10.2, 2.6, 1.2 Hz, 1H), 4.73 (br. t, J = 5.8 Hz, 1H), 3.69 (app. tt, J = 5.8, 1.5 Hz, 2H); 
13C-NMR (101 MHz, CDCl3): δ 150.3 (C), 146.3 (C), 132.5 (CH), 128.4 (2 × CH), 124.6 (2 × CH), 
118.6 (CH2), 46.0 (CH2); MS (EI): m/z 242 [M]
+ (15 %), 186 (50), 122 (100). Data matches that 
reported in the literature.209 
N-Allyl-4-methylbenzenesulfonamide 490 
 Prepared according to GP7 using allylamine (0.9 mL, 12.0 mmol) and p-
methylbenzenesulfonyl chloride (1.9 g, 10.0 mmol) to give sulfonamide 490 (2.0 
g, 83%) as white solid; mp: 63-65 °C; 1H-NMR (300 MHz, CDCl3): δ 7.75 (d, J = 8.2 Hz, 1H), 7.30 
(d, J = 8.2 Hz, 1H), 5.71 (ddt, J = 17.0, 10.2, 5.8 Hz, 1H), 5.15 (app. ddd, J = 17.0, 2.8, 1.5 Hz, 1H), 
5.08 (app. ddd, J = 10.2, 2.8, 1.3 Hz, 1H), 4.75 (br. t, J = 6.1 Hz, 1H), 3.57 (app. tt, J = 6.1, 1.4 Hz, 
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2H), 2.42 (s, 3H); IR: νmax (cm
-1) 3241, 3099, 3041, 2851, 1650, 1423, 1330, 1165, 937, 671. Data 
matches that reported in the literature.208 
N-Allyl-2,4,6-triisopropylbenzenesulfonamide 491 
This sulfonamide was donated by a group member (Alex Cremonesi). 
 
Diethyl allylphosphoramidate 492 
Allylamine (1.3 mL, 17.5 mmol, 1.0 equiv.) and Et3N (2.7 mL, 26.3 mmol, 1.5 
equiv.) were dissolved in CH2Cl2 (30 mL, 0.6 M) and cooled to 0 °C. 
Diethylchlorophosphate (3.0 mL, 21.0 mmol, 1.2 equiv.) was added dropwise and the resulting 
solution stirred at room temperature for 16 hours. H2O (50 mL) was added and the aqueous 
phase was extracted with CH2Cl2 (2 × 50 mL), dried over Na2SO4, filtered and the solvent was 
removed under reduced pressure. Purification by flash column chromatography [hexane:Et2O 
(75:25)] gave the phosphoramidate 492 (3.0 g, 89%) as a clear oil; 1H-NMR (300 MHz, CDCl3): δ 
5.94 – 5.80 (m, 1H), 5.28 – 5.16 (m, 1H), 5.16 – 5.07 (m, 1H), 4.24 – 3.88 (m, 4H), 3.71 – 3.44 (m, 
2H), 1.56 – 1.14 (m, 6H); 13C-NMR (101 MHz, CDCl3): δ 136.2 (CH), 115.4 (CH2), 62.4 (d, JC-P = 5.0 
Hz, 2 × CH2), 43.8 (CH2), 16.3 (d, JC-P = 6.9 Hz, 2 × CH3); IR: νmax (cm
-1) 3223, 2982, 2906, 1444, 
1228, 1024, 956, 794. Data matches that reported in the literature.210 
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N-(But-3-en-1-yl)-4-methylbenzenesulfonamide 551 
p-Methylbenzenesulfonamide (1.0 g, 5.8 mmol, 1.0 equiv.) and 4-bromo-1-
butene (0.65 mL, 6.4 mmol, 1.1 equiv.) were dissolved in acetone (5.8 mL, 1.0 
M). K2CO3 (1.6 g, 11.7 mmol, 2.0 equiv.) was added and the mixture was heated to 60 °C for 16 
hours. Saturated NH4Cl solution (15 mL) was added and the aqueous phase was extracted with 
Et2O (3 × 20mL). The combined organic layers were washed with brine, dried over Na2SO4, 
filtered and the solvent was removed under reduced pressure. Purification by flash column 
chromatography [hexane:EtOAc (9:1), then hexane:EtOAc (8:2)] gave the sulfonamide 551 (795 
mg, 60%) as a clear oil; 1H-NMR (300 MHz, CDCl3): δ 7.74 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.2 Hz, 
2H), 5.62 (ddt, J = 17.1, 10.4, 6.8 Hz, 1H), 5.09 – 4.97 (m, 2H), 4.56 (br. s, 1H), 3.00 (q, J = 6.6 Hz, 
2H), 2.43 (s, 3H), 2.24 – 2.15 (m, 2H); IR: νmax (cm
-1) 3280, 2928, 1598, 1423, 1322, 1305, 1156, 
1093, 1074, 813, 661. Data matches that reported in the literature.211 
N-(But-3-en-2-yl)-4-methylbenzenesulfonamide 562 
Prepared according to GP8 using imine 559 (395 mg, 2.0 mmol) and 
vinylmagnesium bromide (4.0 mL, 1.0 M solution in THF, 4.0 mmol). Purification 
by filtration through a short (ca. 3 cm) pad of silica, eluting with CH2Cl2 (40 mL) gave the 
sulfonamide 562 (423 mg, 94%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.75 (d, J = 8.2 Hz, 
2H), 7.28 (d, J = 8.2 Hz, 2H), 5.63 (ddd, J = 17.2, 10.4, 5.7 Hz, 1H), 5.05 (d, J = 17.2 Hz, 1H), 4.96 
(d, J = 10.4 Hz, 1H), 4.67 (br. s, 1H), 3.95 – 3.81 (m, 1H), 2.42 (s, 3H), 1.16 (d, J = 6.8 Hz, 3H); IR: 
νmax (cm
-1) 3274, 2979, 2931, 2880, 1599, 1427, 1323, 1305, 1152, 1092, 814; HRMS (ES) m/z 
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calculated for C11H15NO2S (M+H)
+ 226.0919, found 226.1918. Data matches that reported in the 
literature.212 
4-Methyl-N-(1-phenylbut-3-en-1-yl)benzenesulfonamide 563 
Prepared according to GP8 using imine 560 (518 mg, 2.0 mmol) and 
allylmagnesium bromide (4.0 mL, 1.0 M solution in THF, 4.0 mmol) to give the 
sulfonamide 563 (588 mg, 98%) as a clear oil; 1H-NMR (300 MHz, CDCl3): δ 7.55 (d, J = 8.3 Hz, 
2H), 7.20 – 7.11 (m, 5H), 7.11 – 7.03 (m, 2H), 5.58 – 5.43 (m, 1H), 5.08 (d, J = 1.0 Hz, 1H), 5.05 – 
5.01 (m, 1H), 4.96 (br. d, J = 6.6 Hz, 1H), 4.37 (app. q, J = 6.6 Hz, 1H), 2.49 – 2.41 (m, 2H), 2.37 (s, 
3H); IR: νmax (cm
-1) 3255, 3064, 3031, 2984, 2923, 1643, 1600, 1497, 1457, 1447, 1318, 1307, 
1278, 1157, 918. Data matches that reported in the literature.213 
4-Methyl-N-(pent-4-en-2-yl)benzenesulfonamide 564 
Prepared according to GP8 using imine 559 (395 mg, 2.0 mmol) and 
allylmagnesium bromide (4.0 mL, 1.0 M solution in THF, 4.0 mmol). 
Purification by flash column chromatography [hexane:EtOAc (80:20)] gave the sulfonamide 564 
(373 mg, 78%) as a clear oil; 1H-NMR (300 MHz, CDCl3): δ 7.75 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.0 
Hz, 2H), 5.56 (ddt, J = 17.4, 10.3, 6.8 Hz, 1H), 5.07 – 4.94 (m, 2H), 4.53 (br. s, 1H), 3.36 (app. dt, J 
= 12.8, 6.5 Hz, 1H), 2.42 (s, 3H), 2.11 (app. t, J = 6.8 Hz, 2H), 1.06 (d, J = 6.5 Hz, 3H); IR: νmax (cm
-
1) 3278, 3062, 2982, 2938, 1640, 1596, 1423, 1321, 1301, 1144, 1086, 1035, 815, 659. Data 
matches that reported in the literature.214 
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4-Methyl-N-(2-methylhex-5-en-3-yl)benzenesulfonamide 565 
Prepared according to GP8 using imine 561 (1.3 g, 5.8 mmol) and 
allylmagnesium bromide (11.5 mL, 1.0 M solution in THF, 11.5 mmol). 
Purification by flash column chromatography [hexane:EtOAc (90:10)] gave the sulfonamide 565 
(1.1 g, 74%) as a white solid; mp: 66-68 °C; 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.2 Hz, 2H), 
7.28 (d, J = 8.2 Hz, 2H), 5.47 (ddt, J = 17.6, 10.4, 7.2 Hz, 1H), 5.00 – 4.87 (m, 2H), 4.54 (br. d, J = 
8.4 Hz, 1H), 3.08 (app. dq, J = 8.4, 6.2 Hz, 1H), 2.42 (s, 3H), 2.05 (dd, J = 7.2, 6.2 Hz, 2H), 1.83 – 
1.69 (m, 1H), 0.83 (s, 6H); 13C-NMR (101 MHz, CDCl3): δ 143.2 (C), 138.3 (C), 133.9 (CH), 129.6 (2 
× CH), 127.2 (2 × CH), 118.3 (CH2), 58.8 (CH), 36.2 (CH2), 30.9 (CH), 21.6 (CH3), 18.7 (CH3), 17.9 
(CH3); IR: νmax (cm
-1) 3262, 3070, 2958, 2876, 1642, 1600, 1427, 1317, 1158, 907, 812, 665; 
HRMS (ES) m/z calculated for C14H21NO2NaS (M+Na)
+ 290.1191, found 290.1196. 
4-Methyl-N-(2-methylallyl)benzenesulfonamide 573 
This sulfonamide was donated by a group member (Fernando Sanchez-
Cantalejo). 
N-(2-Methylallyl)-4-nitrobenzenesulfonamide 574 
This sulfonamide was donated by a group member (Fernando Sanchez-
Cantalejo). 
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4-Methyl-N-(3-methylbut-2-en-1-yl)benzenesulfonamide 575 
This sulfonamide was donated by a group member (Alex Cremonesi). 
N-Benzyl-4-methylbenzenesulfonamide 580 
Prepared according to GP7 using benzylamine (1.3 mL, 12.0 mmol) and p-
methylbenzenesulfonyl chloride (1.9 g, 10.0 mmol) to give sulfonamide 580 
(2.3 g, 89%) as white solid; mp: 109-110 °C;1H-NMR (300 MHz, CDCl3): δ 7.76 (d, J = 8.3 Hz, 2H), 
7.33 – 7.23 (m, 5H), 7.23 – 7.17 (m, 2H), 4.88 (br. t, J = 6.2 Hz, 1H), 4.11 (d, J = 6.2 Hz, 2H), 2.44 
(s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.6 (C), 137.0 (C), 136.4 (C), 129.8 (2 × CH), 128.8 (2 × 
CH), 128.0 (3 × CH), 127.3 (2 × CH), 47.4 (CH2), 21.7 (CH3); MS (EI): m/z 261 [M]
+ (20 %), 196 
(100). Data matches that reported in the literature.215 
N-(3-Methoxybenzyl)-4-methylbenzenesulfonamide 586 
This sulfonamide was donated by a group member (Joshua Priest). 
(E)-N-(But-2-en-1-yl)methanesulfonamide 682 
This sulfonamide was donated by a group member (Fernando Sanchez-Cantalejo). 
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Preparation of Ynamides 
N-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 234 
Prepared according to GP12 using alkyne 232 (750 mg, 3.4 mmol) and 
sulfonamide 233 (4.91 g, 16.9 mmol). Purification by flash column 
chromatography [hexane:EtOAc (92:8) then hexane:EtOAc (90:10)] gave the 
ynamide 234 (632 mg, 54%) as an orange oil alongside the recovered 
sulfonamide (2.98 g, 85%, based on the consumption of 1.0 equiv. over the reaction); 1H-NMR 
(300 MHz, CDCl3): δ 7.55 (d, J = 8.3 Hz, 2H), 7.50 (dd, J = 7.8, 1.1 Hz, 1H), 7.39 – 7.16 (m, 15H), 
5.71 (s, 1H), 3.35 (s, 3H), 2.41 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 145.0 (C), 143.3 (C), 141.5 
(C), 138.9 (C), 133.2 (C), 132.4 (CH), 129.6 (2 × CH), 129.2 (2 × CH), 128.8 (CH), 128.5 (CH), 128.3 
(4 × CH), 127.3 (3 × CH), 127.2 (CH), 127.0 (CH), 126.3 (2 × CH), 121.6 (C), 87.4 (C), 82.4 (CH), 
68.7 (C), 57.1 (CH3), 21.7 (CH3); IR: νmax (cm
-1) 3063, 2235, 3030, 2984, 2926, 2822, 2235, 1594, 
1491, 1169, 1089; HRMS (ES) m/z calculated for C29H25NO3NaS (M+Na)
+ 490.1453 found 
490.1455. 
N-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)-N-phenylbenzenesulfonamide 244 
Prepared according to GP12 using alkyne 233 (2.0 g, 9.0 mmol) and 
sulfonamide 242 (10.5 g, 45.0 mmol). Purification by flash column 
chromatography [hexane:EtOAc (90:10) then hexane:EtOAc (80:20)] gave the 
ynamide 244 (1.41 g, 35%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.68 
(dd, J = 8.5, 1.2 Hz, 2H), 7.66 – 7.60 (m, 1H), 7.52 – 7.49 (m, 1H), 7.46 – 7.41 (m, 2H), 7.38 – 7.17 
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(m, 13H), 5.71 (s, 1H), 3.35 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 143.7 (C), 141.8 (C), 139.1 (C), 
136.4 (C), 134.2 (CH), 132.4 (CH), 129.6 (2 × CH), 129.3 (2 × CH), 128.9 (CH), 128.8 (CH), 128.6 (2 
× CH), 128.5 (2 × CH), 127.7 (C), 127.6 (C), 127.4 (2 × CH), 126.7 (CH), 126.7 (2 × CH), 121.8 (C), 
87.5 (C), 82.8 (CH), 69.1 (C), 57.5 (CH3); IR: νmax (cm
-1) 2988, 2973, 2902, 1615, 1596, 1581, 
1155, 1075; HRMS (ES) m/z calculated for C28H24NO3S (M+H)
+ 454.1471 found 454.1475. 
N-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)-4-nitro-N-phenylbenzenesulfonamide 245 
Prepared according to GP12 using alkyne 233 (0.39 g, 1.7 mmol) and 
sulfonamide 243 (2.42 g, 8.7 mmol). Purification by flash column 
chromatography [hexane:EtOAc (90:10)] gave the ynamide 245 (366 mg, 42%) 
as a yellow solid; mp: 112-114 °C; 1H-NMR (300 MHz, CDCl3): δ 8.22 (d, J = 8.9 
Hz, 2H), 7.76 (d, J = 8.9 Hz, 2H), 7.54 – 7.50 (m, 1H), 7.41 – 7.20 (m, 13H), 5.69 (s, 1H), 3.37 (s, 
3H); 13C-NMR (101 MHz, CDCl3): δ 151.0 (C), 143.6 (C), 141.6 (C), 141.4 (C), 138.4 (C), 132.4 (CH), 
129.9 (2 × CH), 129.7 (2 × CH), 129.4 (CH), 129.3 (CH), 128.6 (2 × CH), 127.9 (CH), 127.7 (CH), 
127.5 (2 × CH), 127.0 (CH), 126.5 (2 × CH), 124.5 (2 × CH), 121.3 (C), 86.5 (C), 82.9 (CH), 69.7 (C), 
57.6 (CH3); IR: νmax (cm
-1) 2970, 2901, 2156, 1603, 1482, 1453, 1407, 1394, 1250, 858, 836; 
HRMS (ES) m/z calculated for C28H22N2O5SNa (M+Na)
+ 521.1147 found 521.1135. 
N-Benzyl-N-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)methanesulfonamide 252 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (324 mg, 1.1 mmol, GP9) and sulfonamide 246 
(166 mg, 0.9 mmol). Purification by flash column chromatography [hexane:EtOAc 
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(90:10) then hexane:EtOAc (85:15)] gave the ynamide 252 (305 mg, 84%) as pale yellow oil; 1H-
NMR (300 MHz, CDCl3): δ 7.53 – 7.16 (m, 14H), 5.58 (s, 1H), 4.75 (d, J = 14.4 Hz, 1H), 4.66 (d, J = 
14.4 Hz, 1H), 3.33 (s, 3H), 2.86 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.1 (C), 141.3 (C), 134.4 
(C), 132.0 (CH), 128.9 (2 × CH), 128.8 (CH), 128.5 (CH), 128.2 (2 × CH), 127.4 (CH), 127.2 (CH), 
127.0 (4 × CH), 126.4 (CH), 121.4 (C), 86.3 (C), 82.4 (CH), 70.0 (C), 57.1 (CH3), 55.7 (CH2), 39.0 
(CH3); IR: νmax (cm
-1) 2988, 2930, 2234, 1359, 1276, 1261, 1162, 1076, 764, 751; HRMS (ES) m/z 
calculated for C24H23NO3SNa (M+Na)
+ 428.1296 found 428.1276. 
N-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)-N-methylmethanesulfonamide 253 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-
2-(methoxy(phenyl)methyl)benzene (390 mg, 1.3 mmol, GP9) and sulfonamide 
247 (168 mg, 1.1 mmol). Purification by flash column chromatography 
[hexane:EtOAc (80:20)] gave the ynamide 253 (240 mg, 67%) as an orange oil; 1H-NMR (300 
MHz, CDCl3): δ 7.53 (dd, J = 7.8, 0.9 Hz, 1H), 7.42 – 7.18 (m, 8H), 5.70 (s, 1H), 3.40 (s, 3H), 3.28 (s, 
3H), 3.01 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.1 (C), 141.3 (C), 131.9 (CH), 128.4 (CH), 128.3 
(2 × CH), 127.5 (3 × CH), 127.2 (CH), 126.3 (CH), 121.2 (C), 87.6 (C), 82.7 (CH), 68.0 (C), 57.2 
(CH3), 39.1 (CH3), 36.8 (CH3); IR: νmax (cm
-1) 3028, 2932, 2823, 2234, 1159, 1077; HRMS (ES) m/z 
calculated for C18H19NO3NaS (M+Na)
+ 352.0983 found 352.0964. 
N-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)-N-methyl-4-nitrobenzenesulfonamide 254 
Prepared according to GP11 using the freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (325 mg, 1.1 mmol, GP9) and sulfonamide 248 
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(194 mg, 0.9 mmol). Purification by flash column chromatography [hexane:EtOAc (90:10)] gave 
the ynamide 254 (338 mg, 86%) as a yellow solid; mp: 109-111 °C; 1H-NMR (300 MHz, CDCl3): δ 
8.30 (d, J = 9.0 Hz, 2H), 7.99 (d, J = 9.0 Hz, 2H), 7.52 (dd, J = 7.2, 0.5 Hz, 1H), 7.39 – 7.18 (m, 8H), 
5.68 (s, 1H), 3.39 (s, 3H), 3.21 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 151.0 (C), 143.6 (C), 141.9 
(C), 141.6 (C),  132.3 (CH), 129.2 (2 × CH), 128.6 (2 × CH), 127.9 (2 × CH), 127.7 (CH), 127.5 (2 × 
CH), 126.9 (CH), 124.8 (2 × CH), 121.2 (C), 87.2 (C), 82.8 (CH), 68.5 (C), 57.5 (CH3), 39.9 (CH3); IR: 
νmax (cm
-1) 3121, 3061, 3031, 2989, 2930, 2873, 2826, 2238, 1530, 1369, 1347, 1170, 1085, 967; 
HRMS (ES) m/z calculated for C23H20N2O5NaS (M+Na)
+ 459.0991 found 459.1001. 
N-Allyl-N-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)methanesulfonamide 255 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (174 mg, 0.58 mmol, GP9) and sulfonamide 
249 (65 mg, 0.48 mmol). Purification by flash column chromatography 
[hexane:EtOAc (85:15)] gave the ynamide 255 (170 mg, 99%) as an orange oil; 1H-NMR (300 
MHz, CDCl3): δ 7.52 (dd, J = 7.8 Hz, 1H), 7.43 – 7.17 (m, 8H), 5.95 (ddt, J = 17.0, 10.1, 6.4 Hz, 1H), 
5.72 (s, 1H), 5.41 (dd, J = 17.0, 1.1 Hz, 1H) 5.35 (dd, J = 10.1, 1.1 Hz, 1H), 4.15 (ddd, J = 6.4, 2.5, 
1.1 Hz, 2H), 3.40 (s, 3H) 3.04 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.1 (C), 141.4 (C), 132.0 
(CH), 130.9 (CH), 128.5 (CH), 128.2 (2 × CH), 127.4 (CH), 127.2 (CH), 127.1 (2 × CH), 126.4 (CH), 
121.4 (C), 120.6 (CH2), 86.1 (C), 82.6 (CH), 69.6 (C), 57.2 (CH3), 54.3 (CH2), 39.0 (CH3); IR: νmax 
(cm-1) 3028, 2984, 2931, 2823, 2232, 1164; HRMS (ES) m/z calculated for C20H21NO3NaS (M+Na)
+ 
378.1140, found 378.1142. 
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3-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)oxazolidin-2-one 256 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (348 mg, 1.2 mmol, GP9) and commercially 
available 2-oxazolidinone 250 (84 mg, 1.0 mmol). Purification by flash column 
chromatography [hexane:EtOAc (70:30)] gave the ynamide 256 (193 mg, 65%) as 
a pale orange solid; mp: 128-130 °C; 1H-NMR (300 MHz, CDCl3): δ 7.56 (d, J = 7.7 Hz, 1H), 7.48 – 
7.17 (m, 8H), 5.75 (s, 1H), 4.49 (dd, J = 8.8, 7.2 Hz, 2H), 3.96 (dd, J = 8.8, 7.2 Hz, 2H), 3.40 (s, 3 H); 
13C-NMR (101 MHz, CDCl3): δ 155.7 (C), 143.4 (C), 141.3 (C), 131.8 (CH), 128.5 (CH), 128.2 (2 × 
CH), 127.4 (CH), 127.2 (2 × CH), 127.2 (CH), 126.1 (CH), 121.0 (C), 83.7 (C), 82.5 (CH), 69.6 (C), 
63.0 (CH2) , 57.1 (CH3), 46.8 (CH2); IR: νmax (cm
-1) 3068, 2949, 2928, 2876, 2824, 2253, 1770, 
1205, 1075; HRMS (ES) m/z calculated for C19H17NO3Na (M+Na)
+ 330.1106 found 330.1108. 
 
(4S)-4-Benzyl-3-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)oxazolidin-2-one 257 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (324 mg, 1.1 mmol, GP9) and 
commercially available (S)-4-benzyl-2-oxazolididnone 251 (159 mg, 0.9 
mmol). Purification by flash column chromatography [hexane:EtOAc (8:2)] 
gave the ynamide 257 (335 mg, 94%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.55 – 7.48 
(m, 1H), 7.46 – 7.08 (m, 13H), 5.78, 5.77 (2 × s, 1H), 4.37 – 4.18 (m, 2H), 4.12 (dd, J = 7.9, 5.0 Hz, 
1H), 3.38, 3.38 (2 × s, 3H), 3.13 (dd, J = 13.8, 1.9 Hz, 1H), 2.88 (dd, J = 13.8, 8.0 Hz, 1H); 13C-NMR 
(101 MHz, CDCl3): δ 155.6 (C), 143.7 (C), 141.7, 141.6 (C), 134.4 (C), 132.5, 132.5 (CH), 129.7 (2 × 
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CH), 129.4 (2 × CH), 129.0 (C), 128.6 (2 × CH), 127.9 (CH), 127.8 (CH), 127.6 (3 × CH), 126.7 (CH) 
121.5, 121.4 (1 × C), 83.0 (C), 83.0, 83.0 (1 × CH), 72.0 (C), 67.8, 67.8 (1 × CH2), 58.8, 58.7 (1 × 
CH), 57.6 (CH3), 38.3 (CH2); IR: νmax (cm
-1) 3062, 3030, 2983, 2930, 2823, 2950, 1768, 1406, 1208, 
1188,1088, 1074; HRMS (ES) m/z calculated for C26H23NO3Na (M+Na)
+ 420.1576 found 
420.1578. 
N-((2-((4-(t-Butyl)phenyl)(methoxy)methyl)phenyl)ethynyl)-4-methyl-N-
phenylbenzenesulfonamide 278 
Prepared according to GP12 using alkyne 273 (269 mg, 1.0 mmol) and 
sulfonamide 233 (1.20 g, 4.8 mmol). Purification by flash column 
chromatography [hexane:Et2O (90:10)] gave the ynamide 278 (261 mg, 
52%) as a yellow oil; 1H-NMR (300 MHz, CDCl3) δ 7.59 - 7.51 (m, 3H), 7.39 – 
7.16 (m, 14H), 5.69 (s, 1H), 3.35 (s, 3H), 2.41 (s, 3H), 1.27 (s, 9H); 13C-NMR (101 MHz, CDCl3) δ 
150.4 (C), 145.3 (C), 143.8 (C), 139.2 (C), 138.7 (C), 133.5 (C), 132.3 (CH), 129.9 (2 × CH), 129.5 (2 
× CH), 128.8 (CH), 128.7 (CH), 128.5 (2 × CH), 127.4 (CH), 127.0 (2 × CH), 126.7 (2 × CH), 126.6 
(CH), 125.5 (2 × CH), 121.9 (C), 87.7 (C), 82.6 (CH), 69.1 (C), 57.4 (CH3), 34.8 (C), 31.7 (3 × CH3), 
22.0 (CH3); IR: νmax/cm
-1 3062, 2961, 2903, 2869, 2822, 2236, 1594, 1491, 1373, 1171, 1088; 
HRMS (ES) m/z calculated for C33H34NO3S (M+H)
+ 524.2259 found 524.2257. 
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N-((2-((3,5-Difluorophenyl)(methoxy)methyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfon
amide 279 
Prepared according to GP12 using alkyne 274 (250 mg, 1.0 mmol) and 
sulfonamide 233 (1.20 g, 4.8 mmol). Purification by flash column 
chromatography [hexane:Et2O (90:10)] gave the ynamide 279 (150 mg, 
31%) as an orange oil; 1H-NMR (300 MHz, CDCl3) δ 7.56 (d, J = 8.3 Hz, 2H), 
7.45 – 7.16 (m, 11H), 6.88 (dd, J = 8.3, 1.7 Hz, 2H), 6.65 (tt, J = 8.9, 2.3 Hz, 1H), 5.70 (s, 1H), 3.36 
(s, 3H), 2.42 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 162.2 (dd, JC-F = 248.2, 12.5 Hz, 2 × C), 146.3 (t, 
JC-F = 8.4 Hz, C), 145.6 (C), 142.4 (C), 139.0 (C), 133.5 (C), 132.3 (CH), 130.0 (2 × CH), 129.6 (2 × 
CH), 129.0 (CH), 128.8 (CH), 128.4 (2 × CH), 128.1 (CH), 126.6 (2 × CH), 122.1 (C), 109.9 (d, JC-F = 
25.6 Hz, 2 × CH), 102.9 (t, JC-F = 25.6 Hz, CH), 88.1 (C), 81.5 (CH), 68.8 (C), 66.2 (C), 57.5 (CH3), 
22.0 (CH3); IR: νmax/cm
-1 3066, 2989, 2932, 2826, 2235, 1623, 1595, 1491, 1454, 1373, 1171, 
1116, 1089; HRMS (ES) m/z calculated for C20H21NO3SF (M+H)
+ 504.1445 found 504.1458. 
N-((2-(Methoxy(ferrocene)methyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 280 
Prepared according to GP12 using alkyne 275 (194 mg, 0.6 mmol) and 
sulfonamide 233 (0.87 g, 3.5 mmol). Purification by flash column 
chromatography [hexane:EtOAc (90:10)] gave the ynamide 280 (261 mg, 
77%) as an orange oil; 1H-NMR (300 MHz, CDCl3) δ 7.54 (d, J = 8.3 Hz, 2H), 
7.44 (dd, J = 7.8, 1.0 Hz, 1H), 7.37 – 7.17 (m, 9H), 7.14 (app. td, J = 7.5, 1.4 Hz, 1H), 5.41 (s, 1H), 
4.08 (app. d, J = 1.7 Hz, 2H), 4.01 – 3.98 (m, 2H), 3.94 (s, 5H), 3.21 (s, 3H), 2.36 (s, 3H); 13C-NMR 
(101 MHz, CDCl3) δ 145.4 (C), 143.9 (C), 139.2 (C), 133.5 (C), 131.9 (CH), 130.0 (2 × CH2), 129.6 (2 
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× CH2), 128.7 (CH), 128.5 (3 × CH), 127.5 (CH), 126.8 (CH), 126.7 (2 × CH), 122.0 (C), 90.6 (C), 87.6 
(C), 79.4 (CH), 69.3 (C), 69.1 (5 × CH), 68.3 (CH), 67.8 (CH), 67.6 (CH), 66.7 (CH), 57.3 (CH3), 22.1 
(CH3); IR: νmax/cm
-1 3102, 3069, 2937, 2236, 1678, 1594, 1490, 1372, 1171, 1088; HRMS (ES) m/z 
calculated for C33H29NO3SFe (M+H)
+ 575.1218 found 575.1223. 
N-((2-(methoxy(4-methoxyphenyl)methyl)phenyl)ethynyl)-4-methyl-N-
phenylbenzenesulfonamide 281 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(4-methoxyphenyl)methyl)benzene (841 mg, 2.24 mmol, GP9) 
and sulfonamide 233 (493 mg, 2.1 mmol). Purification by flash column 
chromatography [hexane:EtOAc (90:10)] gave the ynamide 281 (300 mg, 
24%) as an orange oil; 1H-NMR (500 MHz, CDCl3): δ 7.59 (d, J = 7.7 Hz, 2H), 7.54 (t, J = 7.5 Hz, 
1H), 7.45 (d, J = 7.9 Hz, 1H), 7.36 (app. t, J = 7.9 Hz, 2H), 7.30 – 7.20 (m, 3H), 7.18 – 7.14 (m, 3H), 
7.15 – 7.07 (m, 2H), 6.67 (d, J = 8.6 Hz, 2H), 5.56 (s, 1H), 3.67 (s, 3H), 3.25 (s, 3H); 13C-NMR (126 
MHz, CDCl3): δ 159.0 (C), 143.7 (C), 138.9 (C), 136.1 (C), 134.1 (CH), 133.7 (C), 132.2 (CH), 129.3 
(2 × CH), 129.1 (2 × CH), 129.1 (C), 128.6 (CH), 128.6 (2 × CH), 128.3 (2 × CH), 127.2 (CH), 126.5 
(2 × CH), 126.2 (CH), 121.4 (C), 113.7 (2 × CH), 87.4 (C), 82.3 (CH), 68.8 (C), 57.2 (CH3), 55.3 (CH3); 
IR: νmax (cm
-1) 3065, 2933, 2908, 2236, 1610, 1590, 1510, 1448, 1373, 1246, 1171, 1087, 1031, 
723, 686; HRMS (ES) m/z calculated for C29H26NO4S (M+H)
+ 484.1589, found 484.1577. 
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N-((2-(Furan-2-yl(methoxy)methyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 
282 
Prepared according to GP11 using alkyne 277 (250 mg, 1.2 mmol) and 
sulfonamide 233 (1.5 g, 5.9 mmol). Purification by flash column 
chromatography [hexane:EtOAc (94:4)] gave the ynamide 282 (184 mg, 
34%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.81 (d, J = 8.4 Hz, 1H), 7.68 – 7.62 (m, 1H), 
7.53 (d, J = 8.3 Hz, 2H), 7.42 – 7.20 (m, 9H), 6.26 (dd, J = 3.2, 1.8 Hz, 1H), 6.04 (d, J = 3.2 Hz, 1H), 
5.73 (s, 1H), 3.37 (s, 3H), 2.42 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 153.7 (C), 145.1 (C), 142.8 
(CH), 140.3 (C), 138.9 (C), 133.2 (C), 131.8 (CH), 129.7 (2 × CH), 129.3 (2 × CH), 128.4 (2 × CH), 
128.3 (CH), 127.8 (CH), 126.8 (CH), 126.3 (2 × CH), 121.8 (C), 110.2 (CH), 109.0 (CH), 87.8 (C), 
76.4 (CH), 68.3 (C), 57.2 (CH3), 21.8 (CH3); IR: νmax (cm
-1) 3070, 2928, 2825, 2238, 1595, 1491, 
1373, 1170, 1088, 692; HRMS (ES) m/z calculated for C27H23NO4NaS (M+Na)
+ 480.1245 found 
480.1244. 
N-((2-(Methoxy(2-methoxyphenyl)methyl)phenyl)ethynyl)-4-methyl-N-
phenylbenzenesulfonamide 294 
Prepared according to GP12 using alkyne 289 (252 mg, 1.0 mmol) and 
sulfonamide 233 (1.24 g, 5.0 mmol). Purification by flash column 
chromatography [hexane:EtOAc (95:5) then hexane:EtOAc (90:10)] gave the 
ynamide 294 (192 mg, 39%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 
7.55 (d, J = 8.3 Hz, 2H), 7.44 – 7.37 (m, 1H), 7.35 – 7.16 (m, 12H), 6.92 (app. td, J = 7.5, 0.9 Hz, 
1H), 6.76 (dd, J = 8.3, 0.7 Hz, 1H), 6.00 (s, 1H), 3.57 (s, 3H), 3.30 (s, 3H), 2.40 (s, 3H); 13C-NMR 
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(101 MHz, CDCl3): δ 157.5 (C), 145.2 (C), 142.9 (C), 139.4 (C), 133.4 (C), 132.5 (CH), 129.9 (C), 
129.8 (2 × CH), 129.4 (2 × CH), 128.8 (CH), 128.6 (2 × CH), 128.4 (2 × CH), 127.6 (CH), 127.5 (CH), 
127.4 (CH), 126.4 (2 × CH), 122.9 (C), 120.5 (CH), 110.8 (CH), 86.9 (C), 77.5 (CH), 69.3 (C), 57.6 
(CH3), 55.5 (CH3), 22.0 (CH3); IR: νmax/cm
-1 2968, 2901, 2238, 1711, 1595, 1372, 1244, 1172, 
1084; HRMS (ES) m/z calculated for C30H28NO4S (M+H)
+ 498.1739 found 498.1741. 
N-((2-(Methoxy(o-tolyl)methyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 293 
Prepared according to GP11 using alkyne 290 (236 mg, 1.0 mmol) and 
sulfonamide 233 (1.24 g, 5.0 mmol). Purification by flash column 
chromatography [hexane:EtOAc (95:5)] gave the ynamide 293 (190 mg, 
39%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.47 (d, J = 8.3 Hz, 2H), 
7.44 – 7.39 (m, 1H), 7.35 – 7.06 (m, 14H), 5.81 (s, 1H), 3.36 (s, 3H), 2.41 (s, 3H), 2.14 (s, 3H); 13C-
NMR (101 MHz, CDCl3): δ 145.3 (C), 141.7 (C), 139.5 (C), 139.2 (C), 137.3 (C), 133.4 (C), 132.3 
(CH), 130.8 (CH), 129.9 (2 × CH), 129.5 (2 × CH), 128.6 (CH), 128.5 (CH), 128.5 (2 × CH), 128.0 
(CH), 127.8 (2 × CH), 126.8 (CH), 126.5 (2 × CH), 126.0 (CH), 123.2 (C), 87.7 (C), 80.3 (CH), 69.0 
(C), 57.8 (CH3), 22.0 (CH3), 19.5 (CH3); IR: νmax (cm
-1) 2981, 2923, 2901, 2235, 1595, 1488, 1372, 
1170; HRMS (ES) m/z calculated for C30H28NO3S (M+H)
+ 482.1790 found 482.1803. 
N-((2-(Methoxy(naphthalen-1-yl)methyl)phenyl)ethynyl)-4-methyl-N-
phenylbenzenesulfonamide 294 
Prepared according to GP11 using alkyne 291 (0.80 g, 2.9 mmol) and 
sulfonamide 233 (3.63 g, 14.7 mmol). Purification by flash column 
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chromatography [(hexane:EtOAc (92:8) then hexane:EtOAc (90:10)] followed by recrystallization 
(hexane:CH2Cl2) gave the ynamide 294 (605 mg, 40%) as a white solid; mp: 136-138 °C;
 1H-NMR 
(300 MHz, CDCl3): δ 7.91 (d, J = 8.4 Hz, 1H), 7.84 (dd, J = 8.4, 0.9 Hz, 1H), 7.78 (dd, J = 7.3, 2.0 Hz, 
1H), 7.55 – 7.10 (m, 17H), 6.38 (s, 1H), 3.44 (s, 3H), 2.37 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
144.9 (C), 141.9 (C), 138.7 (C), 136.6 (C), 133.9 (C), 133.1 (C), 132.3 (CH), 131.3 (C), 129.5 (2 × 
CH), 129.1 (2 × CH), 128.6 (2 × CH), 128.4 (CH), 128.2 (2 × CH), 128.1 (2 × CH), 127.8 (CH), 127.7 
(CH), 126.2 (2 × CH), 125.5 (CH), 125.2 (CH), 124.3 (CH), 123.9 (CH), 122.6 (C), 87.5 (C), 79.7 (CH), 
68.6 (C), 57.5 (CH3), 21.6 (CH3); IR: νmax (cm
-1) 3062, 2930, 2820, 2235, 1596, 1482, 1456, 1368, 
1173, 1088, 1076; HRMS (ES) m/z calculated for C33H27NO3NaS (M+Na)
+ 540.1609 found 
540.1611. 
N-Allyl-N-((2-(methoxy(naphthalen-1-yl)methyl)phenyl)ethynyl)methanesulfonamide 295 
Prepared according to GP11 using freshly prepared 1-((2-
(bromoethynyl)phenyl)(methoxy)methyl)naphthalene (380 mg, 1.08 mmol, 
GP10) and sulfonamide 249 (122 mg, 0.9 mmol). Purification by flash column 
chromatography [(hexane:EtOAc (90:10)] gave the ynamide 295 (280 mg, 64%) 
as pale yellow oil; 1H-NMR (300 MHz, CDCl3): δ 8.11 (d, J = 8.2 Hz, 1H), 7.88 – 7.83 (m, 1H), 7.79 
(d, J = 8.2 Hz, 1H), 7.58 – 7.39 (m, 5H), 7.37 – 7.23 (m, 3H), 6.44 (s, 1H), 5.71 (ddt, J = 17.1, 10.1, 
6.3 Hz, 1H), 5.24 (dd, J = 17.1, 1.2 Hz, 1H), 5.19 (dd, J = 10.1, 1.0 Hz, 1H), 4.05-4.83, (m, 2H), 3.56 
(s, 3H), 2.71 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 142.2 (C), 137.0 (C), 134.2 (C), 132.7 (CH), 
132.0 (C), 131.0 (CH), 129.0 (CH), 128.8 (CH), 128.7 (CH), 127.9 (CH), 127.8 (CH), 126.6 (CH), 
126.0 (CH), 125.6 (CH), 125.1 (CH), 124.2 (CH), 122.6 (C), 120.7 (CH2), 86.7 (C), 80.1 (CH), 69.5 
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(C), 58.1 (CH3), 54.5 (CH2), 38.9 (CH3); IR: νmax (cm
-1) 3073, 2929, 2822, 2232, 1356, 1162; HRMS 
(ES) m/z calculated for C24H24NO3S (M+H)
+ 406.1477 found 406.1476. 
3-((4,5-Dimethoxy-2-(methoxy(phenyl)methyl)phenyl)ethynyl)oxazolidin-2-one 311 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-4,5-
dimethoxy-2-(methoxy(phenyl)methyl)benzene (815 mg, 2.26 mmol, GP9) 
and commercially available 2-oxazolidinone 250 (162 mg, 1.9 mmol), stirring 
for 42 hours. Purification by flash column chromatography [hexane:EtOAc 
(55:45)] gave the ynamide 311 (358 mg, 52%) a yellow solid; mp: 137-139 °C; 1H-NMR (300 MHz, 
CDCl3): δ 7.45 – 7.38 (m, 2H), 7.35 – 7.17 (m, 3H), 6.99 (s, 1H), 6.90 (s, 1H), 5.72 (s, 1H), 4.49 (dd, 
J = 8.8, 7.2 Hz, 2H), 3.95 (dd, J = 8.8, 7.2 Hz, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 3.39 (s, 3H); 13C-NMR 
(101 MHz, CDCl3) δ 156.2 (C), 150.2 (C), 148.1 (C), 142.1 (C), 137.6 (2 × C), 128.6 (2 × CH), 127.7 
(CH), 127.2 (2 × CH), 114.7 (CH), 113.2 (C), 109.2 (CH), 82.5 (CH), 69.8 (C), 63.3 (CH2), 57.4 (CH3), 
56.3 (CH3), 56.3 (CH3), 47.3 (CH2); IR: νmax (cm
-1) 2991, 2836, 2827, 2257, 1748, 1605, 1514, 
1424, 1392, 1259, 1209, 1066; HRMS (ES) m/z calculated for C21H21NO5 (M)
+ 367.1420 found 
367.1411. 
3-((4-Methoxy-2-(methoxy(phenyl)methyl)phenyl)ethynyl)oxazolidin-2-one 312 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-4-
methoxy-2-(methoxy(phenyl)methyl)benzene (225 mg, 0.89 mmol, GP9) and 
commercially available 2-oxazolidinone 250 (65 mg, 0.7 mmol). Purification by 
flash column chromatography [hexane:EtOAc (65:35)] gave the ynamide 312 (64 mg, 25%) as an 
white solid; mp: 184-185 °C; 1H-NMR (300 MHz, CDCl3): δ 7.47 – 7.40 (m, 2H), 7.38-7.20 (m, 4H), 
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7.09 (d, J = 2.7 Hz, 1H), 6.75 (dd, J = 8.5, 2.7 Hz, 1H), 5.72 (s, 1H), 4.49 (dd, J = 8.8, 7.2 Hz, 2H), 
3.94 (dd, J = 8.8, 7.1 Hz, 2H), 3.81 (s, 3H), 3.40 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 160.4 (C), 
156.2 (C), 146.1 (C), 141.6 (C), 134.2 (CH), 128.6 (2 × CH), 127.8 (CH), 127.6 (2 × CH), 113.6 (CH), 
113.3 (C), 111.7 (CH), 82.8 (CH), 82.6 (C), 69.70 (C), 63.3 (CH2), 57.5 (CH3), 55.7 (CH3), 47.3 (CH2); 
IR νmax (cm
-1) 2927, 2918, 2840, 2823, 2259, 1761, 1608, 1457, 1076, 709; HRMS (ES) m/z 
calculated for C20H19NO4Na (M+Na)
+ 360.1212 found 360.1209. 
N-Allyl-N-((4-fluoro-2-(methoxy(phenyl)methyl)phenyl)ethynyl)methanesulfonamide 313 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-4-fluoro-
2-(methoxy(phenyl)methyl)benzene (377 mg, 1.18 mmol, GP10) and 
sulfonamide 249 (133 mg, 1.0 mmol). Purification by flash column 
chromatography [hexane:EtOAc (80:20)] gave the ynamide 313 (293 mg, 64%) as pale yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 7.42 – 7.21 (m, 7H), 6.91 (td, J = 8.3, 2.8 Hz, 1H), 5.93 (ddt, J = 16.5, 
10.1, 6.4 Hz, 1H), 5.67 (s, 1H), 5.40 (ddd, J = 16.5, 2.5, 1.2 Hz, 1H), 5.34 (ddd, J = 10.1, 2.0, 1.0 Hz, 
1H), 4.14 (ddt, J = 6.4, 2.5, 1.2 Hz, 2H), 3.39 (s, 3H), 3.04 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 
163.1 (d, JC-F = 249.8 Hz, C), 146.7 (d, JC-F = 7.2 Hz, C), 141.0 (C), 134.5 (d, J = 8.2 Hz, CH), 131.2 
(CH), 128.7 (2 × CH), 128.1 (CH), 127.5 (2 × CH), 121.0 (CH2), 117.5 (C), 115.0 (d, J = 22.3 Hz, CH), 
113.9 (d, J = 23.3 Hz, CH), 86.1 (C), 82.6 (CH), 68.8 (C), 57.6 (CH3), 54.6 (CH2), 39.4 (CH3); IR: νmax 
(cm-1) 2990, 2902, 2932, 2826, 2236, 1604, 1493, 1358, 1164, 1096, 1074; HRMS (ES) m/z 
calculated for C20H21NO3SF (M+H)
+ 374.1226 found 374.1230. 
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N-((2-((Benzyloxy)(phenyl)methyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 321 
Prepared according to GP12 using alkyne 318 (200 mg, 0.7 mmol) and 
sulfonamide 233 (0.83 g, 3.4 mmol). Purified by flash column 
chromatography [hexane:EtOAc (94:6)] to give the ynamide 321 (133 mg, 
36%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.55 (dd, J = 7.8, 1.0 Hz, 
1H), 7.47 – 7.43 (m, 2H), 7.33 (dd, J = 7.7, 1.1 Hz, 1H), 7.30 – 7.09 (m, 19H), 5.88 (s, 1H), 4.67 (d, 
J = 11.7 Hz, 1H), 4.42 (d, J = 11.7 Hz, 1H), 2.33 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 145.3 (C), 
143.7 (C), 142.0 (C), 139.1 (C), 138.7 (C), 133.4 (C), 132.4 (CH), 130.0 (2 × CH), 129.5 (2 × CH), 
128.9 (CH), 128.6 (2 × CH), 128.5 (2 × CH), 128.5 (3 × CH), 128.0 (2 × CH), 127.8 (CH), 127.6 (2 × 
CH), 127.4 (2 × CH), 127.1 (CH), 126.7 (2 × CH), 122.0 (C), 87.8 (C), 80.5 (CH), 71.2 (CH2), 69.0 (C), 
22.0 (CH3); IR: νmax (cm
-1) 3064, 3031, 2925, 2864, 2235, 1595, 1492, 1453, 1373, 1171; HRMS 
(ES) m/z calculated for C35H29NO3NaS (M+Na)
+ 566.1766 found 566.1751. 
N-((2-((Allyloxy)(phenyl)methyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 322 
Prepared according to GP12 using alkyne 319 (250 mg, 1.0 mmol) and 
sulfonamide 233 (1.24 g, 5.0 mmol). Purification by flash column 
chromatography [hexane:EtOAc (94:6)] gave the ynamide XX (228 mg, 46%) 
as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.57 – 7.51 (m, 3H), 7.39 – 
7.16 (m, 13H), 5.94 (ddt, J = 17.2, 10.4, 5.4 Hz, 1H), 5.87 (s, 1H), 5.24 (ddt, J = 17.2, 3.0, 1.6 Hz, 
1H), 5.13 (app. ddt, J = 10.4, 3.0, 1.6 Hz, 1H), 3.97 (app. ddd, J = 5.4, 3.1, 1.6 Hz, 2H), 2.41 (s, 3H); 
c 145.3 (C), 143.8 (C), 142.0 (C), 139.2 (C), 135.0 (CH), 133.5 (C), 132.3 (CH), 129.9 (2 × CH), 129.5 
(2 × CH), 128.8 (CH), 128.7 (CH), 128.5 (3 × CH), 127.6 (CH), 127.5 (CH), 127.4 (2 × CH), 126.9 
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(CH), 126.7 (2 × CH), 121.9 (C), 117.2 (CH2), 87.7 (C), 80.3 (CH), 70.2 (CH2), 69.0 (C), 22.0 (CH3); 
IR: νmax/cm
-1 3064, 3030, 2860, 2235, 1594, 1491, 1451, 1372, 1170, 1056; HRMS (ES) m/z 
calculated for C31H27NO3NaS (M+Na)
+ 516.1609 found 516.1611. 
N-Allyl-N-((2-((allyloxy)(phenyl)methyl)phenyl)ethynyl)methanesulfonamide 323 
Prepared according to GP11 using freshly prepared 1-((allyloxy)(phenyl)methyl)-
2-(bromoethynyl)benzene (738 mg, 1.93 mmol, GP10) and sulfonamide 249 (254 
mg, 1.9 mmol). Purification by flash column chromatography [hexane:EtOAc 
(90:10)] gave the ynamide 323 (0.50 g, 69%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.59 
(dd, J = 7.8, 1.1 Hz, 1H), 7.45 – 7.17 (m, 8H), 6.06 – 5.86 (m, 2H), 5.89 (s, 1H), 5.40 (app. ddd, J = 
17.1, 2.4, 1.1 Hz, 1H), 5.34 (dd, J = 10.1, 1.1 Hz, 1H), 5.32 (app. ddd, J = 17.2, 3.4, 1.7 Hz, 1 H), 
5.20 (app. ddd, J = 10.4, 3.0, 1.3 Hz, 1H), 4.15 (dd, J = 6.4, 1.2 Hz, 2H), 4.06 – 4.00 (m, 2H), 3.03 
(s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.6 (C), 141.9 (C), 135.1 (CH), 132.4 (CH), 131.2 (CH), 
128.9 (CH), 128.6 (2 × CH), 127.7 (CH), 127.6 (2 × CH), 127.5 (CH), 127.0 (CH), 121.6 (C), 120.9 
(CH2), 117.3 (CH2), 86.4 (C), 80.3 (CH), 70.3 (CH2), 69.8 (C), 54.7 (CH2), 39.4 (CH3); IR: νmax (cm
-1) 
3064, 3028, 2930, 2860, 2233, 1356, 1324, 1163, 922; HRMS (ES) m/z calculated for C22H24NO3S 
(M+H)+ 382.1477 found 382.1478. 
N-((2-(((Benzyloxy)methoxy)(phenyl)methyl)phenyl)ethynyl)-4-methyl-N-
phenylbenzenesulfonamide 324 
Prepared according to GP12 using alkyne 320 (400 mg, 1.2 mmol) and 
sulfonamide 233 (1.5 g, 6.1 mmol). Purification by flash column 
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chromatography [hexane:EtOAc (95:5) then (92:8)] gave the ynamide 324 (284 mg, 41%) as a 
yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.63 (d, J = 7.9 Hz, 2H), 7.54 (d, J = 8.2 Hz, 2H), 7.40 – 
7.18 (m, 17H), 7.11 (d, J = 8.2 Hz, 2H), 6.24 (s, 1H), 4.84 – 4.79 (m, 2H), 4.61 (d, J = 11.8 Hz, 1H), 
4.55 (d, J = 11.8 Hz, 1H), 2.34 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 145.0 (C), 143.4 (C), 141.6 (C), 
138.9 (C), 138.0 (C), 133.2 (C), 132.2 (CH), 129.7 (2 × CH), 129.2 (2 × CH), 128.5 (3 × CH), 128.4 (2 
× CH), 128.3 (3 × CH), 128.1 (2 × CH), 127.7 (CH), 127.5 (CH), 127.4 (2 × CH), 127.4 (CH), 126.8 
(CH), 126.5 (2 × CH), 121.6 (C), 93.0 (CH2), 87.7 (C), 77.2 (CH), 69.9 (CH2), 68.7 (C), 21.8 (CH3); IR: 
νmax (cm
-1) 3064, 3031, 2945, 2887, 1595, 1492, 1373, 1169, 1035, 1024, 749, 691, 653; HRMS 
(ES) m/z calculated for C36H32NO4S (M+H)
+ 575.7145, found 575.7137. 
N-((2-(1-(Allyloxy)allyl)phenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 327 
Prepared according to GP12 using alkyne 326 (200 mg, 1.0 mmol) and 
sulfonamide 233 (1.2 g, 5.1 mmol). Purification by flash column 
chromatography [hexane:EtOAc (94:6)] gave the ynamide XX (192 mg, 43%) 
as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.60 (d, J = 8.3 Hz, 2H), 7.48 
(dd, J = 7.8, 1.2 Hz, 1H), 7.40 – 7.27 (m, 9H), 7.21 (td, J = 7.5, 1.4 Hz, 1H), 5.99 – 5.78 (m, 2H), 
5.28 – 5.24 (m, 2H), 5.21 (app. dt, J = 4.8, 1.5 Hz, 1H), 5.11 (app. ddd, J = 10.4, 2.9, 1.5 Hz, 2H), 
3.93 (ddd, J = 5.4, 2.7, 1.3 Hz, 2H), 2.43 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 145.3 (C), 142.6 (C), 
139.1 (C), 138.2 (CH), 135.0 (CH), 133.4 (C), 132.1 (CH), 129.8 (2 × CH), 129.4 (2 × CH), 128.7 
(CH), 128.6 (CH), 128.5 (2 × CH), 127.5 (CH), 126.6 (CH), 126.5 (2 × CH), 121.6 (C), 117.0 (CH2), 
116.3 (CH2), 87.6 (C), 79.6 (CH), 69.7 (CH2), 68.6 (C), 22.0 (CH3); IR: νmax (cm
-1) 3067, 2989, 2925, 
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2858, 2236, 1595, 1491, 1374, 1187, 1174, 763, 751; HRMS (ES) m/z calculated for 
C27H25NO3NaS (M+Na)
+ 466.1453, found 466.1454. 
N-Allyl-N-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)-4-nitrobenzenesulfonamide 493 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (325 mg, 1.1 mmol, GP10) and sulfonamide 489 
(205 mg, 0.9 mmol). Purification by flash column chromatography [hexane:EtOAc 
(90:10)] gave the ynamide 493 (246 mg, 59%) as a yellow solid; mp: 68-70 °C; 1H-
NMR (300 MHz, CDCl3): δ 8.28 (d, J = 8.9 Hz, 2H), 8.00 (d, J = 8.9 Hz, 2H), 7.51 (d, J = 7.9 Hz, 1H), 
7.40 – 7.17 (m, 8H), 5.79 (ddt, J = 16.5, 10.2, 6.7 Hz, 1H), 5.68 (s, 1H), 5.33 – 5.27 (m, 1H), 5.26 
(dd, J = 10.3, 0.9 Hz, 1H), 4.21 – 4.05 (m, 2H), 3.37 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 150.7 
(C), 143.3 (C), 143.2 (C), 141.5 (C), 132.3 (CH), 130.3 (CH), 129.0 (3 × CH), 128.4 (2 × CH), 127.7 
(CH), 127.5 (CH), 127.2 (2 × CH), 126.8 (CH), 124.5 (2 × CH), 121.2 (C), 121.0 (CH2), 85.4 (C), 82.5 
(CH), 70.0 (C), 57.3 (CH3), 55.0 (CH2); IR: νmax (cm
-1) 3108, 3067, 2992, 2926, 2879, 2822, 2243, 
1537, 1369, 1351, 1172, 1086, 1076, 853; HRMS (ES) m/z calculated for C25H22N2O5NaS (M+Na)
+ 
485.1147, found 485.1133. 
N-Allyl-N-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)-4-methylbenzenesulfonamide 494  
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (555 mg, 1.8 mmol, GP10) and sulfonamide 
490 (324 mg, 1.5 mmol). Purification by flash column chromatography 
[hexane:EtOAc (90:10)] gave the ynamide 494 (488 mg, 74%) as an orange solid; 
mp: 81-82 °C; 1H-NMR (300 MHz, CDCl3): δ 7.78 (d, J = 8.3 Hz, 2H), 7.47 (d, J = 7.2 Hz, 1H), 7.40 – 
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7.14 (m, 10H), 5.77 (ddt, J = 16.9, 10.2, 6.8 Hz, 1H), 5.70 (s, 1H), 5.26 (dd, J = 16.9, 1.2 Hz, 1H), 
5.21 (dd, J = 10.2, 1.1 Hz, 1H), 4.15 – 3.98 (m, 2H), 3.36 (s, 3H), 2.43 (s, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 144.9 (C), 143.3 (C), 141.8 (C), 134.9 (C), 132.1 (CH), 131.1 (CH), 130.0 (2 × CH), 128.5 
(CH), 128.4 (2 × CH), 127.8 (2 × CH), 127.4 (CH), 127.3 (CH), 127.0 (2 × CH), 126.5 (CH), 121.9 (C), 
120.3 (CH2), 86.7 (C), 82.4 (CH), 69.4 (C), 57.2 (CH3), 54.6 (CH2), 21.8 (CH3); IR: νmax (cm
-1) 2989, 
2934, 2874, 2827, 2232, 1596, 1448, 1360, 1170, 1075, 764, 658; HRMS (ES) m/z calculated for 
C26H25NO3NaS (M+Na)
+ 454.1453, found 454.1468. 
N-Allyl-2,4,6-triisopropyl-N-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)-benzenesulfonamide 
495 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (348 mg, 1.2 mmol, GP10) and sulfonamide 
491 (173 mg, 0.9 mmol). Purification by flash column chromatography 
[hexane:EtOAc (90:10)] gave the ynamide 495 (125 mg, 34%) as a yellow oil; 1H-
NMR (300 MHz, CDCl3): δ 7.41 (d, J = 7.9 Hz, 1H), 7.34 (dd, J = 8.0, 1.3 Hz, 2H), 7.29 – 7.16 (m, 
6H), 7.16 – 7.06 (m, 2H), 5.93 (ddt, J = 16.6, 10.1, 6.4 Hz, 1H), 5.64 (s, 1H), 5.34 (dd, J = 17.0, 1.2 
Hz, 1H), 5.28 (dd, J = 10.1, 1.0 Hz, 1H), 4.22 – 4.09 (m, 4H), 3.28 (s, 3H), 2.91 (app. dt, J = 13.8, 
6.9 Hz, 1H), 1.27 – 1.20 (m, 18H); 13C-NMR (101 MHz, CDCl3): δ 154.4 (C), 152.2 (2 × C), 143.6 
(C), 142.0 (C), 132.6 (CH), 131.8 (CH), 130.5 (C), 128.5 (CH), 128.4 (2 × CH), 127.4 (CH), 127.2 
(CH), 126.9 (2 × CH), 126.5 (CH), 124.3 (2 × CH), 122.1 (C), 120.6 (CH2), 86.6 (C), 83.0 (CH), 70.9 
(C), 57.2 (CH3), 52.7 (CH2), 34.5 (CH), 30.1 (2 × CH), 25.1 (2 × CH3), 25.0 (2 × CH3), 23.8 (2 × CH3); 
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IR: νmax (cm
-1) 2960, 2929, 2871, 2823, 2229, 1599, 1370, 1335, 1168, 1097, 1076, 757, 698, 663; 
HRMS (ES) m/z calculated for C34H42NO3S (M+H)
+ 544.2885, found 544.2878. 
Diethyl allyl((2-(methoxy(phenyl)methyl)phenyl)ethynyl)phosphoramidate 496 
Prepared using a modified version of GP11: Freshly prepared 1-
(bromoethynyl)-2-(methoxy(phenyl)methyl)benzene (349 mg, 1.2 mmol, 1.3 
equiv., GP9), diethyl allylphosphoramidate 492 (173 mg, 0.9 mmol, 1.0 
equiv.), K3PO4 (379 mg, 1.8 mmol, 2.0 equiv.), CuSO4∙5H2O (33.4 mg, 0.1 
mmol, 0.15 equiv.) and 1,10-phenanthroline (48.3 mg, 0.3 mmol, 0.3 equiv.) were combined in a 
flask which was purged with argon for 5 minutes. Toluene (1.0 M) was added and the resulting 
solution was heated to 95 °C and stirred 24 hours. Once cooled to room temperature, the 
resulting mixture was diluted with CH2Cl2 and filtered through a short pad (ca. 1 cm) of silica, 
eluting with CH2Cl2 (20 mL). The solvent was removed under reduced pressure and purification 
by flash column chromatography [hexane:EtOAc (90:10)] gave the ynamide XX (125 mg, 34%) as 
a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.46 – 7.41 (m, 3H), 7.35 – 7.13 (m, 6H), 5.96 (ddt, J = 
16.7, 10.1, 6.2 Hz, 1H), 5.77 (s, 1H), 5.36 (app. dq, J = 16.7, 1.2 Hz, 1H), 5.28 (dd, J = 10.1, 1.2 Hz, 
1H), 4.25 – 4.10 (m, 4H), 4.05 – 3.97 (m, 2H), 3.38 (s, 3H), 1.36 (app. tdd, J = 7.1, 4.2, 1.0 Hz, 6H); 
13C-NMR (101 MHz, CDCl3): δ 142.7 (C), 142.0 (C), 133.0 (CH), 131.6 (CH), 128.3 (2 × CH), 127.6 
(CH), 127.3 (CH), 127.2 (CH), 126.8 (2 × CH), 126.3 (CH), 122.9 (C), 119.1 (CH2), 90.1 (C), 90.1 (C), 
82.4 (CH), 63.9 (CH2), 57.1 (CH3), 53.9 (CH2), 53.9 (CH2), 16.2 (CH3), 16.2 (CH3); IR: νmax (cm
-1) 
3063, 2983, 2933, 2822, 2235, 1268, 1019, 758; HRMS (ES) m/z calculated for C23H28NO4PNa 
(M+Na)+ 436.1654, found 436.1651. 
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N-Allyl-N-((2-(methoxymethyl)phenyl)ethynyl)-4-methylbenzenesulfonamide 500 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxymethyl)benzene (377 mg, 1.7 mmol, GP10) and sulfonamide 490 (188 
mg, 1.4 mmol). Purification by flash column chromatography [hexane:Et2O (80:20)] 
gave the ynamide 500 (472 mg, 95%) as a white solid; mp: 33-35 °C; 1H-NMR (300 MHz, CDCl3): 
δ 1H-NMR (300 MHz, CDCl3): δ 7.85 (d, J = 8.3 Hz, 2H), 7.45 – 7.14 (m, 6H), 5.80 (ddt, J = 16.5, 
10.1, 6.3 Hz, 1H), 5.31 (app. dq, J = 17.1, 1.2 Hz, 1H), 5.26 (app. dq, J = 10.1, 1.2 Hz, 1H), 4.53 (s, 
2H), 4.07 (app. dt, J = 6.3, 1.2 Hz, 2H), 3.42 (s, 3H), 2.45 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
144.9 (C), 139.5 (C), 134.9 (C), 131.6 (CH), 131.1 (CH), 130.0 (2 × CH), 128.0 (CH), 127.9 (2 × CH), 
127.6 (CH), 127.3 (CH), 121.6 (C), 120.3 (CH2), 86.7 (C), 72.8 (CH2), 69.0 (C), 58.6 (CH3), 54.5 
(CH2), 21.8 (CH3); IR: νmax (cm
-1) 3066, 2997, 2925, 2857, 2814, 2228, 1363, 1166, 1109, 758, 662; 
HRMS (ES) m/z calculated for C20H21NO3SNa (M+Na)
+ 378.1140, found 378.1147. 
N-Allyl-N-((2-(methoxy(2-methoxyphenyl)methyl)phenyl)ethynyl)-4-
methylbenzenesulfonamide 501 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(2-methoxyphenyl)methyl)benzene (276 mg, 0.8 mmol, GP10) and 
sulfonamide 490 (147 mg, 0.7 mmol). Purification by flash column 
chromatography [hexane:EtOAc (92:8) then hexane:EtOAc (90:10)] gave the 
ynamide 501 (276 mg, 86%) as a pale yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 
2H), 7.38 – 7.14 (m, 8H), 6.95 (app. td, J = 7.5, 0.9 Hz, 1H), 6.83 (dd, J = 8.2, 0.7 Hz, 1H), 5.99 (s, 
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1H), 5.75 (ddt, J = 16.8, 10.1, 6.3 Hz, 1H), 5.25 (ddd, J = 16.8, 2.6, 1.3 Hz, 1H), 5.18 (dd, J = 10.1, 
1.1 Hz, 1H), 4.04 (ddt, J = 6.3, 4.1, 1.1 Hz, 2H), 3.71 (s, 3H), 3.34 (s, 3H), 2.42 (s, 3H); 13C-NMR 
(101 MHz, CDCl3): δ 157.3 (C), 144.7 (2 × C), 142.4 (C), 134.9 (C), 132.1 (CH), 131.1 (CH), 129.8 (2 
× CH), 128.6 (CH), 128.0 (CH), 127.9 (2 × CH), 127.4 (CH), 127.3 (CH), 127.2 (CH), 122.9 (C), 120.3 
(CH), 120.1 (CH2), 110.6 (CH), 86.1 (C), 77.3 (CH), 69.3 (C), 57.5 (CH3), 55.5 (CH3), 54.7 (CH2), 21.8 
(CH3); IR: νmax (cm
-1) 3073, 3027, 2933, 2838, 2232, 1599, 1490, 1463, 1364, 1243, 1169, 1087, 
661, 753; HRMS (ES) m/z calculated for C27H27NO4SNa (M+Na)
+ 484.1559, found 484.1568. 
N-Allyl-N-((2-(methoxy(o-tolyl)methyl)phenyl)ethynyl)-4-methylbenzenesulfonamide 502 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(o-tolyl)methyl)benzene (243 mg, 0.8 mmol, GP10) and sulfonamide 490 
(113 mg, 0.5 mmol). Purification by flash column chromatography [hexane:EtOAc 
(92.5:7.5)] gave the ynamide 502 (238 mg, 99%) as an orange solid; 1H-NMR (300 
MHz, CDCl3): δ 7.69 (d, J = 8.3 Hz, 2H), 7.39 – 7.32 (m, 1H), 7.29 – 7.10 (m, 9H), 5.82 (s, 1H), 5.70 
(ddt, J = 16.8, 10.1, 6.3 Hz, 1H), 5.20 (dd, J = 16.8, 1.2 Hz, 1H), 5.17 (dd, J = 10.1, 1.2 Hz, 1H), 4.06 
(app. ddt, J = 14.6, 6.3, 1.2 Hz, 1H), 3.96 (app. ddt, J = 14.6, 6.3, 1.2 Hz, 1H), 3.40 (s, 3H), 2.42 (s, 
3H), 2.20 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.8 (C), 141.5 (C), 139.4 (C), 136.9 (C), 134.9 
(C), 132.2 (CH), 131.0 (CH), 130.6 (CH), 129.9 (2 × CH), 128.3 (CH), 127.9 (CH), 127.8 (2 × CH), 
127.5 (2 × CH), 126.5 (CH), 125.8 (CH), 123.2 (C), 120.2 (CH2), 86.7 (C), 80.0 (CH), 69.2 (C), 57.6 
(CH3), 54.6 (CH2), 21.8 (CH3), 19.4 (CH3); IR: νmax (cm
-1) 3065,2993, 2931, 2876, 2818, 2232, 1595, 
1448, 1365, 1170, 1086, 1066, 757, 662; HRMS (ES) m/z calculated for C27H28NO3S (M+H)
+ 
446.1790, found 446.1787. 
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N-Allyl-N-((2-(methoxy(naphthalen-1-yl)methyl)phenyl)ethynyl)-4-methylbenzenesulfonamide 
503 
Prepared according to GP11 using freshly prepared 
((2-(bromoethynyl)phenyl)-(methoxy)methyl)naphthalene (275 mg, 0.8 mmol, 
GP10) and sulfonamide 490 (138 mg, 0.7 mmol). Purification by flash column 
chromatography [hexane:EtOAc (90:10)] gave the ynamide 503 (302 mg, 96%) as a 
pale yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.96 – 7.89 (m, 1H), 7.87 – 7.76 (m, 2H), 7.74 (d, J = 
8.3 Hz, 2H), 7.52 – 7.35 (m, 5H), 7.33 – 7.17 (m, 5H), 6.37 (s, 1H), 5.60 (ddt, J = 16.8, 10.2, 6.2 Hz, 
1H), 5.11 (ddd, J = 16.8, 2.5, 1.3 Hz, 1H), 5.04 (dd, J = 10.2, 1.2 Hz, 1H), 4.00 (ddt, J = 14.6, 6.2, 
1.3 Hz, 1H), 3.84 (ddt, J = 14.6, 6.2, 1.2 Hz, 1H), 3.48 (s, 3H), 2.38 (s, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 144.9 (C), 142.1 (C), 137.0 (C), 135.0 (C), 134.1 (C), 132.4 (CH), 131.6 (C), 131.0 (CH), 
130.0 (2 × CH), 128.8 (CH), 128.5 (CH), 128.4 (CH), 127.9 (3 × CH), 127.8 (CH), 126.3 (CH), 125.7 
(CH), 125.5 (CH), 124.5 (CH), 124.2 (CH), 123.0 (C), 120.3 (CH2), 87.1 (C), 79.7 (CH), 69.3 (C), 57.8 
(CH3), 54.5 (CH2), 21.8 (CH3); IR: νmax (cm
-1) 3055, 2987, 2923, 2821, 2230, 1597, 1365, 1168, 
1088, 757, 660; HRMS (ES) m/z calculated for C30H28NO3S (M+H)
+ 482.1790, found 482.1786. 
N-Allyl-N-((2-(1-(allyloxy)allyl)phenyl)ethynyl)-4-methylbenzenesulfonamide 504 
Prepared according to GP11 using freshly prepared 1-(1-(allyloxy)allyl)-2-
(bromoethynyl)benzene (338 mg, 1.2 mmol, GP9) and sulfonamide 490 (215 
mg, 1.0 mmol). Purification by flash column chromatography [hexane:EtOAc 
(90:10)] gave the ynamide 504 (235 mg, 43%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.83 
(d, J = 8.3 Hz, 2H), 7.48 – 7.43 (m, 1H), 7.38 – 7.27 (m, 4H), 7.23 – 7.16 (m, 1H), 6.00 – 5.71 (m, 
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3H), 5.34 – 5.21 (m, 5H), 5.17 – 5.09 (m, 2H), 4.07 (app. dt, J = 6.3, 1.2 Hz, 2H), 3.93 (app. dt, J = 
5.5, 1.4 Hz, 2H), 2.45 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.9 (C), 142.3 (C), 138.1 (CH), 134.9 
(CH), 131.9 (CH), 131.1 (CH), 130.0 (2 × CH), 128.4 (CH), 127.9 (2 × CH), 127.3 (CH), 126.4 (CH), 
121.6 (C), 120.3 (CH2), 116.8 (CH2), 116.3 (C), 115.9 (CH2), 86.8 (C), 79.4 (CH), 69.6 (CH2), 69.0 
(C), 54.5 (CH2), 21.8 (CH3); IR: νmax (cm
-1) 3069, 2926, 2858, 2232, 1645, 1597, 1447, 1419, 1366, 
1170, 762; HRMS (ES) m/z calculated for C24H25NO3SNa (M+Na)
+ 430.1453, found 430.1444. 
N-Allyl-N-((2-((allyloxy)(phenyl)methyl)phenyl)ethynyl)-4-methylbenzenesulfonamide 506 
Prepared according to GP11 using freshly prepared N-allyl-N-((2-
((allyloxy)(phenyl)methyl)phenyl)ethynyl)methanesulfonamide (340 mg, 1.0 
mmol, GP10) and sulfonamide 490 (183 mg, 0.9 mmol). Purification by flash 
column chromatography [hexane:EtOAc (95:5)] gave the ynamide 506 (361 mg, 
91%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.78 (d, J = 8.3 Hz, 2H), 7.53 (dd, J = 7.5, 0.7 
Hz, 1H), 7.42 – 7.13 (m, 10H), 5.96 (ddt, J = 17.2, 11.4, 5.5 Hz, 1H), 5.96 (s, 1H) 5.76 (ddt, J = 
16.5, 10.1, 6.3 Hz, 1H), 5.30 (app. dq, J = 17.2, 1.7 Hz, 1H), 5.30 – 5.13 (m, 2H), 5.21 (dt, J = 11.4, 
1.2 Hz, 1H), 4.14 – 4.03 (m, 2H), 4.03 – 3.91 (m, 2H), 2.43 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
144.9 (C), 143.5 (2 × C), 142.0 (C), 134.9 (CH), 132.1 (CH), 131.1 (CH), 130.0 (2 × CH), 128.5 (CH), 
128.3 (2 × CH), 127.8 (2 × CH), 127.4 (CH), 127.3 (CH), 127.0 (2 × CH), 126.7 (CH), 121.8 (C), 
120.3 (CH2), 116.9 (CH2), 86.7 (C), 80.0 (CH), 70.0 (CH2), 69.4 (C), 54.5 (CH2), 21.8 (CH3); ); IR: νmax 
(cm-1) 3075, 3035, 2987, 2927, 2861, 2231, 1597, 1364, 1168, 758, 699, 661; HRMS (ES) m/z 
calculated for C28H28NO3S (M+H)
+ 458.1790, found 458.1779. 
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N-Allyl-N-((2-(((benzyloxy)methoxy)(phenyl)methyl)phenyl)ethynyl)-4-
methylbenzenesulfonamide 508 
Prepared according to GP11 using freshly prepared 1-
(((benzyloxy)methoxy)(phenyl)methyl)-2-(bromoethynyl)benzene (331 mg, 
0.8 mmol, GP10) and sulfonamide 490 (143 mg, 0.7 mmol). Purification by 
flash column chromatography [hexane:EtOAc (93:7), 1% NEt3] gave the 
ynamide 508 (329 mg, 90%) as a yellow oil; 1H-NMR (300 MHz, CDCl3) δ 7.78 (d, J = 8.3 Hz, 2H), 
7.66 – 7.53 (m, 1H), 7.40 (dd, J = 8.0, 1.3 Hz, 2H), 7.38 – 7.16 (m, 15H), 6.26 (s, 1H), 5.71 (ddt, J = 
16.8, 10.1, 6.3 Hz, 1H), 5.20 (dd, J = 16.8, 1.2 Hz, 1H), 5.13 (dd, J = 10.1, 1.2 Hz, 1H), 4.85 (d, J = 
6.8 Hz, 1H), 4.82 (d, J = 6.8 Hz, 1H), 4.64 (d, J = 11.8 Hz, 1H), 4.57 (d, J = 11.8 Hz, 1H), 4.02 – 3.97 
(m, 1H), 2.37 (s, 1H); 13C-NMR (101 MHz, CDCl3) δ 144.7 (C), 143.1 (C), 141.7 (C), 138.0 (C), 134.8 
(C), 132.0 (CH), 131.0 (CH), 129.9 (2 × CH), 128.4 (2 × CH), 128.4 (2 × CH), 128.3 (CH), 128.1 (2 × 
CH), 127.8 (2 × CH), 127.7 (CH), 127.5 (CH), 127.3 (3 × CH), 126.82 (CH), 121.8 (C), 120.3 (CH2), 
92.9 (CH2), 86.9 (C), 77.0 (CH), 69.9 (CH2), 69.2 (C), 54.5 (CH2), 21.7 (CH3); IR: νmax (cm
-1) 3060, 
3030, 2931, 2886, 2231, 1394, 1598, 1494, 1453, 1366, 1169, 1024, 732, 696, 661; HRMS (ES) 
m/z calculated for C33H31NO4SNa (M+Na)
+ 560.1871, found 560.1879. 
N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 515 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxolane (462 mg, 1.8 mmol, GP10) and sulfonamide 490 (323 mg, 1.5 
mmol). Purification by flash column chromatography [hexane:EtOAc (80:20), 1% 
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Et3N] gave the ynamide 515 (536 mg, 91%) as a white solid; mp: 38-40 °C; 
1H-NMR (300 MHz, 
CDCl3): δ 7.88 (d, J = 8.4 Hz, 2H), 7.59 – 7.55 (m, 1H), 7.38 – 7.25 (m, 5H), 6.10 (s, 1H), 5.79 (ddt, 
J = 16.8, 10.1, 6.3 Hz, 2H), 5.29 (app. dq, J = 16.8, 1.3 Hz, 1H), 5.22 (ddd, J = 10.1, 2.2, 1.0 Hz, 
1H), 4.24 – 4.11 (m, 2H), 4.11 – 3.97 (m, 4H), 2.44 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.8 
(C), 138.0 (C), 134.8 (C), 131.4 (CH), 130.9 (CH), 129.9 (2 × CH), 129.0 (CH), 127.9 (2 × CH), 127.7 
(CH), 125.9 (CH), 122.4 (C), 120.2 (CH2), 101.9 (CH), 86.9 (C), 68.7 (C), 65.5 (2 × CH2), 54.4 (CH2), 
21.7 (CH3); IR: νmax (cm
-1) 3077, 2951, 2889, 2226, 1358, 1167, 1066, 763, 661; HRMS (ES) m/z 
calculated for C21H21NO4NaS (M+Na)
+ 406.1089, found 406.1076. 
N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-N-allyl-4-nitrobenzenesulfonamide 516 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxolane (293 mg, 1.2 mmol, GP10) and sulfonamide 490 (235 mg, 1.0 
mmol). Purification by flash column chromatography [toluene:hexane (80:20), 1% 
Et3N] gave the ynamide 516 (288 mg, 72%) as a bright yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 
8.39 (d, J = 9.0 Hz, 2H), 8.22 (d, J = 9.0 Hz, 2H), 7.63 – 7.55 (m, 1H), 7.38 – 7.11 (m, 5H), 6.10 (s, 
1H), 5.78 (ddt, J = 16.5, 10.1, 6.4 Hz, 1H), 5.35 (app. ddd, J = 17.1, 2.4, 1.2 Hz, 1H), 5.27 (dd, J = 
10.1, 1.0 Hz, 1H), 4.23 – 4.10 (m, 4H), 4.08 – 4.01 (m, 2H); 13C-NMR (101 MHz, CDCl3): δ 150.7 
(C), 143.2 (C), 138.5 (C), 131.7 (CH), 130.2 (CH), 129.3 (2 × CH), 129.1 (CH), 128.4 (CH), 126.1 
(CH), 124.6 (2 × CH), 121.6 (C), 121.0 (CH2), 101.9 (CH), 85.6 (C), 69.4 (C), 65.6 (2 × CH2), 54.9 
(CH2); IR: νmax (cm
-1) 3105, 3021, 2979, 2887, 2237, 1532, 1375, 1349,1174, 1068, 909, 754, 730; 
HRMS (ES) m/z calculated for C20H19N2O6S (M+H)
+ 415.0964, found 415.0970. 
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N-((2-(1,3-Dioxolan-2-yl)-4,5-dimethoxyphenyl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 
517 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)-4,5-
dimethoxyphenyl)-1,3-dioxolane (259 mg, 0.8 mmol, GP10) and sulfonamide 
490 (146 mg, 0.7 mmol). Purification by flash column chromatography 
[hexane:EtOAc (80:20), 1% Et3N then hexane:EtOAc (60:40), 1% Et3N] gave the ynamide 517 
(288 mg, 94%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.86 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 
8.2 Hz, 2H), 7.07 (s, 1H), 6.80 (s, 1H), 5.99 (s, 1H), 5.78 (ddt, J = 16.8, 10.1, 6.3 Hz, 1H), 5.28 (dd, J 
= 16.8, 1.2 Hz, 1H), 5.22 (dd, J = 10.1, 1.2 Hz, 1H), 4.21 – 4.14 (m, 2H), 4.05 (app. dt, J = 6.3, 1.2 
Hz, 1H), 4.03 – 3.97 (m, 2H), 3.90 (s, 3H), 3.85 (s, 3H), 2.44 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
149.4 (C), 149.3 (C), 144.7 (C), 134.9 (C), 131.6 (C), 131.1 (CH), 129.9 (2 × CH) , 128.0 (2 × CH), 
120.1 (CH2), 114.7 (C), 114.2 (CH), 108.7 (CH), 101.8 (CH), 85.3 (C), 68.2 (C), 65.4 (2 × CH2), 56.2 
(CH3), 56.0 (CH3), 54.5 (CH2), 21.8 (CH3);  IR: νmax (cm
-1) 2948, 2888, 2839, 2237, 1603, 1515, 
1361, 1167, 1089, 732, 661; HRMS (ES) m/z calculated for C23H25NO6NaS (M+Na)
+ 466.1300, 
found 466.1307. 
N-((2-(1,3-Dioxolan-2-yl)-4-fluorophenyl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 518 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)-5-
fluorophenyl)-1,3-dioxolane (204 mg, 0.8 mmol, GP10) and sulfonamide 490 
(132 mg, 0.63 mmol). Purification by flash column chromatography 
[hexane:EtOAc (90:10), 1% Et3N] gave the ynamide 518 (229 mg, 91%) as a yellow oil; 
1H-NMR 
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(300 MHz, CDCl3): δ 7.87 (d, J = 8.4 Hz, 2H), 7.36 – 7.31 (m, 2H), 7.31 – 7.25 (m, 2H), 6.97 (td, J = 
8.3, 2.8 Hz, 1H), 6.05 (d, J = 1.5 Hz, 1H), 5.77 (ddt, J = 16. 8 10.1, 6.3 Hz, 1H), 5.29 (app. dq, J = 
16.8, 1.2 Hz, 1H), 5.23 (ddd, J = 10.1, 2.2, 1.2 Hz, 1H), 4.19 – 4.11 (m, 2H), 4.09 – 3.99 (m, 4H), 
2.44 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 162.2 (d, JC-F = 249.0 Hz, C), 144.9 (C), 141.1 (d, J = 7.1 
Hz, C), 134.9 (C), 133.5 (d, JC-F = 7.9 Hz, CH), 130.9 (CH), 129.9 (2 × CH), 127.9 (2 × CH), 120.3 
(CH2), 118.4 (C), 116.3 (d, JC-F = 22.3 Hz, CH), 113.4 (d, JC-F = 23.6 Hz, CH), 101.2 (CH), 86.5 (C), 
67.7 (C), 65.6 (2 × CH2), 54.4 (CH2), 21.8 (CH3); IR: νmax (cm
-1) 3076, 2957, 2890, 2237, 1486, 
1363, 1168, 661; HRMS (ES) m/z calculated for C21H21NO4SF (M+H)
+ 402.1175, found 402.1179. 
N-((2-(1,3-Dioxolan-2-yl)cyclohex-1-en-1-yl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 535 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)cyclohex-1-en-1-yl)-1,3-
dioxolane (403 mg, 1.6 mmol, GP10) and sulfonamide 490 (276 mg, 1.3 mmol). 
Purification by flash column chromatography [hexane:EtOAc (85:15), 1% Et3N] 
gave the ynamide 535 (384 mg, 76%) as a pale yellow solid; mp: 51-53 °C; 1H-NMR 
(300 MHz, CDCl3): δ 7.78 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 5.72 (ddt, J = 16.8, 10.1, 6.4 
Hz, 1H), 5.71 (s, 1H),  5.23 (dd, J = 16.8, 1.2 Hz, 1H), 5.19 (dd, 10.1, 1.1 Hz, 1H), (dd, J = 6.6, 1.1 
Hz, 1H), 4.03 – 3.93 (m, 4H), 3.92 – 3.85 (m, 2H), 2.44 (s, 3H), 2.17 – 2.08 (m, 4H), 1.58 - 1.72 (m, 
J = 7.7, 4.7 Hz, 4H); 13C-NMR (101 MHz, CDCl3): δ 144.7 (C), 138.7 (C), 134. 8 (C), 131.1 (CH), 
129.9 (2 × CH), 127.9 (2 × CH), 121.6 (C), 120.2 (CH2), 103.4 (CH), 86.3 (C), 70.0 (C), 65.5 (2 × 
CH2), 54.4 (CH2), 30.7 (CH2), 22.3 (CH2), 21.9 (CH2), 21.8 (CH2), 21.6 (CH3); IR: νmax (cm
-1) 2932, 
2872, 2227, 1671, 1343, 1163, 662; HRMS (ES) m/z calculated for C21H25NO4SNa (M+Na)
+ 
410.1402, found 410.1407. 
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N-((4-(1,3-Dioxolan-2-yl)pyridin-3-yl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 536 
Prepared according to GP11 using freshly prepared 3-(bromoethynyl)-4-(1,3-
dioxolan-2-yl)pyridine (215 mg, 0.8 mmol, GP10) and sulfonamide 490 (149 mg, 
0.7 mmol). Purification by flash column chromatography [hexane:EtOAc (65:35), 
1% Et3N] gave the ynamide 536 (233 mg, 86%) as a pale orange solid; mp: 44-46 °C; 
1H-NMR 
(300 MHz, CDCl3): δ 8.52 (s, 1H), 8.49 (d, J = 5.1 Hz, 1H), 7.87 (d, J = 8.3 Hz, 2H), 7.44 (d, J = 5.1 
Hz, 1H), 7.35 (d, J = 8.1 Hz, 2H), 6.02 (s, 1H), 5.78 (ddt, J = 16.9, 10.2, 6.4 Hz, 1H), 5.30 (dd, J = 
16.9, 1.1 Hz, 1H), 5.26 (dd, J = 10.2, 1.0 Hz, 1H), 4.19 – 4.11 (m, 2H), 4.11 – 4.03 (m, 4H), 2.44 (s, 
3H); 13C-NMR (101 MHz, CDCl3): δ 152.0 (CH), 148.2 (CH), 146.2 (C), 145.1 (C), 134.8 (C), 130.8 
(CH), 130.0 (2 × CH), 128.0 (2 × CH), 120.6 (CH2), 119.9 (CH), 119.3 (C), 100.8 (CH), 89.9 (C), 66.3 
(C), 65.8 (2 × CH2), 54.4 (CH2), 21.8 (CH3); IR: νmax (cm
-1)2293, 2957, 2889, 2232, 1596, 1363, 
1166, 1086, 940, 661; HRMS (ES) m/z calculated for C20H21N2O4S (M+H)
+ 385.1222, found 
285.1225. 
N-((2-(1,3-Dioxolan-2-yl)thiophen-3-yl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 537 
Prepared according to GP11 using freshly prepared 2-(3-(bromoethynyl)thiophen-
2-yl)-1,3-dioxolane (181 mg, 0.7 mmol, GP10) and sulfonamide 490 (124 mg, 0.6 
mmol). Purification by flash column chromatography [hexane:EtOAc (85:15), 1% 
Et3N] gave the ynamide 537 (195 mg, 85%) as a yellow oil; 
1H-NMR (300 MHz, 
CDCl3): δ 7.84 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 7.22 (d, J = 5.1 Hz, 1H), 6.92 (d, J = 5.1 
Hz, 1H), 6.14 (s, 1H), 5.76 (ddt, 16.8, 10.2, 6.3 Hz, 1H), 5.27 (app. ddd, J = 17.2, 2.6, 1.3 Hz, 1H), 
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5.22 (dd, J = 10.2, 1.1 Hz, 1H), 4.19 – 4.09 (m, 2H), 4.08 – 3.94 (m, 4H), 2.45 (s, 3H); 13C-NMR 
(101 MHz, CDCl3): δ 144.8 (C), 143.3 (C), 134.8 (C), 130.9 (CH), 130.1 (CH), 129.9 (2 × CH), 128.0 
(2 × CH), 125.5 (CH), 121.3 (C), 120.3 (CH2), 99.3 (CH), 85.6 (C), 65.5 (2 × CH2), 64.6 (C), 54.5 
(CH2), 21.8 (CH3); IR: νmax (cm
-1) 3109, 3091, 2996, 2952, 2895, 2242, 1648, 1596, 1544, 1447, 
1360, 1346, 1166, 936, 745; HRMS (ES) m/z calculated for C19H20NO4S2 (M+H)
+ 390.0834, found 
390.0840. 
N-((2-(1,3-Dioxolan-2-yl)-6-methoxyphenyl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 538 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)-3-
methoxyphenyl)-1,3-dioxolane (264 mg, 1.1 mmol, GP10) and sulfonamide 490 
(195 mg, 0.9 mmol). Purification by flash column chromatography [toluene:EtOAc 
(98:2), 1% Et3N] gave the ynamide XX (180 mg, 47%) as a white solid; mp: 84-86 °C; 
1H-NMR 
(300 MHz, CDCl3): δ 7.93 (d, J = 8.2 Hz, 2H), 7.32 (d, J = 8.2 Hz, 2H), 7.28 – 7.15 (m, 3H), 6.85 (dd, 
J = 8.0, 1.3 Hz, 1H), 6.11 (s, 1H), 5.83 (ddt, J = 16.8, 10.1, 6.4 Hz, 1H), 5.32 (app. dq, J = 16.8, 1.3 
Hz, 1H), 5.23 (dd, J = 10.1, 1.1 Hz, 1H), 4.19 – 4.13 (m, 2H), 4.09 – 3.99 (m, 4H), 3.84 (s, 3H), 2.43 
(s, 3H); 13C-NMR (101 MHz, CDCl3): δ 159.6 (C), 144.6 (C), 139.7 (C), 135.0 (C), 131.0 (CH), 129.8 
(2 × CH), 128.4 (CH), 128.1 (2 × CH), 120.3 (CH2), 118.0 (CH), 112.2 (C), 111.3 (CH), 101.9 (CH), 
91.2 (C), 65.5 (2 × CH2), 65.0 (C), 56.1 (CH3), 54.5 (CH2), 21.8 (CH3); IR: νmax (cm
-1) 3237, 2967, 
2887, 2840, 2241, 1674, 1596, 1355, 1278, 1167, 1051, 1028, 663; HRMS (ES) m/z calculated for 
C22H24NO5S (M+H)
+ 414.1375, found 414.1375. 
N-Allyl-N-((2-(dimethoxymethyl)-4-methoxyphenyl)ethynyl)-4-methylbenzenesulfonamide 542 
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Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(dimethoxymethyl)-4-methoxybenzene (175 mg, 0.6 mmol, GP10) and 
sulfonamide 490 (108 mg, 0.5 mmol). Purification by flash column 
chromatography [hexane:EtOAc (85:15), 1% Et3N] gave the ynamide 542 (184 mg, 91%) as a 
yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.86 (d, J = 8.2 Hz, 2H), 7.34 (d, J = 8.2 Hz, 2H), 7.26 (d, J 
= 8.5 Hz, 1H), 7.10 (d, J = 2.7 Hz, 1H), 6.79 (dd, J = 8.5, 2.7 Hz, 1H), 5.80 (ddt, J = 16.8, 10.1, 6.3 
Hz, 1H), 5.55 (s, 1H), 5.29 (dd, J = 16.8, 1.3 Hz, 1H), 5.23 (dd, J = 10.1, 1.1 Hz, 1H), 4.05 (d, J = 6.3 
Hz, 2H), 3.81 (s, 3H), 3.38 (s, 6H), 2.44 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 159.6 (C), 144.7 (C), 
141.4 (C), 134.9 (C), 133.6 (CH), 131.2 (CH), 129.9 (2 × CH), 127.9 (2 × CH), 120.2 (CH2), 115.1 
(CH), 113.9 (C), 110.9 (CH), 102.7 (CH), 85.0 (C), 68.3 (C), 55.5 (2 × CH3), 54.6 (CH3), 54.5 (CH2), 
21.8 (CH3); IR: νmax (cm
-1) 2996, 2936, 2833, 2236, 1607, 1496, 1358, 1293, 1165, 1072, 661; 
HRMS (ES) m/z calculated for C22H26NO5S (M+H)
+ 416.1532, found 416.1519. 
N-((2-(1,3-Dioxan-2-yl)phenyl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 545 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxane (261 mg, 1.0 mmol, GP10) and sulfonamide 490 (172 mg, 0.8 mmol). 
Purification by flash column chromatography [toluene:EtOAc (95:5), 1% Et3N] 
gave the ynamide 543 (121 mg, 37%) as a white solid; mp: 110-112 °C; 1H-NMR (300 MHz, 
CDCl3): δ 7.77 (d, J = 8.4 Hz, 2H), 7.58 (d, J = 7.6 Hz, 1H), 7.34 – 7.08 (m, 5H), 5.83 (s, 1H), 5.70 
(ddt, J = 17.0, 10.1, 6.3 Hz, 1H), 5.22 (ddd, J = 17.0, 2.8, 1.5 Hz, 1H), 5.16 (dd, J = 10.1, 1.2 Hz, 
1H), 4.19 – 4.11 (m, 2H), 4.04 – 3.92 (m, 4H), 2.34 (s, 3H), 2.25 – 2.04 (m, 1H), 1.39 – 1.30 (m, 
1H); 13C-NMR (101 MHz, CDCl3): δ 144.9 (C), 139.3 (C), 134.9 (C), 131.1 (CH), 131.0 (CH), 130.0 (2 
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× CH), 128.7 (CH), 128.0 (CH), 127.8 (2 × CH), 126.0 (CH), 121.4 (C), 120.3 (CH2), 100.1 (CH), 86.5 
(C), 69.0 (C), 67.7 (2 × CH2), 54.4 (CH2), 26.0 (CH2), 22.0 (CH3); IR: νmax (cm
-1) 2979, 2957, 2933, 
2865, 2233, 1356, 1159, 1002, 757, 658; HRMS (ES) m/z calculated for C22H23NO4SNa (M+Na)
+ 
420.1245, found 420.12468. 
N-Allyl-4-methyl-N-((2-(4-methyl-1,3-dioxolan-2-yl)phenyl)ethynyl)benzenesulfonamide 546 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-4-
methyl-1,3-dioxolane (381 mg, 1.4 mmol, GP10) and sulfonamide 490 (251 mg, 1.2 
mmol). Purification by flash column chromatography [hexane:toluene:Et2O 
(50:48:2), 1% Et3N then hexane:EtOAc (90:10), 1% Et3N] gave the ynamide 544 (440 mg, 93%) as 
a yellow oil as a 1:1 mixture of diastereoisomers; 1H-NMR (300 MHz, CDCl3): δ 7.89 and 7.88 (2 × 
d, J = 8.4 Hz, 2H), 7.65 – 7.60 and 7.59 – 7.53 (2 × m, 1H), 7.37 – 7.23 (m, 5H), 6.26 and 6.15 (2 × 
s, 1H), 5.88 – 5.71 (m, 1H), 5.34 – 5.20 (m, 2H), 4.47 – 4.28 (m) and 4.13 (dd, J = 7.4, 6.6 Hz, 2H), 
4.08 – 4.03 (m, 2H), 3.62 (t, J = 8.0 Hz) and 3.57 (dd, J = 8.5, 8.0 Hz, 1H), 2.44 (s, 3H), 1.41 and 
1.35 (2 × d, J = 6.1 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.8 (C), 138.6 and 138.1 (C), 134.9 
(C), 131.5 (CH), 131.3 and 131.0 (CH), 129.9 (2 × CH), 129.0 and 128.9 (CH), 128.0 (2 × CH), 127.9 
and 127.7 (CH), 126.1 and 126.0 (CH), 122.5 and 122.3 (C), 120.3 (CH2), 101.9 and 101.2 (CH), 
87.0 and 86.9 (C), 73.6 and 72.6 (CH), 72.4 and 71.5 (CH2), 68.9 and 68.8 (C), 54.4 (CH2), 21.8 
(CH3), 18.7 and 18.6 (CH3); IR: νmax (cm
-1) 2977, 2934, 2875, 2233, 1597, 1362, 1169, 1088, 759, 
661; HRMS (ES) m/z calculated for C22H23NO4SNa (M+Na)
+ 420.1245, found 420.1238. 
N-((2-(1,3-dithiolan-2-yl)-4-methoxyphenyl)ethynyl)-N-allyl-4-methylbenzenesulfonamide 550 
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Prepared according to GP12 using alkyne 549 (160 g, 0.8 mmol) and 
sulfonamide 490 (715 mg, 3.9 mmol). Purification by flash column 
chromatography [hexane:toluene (50:50), 1% Et3N] gave the ynamide 550 (98 
mg, 32%) as a bright red oil with some low level impurities which could not be removed; 1H-
NMR (300 MHz, CDCl3): δ 7.87 (d, J = 8.3 Hz, 2H), 7.40 – 7.31 (m, 2H), 7.31 – 7.22 (m, 1H), 7.20 – 
7.14 (m, 1H), 6.72 (dd, J = 8.5, 2.7 Hz, 1H), 5.96 (s, 1H), 5.81 (ddt, J = 16.8, 10.1, 6.4 Hz, 1H), 5.31 
(ddd, J = 16.8, 2.5, 1.1 Hz, 1H), 5.25 (dd, J = 10.1, 1.1 Hz, 1H), 4.08 (app. dt, J = 6.4, 1.1 Hz, 2H), 
3.81 (s, 3H), 3.51 – 3.36 (m, 2H), 3.36 – 3.25 (m, 2H), 2.45 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
159.7 (C), 144.8 (2 × C), 134.8 (C), 133.7 (CH), 131.1 (CH), 123.0 (2 × CH), 128.0 (2 × CH), 120.4 
(CH2), 114.1 (C), 113.4 (CH), 113.1 (CH) , 86.6 (C), 68.4 (C), 55.5 (CH), 54.6 (CH2), 53.6 (CH3), 39.8 
(2 × CH2), 21.8 (CH3); IR: νmax (cm
-1) 3066, 2925, 2838, 2234, 1603, 1362, 1277, 1168, 814, 663; 
HRMS (ES) m/z calculated for C22H24NO3S3 (M+H)
+ 446.0981, found 446.0905. 
N-(2-(1,3-Dioxolan-2-yl)phenyl)-N-(but-3-en-1-yl)-4-methylbenzenesulfonamide 552 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxolane (580 mg, 2.3 mmol, GP10) and sulfonamide 551 (429 mg, 1.9 
mmol). Purification by flash column chromatography [hexane:EtOAc (85:15), 1% 
Et3N] gave the ynamide 552 (758 mg, 99%) as a yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 7.88 (d, J 
= 8.3 Hz, 2H), 7.62 – 7.55 (m, 1H), 7.38 – 7.28 (m, 5H), 6.12 (s, 1H), 5.75 (ddt, J = 17.1, 10.2, 6.8 
Hz, 1H), 5.12 (ddd, J = 17.1, 3.1, 1.3 Hz, 1H), 5.05 (d, J = 10.2, 2.6, 1.3 Hz, 1H), 4.21 – 4.11 (m, 
2H), 4.11 – 4.01 (m, 2H), 2.51 – 2.42 (m, 2H), 2.44 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.7 
(C), 138.2 (C), 134.8 (C), 133.7 (CH), 131.5 (CH), 129.9 (2 × CH), 129.0 (CH), 127.8 (2 × CH), 127.8 
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(CH), 125.9 (CH), 122.4 (C), 117.9 (CH2), 101.9 (CH), 86.9 (C), 68.9 (C), 65.5 (2 × CH2), 51.0 (CH2), 
32.3 (CH2), 21.7 (CH3); IR: νmax (cm
-1) 3082, 2984, 2885, 2233, 1642, 1597, 1363, 1168, 1067, 757; 
HRMS (ES) m/z calculated for C20H24NO4S (M+H)
+ 374.4659, found 374.4687. 
N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-N-(but-3-en-2-yl)-4-methylbenzenesulfonamide 566 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxolane (134 mg, 0.5 mmol, GP10) and sulfonamide 562 (100 mg, 0.4 
mmol). Purification by flash column chromatography [hexane:toluene:Et2O 
(50:47:3), 1% Et3N] gave the ynamide 566 (117 mg, 66%) as a yellow oil; 
1H-NMR (300 MHz, 
CDCl3): δ 7.87 (d, J = 8.3 Hz, 2H), 7.58 (app. dt, J = 5.7, 3.1 Hz, 1H), 7.38 – 7.24 (m, 5H), 6.10 (s, 
1H), 5.73 (ddd, J = 17.0, 10.6, 6.5 Hz, 1H), 5.16 (app. dt, J = 17.0, 1.1 Hz, 1H), 5.08 (app. dt, J = 
10.6, 1.0 Hz, 1H), 4.68 – 4.61 (m, 1H), 4.20 – 4.10 (m, 2H), 4.09 – 3.98 (m, 2H), 2.43 (s, 3H), 1.33 
(d, J = 6.8 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.6 (C), 138.0 (C), 136.3 (CH), 135.8 (C), 131.4 
(CH), 129.8 (2 × CH), 129.0 (CH), 127.9 (2 × CH), 127.7 (CH), 125.9 (CH), 122.7 (C), 117.1 (CH2), 
101.9 (CH), 84.7 (C), 70.5 (C), 65.5 (2 × CH2), 58.2 (CH), 21.8 (CH3), 18.7 (CH3); IR: νmax (cm
-1) 
3067, 2982, 2887, 2232, 1598, 1360, 1168, 1088, 1066, 942, 729, 666; HRMS (ES) m/z calculated 
for C22H24NO4S (M+H)
+ 389.1426, found 398.1420. 
N-((2-(1,3-Dioxolan-2-yl)cyclohex-1-en-1-yl)ethynyl)-N-(1-phenylbut-3-en-1-
yl)benzenesulfonamide 567 
Prepared according to GP11 using freshly prepared 2-(2-
(bromoethynyl)cyclohex-1-en-1-yl)-1,3-dioxolane (191 mg, 0.7 mmol, GP10) 
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and sulfonamide 563 (203 mg, 0.7 mmol). Purification by flash column chromatography 
[hexane:toluene:Et2O (50:47:3), 1% Et3N] gave the ynamide 567 (219 mg, 68%) as a yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 7.53 (d, J = 8.3 Hz, 2H), 7.29 – 7.17 (m, 5H), 7.13 (d, J = 8.0 Hz, 2H), 
5.70 (s, 1H), 5.61 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 5.08 (ddd, J = 17.1, 2.9, 1.3 Hz, 1H), 5.04 – 4.94 
(m, 3H), 4.04 – 3.93 (m, 2H), 3.93 – 3.84 (m, 2H), 2.81 – 2.68 (m, 1H), 2.64 – 2.52 (m, 1H), 2.36 
(s, 3H), 2.24 – 2.09 (m, 4H), 1.68 – 1.61 (m, 4H); 13C-NMR (101 MHz, CDCl3): δ 144.1 (C), 138.9 
(C), 138.0 (C), 135.3 (C), 133.6 (CH), 129.3 (2 × CH), 128.5 (2 × CH), 128.1 (CH), 127.8 (2 × CH), 
127.3 (2 × CH), 121.8 (C), 118.4 (CH2), 103.4 (CH), 84.5 (C), 72.6 (C), 65.5 (2 × CH2), 63.4 (CH), 
38.4 (CH2), 30.6 (CH2), 22.3 (CH2), 22.0 (CH2), 21.8 (CH2), 21.7 (CH3); IR: νmax (cm
-1) 3073, 3034, 
2934, 2860, 1669, 1322, 1155, 1087, 918, 667; HRMS (ES) m/z calculated for C19H20NO4S2 (M+H)
+ 
478.2052, found 478.2060. 
N-((2-(1,3-Dioxan-2-yl)phenyl)ethynyl)-4-methyl-N-(pent-4-en-2-yl)benzenesulfonamide 568 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxane (261 mg, 1.0 mmol, GP10) and sulfonamide 564 (172 mg, 0.8 mmol). 
Purification by flash column chromatography [hexane:toluene:Et2O (50:47:3), 1% 
Et3N] gave the ynamide 568 (216 mg, 62%) as a clear oil; 
1H-NMR (300 MHz, CDCl3): δ 7.86 (d, J = 
8.3 Hz, 2H), 7.73 – 7.64 (m, 1H), 7.36 – 7.13 (m, 5H), 5.96 (s, 1H), 5.65 (ddt, J = 17.1, 10.1, 7.1 Hz, 
1H), 5.06 (dd, J = 17.1, 1.7 Hz, 1H), 5.01 – 4.96 (m, 1H), 4.30 – 4.19 (m, 2H), 4.18 – 4.00 (m, 3H), 
2.43 (s, 3H), 2.35 – 2.16 (m, 2H), 1.47 – 1.39 (m, 2H), 1.16 (d, J = 6.6 Hz, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 144.6 (C), 139.2 (C), 136.2 (C), 133.8 (CH), 131.2 (CH), 129.9 (2 × CH), 128.7 (CH), 127.9 
(CH), 127.6 (2 × CH), 126.1 (CH), 121.8 (C), 118.2 (CH2), 100.1 (CH), 83.7 (C), 71.0 (C), 67.7 (2 × 
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CH2), 56.6 (CH), 39.7 (CH2), 26.0 (CH2), 21.8 (CH3), 18.8 (CH3); IR: νmax (cm
-1) 3073, 2976, 2930,  
2855, 2232, 1598, 1361, 1169, 1100, 1088, 977, 759, 735, 676; HRMS (ES) m/z calculated for 
C24H27NO4SNa (M+Na)
+ 448.1559, found 448.1541. 
N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-4-methyl-N-(pent-4-en-2-yl)benzenesulfonamide 569 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxolane (162 mg, 0.6 mmol, GP10) and sulfonamide 564 (128 mg, 0.5 
mmol). Purification by flash column chromatography [hexane:toluene:Et2O 
(50:47:3), 1% Et3N] gave the ynamide 569 (126 mg, 57%) as a clear oil; 
1H-NMR (300 MHz, 
CDCl3): δ 7.90 (d, J = 8.3 Hz, 2H), 7.65 – 7.59 (m, 1H), 7.45 – 7.23 (m, 5H), 6.16 (s, 1H), 5.67 (ddt, 
J = 17.0, 10.1, 7.1 Hz, 1H), 5.08 (dd, J = 17.0, 1.7 Hz, 1H), 5.03 – 4.96 (m, 1H), 4.24 – 4.02 (m, 5H), 
2.46 (s, 3H), 2.45 – 2.20 (m, 2H), 1.17 (d, J = 6.6 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.6 (C), 
138.0 (C), 136.1 (C), 133.9 (CH), 131.5 (CH), 129.9 (2 × CH), 129.0 (CH), 127.7 (2 × CH), 127.7 
(CH), 125.9 (CH), 122.8 (C), 118.2 (CH2), 102.0 (CH), 84.4 (C), 70.7 (C), 65.5 (2 × CH2), 56.8 (CH), 
39.6 (CH2), 21.8 (CH3), 18.8 (CH3); IR: νmax (cm
-1) 3070, 2979, 2936, 2889, 2231, 1598, 1361, 
1168, 1089, 1066, 971, 942, 757, 674; HRMS (ES) m/z calculated for C23H25NO4SNa (M+Na)
+ 
434.1402, found 434.1399. 
N-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)-4-methyl-N-(2-
methylallyl)benzenesulfonamide 576 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (301 mg, 1.0 mmol, GP10) and sulfonamide 
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573 (139 mg, 0.6 mmol). Purification by flash column chromatography [hexane:EtOAc (95:5)] 
gave the ynamide 576 (203 mg, 74%) as an orange oil; 1H-NMR (300 MHz, CDCl3): δ 
1H-NMR 
(300 MHz, CDCl3): δ 7.79 (d, J = 8.3 Hz, 2H), 7.46 (d, J = 7.9 Hz, 1H), 7.41 – 7.12 (m, 10H), 5.70 (s, 
1H), 4.95 (s, 2H), 3.97 (d, J = 2.8 Hz, 2H), 3.35 (s, 3H), 2.43 (s, 3H), 1.75 (s, 3H); 13C-NMR (101 
MHz, CDCl3): δ 144.9 (C), 143.2 (C), 141.9 (C), 138.9 (C), 134.8 (C), 132.0 (CH), 129.9 (2 × CH), 
128.4 (CH), 128.3 (2 × CH), 127.8 (2 × CH), 127.4 (CH), 127.3 (CH), 126.9 (2 × CH), 126.5 (CH), 
122.0 (C), 116.2 (CH2), 86.7 (C), 82.3 (CH), 69.3 (C), 58.1 (CH2), 57.2 (CH3), 21.8 (CH3), 19.8 (CH3); 
IR: νmax (cm
-1) 3065, 3032, 2978, 2927, 2825, 2232, 1598, 1494, 1451, 1169, 1092, 760; HRMS 
(ES) m/z calculated for C27H27NO3SNa (M+Na)
+ 468.1609, found 468.1607. 
N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-N-(2-methylallyl)-4-nitrobenzenesulfonamide 577 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxolane (274 mg, 1.1 mmol, GP10) and sulfonamide 574 (233 mg, 0.9 
mmol). Purification by flash column chromatography [hexane:EtOAc (90:10), 1% 
Et3N then hexane:EtOAc (85:15), 1% Et3N] gave the ynamide 577 (324 mg, 83%) as a yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 8.39 (d, J = 9.0 Hz, 2H), 8.22 (d, J = 9.0 Hz, 2H), 7.62 – 7.56 (m, 1H), 
7.37 – 7.27 (m, 3H), 6.10 (s, 1H), 5.03 – 4.98 (m, 2H), 4.21 – 4.12 (m, 2H), 4.11 – 3.99 (m, 4H), 
1.74 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 150.7 (C), 143.1 (C), 138.5 (C), 138.2 (C), 131.7 (CH), 
129.2 (2 × CH), 129.1 (CH), 128.3 (CH), 126.0 (CH), 124.5 (2 × CH), 121.7 (C), 116.8 (CH2), 101.9 
(CH), 85.7 (C), 69.3 (C), 65.6 (2 × CH2), 58.5 (CH2), 19.8 (CH3); IR: νmax (cm
-1) 3105, 2986, 2950, 
2887, 2237, 1530, 1372, 1348, 1173, 1066, 733; HRMS (ES) m/z calculated for C21H20N2O6SNa 
(M+Na)+ 451.0940, found 451.0938. 
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N-((2-(Methoxy(phenyl)methyl)phenyl)ethynyl)-4-methyl-N-(3-methylbut-2-en-1-
yl)benzenesulfonamide 578 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (266 mg, 0.9 mmol, GP10) and sulfonamide 
575 (176 mg, 0.7 mmol). Purification by flash column chromatography 
[hexane:EtOAc (93:7)] gave the ynamide 578 (277 mg, 82%) as a pale orange 
solid; mp: 49-51 °C; 1H-NMR (300 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 2H), 7.47 (d, J = 8.2 Hz, 1H), 
7.40 – 7.35 (m, 2H), 7.33 – 7.13 (m, 9H), 5.71 (s, 1H), 5.22 – 5.15 (m, 1H), 4.08 (dd, J = 6.4, 5.4 
Hz, 2H), 3.36 (s, 3H), 2.42 (s, 3H), 1.66 (s, 3H), 1.66 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.7 
(C), 143.2 (C), 141.9 (C), 139.4 (C), 135.1 (C), 131.8, (CH) 129.8 (2 × CH), 128.4 (2 × CH), 128.3 
(CH), 127.8 (2 × CH), 127.4 (CH), 127.3 (CH), 126.9 (2 × CH), 126.5 (CH), 122.2 (C), 117.3 (CH), 
87.3 (C), 82.3 (CH), 69.1 (C), 57.1 (CH3), 49.8 (CH2), 25.9 (CH3), 21.8 (CH3), 18.2 (CH3); IR: νmax 
(cm-1) 2980, 2931, 2823, 2231, 1598, 1493, 1449, 1363, 1166, 1090, 1075, 756, 699; HRMS (ES) 
m/z calculated for C28H29NO3SNa (M+Na)
+ 482.1766, found 482.1760. 
N-Benzyl-N-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)-4-methylbenzenesulfonamide 581 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (366 mg, 1.2 mmol, GP9) and sulfonamide 580 
(264 mg, 1.0 mmol). Purification by flash column chromatography [hexane:EtOAc 
(95:5)] gave the ynamide 581 (367 mg, 73%) as pale yellow solid; mp: 80-82 °C; 
1H-NMR (300 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 2H) 7.43 (dd, J = 7.8, 0.9 Hz, 1H), 7.34 – 7.19 (m, 
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14H), 7.18 – 7.12 (m, 1H), 5.50 (s, 1H), 4.66 (d, J = 13.9 Hz, 1H), 4.58 (d, J = 13.9 Hz, 1H), 3.27 (s, 
3H), 2.43 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.7 (C), 143.1 (C), 141.6 (C), 134.6 (C), 134.3 (C) 
131.7 (CH), 129.8 (CH), 128.7 (CH), 128.6 (CH), 128.4 (CH), 128.2 (CH), 128.1 (CH), 127.6 (CH), 
127.2 (CH), 127.1 (CH), 126.7 (CH), 126.3 (CH), 121.7 (C), 86.7 (C), 82.0 (CH), 69.7 (C), 56.9 (CH3), 
55.7 (CH2), 21.7 (CH3); IR: νmax (cm
-1) 3063, 3030, 2983, 2929, 2231, 1168, 1076; HRMS (ES) m/z 
calculated for C30H27NO3NaS (M+Na)
+ 504.1609 found 504.1598. 
N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-N-(3-methoxybenzyl)methanesulfonamide 587 
Prepared according to GP11 using freshly prepared 2-(2-
(bromoethynyl)phenyl)-1,3-dioxolane (779 mg, 3.1 mmol, GP10) and 
sulfonamide 586 (552 mg, 2.6 mmol). Purification by flash column 
chromatography [toluene:EtOAc (94:4), 1% Et3N] gave the ynamide 587 (870 mg, 88%) as a 
yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.60 – 7.54 (m, 1H), 7.39 – 7.25 (m, 4H), 7.12 – 7.01 (m, 
2H), 6.91 (dd, J = 8.2, 2.4 Hz, 1H), 6.00 (s, 1H), 4.69 (s, 2H), 4.18 – 4.06 (m, 2H), 4.06 – 3.93 (m, 
2H), 3.81 (s, 3H), 2.99 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 160.0 (C), 138.4 (C), 136.1 (C), 131.5 
(CH), 130.0 (CH), 129.0 (CH), 128.0 (CH), 125.9 (CH), 121.9 (C), 121.3 (CH), 114.5 (CH), 114.4 
(CH), 101.9 (CH), 86.8 (C), 69.7 (C), 65.4 (2 × CH2), 55.7 (CH2), 55.4 (CH3), 39.1 (CH3); IR: νmax (cm
-
1) 3017, 2945, 2890, 2842, 2236, 1601, 1587, 1355, 1160, 753; HRMS (ES) m/z calculated for 
C20H22NO5S (M+H)
+ 388.1219, found 388.1208. 
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N-Allyl-N-((2-(((benzyloxy)methoxy)(phenyl)methyl)phenyl)ethynyl)methanesulfonamide 663 
Prepared according to GP11 using freshly prepared 1-
(((benzyloxy)methoxy)(phenyl)methyl)-2-(bromoethynyl)benzene (269 mg, 
0.7 mmol, GP10) and sulfonamide 249 (74 mg, 0.6 mmol). Purification by 
flash column chromatography [hexane:EtOAc (85:15), 1% Et3N] gave the ynamide 633 (127 mg, 
50%) as a clear oil; 1H-NMR (300 MHz, CDCl3): δ 7.60 (dd, J = 7.7, 1.0 Hz, 1H), 7.48 – 7.19 (m, 
13H), 6.31 (s, 1H), 5.88 (ddt, J = 16.8, 10.1, 6.4 Hz, 1H), 5.35 (dd, J = 16.8, 1.2 Hz, 1H), 5.27 (dd, J 
= 10.1, 1.2 Hz, 1H), 4.86 (d, J = 6.9 Hz, 1H), 4.82 (d, J = 6.9 Hz, 1H), 4.68 (d, J = 11.6 Hz, 1H), 4.58 
(d, J = 11.6 Hz, 1H), 4.06 (dd, J = 6.4, 0.9 Hz, 2H), 2.88 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.1 
(C), 141.6 (C), 137.9 (C), 132.1 (CH), 131.0 (CH), 128.6 (2 × CH), 128.5 (3 × CH), 128.2 (2 × CH), 
127.8 (CH), 127.6 (CH), 127.5 (CH), 127.3 (2 × CH), 127.1 (CH), 121.6 (C), 120.7 (CH2), 92.7 (CH2), 
86.3 (C), 76.6 (CH), 70.0 (CH2), 69.5 (C), 54.4 (CH2), 38.9 (CH3); IR: νmax (cm
-1) 3062, 3031, 2931, 
2885, 2234, 1359, 1165, 1035, 1024, 732, 697; HRMS (ES) m/z calculated for C27H27NO4NaS 
(M+Na)+ 484.1558, found 484.1554. 
N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-N-allylmethanesulfonamide 664 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl)-
1,3-dioxolane (462 mg, 1.8 mmol, GP10) and sulfonamide 249 (206 mg, 1.5 mmol). 
Purification by flash column chromatography [toluene:EtOAc (95:5), 1% Et3N] gave 
the ynamide 664 (392 mg, 84%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.61 – 7.55 (m, 1H), 
7.41 – 7.36 (m, 1H), 7.35 – 7.28 (m, 2H), 6.12 (s, 1H), 6.01 (ddt, J = 16.8, 10.1, 6.4 Hz, 1H), 5.45 
(app. dq, J = 16.8, 1.3 Hz, 1H), 5.38 (dd, J = 10.1, 1.1 Hz, 1H), 4.21 – 4.13 (m, 4H), 4.11 – 4.00 (m, 
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2H), 3.17 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 138.4 (C), 131.5 (CH), 131.0 (CH), 129.0 (CH), 
128.0 (CH), 125.9 (CH), 121.9 (C), 120.8 (CH2), 102.0 (CH), 86.5 (C), 69.3 (C) 65.5 (2 × CH2), 54.4 
(CH2), 39.2 (CH3); IR: νmax (cm
-1) 3017, 2981, 2938, 2889, 2234, 1354, 1326, 1162, 1066, 940, 759; 
HRMS (ES) m/z calculated for C15H18NO4S (M+H)
+ 308.0957, found 308.0948. 
N-((2-(1,3-Dioxolan-2-yl)-4-fluorophenyl)ethynyl)-N-allylmethanesulfonamide 669 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)-5-
fluorophenyl)-1,3-dioxolane (204 mg, 0.8 mmol, GP10) and sulfonamide 249 (85 
mg, 0.6 mmol). Purification by flash column chromatography [hexane:EtOAc 
(80:20), 1% Et3N] gave the ynamide 669 (159 mg, 78%) as a yellow oil; 
1H-NMR (300 MHz, 
CDCl3): δ 7.37 (dd, J = 8.4, 5.4 Hz, 1H), 7.29 (dd, J = 9.4, 2.8 Hz, 1H), 6.99 (app. td, J = 8.4, 2.8 Hz, 
1H), 6.08 (d, J = 1.3 Hz, 1H), 6.00 (ddt, J = 17.0, 10.1, 6.4 Hz, 1H), 5.44 (ddd, J = 17.0, 2.5, 1.2 Hz, 
1H), 5.38 (dd, J = 10.1, 1.0 Hz, 1H), 4.19 – 4.10 (m, 4H), 4.10 – 3.99 (m, 2H), 3.16 (s, 3H); 13C-
NMR (101 MHz, CDCl3): δ 162.3 (d, JC-F = 249.4 Hz, C), 141.5 (d, JC-F = 7.2 Hz, C), 133.6 (d, JC-F = 8.0 
Hz, CH), 131.0 (CH), 120.8 (CH2), 117.9 (C), 116.3 (d, JC-F = 22.3 Hz, CH), 113.4 (d, JC-F = 23.7 Hz, 
CH), 101.3 (CH), 86.0 (C), 68.1 (C), 65.6 (2 × CH2), 54.3 (CH2), 39.2 (CH3); IR: νmax (cm
-1) 3020, 
2991, 2935, 2892, 2239, 1607, 1496, 1355, 1326, 1268, 1158, 733; HRMS (ES) m/z calculated for 
C15H17NO4SF (M+H)
+ 326.0862, found 326.0872. 
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N-((2-(1,3-Dioxolan-2-yl)-6-methoxyphenyl)ethynyl)-N-allylmethanesulfonamide 670 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)-3-
methoxyphenyl)-1,3-dioxolane (264 mg, 1.1 mmol, GP10) and sulfonamide 249 
(125 mg, 0.9 mmol). Purification by flash column chromatography [toluene:EtOAc 
(93:7), 1% Et3N] gave the ynamide 670 (140 mg, 73%) as a yellow oil; 
1H-NMR (300 MHz, CDCl3): 
δ 7.27 (app. t, J = 7.8 Hz, 1H), 7.18 (dd, J = 7.8, 1.1 Hz, 1H), 6.86 (dd, J = 7.8, 1.1 Hz, 1H), 6.10 (s, 
1H), 6.04 (ddt, J = 16.8, 10.1, 6.4 Hz, 1H), 5.46 (app. dq, J = 16.8, 1.3 Hz, 1H), 5.37 (ddd, J = 10.1, 
2.1, 1.0 Hz, 1H), 4.18 (app. dt, J = 6.5, 1.1 Hz, 2H), 4.16 – 4.08 (m, 2H), 4.08 – 3.99 (m, 2H), 3.85 
(s, 3H), 3.20 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 159.7 (C), 140.0 (C), 131.1 (CH), 128.7 (CH), 
120.7 (CH2), 118.0 (CH), 111.6 (C), 111.3 (CH), 101.9 (CH), 90.7 (C), 65.5 (2 × CH2, C), 56.1 (CH3), 
54.3 (CH2), 38.9 (CH3); IR: νmax (cm
-1) 3003, 2989, 2900, 2924, 2246, 1578, 1478, 1458, 1441, 
1396, 1344, 1276, 1158, 1053, 774; HRMS (ES) m/z calculated for C16H19NO5SNa (M+Na)
+ 
360.0882, found 360.0876. 
N-((2-(1,3-Dioxolan-2-yl)-4,5-dimethoxyphenyl)ethynyl)-N-allylmethanesulfonamide 671 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)-4,5-
dimethoxyphenyl)-1,3-dioxolane (259 mg, 0.8 mmol, GP10) and sulfonamide 
249 (93 mg, 0.7 mmol). Purification by flash column chromatography 
[toluene:EtOAc (60:40), 1% Et3N] gave the ynamide 671 (186 mg, 73%) as a yellow oil; 
1H-NMR 
(300 MHz, CDCl3): δ 7.08 (s, 1H), 6.86 (s, 1H), 6.05 (s, 1H), 6.01 (ddt, J = 16.8, 10.2, 6.4 Hz, 1H), 
5.44 (dd, J = 16.8, 1.2 Hz, 1H), 5.37 (dd, J = 10.2, 1.2 Hz, 1H), 4.22 – 4.12 (m, 4H), 4.09 – 3.98 (m, 
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2H), 3.90 (s, 3H), 3.87 (s, 3H), 3.16 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 149.4 (C), 149.3 (C), 
132.0 (2 × C), 131.1 (CH), 120.6 (CH2), 114.3 (CH), 108.7 (CH), 101.8 (CH), 84.8 (C), 68.7 (C), 65.4 
(2 × CH2), 56.2 (CH3), 56.1 (CH3), 54.4 (CH2), 39.1 (CH3); IR: νmax (cm
-1) 2988, 2978, 2901, 2234, 
1603, 1513, 1350, 1160, 1089; HRMS (ES) m/z calculated for C15H19NO6SNa (M(-C2H2)+Na)
+ 
364.0831, found 364.0837. 
N-((4-(1,3-Dioxolan-2-yl)pyridin-3-yl)ethynyl)-N-allylmethanesulfonamide 676 
Prepared according to GP11 using freshly prepared 3-(bromoethynyl)-4-(1,3-
dioxolan-2-yl)pyridine (215 mg, 0.8 mmol, GP10) and sulfonamide 249 (95 mg, 
0.7 mmol). Purification by flash column chromatography [hexane:EtOAc (40:60), 
1% Et3N] gave the ynamide 676 (123 mg, 86%) as a clear oil; 
1H-NMR (300 MHz, CDCl3): δ 8.60 
(d, J = 0.6 Hz, 1H), 8.52 (d, J = 5.1 Hz, 1H), 7.45 (d, J = 5.1 Hz, 1H), 6.04 (s, 1H), 6.00 (ddt, J = 16.8, 
10.2, 6.4 Hz, 1H), 5.46 (ddd, J = 16.8, 2.4, 1.2 Hz, 1H), 5.40 (dd, J = 10.2, 1.2 Hz, 1H), 4.21 – 4.18 
(m, 2H), 4.17 – 4.09 (m, 2H), 4.09 – 4.02 (m, 2H), 3.19 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
151.9 (CH), 148.5 (CH), 146.6 (C), 130.8 (CH), 121.0 (CH2), 119.9 (CH), 118.8 (C), 100.8 (CH), 89.3 
(C), 66.7 (C), 65.7 (2 × CH2), 54.4 (CH2), 39.5 (CH3); IR: νmax (cm
-1) 3011, 2993, 2929, 2891, 2234, 
1713, 1354, 1161, 1086, 963, 939; HRMS (ES) m/z calculated for C14H17N2O4S (M+H)
+ 309.0909, 
found 309.0899. 
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N-((2-(1,3-Dioxolan-2-yl)thiophen-3-yl)ethynyl)-N-allylmethanesulfonamide 677 
Prepared according to GP11 using freshly prepared 2-(3-(bromoethynyl)thiophen-
2-yl)-1,3-dioxolane (171 mg, 0.7 mmol, GP10) and sulfonamide 249 (79 mg, 0.6 
mmol). Purification by flash column chromatography [hexane:EtOAc (80:20), 1% 
Et3N] gave the ynamide 677 (110 mg, 50%) as a yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 7.24 (d, J 
= 5.1 Hz, 1H), 6.98 (d, J = 5.1 Hz, 1H), 6.22 (s, 1H), 5.98 (ddt, J = 16.9, 10.1, 6.4 Hz, 1H), 5.43 (ddd, 
J = 16.9, 2.5, 1.2 Hz, 1H), 5.37 (dd, J = 10.1, 1.2 Hz, 1H), 4.21 – 4.08 (m, 4H), 4.07 – 3.97 (m, 2H), 
3.14 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.0 (C), 130.9 (CH), 130.1 (CH), 125.5 (CH2), 120.8 
(CH), 120.7 (C), 99.4 (CH), 85.0 (C), 65.5 (2 × CH2), 64.9 (C), 54.4 (CH2), 39.1 (CH3); IR: νmax (cm
-1) 
3115, 3085, 2936, 2892, 2240, 1356, 1164, 1072, 960; HRMS (ES) m/z calculated for 
C13H15NO4S2Na (M+Na)
+ 336.0340, found 336.0343. 
N-((2-(1,3-Dioxolan-2-yl)cyclohex-1-en-1-yl)ethynyl)-N-allylmethanesulfonamide 680 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)cyclohex-
1-en-1-yl)-1,3-dioxolane (263 mg, 1.0 mmol, GP10) and sulfonamide 249 (180 mg, 
0.9 mmol). Purification by flash column chromatography [hexane:EtOAc (70:30), 
1% Et3N] gave the ynamide 680 (190 mg, 72%) as a clear oil with some low level impurities 
which could not be identified; 1H-NMR (300 MHz, CDCl3): δ 
1H-NMR (300 MHz, CDCl3): δ 5.91 
(ddt, J = 16.9, 10.1, 6.4 Hz, 1H), 5.74 (s, 1H), 5.40 (app. ddd, J = 16.9, 2.5, 1.2 Hz, 1H), 5.32 (dd, J 
= 10.1, 1.2 Hz, 1H), 4.07 (app. dt, J = 6.4, 1.1 Hz, 2H), 4.03 – 3.94 (m, 2H), 3.94 – 3.86 (m, 2H), 
3.06 (s, 3H), 2.24 – 2.06 (m, 4H), 1.65 – 1.56 (m, 4H); 13C-NMR (101 MHz, CDCl3): δ 139.0 (C), 
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131.0 (CH), 121.2 (C), 120.6 (CH2), 103.3 (CH), 85.7 (C), 70.3 (C), 65.6 (2 × CH2), 54.3 (CH2), 38.9 
(CH3), 30.7 (CH2), 22.2 (CH2), 22.0 (CH2), 21.8 (CH2); IR: νmax (cm
-1) 3025, 2933, 2885, 2844, 2227, 
1357, 1324, 1163, 1056, 943, 750; HRMS (ES) m/z calculated for C15H22NO4S (M+H)
+ 312.1270, 
found 312.1258. 
(E)-N-((2-(1,3-Dioxolan-2-yl)phenyl)ethynyl)-N-(but-2-en-1-yl)methanesulfonamide 683 
Prepared according to GP10 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl)benzene (289 mg, 1.1 mmol, GP9) and sulfonamide 
682 (142 mg, 1.0 mmol). Purification by flash column chromatography 
[toluene:EtOAc (80:20), 1% Et3N] gave the ynamide 683 (224 mg, 73%) as a white solid; mp: 
126-127 °C; 1H-NMR (300 MHz, CDCl3): δ 7.61 – 7.55 (m, 1H), 7.41 – 7.35 (m, 1H), 7.33 – 7.28 (m, 
2H), 6.12 (s, 1H), 5.96 – 5.83 (m, 1H), 5.74 – 5.60 (m, 1H), 4.19 – 4.08 (m, 4H), 4.08 – 4.01 (m, 
2H), 3.15 (s, 3H), 1.78 (dd, J = 6.4, 1.2 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ 138.4 (C), 133.0 
(CH), 131.5 (CH), 129.0 (CH), 127.9 (CH), 125.9 (CH), 123.8 (CH), 122.2 (C), 102.1 (CH), 86.8 (C), 
69.3 (C), 65.5 (2 × CH2), 54.0 (CH2), 39.2 (CH3), 18.0 (CH3); IR: νmax (cm
-1) 3067, 2997,2888, 2857, 
2814, 2280, 1597, 1362, 1165, 1108, 771, 758; HRMS (ES) m/z calculated for C16H20NO4S (M+H)
+ 
322.1113, found 322.1106. 
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Synthesis of Deuterated Ynamides 
2-((Trimethylsilyl)ethynyl-d)benzaldehyde d-230 
 
A solution of methyl-2-iodobenzoate (2.0 g, 7.6 mmol, 1.0 equiv.) in THF (5 mL) was added 
dropwise to a suspension of LiAlD4 (450 mg, 10.7 mmol, 1.4 equiv.) in THF (15 mL, 0.2 M) at 0 °C. 
The mixture was stirred at room temperature for 1 hour and then cooled again to 0 °C. Water 
(10 mL) was added slowly (take care!) to quench the reaction. Saturated potassium sodium 
tartrate solution (20 mL) was added to help solubilise the suspension and the aqueous phase 
was extracted with Et2O (4 × 20 mL). The combined organic phases were dried over Na2SO4, 
filtered and the solvent removed under reduced pressure to give the pure alcohol 590 (1.2 g, 
68%) as colourless solid; mp: 82-84 °C; 1H-NMR (300 MHz, CDCl3): δ 7.83 (dd, J = 7.9, 1.1 Hz, 1H), 
7.46 (dd, J = 7.5, 1.8 Hz, 1H), 7.37 (td, J = 7.5, 1.1 Hz, 1H), 7.04 – 6.98 (m, 1H), 2.01 (br. s, OH); 
13C-NMR (101 MHz, CDCl3): δ 142.7 (C), 139.4 (CH), 129.5 (CH), 128.7 (CH), 128.7 (CH), 97.7 (C); 
IR: νmax (cm
-1) 3276, 3175, 3059, 1463, 1432, 1010, 736; HRMS (ES) m/z calculated for C7H4D2I 
(M+H(-H2O))
+ 218.9640 found 218.9643. 
Oxalyl chloride (0.4 mL, 4.8 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (3 mL, 0.6 M) and cooled 
to -78 °C. DMSO (1.0 mL, 14.4 mmol, 3 equiv.) was added slowly and the solution stirred for 45 
minutes. Deuterated alcohol 590 (1.1 g, 4.8 mmol, 1.0 equiv.) in CH2Cl2 (5mL) was added slowly 
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and the solution stirred for a further 45 minutes. Et3N (4.0 mL, 28.8 mmol, 6.0 equiv.) was 
added and the solution stirred for 45 minutes before warming to room temperature. Water (15 
mL) was added and the aqueous layer was extracted with Et2O (3 × 10 ml). The organic fractions 
were washed with brine (15 mL), dried over Na2SO4, filtered and the solvent removed under 
reduced pressure to give the desired aldehyde d-230 (956 mg, 4.1 mmol, 85%) which was used 
directly.  
Deuterated aldehyde 591 (934 mg, 4.0 mmol, 1.0 equiv.) was dissolved in Et3N (20 mL, 0.2 M). 
Pd(PPh3)Cl2 (85 mg, 0.1 mmol, 3 mol%) and CuI (46 mg, 0.2 mmol, 6 mol%) were added and the 
solution stirred for 5 minutes. Trimethylsilylacetylene (0.7 mL, 4.8 mmol, 1.2 equiv.) was added 
slowly and the resulting solution stirred at room temperature for 14 hours. The solvent was 
removed under reduced pressure and the crude residue was purified by flash column 
chromatography [hexane:Et2O (98:2)] to give aldehyde d-230 (761 mg, 93%) as a pale yellow 
solid; mp: 44-46 °C; 1H-NMR (300 MHz, CDCl3): δ 7.91 (ddd, J = 7.7, 1.2, 0.7 Hz, 1H), 7.61 – 7.49 
(m, 2H), 7.43 (ddd, J = 7.7, 6.6, 2.1 Hz, 1H), 0.28 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 136.2 (C), 
133.8 (CH), 133.6 (CH), 129.0 (CH), 127.0 (CH), 126.9 (C), 102.5 (C), 100.2 (C), -0.1 (3 × CH3); IR: 
νmax (cm
-1) 2958, 2900, 2123, 1675, 1593, 1246, 841, 756; HRMS (ES) m/z calculated for 
C12H14DOSi (M+H)
+ 204.0955 found 201.0952. 
Phenyl(2-((trimethylsilyl)ethynyl)phenyl)methan-d-ol d-231 
Prepared according to GP2 from aldehyde d-230 (545 mg, 2.7 mmol). Purification 
by flash column chromatography [hexane:EtOAc (95:5)] gave the alcohol d-231 
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(747 mg, 99%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.53 – 7.39 (m, 4H), 7.40 – 7.17 (m, 
5H), 0.24 (s, 9H); MS (ES): m/z 304 [M+Na]+ (100 %). Data matches that reported in the 
literature.57 
1-Ethynyl-2-(methoxy(phenyl)methyl-d)benzene d-232 
Prepared according to GP3 using alcohol d-231 (784 mg, 2.8 mmol). Purification by 
flash column chromatography [hexane:Et2O (95:5)] gave the terminal alkyne d-232 
(427 mg, 69%) as a yellow oil;1H-NMR (300 MHz, CDCl3): δ 7.55 – 7.41 (m, 5H), 7.41 
– 7.19 (m, 4H), 3.41 (s, 3H), 3.36 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 144.6 (C), 141.5 (C), 133.0 
(CH), 129.5 (CH), 128.4 (2 × CH), 127.6 (CH), 127.4 (CH), 127.0 (3 × CH), 126.4 (CH), 121.1 (C), 
82.2 (CH), 82.1 (C), 57.2 (CH3); IR: νmax (cm
-1) 3292, 3077, 2864, 1550, 1435, 1118, 756. Data 
matches that reported in the literature.Error! Bookmark not defined.  
N-Allyl-N-((2-(methoxy(phenyl)methyl-d)phenyl)ethynyl)-4-methylbenzenesulfonamide d-494 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl-d)benzene (243 mg, 0.8 mmol, GP10) and 
sulfonamide 490 (142 mg, 0.7 mmol). Purification by flash column 
chromatography [hexane:Et2O (90:10)] gave the ynamide d-494 (274 mg, 95%) 
as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.79 (d, J = 8.3 Hz, 2H), 7.48 (dd, J = 7.9, 0.9 Hz, 1H), 
7.40 – 7.15 (m, 10H), 5.77 (ddt, J = 16.8, 10.2, 6.3 Hz, 1H), 5.26 (dd, J = 16.8, 1.2 Hz, 2H), 5.22 
(dd, J = 10.2, 1.1 Hz, 1H), 4.15 – 3.99 (m, 2H), 3.36 (s, 3H), 2.43 (s, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 144.9 (C), 143.3 (C), 141.7 (C), 134.9 (C), 132.1 (CH), 131.1 (CH), 123.0 (2 × CH), 128.5 
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(CH), 128.4 (2 × CH), 127.9 (2 × CH), 127.4 (CH), 127.3 (CH), 127.0 (2 × CH), 126.5 (CH), 121.9 (C), 
120.4 (CH2), 86.7 (C), 69.4 (C), 57.2 (CH3), 54.6 (CH2), 21.8 (CH3); IR: νmax (cm
-1) 3023, 2990, 2931, 
2233, 1596, 1493, 1447, 1361, 1171, 1085, 736; HRMS (ES) m/z calculated for C26H25DNO3S 
(M+H)+ 433.1696, found 433.1692. 
((2-(1,3-Dioxolan-2-yl-d)phenyl)ethynyl)trimethylsilane d-592 
Prepared according to GP5 using aldehyde d-230 (670 mg, 3.3 mmol) and 
ethylene glycol. Purification by flash column chromatography [hexane:EtOAc 
(95:5), 1% Et3N] gave the acetal d-592 (663 mg, 81%) as a yellow oil; 
1H-NMR 
(300 MHz, CDCl3): δ 7.57 – 7.51 (m, 1H), 7.52 – 7.46 (m, 1H), 7.38 – 7.26 (m, 2H), 4.26 – 4.12 (m, 
2H), 4.12 – 4.00 (m, 2H), 0.26 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 139.3 (C), 133.0 (CH), 129.1 
(CH), 128.8 (CH), 126.3 (CH), 122.5 (C), 102.2 (C), 99.3 (C), 65.7 (2 × CH2), 0.1 (3 × CH3); IR: νmax 
(cm-1) 2959, 2889, 2157, 1680, 1249, 1075, 861, 839, 757; HRMS (ES) m/z calculated for 
C14H18DO2Si (M+H)
+ 248.1217, found 248.1222. 
2-(2-Ethynylphenyl)-1,3-dioxolane-d d-512 
Prepared according to GP4 from alkyne d-592 (609 mg, 2.5 mmol) to give terminal 
alkyne d-512 (414 mg, 96%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.59 (dd, J = 
7.6, 1.2 Hz, 1H), 7.53 (dd, J = 7.6, 1.3 Hz, 1H), 7.39 (app. td, J = 7.5, 1.6 Hz, 1H), 7.32 (app. td, J = 
7.5, 1.6 Hz, 1H), 4.23 – 4.12 (m, 2H), 4.12 – 4.02 (m, 2H), 3.33 (s, 1H); 13C-NMR (101 MHz, CDCl3): 
δ 139.7 (C), 133.3 (CH), 129.1 (2 × CH), 126.1 (CH), 121.4 (C), 82.0 (CH), 80.9 (C), 65.7 (2 × CH2), 
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the C-D carbon was not visible; IR: νmax (cm
-1) 3288, 2935, 2884, 2124, 1666, 1592, 755, HRMS 
(ES) m/z calculated for C11H9DO2 (M+H)
+ 175.0744, found 175.0741. 
N-((2-(1,3-Dioxolan-2-yl-2-d)phenyl)ethynyl)-N-allyl-4-methylbenzenesulfonamide d-515 
Prepared according to GP11 using freshly prepared 2-(2-(bromoethynyl)phenyl-d)-
1,3-dioxolane (230 mg, 0.9 mmol, GP10) and sulfonamide 490 (160 mg, 0.8 mmol). 
Purification by flash column chromatography [hexane:EtOAc (90:10), 1% Et3N, then 
hexane:EtOAc (80:20), 1% Et3N] gave the ynamide d-515 (279 mg, 96%) as a white solid; mp: 67-
69 °C; 1H-NMR (300 MHz, CDCl3): δ 7.88 (d, J = 8.4 Hz, 2H), 7.59 – 7.55 (m, 1H), 7.37 – 7.23 (m, 
5H), 5.79 (ddt, J = 16.8, 10.1, 6.3 Hz, 1H), 5.30 (app. dq, J = 16.8, 1.3 Hz, 1H), 5.24 (dd, J = 10.1, 
1.2 Hz, 1H), 4.20 – 4.12 (m, 2H), 4.11 – 4.00 (m, 4H), 2.44 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
144.8 (C), 138.0 (C), 134.9 (C), 131.5 (CH), 131.0 (CH), 123.0 (2 × CH), 129.0 (CH), 1278.0 (2 × 
CH), 127.8 (CH), 126.0 (CH), 122.4 (C), 120.3 (CH2), 87.0 (C), 68.8 (C), 65.5 (2 × CH2), 54.4 (CH2), 
45.9 (C), 21.8 (CH3); IR: νmax (cm
-1) 3102, 3066, 2994, 2952, 2893, 2230, 1597, 1351, 1167, 766, 
660; HRMS (ES) m/z calculated for C21H20DNO4SNa (M+Na)
+ 407.1152, found 407.1160. 
N-Allyl-N-((2-(methoxy(phenyl)methyl-d)phenyl)ethynyl)methanesulfonamide d-255 
Prepared according to GP11 using freshly prepared 1-(bromoethynyl)-2-
(methoxy(phenyl)methyl-d)benzene (243 mg, 0.8 mmol, GP10) and sulfonamide 
249 (91 mg, 0.7 mmol). Purification by flash column chromatography 
[hexane:Et2O (85:15)] gave the ynamide d-255 (171 mg, 72%) as a yellow oil; 
1H-NMR (300 MHz, 
CDCl3): δ 7.53 (d, J = 7.8 Hz, 1H), 7.44 – 7.37 (m, 3H), 7.37 – 7.17 (m, 5H), 5.95 (ddt, J = 16.9, 
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10.1, 6.4 Hz, 1H), 5.41 (d, J = 16.9 Hz, 1H), 5.35 (d, J = 10.1 Hz, 1H), 4.16 (dd, J = 6.4, 1.1 Hz, 2H), 
3.40 (s, 3H), 3.04 (s, 3H);13C-NMR (101 MHz, CDCl3): δ 143.2 (C), 141.5 (C), 132.2 (CH), 131.1 
(CH), 128.6 (CH), 128.4 (2 × CH), 127.6 (CH), 127.4 (CH), 127.2 (2 × CH), 126.6 (CH), 121.5 (C), 
120.8 (CH2), 86.2 (C), 82.3 (t, JC-D = 21.8 Hz, CD), 69.7 (C), 57.3 (CH3), 54.5 (CH2), 39.2 (CH3); IR: 
νmax (cm
-1) 3025, 2931, 2820, 2232, 1448, 1356, 1324, 1164, 1084, 1076, 755, 699; HRMS (ES) 
m/z calculated for C20H20DNO3NaS (M+Na)
+ 379.1203, found 379.1217. 
Preparation of Functionalised Indenes 
N-(2-Methoxy-1-phenyl-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 235 
Prepared according to GP13 from ynamide 234 (93.5 mg, 0.2 mmol), stirring for 
2 hours. Purification by flash column chromatography [hexane:EtOAc (93:7) then 
hexane:EtOAc (80:20)] gave the indene 235 (68.6 mg, 73%) as a white solid; mp: 
172-174 °C; 1H-NMR (300 MHz, CDCl3): δ 7.76 (d, J = 8.3 Hz, 2H), 7.54 (d, J = 7.9 
Hz, 2H), 7.39 – 7.16 (m, 10H), 7.16 – 6.91 (m, 4H), 4.65 (s, 1H), 3.63 (s, 3H), 2.41 (s, 3H); 13C-NMR 
(101 MHz, CDCl3): δ 163.8 (C), 143.4 (C), 141.0 (2 × C), 139.4 (C), 138.0 (C), 137.7 (C) 129.1 (6 × 
CH), 128.1 (2 × CH), 127.8 (2 × CH), 127.3 (CH), 127.1 (CH), 126.5 (CH), 125.8 (2 × CH), 124.1 
(CH), 123.0 (CH), 118.1 (CH), 117.6 (C), 58.2 (CH), 51.6 (CH3), 21.5 (CH3); IR: νmax (cm
-1) 2988, 
2973, 2902, 1615, 1596, 1581, 1155, 1075; HRMS (ES) m/z calculated for C29H25NO3NaS (M+Na)
+ 
490.1453 found 490.1440. 
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N-(2-Methoxy-1-phenyl-1H-inden-3-yl)-N-phenylbenzenesulfonamide 258 
Prepared according to GP13 from ynamide 244 (90.7 mg, 0.2 mmol or 1.37 g, 3.0 
mmol) stirring for 1 hour (0.2 mmol scale) or 2 hours (3.0 mmol scale). 
Recrystallisation [hexane:CH2Cl2] gave the indene 258 as a white solid (61.9 mg, 
68%, 0.2 mmol scale or 856.2 mg, 62%, 3.0 mmol scale); mp: 199-201 °C; 1H-NMR (300 MHz, 
CDCl3): δ 7.91 – 7.86 (m, 2H), 7.59 – 7.51 (m, 3H), 7.48 – 7.40 (m, 2H), 7.36 – 7.18 (m, 8H), 7.17 – 
6.94 (m, 4H), 4.64 (s, 1H), 3.58 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 163.8 (C), 140.9 (2 × C), 
140.9 (C), 139.4 (C), 137.6 (C), 132.6 (CH), 129.2 (2 × CH), 129.1 (2 × CH), 128.5 (2 × CH), 128.0 (2 
× CH), 127.7 (2 × CH), 127.4 (CH), 127.2 (CH), 126.8 (CH), 126.2 (2 × CH), 124.1 (CH), 123.3 (CH), 
118.1 (CH), 118.0 (C) 58.1 (CH), 51.5 (CH3); IR: νmax (cm
-1) 3076, 2948, 2856, 1614, 1489, 1342, 
1167, 1159, 757, 691; HRMS (ES) m/z calculated for C28H24NO3S (M+H)
+ 454.1477 found 
454.1476. 
N-(2-Methoxy-1-phenyl-1H-inden-3-yl)-4-nitro-N-phenylbenzenesulfonamide 259 
Prepared according to GP13 from ynamide 245 (149.6 mg, 0.3 mmol) stirring 
for 45 minutes. Purification by flash column chromatography [hexane:Et2O 
(90:10) then hexane:EtOAc (90:10)] gave the indene 259 (113.9 mg, 76%) as a 
yellow solid; mp: 187-189 °C; 1H-NMR (300 MHz, CDCl3): δ 8.27 (d, J = 9.0 Hz, 
2H), 8.00 (d, J = 9.0 Hz, 2H), 7.56 – 7.49 (m, 2H), 7.39 – 7.27 (m, 6H), 7.20 – 7.15 (m, 4H), 7.02 – 
6.97 (m, 2H), 4.66 (s, 1H), 3.52 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 163.9 (C), 150.3 (C), 146.9 
(C), 140.7 (C), 140.5 (C), 139.8 (C), 137.5 (C), 129.8 (2 × CH), 129.7 (2 × CH), 129.6 (2 × CH), 128.2 
(CH), 128.0 (CH), 127.8 (3 × CH), 127.6 (2 × CH), 124.9 (CH), 124.0 (CH), 123.8 (2 × CH), 118.3 (C), 
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118.1 (CH), 58.4 (CH), 51.6 (CH3); IR: νmax (cm
-1) 3100, 3071, 3029, 2945, 2859, 1607, 1533, 1345, 
1321, 1154, 696; HRMS (ES) m/z calculated for C28H23N2O5S (M+H)
+ 499.1328 found 499.1315. 
N-Benzyl-N-(2-methoxy-1-phenyl-1H-inden-3-yl)methanesulfonamide 260 
Prepared according to GP13 from ynamide 252 (81.1 mg, 0.2 mmol), stirring for 3 
hours. Recrystallisation [hexane:CH2Cl2] gave the indene 260 (62.5 mg, 77%) as a 
white solid; mp: 198-199 °C; 1H-NMR (400 MHz, DMSO, 110 °C): δ: 7.38 (d, J = 7.3 
Hz, 2H), 7.32 – 7.07 (m, 8H), 7.00 (d, J = 5.0 Hz, 2H), 6.95 – 6.85 (m, 2H), 4.85 (s, 1H), 
4.83 (d, J = 14.3 Hz, 1H), 4.77 (d, J = 14.3 Hz, 1H), 3.60 (s, 3H), 3.14 (s, 3H); 13C-NMR (101 MHz, 
DMSO, 110 °C) δ: 162.6 (C), 140.5 (C), 139.3 (C), 137.4 (C), 136.1 (C), 128.2 (2 × CH), 128.0 (2 × 
CH), 127.5 (3 × CH), 126.9 (3 × CH), 126.4 (CH), 126.0 (CH), 123.0 (CH), 122.2 (CH), 117.5 (CH2), 
115.6 (C), 57.5 (CH), 51.8 (CH3), 49.8 (CH3); IR: νmax (cm
-1) 3032, 2947, 2932, 1620, 1458, 1338, 
1320, 1159, 1148, 759; HRMS (ES) m/z calculated for C24H23NO3S (M+H)
+ 405.1399 found 
405.1382. 
N-(2-Methoxy-1-phenyl-1H-inden-3-yl)-N-methylmethanesulfonamide 261 
Prepared according to GP13 from ynamide 253 (65.8 mg, 0.2 mmol), stirring for 24 
hours. Purification by flash column chromatography [hexane:EtOAc (85:15)] gave 
the indene 261 (15.1 mg, 23%) as a white solid; mp: 180-182 °C; 1H-NMR (300 MHz, 
CDCl3): δ 7.35 – 7.17 (m, 7H), 7.03 – 6.99 (m, 2H), 4.64 (s, 1H), 3.78 (s, 3H), 3.33 (s, 3H), 3.04 (s, 
3H); 13C-NMR (101 MHz, CDCl3): δ 162.2 (C), 140.5 (C), 139.6 (C), 137.5 (C), 129.2 (2 × CH), 127.6 
(2 × CH), 127.4 (CH), 127.3 (CH), 124.3 (CH), 123.4 (CH), 118.0 (CH), 117.9 (C), 58.4 (CH), 51.5 
(CH3), 38.1 (CH3), 36.9 (CH3); IR: νmax (cm
-1) 3024, 2952, 2857, 1619, 1452, 1330, 1318, 1255, 
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1230, 1153, 1133, 956, 854; HRMS (ES) m/z calculated for C18H19NO3SNa (M+Na)
+ 352.0993 
found 352.1002. 
N-(2-methoxy-1-phenyl-1H-inden-3-yl)-N-methyl-4-nitrobenzenesulfonamide 263 and N-(3-
methoxy-1-phenyl-1H-inden-2-yl)-N-methyl-4-nitrobenzenesulfonamide 264 
Prepared according to GP13 from ynamide 254 (76.8 mg, 0.18 mmol), stirring for 24 hours. 
Purification by flash column chromatography [hexane:EtOAc (90:10)] gave the indenes 263 and 
264. 
263: Further purification was necessary by recrystallisation [hexane:CH2Cl2] to give 
263 (22.2 mg, 29%) as a yellow solid; mp: 68-70 °C; 1H-NMR (300 MHz, CDCl3): δ 
8.30 (d, J = 8.8 Hz, 2H), 8.07 (d, J = 8.9 Hz, 2H), 7.32 (d, J = 7.1 Hz, 2H), 7.28 (d, J = 7.0 
Hz, 1H), 7.19 – 7.08 (m, 3H), 7.00 (d, J = 4.2 Hz, 2H), 6.90 (br. s, 1H), 4.57 (s, 1H), 
3.51 (broad s, 3H), 3.32 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 163.4 (C), 150.4 (C), 145.4 (C), 
140.2 (C), 139.7 (C), 137.5 (C), 129.6 (2 × CH), 129.4 (2 × CH), 128.0 (3 × CH), 127.5 (CH), 124.7 
(CH), 124.2 (2 × CH), 123.8 (CH), 118.3 (CH), 117.0 (C), 58.5 (CH), 51.9 (CH3), 37.6 (CH3); IR: νmax 
(cm-1) 3105, 3072, 3026, 2945, 1622, 1606, 1527, 1348, 1318, 1161, 849; HRMS (ES) m/z 
calculated for C23H20N2O5SNa (M+Na)
+ 459.0991 found 459.1000. 
264: (17.6 mg, 23%); Yellow solid; mp: 121-123 °C; 1H-NMR (400 MHz, CDCl3): δ 
8.33 (d, J = 8.9 Hz, 2H), 7.92 (d, J = 8.9 Hz, 2H), 7.45 (d, J = 7.5 Hz, 1H), 7.32 (t, J = 
7.2 Hz, 1H), 7.27 – 7.16 (m, 4H), 7.09 (d, J = 7.5 Hz, 1H), 6.86 (dd, J = 7.5, 1.9 Hz, 
2H), 4.66 (s, 1H), 3.88 (s, 3H), 2.90 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 153.6 (C), 
150.3 (C), 145.4 (C), 144.9 (C), 138.9 (C), 137.8 (C), 129.0 (4 × CH), 128.7 (2 × CH), 127.7 (2 × CH), 
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127.4 (CH), 124.8 (CH), 124.4 (2 × CH), 124.3 (C), 120.0 (CH), 58.9 (CH), 53.6 (CH3), 39.3 (CH3); IR: 
νmax (cm
-1) 3111, 1988, 1954, 2902, 1628, 1607, 1537, 1346, 1067, 736; HRMS (ES) m/z 
calculated for C23H21N2O5S (M+H)
+ 437.1171 found 437.1158. 
N-Allyl-N-(2-methoxy-1-phenyl-1H-inden-3-yl)methanesulfonamide 265 and N-allyl-N-(3-
methoxy-1-phenyl-1H-inden-2-yl)methanesulfonamide 266 
Prepared according to GP13 from ynamide 255 (71.1 mg, 0.2 mmol) stirring for 1 hour. 
Purification by flash column chromatography [hexane:EtOAc (85:15) then hexane:EtOAc (70:30)] 
gave the indenes 265 and 266. 
265: (52.7 mg, 74%); White solid; mp: 156-158 °C; 1H-NMR (300 MHz, CDCl3): δ 
7.34-7.18 (m, 7H), 7.03-6.97 (m, 2H), 5.95 (ddt, J = 16.5, 10.0, 6.5 Hz 1H), 5.28 (d, J 
= 16.5 Hz, 1H), 5.17 (d, J = 10.0 Hz, 1H), 4.68 (s, 1H), 4.29 (d, J = 6.5 Hz, 2H), 3.73 
(s, 3H), 3.06 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 162.9 (C), 141.2 (C), 139.8 (C), 137.6 (C), 133.6 
(CH), 129.3 (2 × CH), 127.8 (2 × CH), 127.6 (CH), 127.5 (CH), 124.4 (CH), 123.3 (CH), 118.8 (CH2), 
118.3 (CH), 116.4 (C), 58.5 (CH3), 52.3 (CH2), 51.5 (CH), 39.8 (CH3); IR: νmax (cm
-1) 2986, 2951, 
2926, 2858, 1602, 1495, 1451, 1145; HRMS (ES) m/z calculated for C20H21NO3NaS (M+Na)
+ 
C20H21NO3NaS 378.1140 found 378.1145. 
266: (6.4 mg, 9%); Clear oil; 1H-NMR (300 MHz, CDCl3): δ 7.49 (d, J = 7.6 Hz, 1H), 
7.32 (td, J = 7.8, 0.9 Hz, 1H), 7.29 – 7.19 (m, 4H), 7.14 – 7.09 (m, 3H), 5.45 (ddt, J 
= 17.0, 10.0, 6.5 Hz, 1H), 5.10 (dd, J = 17.0, 1.2 Hz, 1H), 5.02 (dd, J = 10.0, 1.2 
Hz, 1H), 4.67 (s, 1H), 4.16 (s, 3H), 3.96 (dd, J = 6.5, 1.2 Hz, 2H), 2.54 (s, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 153.2 (C), 144.3 (C), 138.6 (C), 138.1 (C), 133.1 (CH), 129.3 (2 × CH), 128.7 (2 × CH), 
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127.4 (CH), 126.9 (2 × CH), 124.4 (CH), 123.0 (C), 119.5 (CH), 118.9 (CH2), 58.6 (CH3), 53.3 (CH2), 
53.1 (CH), 39.7 (CH3); IR: νmax (cm
-1) 3070, 3025, 2992, 2945, 2876, 2848, 1624, 1604, 1585, 
1147, 1079; HRMS (ES) m/z calculated for C20H21NO3NaS (M+Na)
+ 378.1140 found 378.1137. 
3-(2-Methoxy-1-phenyl-1H-inden-3-yl)oxazolidin-2-one 267 
Prepared according to GP13 from ynamide 256 (92.2 mg, 0.3 mmol), stirring for 2 
hours. Purification by flash column chromatography [toluene:EtOAc (95:5)] gave 
the indene 276 (71.8 mg, 78%) as white needles; mp: 175-177 °C; 1H-NMR (300 
MHz, CDCl3): δ 7.36 – 7.12 (m, 7H), 7.05 – 7.00 (m, 2H), 4.65 (s, 1H), 4.60 – 4.52 (m, 2H), 4.09 – 
4.00 (m, 2H), 3.76 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 160.5 (C), 156.7 (C), 139.7 (C), 139.3 (C), 
137.4 (C), 129.1 (2 × CH), 127.8 (2 × CH), 127.4 (CH), 127.2 (CH), 124.3 (CH), 123.5 (CH), 117.5 
(CH), 113.8 (C), 62.7 (CH2), 58.3 (CH3), 51.9 (CH), 46.2 (CH2); IR: νmax (cm
-1) 3057, 3005, 2948, 
2923, 2855, 1740, 1641, 1465, 1412, 1325, 1106, 1033, 754; HRMS (ES) m/z calculated for 
C19H17NO3Na (M+Na)
+ 330.1106 found 330.1111. 
N-(1-(4-(t-Butyl)phenyl)-2-methoxy-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 283 
Prepared according to GP13 from ynamide 278 (104.7 mg, 0.2 mmol), stirring 
for 30 minutes. Purification by flash column chromatography [hexane:Et2O 
(95:5) then hexane:Et2O (90:10)] gave the indene 283 (83.2 mg, 79%) as a white 
solid; mp: 174-176 °C; 1H-NMR (300 MHz, CDCl3): δ 7.76 (d, J = 8.3 Hz, 2H), 7.54 
(d, J = 7.9 Hz, 2H), 7.34 – 7.27 (m, 4H), 7.25 – 7.17 (m, 3H), 7.17 – 7.05 (m, 3H), 7.04 – 6.93 (m, 
3H), 4.63 (s, 1H), 3.65 (s, 3H), 2.41 (s, 3H), 1.28 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 164.4 (C), 
150.5 (C), 143.7 (C), 141.4 (C), 141.3 (C), 139.9 (C), 138.4 (C), 134.7 (C), 129.5 (2 × CH), 129.4 (2 × 
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CH), 128.5 (2 × CH), 127.6 (2 × CH), 127.3 (CH), 126.8 (CH), 126.4 (CH), 126.1 (2 × CH), 124.3 (2 × 
CH), 123.7 (CH), 118.4 (CH), 117.7 (C), 58.5 (CH3), 51.5 (CH), 34.8 (C), 31.7 (3 × CH3), 21.9 (CH3); 
IR: νmax (cm
-1) 3049, 3025, 2948, 2912, 2852, 1621, 1489, 1460, 1348, 1332, 1161, 1131, 1094, 
1053, 760; HRMS (ES) m/z calculated for C33H33NO3SNa (M+Na)
+ 546.2079 found 546.2100. 
N-(1-(3,5-Difluorophenyl)-2-methoxy-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 
284 
Prepared according to GP13 from ynamide 279 (100.7 mg, 0.2 mmol), stirring for 
30 minutes. Recrystallisation [hexane:CH2Cl2] gave the indene 284 (62.1 mg, 62%) 
as a white solid; mp: 185-187 °C; 1H-NMR (300 MHz, CDCl3): δ 7.74 (d, J = 8.2 Hz, 
2H), 7.52 (d, J = 8.2 Hz, 2H), 7.36 – 7.08 (m, 6H), 7.04 – 6.94 (m, 3H), 6.80 – 6.65 
(m, 3H), 4.60 (s, 1H), 3.70 (s, 3H), 2.41 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 163.2 (dd, JC-F = 
249.4, 12.8 Hz, 2 × C), 163.0 (C), 144.0 (C), 142.1 (t, JC-F = 9.0 Hz, C), 141.3 (C), 141.2 (C), 138.4 
(C), 138.1 (C), 129.6 (4 × CH), 128.4 (2 × CH), 127.9 (CH), 126.9 (CH), 125.8 (2 × CH), 124.8 (CH), 
123.6 (CH), 119.0 (CH), 118.3 (C), 111.2 (d, JC-F = 25.5 Hz, 2 × CH), 103.4 (t, JC-F = 25.3 Hz, CH), 
58.7 (CH), 51.5 (CH3), 21.90 (CH3); IR: νmax (cm
-1) 3082, 3055, 3019, 2945, 2855, 1622, 1595, 
1491, 1464, 1449, 1330, 1156, 1123, 1046, 764; HRMS (ES) m/z calculated for C29H23NO3F2NaS 
(M+Na)+ 526.1264 found 526.1270. 
N-(2-Methoxy-1-ferrocene-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 285 
Prepared according to GP13 from ynamide 280 (115.1 mg, 0.2 mmol), stirring for 3 hours. 
Purification by flash column chromatography [hexane:EtOAc (90:10) then hexane:Et2O (90:10)] 
gave the indene 285 (58.4 mg, 51%) as a viscous orange oil; 1H-NMR (300 MHz, CDCl3): δ 7.51 (d, 
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J = 8.3 Hz, 2H), 7.45 – 7.38 (m, 2H), 7.32 – 7.09 (m, 9H), 4.86 (s, 1H), 4.11 (d, J = 
1.3 Hz, 1H), 4.02 (app. t, J = 2.0 Hz, 2H), 3.95-3.93 (m, 1H), 3.87 (s, 3H), 3.47 (s, 
5H), 2.33 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 147.8 (C), 144.0 (C), 142.3 (2 × C), 
140.1 (C), 137.0 (C), 129.5 (2 × CH), 129.4 (2 × CH), 128.6 (CH), 128.5 (2 × CH), 
128.1 (CH), 127.6 (CH), 126.7 (2 × CH), 122.8 (C), 121.7 (CH), 120.2 (CH), 89.9 (C), 68.7 (5 × CH), 
67.8 (CH), 67.7 (CH), 67.1 (2 × CH), 60.0 (CH), 48.6 (CH3), 21.9 (CH3); IR: νmax (cm
-1) 3059, 3014, 
2943, 2923, 2842, 1695, 1590, 1489, 1353, 1158, 1091; HRMS (ES) m/z calculated for 
C33H29NO3SFe (M+H)
+ 575.1218 found 575.1199. 
N-(2-Methoxy-1-(2-methoxyphenyl)-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 
296 
Prepared according to GP13 from ynamide 292 (99.5 mg, 0.2 mmol), stirring for 5 
hours. Purification by flash column chromatography [hexane:toluene:Et2O 
(50:46:4)] then recrystallization [hexane:CH2Cl2] gave the indene 296 (39.8 mg, 
40%) as a white solid; mp: 170-171 °C; 1H-NMR (400 MHz, DMSO, 110 °C): δ 7.75 
(d, J = 8.3 Hz, 2H), 7.51 – 7.46 (m, 2H), 7.39 - 7.32 (m, 4H), 7.28 – 7.19 (m, 2H), 7.14 - 7.04 (m, 
3H), 7.01 – 6.92 (m, 2H), 6.86 – 6.80 (m, 2H), 5.27 (s, 1H), 3.85 (s, 3H), 3.52 (s, 3H), 2.98 (s, 3H); 
13C-NMR (101 MHz, DMSO, 110 °C): δ 163.7 (C), 156.8 (C), 143.0 (2 × C), 140.5 (C), 140.4 (C), 
139.2 (C), 137.2 (C), 128.7 (2 × CH), 128.4 (2 × CH), 128.0 (CH), 127.1 (2 × CH), 126.0 (CH), 125.7 
(CH), 125.3 (CH), 124.8 (2 × CH), 123.1 (CH), 122.1 (CH), 120.4 (CH), 116.9 (CH), 111.7 (CH), 57.1 
(CH3), 55.5 (CH3), 43.8 (CH), 20.3 (CH3); In this case, it was not possible to observe the N-bound 
quaternary carbon of the indene core; IR: νmax (cm
-1) 3031, 2952, 2836, 1630, 1595, 1492, 1462, 
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1344, 1244, 1162, 1048; HRMS (ES) m/z calculated for C30H28NO4S (M+H)
+ 498.1739 found 
498.1757. 
N-(2-Methoxy-1-(o-tolyl)-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 297 and N-(3-
methoxy-1-(o-tolyl)-1H-inden-2-yl)-4-methyl-N-phenylbenzenesulfonamide 298 
Prepared according to GP13 from ynamide 293 (96.3 mg, 0.2 mmol), stirring for 16 hours. 
Purification by flash column chromatography [hexane:EtOAc (95:5) then hexane:EtOAc (85:15)] 
gave the indenes 297 and 298. 
297: (35.7 mg, 37%); White solid; mp: 208-210 °C; Broadening and splitting of 
some signals due to restricted rotation, some nuclei therefore have 2 resonances 
assigned to them; 1H-NMR (300 MHz, CDCl3): δ 7.78 - 7.72 (m, 2H) 7.59 – 7.41 (m, 
2H), 7.37 – 6.86 (m, 13H), 4.97 and 4.68 (s, 1H), 3.62 and 3.57 (s, 3H), 2.66 (s, 3H), 
2.41 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ: 164.4 and 163.3 (C), 143.4 (C), 141.3 (C). 141.1 (C), 
139.7 (C), 138.1 (C), 136.0, (C) 135.5 (C), 132.5 and 130.8 (CH), 131.6 and 129.1 (4 × CH), 128.13 
(2 × CH), 128.1 and 127.7 (CH), 127.2 (CH), 127.1 and 126.9 and 126.7 (2 × CH), 126.5 and 126.3 
(CH), 126.1 and 125.8 (CH), 124.0 (CH), 122.9 (CH), 118.3 and 118.1 (CH), 117.4 (C), 58.66 and 
57.77 (CH3), 53.8 and 47.3 (CH), 21.6 (CH3), 20.1 (CH3); IR: νmax (cm
-1) 3062, 3019, 2947, 2855, 
1623, 1592, 1487, 1461, 1334, 1165, 1053, 963; HRMS (ES) m/z calculated for C30H28NO3S 
(M+H)+ 482.1790 found 482.1795. 
298: (26.7 mg, 28%); White solid; mp: 183-185 °C; 1H-NMR (400 MHz, 
CDCl3): δ 7.60 (d, J = 8.3 Hz, 2H) 7.50 – 7.45 (m, 2H), 7.42 (d, J = 7.5 Hz, 1H), 
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7.33 – 7.15 (m, 8H), 7.13 – 7.02 (m, 3H), 6.98 (dd, J = 7.3, 0.7 Hz, 1H), 5.55 (s, 1H), 3.64 (s, 3H), 
2.47 (s, 3H), 2.38 (s, 3H); 13C-NMR (101 MHz, CDCl3) δ 148.3 (C), 143.9 (C), 142.7 (C), 141.6 (C), 
139.9 (C), 139.5 (C), 137.1 (C), 135.4 (C), 130.6 (CH), 129.5 (2 × CH), 129.3 (2 × CH), 128.6 (2 × 
CH), 128.5 (CH), 128.2 (CH), 127.7 (CH), 127.6 (CH), 127.1 (CH), 126.8 (CH), 126.6 (2 × CH), 121.3 
(CH), 120.5 (C), 120.3 (CH), 58.44 (CH), 52.3 (CH3), 21.9 (CH3), 20.1 (CH3); IR: νmax (cm
-1) 3068, 
2988, 2973, 2902, 1693, 1587, 1349, 1224, 1166, 1066, 1054; HRMS (ES) m/z calculated for 
C30H27NO3NaS (M+Na)
+ 504.1609 found 504.1610. 
N-(2-Methoxy-1-(naphthalen-1-yl)-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 299 
and N-(3-methoxy-1-(naphthalen-1-yl)-1H-inden-2-yl)-4-methyl-N-phenylbenzenesulfonamide 
300 
Prepared according to GP13 from ynamide 294 (103.5 mg, 0.2 mmol), stirring for 3 hours. 
Purification by flash column chromatography [toluene:hexane:Et2O (49:49:2) then 
hexane:EtOAc (80:20)] gave the indenes 299 and 300. 
299: (52.0 mg, 50%); White solid; mp: 202-204 °C; Broadening and splitting of 
some signals due to restricted rotation, some nuclei therefore have 2 resonances 
assigned to them; 1H-NMR (400 MHz, CDCl3) δ: 8.33 (d, J = 8.5 Hz, 1H), 7.81 (d, J = 
7.6 Hz, 1H), 7.73 – 7.60 (m, 3H), 7.60 – 7.50 (m, 1H), 7.50 – 7.30 (m, 3H), 7.29 - 
6.66 (m, 11H), 5.45 and 4.86 (s, 1H), 3.40 and 3.37 (s, 3H), 2.28 and 2.26 (s, 3H); 13C-NMR (101 
MHz, CDCl3) δ: 164.2 (C), 143.8 and 143.6 (C), 141.4 and 141.2 (C), 140.0 (C), 138.9 (C), 138.6 
and 138.4 (C), 134.8 and 134.5 (C), 133.9 and 133.7 (C), 132.3 and 131.8 (C), 129.7 (CH), 129.5, 
129.1 (4 × CH), 128.7 and 128.5 (2 × CH), 128.4 (CH), 128.1 (CH), 127.7 and 127.5 (CH), 127.3 
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and 127.1 (1 × CH), 127.0 (CH), 126.9 (CH), 126.6 and 126.4 (2 × CH), 126.1 and 125.7 (CH), 
124.5 and 124.3 (CH), 123.4 (2 × CH), 123.3 and 123.1 (CH), 117.4 and 117.3 (C), 58.9 and 58.4 
(CH), 46.3 (CH3), 21.9 (CH3); IR: νmax (cm
-1) 3058, 3022, 2948, 2855, 1632, 1594, 1491, 1462, 
1344, 1328, 1161, 1092, 1050; HRMS (ES) m/z calculated for C33H28NO3S (M+H)
+ 518.1790 found 
518.1808. 
300: (37.6 mg, 36%); White solid; mp: 172-173 °C; 1H-NMR (300 MHz, 
CDCl3): δ 8.31 (d, J = 8.4 Hz, 1H), 7.88 (d, J = 7.9 Hz, 1H), 7.73 (d, J = 8.2 Hz, 
1H), 7.64 (d, J = 8.3 Hz, 2H), 7.62 – 7.57 (m, 1H), 7.57 – 7.50 (m, 4H), 7.47 (d, 
J = 7.5 Hz, 1H), 7.39 – 7.30 (m, 3H), 7.27 – 7.17 (m, 4H), 7.08-6.96 (m, 2H), 6.11 (s, 1H), 3.72 (s, 
3H), 2.39 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 148.2 (C), 143.8 (C), 142.1 (2 × C), 139.8 (C), 
136.8 (2 × C), 134.1 (C), 131.5 (C), 129.3 (2 × CH), 129.2 (2 × CH), 129.0 (CH), 128.5 (CH), 128.4 (2 
× CH), 127.9 (CH), 127.5 (2 × CH), 126.5 (2 × CH), 126.3 (CH), 126.1 (CH), 125.8 (CH), 124.3 (CH), 
123.7 (CH), 121.2 (CH), 120.2 (CH), 119.3 (C), 58.5 (CH), 52.1 (CH3), 21.7 (CH3); IR: νmax (cm
-1) 
3062, 2953, 2849, 1701, 1353, 1225, 1160, 1092, 937, 750; HRMS (ES) m/z calculated for 
C33H28NO3S (M+H)
+ 518.1790 found 518.1788. 
N-Allyl-N-(2-methoxy-1-(naphthalen-1-yl)-1H-inden-3-yl)methanesulfonamide 301 
Prepared according to GP13 from ynamide 295 (81.1 mg, 0.2 mmol), stirring for 1 
hour. Purification by flash column chromatography [hexane:EtOAc (90:10) then 
hexane:EtOAc (80:20)] gave the indene 301 (66.8 mg, 82%) as a white solid; mp: 
166-168 °C; Broadening and splitting of some signals due to restricted rotation, 
some nuclei therefore have 2 resonances assigned to them;  1H-NMR (400 MHz, DMSO, 70 °C): δ 
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8.72 (d, J = 8.5 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.97 – 7.78 (m, 2H), 7.73 (app. t, J = 7.4 Hz, 1H), 
7.67 – 7.51 (m, 1H), 7.44 – 7.03 (m, 3H), 7.01 – 6.79 (m, 2H), 5.98 (ddt, J = 16.6, 10.2, 6.3 Hz, 
1H), 5.93 (s, 1H), 5.40-5.30 (m, 1H), 5.20 (d, J = 10.2 Hz, 1H), 4.29 (d, J = 6.3 Hz, 2H), 3.67, 3.62 (2 
× s, 3H), 3.17, 3.11 (2 × s, 3H); 13C-NMR (101 MHz, CDCl3): δ 162.9 (C), 140.9 (C), 139.8 and 138.6 
(C), 134.5 and 134.2 (C), 133.7 (CH), 133.3 and 133.1 (C), 131.5 and 130.1 (C), 129.4 and 128.9 
(CH), 128.5 and 127.9 (CH), 127.6 and 127.4 (CH), 126.7 (CH), 126.1 (CH), 125.9 and 125.4 (CH), 
124.4 and 124.1 (CH), 123.4 (CH), 123.0 (CH), 122.8 and 122.7 (CH), 118.7 and 118.5 (CH2), 118.3 
(CH), 116.7 (C), 58.8 and 58.3 (CH), 52.3 and 52.2 (CH2), 45.8 (CH3), 39.8 (CH3); IR: νmax (cm
-1) 
3014, 2939, 2852, 1622, 1463, 1334, 1319, 1148, 760; HRMS (ES) m/z calculated for 
C24H23NO3NaS (M+Na)
+ 428.1296 found 428. 1294. 
3-(2,5,6-Trimethoxy-1-phenyl-1H-inden-3-yl)oxazolidin-2-one 314 
Prepared according to GP13 from ynamide 311 (73.5 mg, 0.2 mmol), stirring for 
1 hour. Purification by flash column chromatography [hexane:EtOAc (50:50) 
then hexane:EtOAc (40:60)] then recrystallisation [EtOH] gave the indene 314 
(55.1 mg, 75%) as a white solid; mp: 164-166 °C; 1H-NMR (400 MHz, CDCl3): δ 7.35 – 7.23 (m, 
3H), 7.23 – 7.17 (m, 2H), 6.76 (s, 1H), 6.62 (s, 1H), 4.57 (t, J = 8.1 Hz, 2H), 4.57 (s, 1H), 4.10 – 4.01 
(m, 2H), 3.89 (s, 3H), 3.74 (s, 3H), 3.70 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 159.2 (C), 159.1 (C), 
156.8 (C), 149.0 (C), 146.9 (C), 137.9 (C), 132.0 (C), 129.2 (2 × CH), 128.0 (2 × CH), 127.5 (CH), 
114.3 (C), 108.7 (CH), 102.6 (CH), 62.9 (CH2), 58.6 (CH), 56.6 (CH3), 56.4 (CH3), 51.6 (CH3), 46.3 
(CH2); IR: νmax (cm
-1) 2954, 2923, 2854, 1747, 1716, 1640, 1493, 1454, 1406, 1302, 1210, 1086, 
1031; HRMS (ES) m/z calculated for C21H21NO5Na (M+Na)
+ 390.1317 found 390.1320. 
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3-(2,6-Dimethoxy-1-phenyl-1H-inden-3-yl)oxazolidin-2-one 315 
Prepared according to GP13 from ynamide 312 (27.9 mg, 0.08 mmol), stirring 
for 30 minutes. Purification by flash column chromatography [hexane:EtOAc 
(65:35)] gave the indene 315 (18.8 mg, 67%) as a white solid; mp: 150-152 °C; 
1H-NMR (300 MHz, CDCl3): δ 7.36 – 7.18 (m, 5H), 7.06 (d, J = 8.3 Hz, 1H), 6.76 (dd, J = 8.3, 2.4 Hz, 
1H), 6.64 (d, J = 2.3 Hz, 1H), 4.61 (s, 1H), 4.59 – 4.51 (m, 2H), 4.09 – 4.01 (m, 2H), 3.72 (s, 3H), 
3.70 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 158.6 (C), 157.9 (C), 157.0 (C), 141.9 (C), 138.0 (C), 
132.2 (C), 129.4 (2 × CH), 128.2 (2 × CH), 127.7 (CH), 118.6 (CH), 114.3 (C), 112.3 (CH), 111.5 
(CH), 63.1 (CH2), 58.7 (CH), 55.9 (CH3), 52.1 (CH3), 46.5 (CH2); IR: νmax (cm
-1) 2944, 2834, 1743, 
1649, 1479, 1453, 1416, 1107, 1025; HRMS (ES) m/z calculated for C20H19NO4Na (M+Na)
+ 
360.1212 found 360.1210. 
N-Allyl-N-(6-fluoro-2-methoxy-1-phenyl-1H-inden-3-yl)methanesulfonamide 316 and N-allyl-N-
(6-fluoro-3-methoxy-1-phenyl-1H-inden-2-yl)methanesulfonamide 317 
Prepared according to GP13 from ynamide 315 (108.7 mg, 0.3 mmol), using 10 mol% (p-
CF3C6H4)3PAuNTf2 and stirring for 24 hours. Purification by flash column chromatography 
[hexane:EtOAc (87.5:12.5) then hexane:EtOAc (85:15)] gave the indenes 316 and 317. 
316: (70.7 mg, 65%); White solid; mp: 147-149 °C; 1H-NMR (300 MHz, CDCl3): δ 
7.36 – 7.16 (m, 6H), 6.92 (ddd, J = 9.8, 8.6, 2.4 Hz, 1H), 6.70 (dd, J = 8.4, 2.4 Hz, 
1H), 5.92 (ddt, J = 17.3, 10.0, 6.3 Hz, 1H), 5.27 (d, J = 17.3 Hz, 1H), 5.17 (d, J = 10.0 
Hz, 1H), 4.65 (s, 1H), 4.26 (d, J = 6.3 Hz, 2H), 3.71 (s, 3H), 3.05 (s, 3H); 13C-NMR 
(101 MHz, CDCl3): δ 161.8 (C), 161.2 (d, JC-F = 242.9 Hz, C), 141.3 (d, JC-F = 7.7 Hz, C), 136.8 (2 × C), 
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133.4 (CH), 129.3 (2 × CH), 127.7 (2 × CH), 127.6 (CH), 119.1 (d, JC-F = 8.0 Hz, CH), 118.8 (CH2), 
116.0 (C) 114.1 (d, JC-F = 22.6 Hz, CH), 111.2 (d, JC-F = 24.2 Hz, CH), 58.3 (CH), 52.1 (CH2), 51.14 
(CH3), 39.42 (CH3); IR: νmax (cm
-1) 3064, 3034, 2957, 2927, 2861, 1623, 1601, 1478, 1478, 1329, 
1318, 1037; HRMS (ES) m/z calculated for C20H20NO3FNaS (M+Na)
+ 396.1046 found 396.1052. 
317: (13.9 mg, 13%); White solid; mp: 76-78 °C; 1H-NMR (300 MHz, CDCl3): δ 
7.41 (dd, J = 8.4, 5.0 Hz, 1H), 7.34 – 7.22 (m, 3H), 7.15 – 7.08 (m, 2H), 7.06 – 
6.96 (m, 1H), 6.81 (dd, J = 8.4, 2.3 Hz, 1H), 5.47 (ddt, J = 17.0, 10.0, 6.7 Hz, 1H), 
5.12 (dd, J = 17.0, 1.3 Hz, 1H), 5.05 (dd, J = 10.0, 1.2 Hz, 1H), 4.62 (s, 1H), 4.15 (s, 3H), 3.95 (d, J = 
6.7 Hz, 2H), 2.47 (s, 3H); 13C-NMR (101 MHz, CDCl3) :δ 162.9 (d, JC-F = 245.9 Hz, C), 153.0 (C), 
146.8 (d, JC-F = 8.3 Hz, C), 138.4 (C), 134.3 (C), 133.3 (CH), 129.6 (2 × CH), 129.2 (2 × CH), 128.0 
(CH), 122.2 (C), 120.9 (d, JC-F = 8.5 Hz, CH), 119.5 (CH2), 114.4 (d, JC-F = 22.9 Hz, CH), 112.4 (d, JC-F 
= 23.4 Hz, CH), 58.9 (CH), 53.7 (CH2), 53.4 (CH3), 40.1 (CH3); IR: νmax (cm
-1) 3034, 2951, 2926, 
3034, 1630, 1609, 1484, 1361, 1333, 1149, 1127, 964; HRMS (ES) m/z calculated for C20H21NO3FS 
(M+H)+ 374.1226 found 374.1227. 
N-(2-(Benzyloxy)-1-phenyl-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 328 
Prepared according to GP13 from ynamide 321 (108.7 mg, 0.2 mmol), stirring 
for 3 hours. Purification by flash column chromatography [hexane:Et2O (9:1)] 
then recrystallisation [hexane:CH2Cl2] gave the indene 328 (58.7 mg, 54%) as 
a white solid; mp: 176-178 °C; 1H-NMR (300 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz, 
2H), 7.48 (d, J = 7.5 Hz, 2H), 7.38 – 7.11 (m, 13H), 7.08 (d, J = 8.0 Hz, 2H), 7.01 – 6.95 (m, 4H), 
4.90 (d, J = 11.8 Hz, 1H), 4.84 (d, J = 11.8 Hz, 1H), 4.66 (s, 1H), 2.33 (s, 3H); 13C-NMR (101 MHz, 
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CDCl3) δ 163.0 (C), 143.6 (C), 141.3 (C), 141.2 (C), 139.9 (C), 138.2 (C), 138.0 (C), 136.5 (C), 129.6 
(2 × CH), 129.5 (2 × CH), 129.4 (2 × CH), 128.7 (2 × CH), 128.5 (2 × CH), 128.4 (CH), 128.2 (2 × 
CH), 127.8 (3 × CH), 127.6 (CH), 126.9 (CH), 126.5 (2 × CH), 124.6 (CH), 123.6 (CH), 119.1 (C), 
118.7 (CH), 72.6 (CH2), 52.1 (CH), 21.9 (CH3); IR: νmax (cm
-1) 2981, 2970, 2901, 1624, 1596, 1329, 
1224, 1161, 1092, 1033; HRMS (ES) m/z calculated for C35H30NO3S (M+H)
+ 544.1946 found 
544.1941. 
N-(2-(Allyloxy)-1-phenyl-1H-inden-3-yl)-4-methyl-N-phenylbenzenesulfonamide 329 
Prepared according to GP13 from ynamide 322 (98.7 mg, 0.2 mmol), stirring for 
6 hours. Recrystallisation [hexane:CH2Cl2] gave the indene XX (63.4 mg, 64%) as 
a white solid; mp: 176-178 °C; 1H-NMR (300 MHz, CDCl3): δ 7.79 (d, J = 8.3 Hz, 
2H), 7.59 – 7.48 (m, 12H), 7.34 – 7.13 (m, 2H), 6.98 (dd, J = 3.5, 2.5 Hz, 2H), 5.63 
(ddt, J = 17.5, 10.5, 5.4 Hz, 1H), 5.12-5.09 (m, 1H), 5.07-5.05 (m, 1H),  4.65 (s, 1H), 4.35 (d, J = 5.4 
Hz, 2H), 2.40 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 162.8 (C), 143.4 (C), 141.0 (2 × C), 139.6 (C), 
138.1 (C), 137.7 (C), 132.8 (CH), 129.2 (4 × CH), 129.1 (2 × CH), 128.2 (2 × CH), 127.8 (2 × CH), 
127.4 (CH), 127.2 (CH), 126.7 (CH), 126.4 (2 × CH), 124.2 (CH), 123.3 (CH), 118.5 (C), 118.3 (CH), 
117.7 (CH2), 71.2 (CH2), 51.7 (CH), 21.6 (CH3); IR: νmax (cm
-1) 3061, 3043, 3025, 2917, 1621, 1596, 
1489, 1455, 1325, 1160, 1126, 1090, 757, 694; HRMS (ES) m/z calculated for C31H27NO3SNa 
(M+Na)+ 516.1609 found 516.1592. 
N-Allyl-N-(2-(allyloxy)-1-phenyl-1H-inden-3-yl)methanesulfonamide 330 
Prepared according to GP13 from ynamide 324 (114.4 mg, 0.3 mmol), stirring for 2 hours. 
Purification by flash column chromatography [hexane:EtOAc (90:10) then hexane:EtOAc (85:15)] 
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gave the indene 330 (80.8 mg, 71%) as a white solid; mp 112-114 °C; 1H-NMR 
(300 MHz, CDCl3): δ 7.28 – 7.11 (m, 7H), 6.97 – 6.87 (m, 2H), 5.87 (ddt, J = 17.2, 
10.0, 6.4 Hz, 1H), 5.74 (ddt, J = 16.2, 10.6, 5.5 Hz, 1H), 5.28 (d, J = 17.2 Hz, 1H) 
5.19 (app. ddd, J = 17.2, 3.0, 1.5 Hz, 1H), 5.13 (app. ddd, J = 10.6, 2.4, 1.2 Hz, 1H), 5.08 (d, J = 
10.0 Hz, 1H), 4.62 (s, 1H), 4.35 (m, 2H), 4.23 (d, J = 6.4 Hz, 2H), 3.00 (s, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 161.7 (C), 141.0 (C), 139.7 (C), 137.4 (C), 133.6 (CH), 132.8 (CH), 129.3 (2 × CH), 127.7 
(2 × CH), 127.5 (CH), 127.4 (CH), 124.4 (CH), 123.1 (CH), 118.6 (C), 118.4 (2 × CH2), 118.3 (CH), 
71.4 (CH2), 52.1 (CH2), 51.5 (CH), 39.8 (CH3); IR: νmax (cm
-1) 3084, 2986, 2921, 1620, 1335, 1343, 
1318, 1148; HRMS (ES) m/z calculated for C22H23NO3NaS (M+Na)
+ 404.1296 found 404.1283. 
13C-Labelling Study: Substrates Preparation 
 
13C-N,N-Diethylbenzamide 337 
13C-Enriched benzoic acid (1.25 g, 10.2 mmol, 13C:12C 1:4) was dissolved in thionyl 
chloride (5.0 mL, 2.0 M) and heated at reflux for 3 hours. The excess thionyl chloride 
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was removed under reduced pressure and the crude residue dissolved in CH2Cl2 (5.0 mL, 2.0 M). 
Diethylamine (2.0 mL, 19.4 mmol, 1.9 equiv.) in CH2Cl2 (7.5 mL) was added dropwise and the 
resulting solution was stirred for 16 hours at room temperature. The solution was diluted with 
CH2Cl2 (20 mL) and washed with a saturated NaHCO3 solution (20 mL), 1 M HCl solution (20 mL) 
and water (20 mL). After drying over Na2SO4 and filtering, the solvent removed under reduced 
pressure to give the 13C enriched amide 337 (1.55 g, 86% over two steps) as a brown liquid 
which immediately without further purification.  
13C-N,N-Diethyl-2-(hydroxy(phenyl)methyl)benzamide 338 
A solution of TMEDA (2.8 mL, 19.0 mmol, 2.4 equiv.) in THF (70 mL, 0.3 M) was 
cooled to -78 °C before the dropwise addition of sec-BuLi (1.4 M in cyclohexane, 
13.5 mL, 19.0 mmol, 2.4 equiv.). After stirring at this temperature for 10 minutes, a 
solution of the 13C-enriched amide 338 (1.40 g, 7.9 mmol, 13C:12C 1:4, 1.0 equiv.) in THF (70 mL) 
was added dropwise and the resulting solution stirred for a further 20 minutes.  A solution of 
benzaldehyde (1.9 mL, 19.0 mmol, 2.4 equiv.) in THF (2 mL) was added dropwise and stirring 
continued for 3 hours at -78 °C. The reaction warmed to room temperature and a saturated 
solution of NH4Cl (100 mL) was added slowly. The aqueous layer was extracted with Et2O (2 × 75 
mL), and washed with brine (75 mL) before drying over Na2SO4, filtering and removal of the 
solvent under reduced pressure. Purification by flash column chromatography [hexane:EtOAc 
(70:30)] gave the 13C-enriched benzhydric alcohol S35 (1.90 g, 85%) as pale yellow oil; 1H-NMR 
(300 MHz, CDCl3) δ: 7.63 – 7.12 (m, 9H), 5.92 and 5.72 (bs, 1H), 4.15 (bs, 1 H), 3.51 and 3.17 (bs, 
2H), 2.91 and 2.41 (bs, 2H), 0.93 and 0.84 (bs, 6H); 13C-NMR (101 MHz, CDCl3) δ: Resonances not 
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listed due to the complex spectra arising from restricted rotation of the amide; IR: νmax (cm
-1) 
3357, 3029, 2975, 2936, 2874, 2936, 1608, 1595, 1431; HRMS (ES) m/z calculated for 
C17
13CH21NO2Na (M+Na)
+ 306.1470 found 306.1478. 
13C-N,N-Diethyl-2-(methoxy(phenyl)methyl)benzamide 339 
13C-enriched benzhydric alcohol 338 (1.80 g, 6.4 mmol, 1 equiv.) was dissolved in 
THF (32 mL, 0.2 M) and cooled to 0 °C with an ice bath. NaH (60% dispersion in 
mineral oil, 0.56 g, 14.0 mmol, 2.2 equiv.) was added in one portion and the 
resulting mixture stirred at 0 °C for 30 minutes. MeI (0.7 mL, 11.4 mmol, 1.8 equiv.) was added 
dropwise, the ice bath removed and the mixture was stirred at room temperature for 45 
minutes. Saturated NH4Cl solution (50 mL) was added and the aqueous layer was extracted with 
Et2O (2 × 50 mL), and washed with brine (50 mL) before drying over Na2SO4, filtering and 
removal of the solvent under reduced pressure. Purification by flash column chromatography 
[hexane:EtOAc (80:20)] gave the 13C-enriched methyl ether 339 (1.76 g, 93%) as a pale yellow 
solid; mp: 54-56 °C; 1H-NMR (300 MHz, CDCl3) δ: 7.95 – 6.91 (m, 9H), 5.58 and 5.46 (bs, 1H), 
3.93 – 3.09 (m, 3H), 3.35 (s, 3H), 2.51 and 2.21 (bs, 1H), 1.32 - 0.78 (m, 6H); 13C-NMR (101 MHz, 
CDCl3) δ: Resonances not listed due to the complex spectra arising from restricted rotation of 
the amide; IR: νmax (cm
-1) 2994, 2974, 2942, 2924, 2821, 1618, 1579, 1453, 1432, 1096; HRMS 
(ES) m/z calculated for C18
13CH21NO2Na (M+Na)
+ 320.1626 found 306.1617. 
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13C-2-(Methoxy(phenyl)methyl)benzaldehyde 341 
n-BuLi (2.5 M in hexane, 10.6 mL, 26.9 mmol, 5.0 equiv.) was added dropwise to a 
solution of DIBAL (1.0 M in cyclohexane, 26.9 mL, 26.9 mmol, 5.0 equiv.) in THF (18 
mL, 1.5 M) at 0 °C and the resulting solution stirred for 30 minutes. A solution of 
benzamide 339 (1.60 g, 5.4 mmol, 1.0 equiv.) in THF (18 mL, 1.5 M) was added dropwise and the 
mixture was allowed to warm to room temperature over 1.5 hours. 0.5 M solution (20 mL) was 
added carefully and the product extracted using Et2O (2 × 30 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, filtered and the solvent removed under reduced 
pressure to give the crude 13C-benzyl alcohol 340. A small sample (ca. 40 mg) was removed for 
analysis and the remaining material was used directly. DMSO (1.1 mL, 15.7 mmol, 3.0 equiv.) 
was added to a solution of oxalyl chloride (0.4 mL, 5.3 mmol, 1.0 equiv.) in CH2Cl2 (3.0 mL, 1.8 
M) cooled to -78 °C. After stirring for 45 minutes at this temperature, the crude alcohol (1.20 g, 
5.3 mmol, 1.0 equiv.) in CH2Cl2 (5.0 mL) was added and the resulting mixture stirred for a further 
45 minutes. Et3N (4.4 mL, 31.5 mmol, 6.0 equiv.) was added and stirring continued for 45 
minutes. The mixture was allowed to warm to room temperature and water (ca. 20 mL) was 
added before extraction with Et2O (2 × 20 mL). The combined organic layers were washed with 
brine, dried over Na2SO4, filtered and the solvent removed under reduced pressure to give the 
aldehyde 341 (1.14 g, 94% over two steps) as a yellow oil; 1H-NMR (300 MHz, CDCl3) δ: 10.23 (s, 
1H, 13C satellite peaks at 10.52 and 9.93, JC-H = 176.6 Hz ), 7.84 (dd, J = 7.6, 1.3 Hz, 1H), 7.73 – 
7.57 (m, 2H), 7.47 (td, J = 7.5, 1.4 Hz, 1H), 7.41 – 7.23 (m, 5H), 6.17 (s, 1H), 3.40 (s, 3H); 13C-NMR 
(101 MHz, CDCl3) δ: 192.7 (CH, 
13C-enriched signal), 143.9 (C), 141.1 (C), 133.9 (CH), 133.6 (C), 
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132.6 (CH), 128.5 (2 × CH), 128.1 (CH), 128.0 (CH), 127.7 (CH), 127.5 (2 × CH), 81.1 (CH), 57.2 
(CH3); IR: νmax (cm
-1) 3064, 3030, 2986, 2932, 2901, 2822, 1694, 1597, 1451, 1085, 1075; HRMS 
(ES) m/z calculated for C14
13CH14O2Na (M+Na)
+ 249.2605 found 249.2611. 
13C-1-(2,2-Dibromovinyl)-2-(methoxy(phenyl)methyl)benzene 342 
CBr4 (1.47 g, 4.4 mmol, 2.0 equiv.) and PPh3 (2.32 g, 8.8 mmol, 4.0 equiv.) were 
combined in a flask which was evacuated and refilled (× 3). CH2Cl2 (15 mL, 0.2 M) 
was added and the resulting solution stirred for 10 minutes at room temperature. 
Aldehyde S37 (0.50 g, 2.2 mmol, 1 equiv.) in CH2Cl2 (2 mL) was added at 0 °C and stirred for 45 
minutes, slowly warming to room temperature. The solvent was removed under reduced 
pressure and the residue was dissolved in the minimum quantity of CH2Cl2. Hexane was added 
to the flask and quickly filtered through a pad of silica. This was repeated until all the contents 
had been transferred to the filter bed. The filter cake was washed with a hexane:Et2O mixture 
(95:5, 200 mL) and the solvent removed to give the dibromoolefin 342 (0.70 g, 83%) as a yellow 
oil which was used immediately in the ynamide formation. 
13C-N-Allyl-N-((2-(methoxy(phenyl)methyl)phenyl)ethynyl)methanesulfonamide 13C-255 
Cs2CO3 (1.1 g, 4.8 mmol, 4.0 equiv.) and CuI (27 mg, 0.1 mmol, 12 mol%) were 
combined in a flask which was evacuated and refilled with argon (× 3). A solution 
of dibromoolefin 342 (0.68 g, 1.8 mmol, 1.5 equiv.) and sulfonamide 249 (0.16 g, 
1.2 mmol, 1.0 equiv.) in DMF (2.4 mL, 0.5 M) was added, followed by DMEDA (24 µL, 0.2 mmol, 
19 mol%). The resulting solution was stirred at 70 °C for 14 hours. The reaction mixture was 
filtered through a short (ca. 1 cm) pad of silica, eluting with Et2O (50 mL). The filtrate was 
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washed with water (2 × 30 mL), then brine (30 mL), dried over Na2SO4, filtered and the solvent 
removed under reduced pressure. Purification by flash column chromatography [hexane:EtOAc 
(8.5:1.5)] gave the 13C-labelled ynamide (0.250 mg, 59%) as a yellow oil. Data matches that 
reported above for 255. 
Derivatisation on Indenes 
2-Methoxy-1-((4-nitrophenyl)sulfonyl)-N,3-diphenyl-1H-inden-1-amine 352  
 
Indene 259 (34.9 mg, 0.07 mmol, 1.0 equiv.) was dissolved in acetone (0.8 mL, 0.06 M) 
containing Et3N (20 µL, 0.1 mmol, 2.0 equiv.) and the resulting solution was stirred for 1 hour at 
room temperature. The solvent was removed under reduced pressure and the crude solid was 
recrystallised [hexane:CH2Cl2] to give the C-sulfonylated amine 352 (25.3 mg, 72%) as a yellow 
solid; mp: 198-199 °C; 1H-NMR (400 MHz, CDCl3): δ 8.22 (d, J = 8.9 Hz, 2H), 7.88 (d, J = 8.9 Hz, 
2H), 7.46 – 7.34 (m, 5H), 7.27 (d, J = 5.8 Hz, 1H), 7.19 (td, J = 7.5, 0.8 Hz, 1H), 7.10 – 7.02 (m, 3H), 
6.94 (d, J = 7.4 Hz, 1H), 6.78 (t, J = 7.3 Hz, 1H), 6.54 (d, J = 7.8 Hz, 2H), 4.43 (s, 1H, NH), 3.41 (s, 
3H); 13C-NMR (101 MHz, CDCl3): δ 161.4 (C), 150.2 (C), 147.9 (C), 146.0 (C), 144.3 (C), 141.8 (C), 
133.7 (C), 130.2 (2 × CH), 129.1 (3 × CH), 128.8 (2 × CH), 128.1 (CH), 127.2 (2 × CH), 125.4 (CH), 
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124.5 (2 × CH), 123.7 (CH), 120.4 (CH), 120.0 (CH), 119.1 (C), 117.6 (2 × CH), 72.8 (C), 60.6 (CH3); 
IR: νmax (cm
-1) 3341, 3082, 3051, 3014, 2988, 2939, 2844, 1635, 1594, 1514, 1451, 1345, 1329, 
1047; HRMS (ES) m/z calculated for C28H22N2O5NaS (M+Na)
+ 521.1147 found 521.1121. 
(E)-N-(2-Methoxy-3-phenyl-1H-inden-1-ylidene)aniline 353 
Indene 235 (35.0 mg, 0.075 mmol, 1 equiv.) was dissolved in acetone (1.3 mL, 0.06 
M) at room temperature. Diazabicyclo[5.4.0]undec-7-ene (22 µL, 0.2 mmol, 2 
equiv.) was added and the solution stirred for 1.5 h. The solvent was removed 
under reduced pressure and purification of the crude residue by flash column 
chromatography [hexane:EtOAc (95:5)] gave the imine 353 (18.8 mg, 81%) as a red solid; mp: 
118-119 °C; 1H-NMR (300 MHz, CDCl3): δ 7.55 (dd, J = 8.3, 1.3 Hz, 2H), 7.51 – 7.45 (m, 2H), 7.43 – 
7.37 (m, 3H), 7.23 - 7.17 (m, 1H), 7.09 (td, J = 7.6, 1.0 Hz, 1H), 7.02 – 6.98 (m, 2H), 6.90 (d, J = 7.4 
Hz, 1H), 6.74 (td, J = 7.6, 1.0 Hz, 1H), 6.32 (d, J = 7.4 Hz, 1H), 3.85 (s, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 162.2 (C), 151.9 (C), 151.5 (C), 145.6 (C), 132.7 (C), 131.6 (CH), 129.5 (2 × CH), 129.5 (2 
× CH), 128.8 (CH), 128.6 (2 × CH), 127.9 (C), 125.9 (CH), 125.7 (CH), 124.7 (C), 124.5 (CH), 119.8 
(CH), 118.5 (2 × CH), 61.1 (CH3); IR: νmax (cm
-1) 3079, 3058, 2931, 2852, 1643, 1618, 1592, 1483, 
1457, 1347, 1059, 1020; HRMS (ES) m/z calculated for C22H18NO (M+H)
+ 312.1388 found 
312.1386. 
3-(2,5,6-trimethoxy-3-phenyl-1H-inden-1-yl)oxazolidin-2-one 354 
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Prepared according to GP13 from ynamide 311 (110.2 mg, 0.3 mmol), stirring for 1.5 hours. 
Purification by flash column chromatography [hexane:EtOAc (65:35), 1% Et3N] gave the isomeric 
indene 354 (79.6 mg, 72%) as a white solid; mp: 181-183 °C; 1H-NMR (300 MHz, CDCl3): δ 7.55 – 
7.43 (m, 4H), 7.40 – 7.32 (m, 1H), 6.95 (s, 1H), 6.76 (s, 1H), 5.66 (s, 1H), 4.45 – 4.30 (m, 2H), 3.89 
(s, 3H), 3.82 (s, 3H), 3.78 (s, 3H), 3.35 (td, J = 8.8, 6.8 Hz, 1H), 3.15 (app. dd, J = 16.1, 8.8 Hz, 1H); 
13C-NMR (101 MHz, CDCl3): δ 159.0 (C), 155.6 (C), 149.7 (C), 147.0 (C), 136.4 (C), 132.7 (C), 128.9 
(2 × CH), 128.5 (2 × CH), 127.6 (CH), 126.5 (C), 120.5 (C), 108.2 (CH), 103.9 (CH), 62.4 (CH2), 59.6 
(CH), 56.8 (CH3), 56.6 (CH3), 56.2 (CH3), 40.2 (CH2); IR: νmax (cm
-1) 2995, 2928, 2827, 1735, 1621, 
1496, 1418, 1305, 1172, 1073; HRMS (ES) m/z calculated for C21H22NO5Na (M+H)
+ 368.1498 
found 368.1496. 
(Z)-6-(Methylsulfonyl)-11-phenyl-2,5,6,11-tetrahydroindeno[2,1-b][1,4]oxazocine 355 
Indene 330 (50.0 mg, 0.13 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (44 mL, 0.003 
M) and Grubbs(II) catalyst (2.8 mg, 2.5 mol%) was added. The resulting solution 
was stirred at room temperature for 4.5 hours before filtering through a short pad 
(ca. 1 cm) of silica, eluting with CH2Cl2 (50 mL). The solvent was removed under reduced 
pressure and the crude solid was recrystallised [hexane:CH2Cl2] to give the oxazocine 335 (38.3 
mg, 77%) as a white solid; mp: 144-146 °C; 1H-NMR (300 MHz, CDCl3): δ 7.34 – 7.19 (m, 4H), 
7.19 – 7.13 (m, 3H), 7.10 – 6.97 (m, 2H), 5.91 – 5.75 (m, 2H), 5.27 – 5.00 (m, 2H), 4.64-4.33 (m, 
2H), 4.46 (s, 1H), 3.20 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 164.2 (C), 141.4 (C), 140.3 (C), 138.2 
(C), 134.4 (CH), 129.2 (2 × CH), 128.5 (2 × CH), 127.6 (CH), 127.5 (CH), 124.5 (CH), 124.4 (CH), 
123.2 (CH), 116.2 (CH), 111.5 (C), 62.5 (CH2), 53.74 (CH), 50.8 (CH2), 42.4 (CH3); IR: νmax (cm
-1) 
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3028, 3010, 2977, 2937, 1617, 1465, 1455, 1439, 1329, 1146, 962; HRMS (ES) m/z calculated for 
C20H19NO3NaS (M+Na)
+ 376.0983 found 376.0988. 
1-(Methylsulfonyl)-3'-phenyl-3-vinylspiro[azetidine-2,1'-inden]-2'(3'H)-one 356 
 
Oxazocine 355 (20 mg, 0.06 mmol) was heated in toluene (1.0 mL, 0.06 M) for 5.5 hours (it was 
not possible to monitor the reaction by TLC). One cooled to room temperature, the solvent was 
removed under reduced pressure and the crude residue was purified by flash column 
chromatography [hexane:EtOAc (80:20)] to give the vinyl azetidine 356 (14.2 mg, 71%) as a clear 
oil; 1H-NMR (400 MHz, CDCl3): δ 7.75 (app. d, J = 7.6 Hz, 1H, major and 1H, minor), 7.57 – 7.40 
(m, 1H, major, 2H, minor), 7.39 – 7.23 (m, 4H, major, 4H, minor), 7.21 (d, J = 7.6 Hz, 1H, minor), 
7.15 – 7.10 (m, 1H, major, 1H, minor), 7.03 (d, J = 7.7 Hz, 2H, major), 5.91 (ddd, J = 17.0, 10.2, 
9.1 Hz, 1H, major), 5.52 (ddd, J = 17.0, 10.1, 9.0 Hz, 1H, minor), 5.21 (d, J = 9.1 Hz, 1H, major), 
5.18 (d, J = 17.0 Hz, 1H, major), 4.96 (d, J = 17.0 Hz, 1H, minor), 4.81 (d, J = 10.1 Hz, 1H, minor), 
4.80 (s, 1H, minor), 4.43 (s, 1H, major), 4.27 – 4.16 (m, 2H, major and 1H, minor) and 4.09 (dd, J 
= 8.3, 6.3 Hz, 1H, minor), 3.54 – 3.41 (m, 1H, major and 1H minor), 2.96 (s, 3H, major), 2.94 (s, 
3H, minor); 13C-NMR (101 MHz, CDCl3): δ 212.2 (C, major), 210.7 (C, minor), 140.6 (C, minor), 
140.4 (C, major), 140.3 (C, major), 140.1 (C, minor), 137.3 (C, major), 137.3 (C, minor), 132.3 
(CH, major), 132.2 (CH, minor), 130.6 (CH, minor), 130.1 (CH, major), 129.6 (2 × CH, major), 
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129.1 (CH, minor), 129.0 (CH, major), 128.8 (2 × CH, major), 128.7 (2 × CH, minor), 128.5 (2 × CH, 
minor), 127.6 (CH, major), 127.4 (CH, minor), 126.1 (CH, minor), 125.5 (CH, major), 124.3 (CH, 
minor), 123.8 (CH, major), 121.1 (CH2, minor), 120.2 (CH2, major), 82.0 (C, major), 81.5 (C, 
minor), 57.4 (CH, major), 56.9 (CH, minor), 52.9 (CH2, minor), 52.6 (CH2, major), 48.7 (CH, 
major), 47.3 (CH, minor), 40.7 (CH3, major), 40.0 (CH3, minor); IR: νmax (cm
-1) 2893, 1754, 1496, 
1328, 1145, 1053, 1036, 967, 738, 700; HRMS (ES) m/z calculated for C20H19NO3NaS (M+Na)
+ 
376.0983, found 376.0983. 
Carboalkoxylation Crossover Study 
 
Ynamides 245 (24.9 mg, 0.05 mmol, 1.0 equiv.) and 322 (24.7 mg, 0.05 mmol, 1.0 equiv.) were 
dissolved in CH2Cl2 (1.0 mL, 0.1 M). (p-CF3C6H4)3PAuNTf2 (4.7 mg, 0.0026 mmol) was added and 
the solution stirred at room temperature for 2 hours. The reaction mixture was filtered through 
a pipette containing a short silica pad (ca. 1 cm), eluting with EtOAc (10 mL) and the solvent 
removed under reduced pressure. 1,2,4,5-Tetramethyl benzene (2.5 mg, 0.019 mmol) was 
added to the flask as an internal standard and the mixture was taken up in CDCl3 for analysis. 
1H-NMR yields were calculated from 1H-NMR spectroscopy: 259 = 62% and 329 = 65% based on 
the internal standard. Formation of crossover products was not observed. 
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Preparation of Functionalised Tetracycles 
3a-Methoxy-3-(methylsulfonyl)-4-phenyl-1,1a,2,3,3a,4-hexahydrocyclopropa[c]indeno[2,1-
b]pyrrole 357 
Prepared according to GP14 from ynamide 255 (71.1 mg, 0.2 mmol), heating at 
120 °C for 6 hours. Purification by flash column chromatography [hexane:EtOAc 
(90:10), then hexane:EtOAc (80:20)] gave the tetracycle 357 (34.8 mg, 49%) as a single 
diastereoisomer as a white solid. (It was not possible to isolate the minor diastereoisomer (25% 
by 1H-NMR)); mp: 138 -140 °C; 1H-NMR (300 MHz, CDCl3): δ 7.39-7.31 (m, 6H), 7.21 (app. td, J = 
7.5, 1.1 Hz, 1H) 7.01 (dd, J = 9.9, 7.5 Hz, 2H), 4.55 (s, 1H), 3.98 (dd, J = 9.8, 3.6 Hz, 1H), 3.90 (d, J 
= 9.8 Hz, 1H), 3.10 (s, 3H), 2.70 (s, 3H), 1.69-1.55 (m, 2H), 1.07 (m, 1H); 13C-NMR (101 MHz, 
CDCl3): δ 142.8 (C), 142.4 (C), 141.2 (C), 129.6 (CH), 128.3 (2 × CH), 127.8 (CH), 127.6 (2 × CH), 
127.3 (CH), 126.2 (CH), 120.1 (CH), 88.9 (C), 80.0 (CH), 54.0 (CH2), 52.5 (CH3), 41.4 (CH3), 38.5 
(C), 26.6 (CH), 11.3 (CH2); IR: νmax (cm
-1) 3026, 2939, 2829, 2827, 1152; HRMS (ES) m/z calculated 
for C20H21NO3NaS (M+Na)
+ 378.1140, found 378.1137. 
4-Methoxy-4-phenyl-3-tosyl-1,1a,2,3,3a,4-hexahydrocyclopropa[c]indeno[2,1-b]pyrrole 498 
Prepared according to GP14 from ynamide 494 (86.3 mg, 0.2 mmol), heating 
at 120 °C for 1 hour. Purification by flash column chromatography 
[hexane:EtOAc (90:10)] gave tetracycle 498 (69.5 mg, 81%) as a 1:2.2 mixture of 
diastereoisomers as a white solid; mp: 146-148 °C; 1H-NMR (400 MHz, CDCl3): δ 7.47 (d, J = 8.3 
Hz, 2H, minor), 7.34 (d, J = 8.3 Hz, 2H, major), 7.21 – 7.11 (m, 6H, major and 6H, minor), 7.10 – 
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7.00 (m, 3H, major and 3H minor), 6.92 – 6.86 (m, 1H, major, 1H, minor) 6.76 (d, J = 7.4 Hz, 1H, 
major) 6.72 – 6.69 (m, 1H, minor), 4.86 (s, 1H, minor), 4.24 (s, 1H, major), 3.94 (dd, J = 10.6, 4.1 
Hz, 1H, major), 3.57 (d, J = 10.6 Hz, 1H, major), 3.35 (s, 3H, minor), 3.04 (d, J = 11.3 Hz, 1H, 
minor), 2.88 (s, 3H, major), 2.27 (s, 3H, minor), 2.24 (s, 3H, major), 2.22 – 2.15 (m, 1H, minor), 
1.40 – 1.34 (m, 1H, major), 1.15 – 1.03 (m, 1H, major, 2H, minor), -0.03 (app. t, J = 5.4 Hz, 1H, 
major), -0.20 – -0.28 (m, 1H, minor); 13C-NMR (101 MHz, CDCl3): δ 143.4 (C, minor), 143.1 (C, 
major), 143.0 (C, minor), 142.7 (C, major), 142.2 (C, major), 141.7 (C, minor), 141.1 (C, minor), 
140.2 (C, major), 137.3 (C, major), 137.1 (C, minor), 129.8 (2 × CH, minor), 129.6 (2 × CH, major), 
129.4 (CH, major), 129.2 (CH, minor), 128.1 (2 × CH, minor), 127.9 (2 × CH, major), 127.8 (2 × CH, 
minor), 127.7 (2 × CH, major and CH, minor), 127.6 (2 × CH, minor), 127.2 (CH, major), 127.20 (2 
× CH, major and CH, minor), 127.15 (CH, major), 126.1 (CH, major), 125.7 (CH, minor), 119.9 (CH, 
major), 119.4 (CH, minor), 91.8 (C, major), 88.9 (C, minor), 80.0 (CH, major), 72.9 (CH, minor), 
54.7 (CH2, major), 52.7 (CH2, minor), 52.0 (CH, minor), 51.9 (CH, major), 38.5 (C, major), 37.7 (C, 
minor), 27.1 (CH3, minor), 26.7 (CH3, major), 21.6 (CH3, major and CH3 minor), 11.5 (CH2, minor), 
11.0 (CH2, major); IR: νmax (cm
-1) 3052, 2950, 2930, 2892, 2862, 1598, 1492, 1462, 1447, 1349, 
1161, 1100, 1079, 664; HRMS (ES) m/z calculated for C26H26NO3S (M+H)
+ 432.1633, found 
432.1611. 
Note: The reaction can also be conducted at room temperature over a 24 hour period to give 
the tetracycle 498 (72.4 mg, 84%) as a 1:3.8 mixture of diastereoisomers as a white solid. 
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4-(Allyloxy)-4-phenyl-3-tosyl-1,1a,2,3,3a,4-hexahydrocyclopropa[c]indeno[2,1-b]pyrrole 507 
 Prepared according to GP14 from ynamide 506 (91.5 mg, 0.2 mmol) heating at 60 °C for 2 
hours. Purification by flash column chromatography [hexane:EtOAc (92:8)] 
gave tetracycle 507 (78.7 mg, 86%) as a 1:3 mixture of diastereoisomers as 
a white solid. Recrystallisation [hexane:CH2Cl2] allowed isolation of the 
major diastereoisomer (54.2 mg, 59%); mp: 146-147 °C; 1H-NMR (400 MHz, CDCl3): δ 7.63 (d, J = 
8.3 Hz, 2H minor), 7.53 (d, J = 8.3 Hz, 2H, major), 7.35 – 7.27 (m, 6H major and 6H minor), 7.24 – 
7.16 (m, 3H major and 3H minor), 7.07 (dd, J = 6.1, 3.1 Hz, 1H, minor), 7.03 (d, J = 7.5 Hz, 1H, 
major), 6.93 (d, J = 7.5 Hz, 1H, major), 6.88 – 6.85 (m, 1H, minor), 6.08 (ddt, J = 17.2, 10.4, 5.1 
Hz, 1H, minor), 5.77 (ddt, J = 17.2, 10.5, 4.4 Hz, 1H, major), 5.47 (app. dq, J = 17.2, 1.7 Hz, 1H, 
minor), 5.27 (app. ddd, J = 17.2, 3.8, 1.9 Hz, 1H, major), 5.21 (app. ddd, J = 10.4, 3.2, 1.7 Hz, 1H, 
minor), 5.06 (app. dq, J = 10.5, 1.9 Hz, 1H, major), 5.00 (s, 1H, minor), 4.48 (s, 1H, major), 4.35 
(ddt, J = 12.4, 5.1, 1.7 Hz, 1H, minor), 4.11 (dd, J = 10.5, 4.4 Hz, 1H, major), 4.02 (app. ddt, J = 
12.4, 5.1, 1.7 Hz, 1H, minor), 3.90 (app. ddt, J = 13.2, 4.5, 1.8 Hz, 1H, major), 3.77 (d, J = 10.5 Hz, 
1H, major), 3.44 (app. ddt, J = 13.2, 4.4, 1.9 Hz, 1H, major), 3.23 (d, J = 11.3 Hz, 1H, minor), 2.44 
(s, 3H, minor), 2.41 (s, 3H, major), 2.40 – 2.34 (m, 1H, minor), 1.58 – 1.52 (m, 1H, major), 1.33 
(dd, J = 8.0, 6.2 Hz, 1H, major), 1.29 – 1.20 (m, 2H, minor), 0.28 (app. t, J = 5.4 Hz, 1H, major), -
0.05 (app. t, J = 3.3 Hz, 1H, minor); 13C-NMR (101 MHz, CDCl3): δ 143.5 (C, minor), 143.6 (C, 
minor), 143.1 (C, major), 142.8 (C, major), 142.7 (C, major), 141.6 (C, minor), 141.1 (C, minor), 
140.6 (C, major), 137.6 (C, major), 137.2 (C, minor), 135.3 (CH, minor), 135.2 (2 × CH, major), 
129.8 (CH, major), 129.6 (3 × CH, major), 129.4 (2 × CH, minor), 129.3 (2 × CH, minor), 128.1 (2 × 
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CH, minor), 128.0 (2 × CH, major), 127.9 (2 × CH, minor), 127.6 (2 × CH, minor), 127.5 (2 × CH, 
major and 2 × CH, minor), 127.4 (CH, major), 127.3 (2 × CH, major), 126.3 (CH, major), 125.7 (CH, 
minor), 120.0 (CH, major), 119.4 (CH, minor), 116.1 (CH2, minor), 115.0 (CH2, major), 88.6 (C, 
major, corresponding minor C is not visible), 80.2 (CH, major), 74.5 (CH, minor), 65.5 (CH2, 
minor), 64.9 (CH2, major), 54.7 (CH2, major), 52.8 (CH2, minor), 38.5 (C, major), 37.8 (C, minor), 
27.2 (CH, minor), 26.9 (CH, major), 21.7 (CH3, major and CH3, minor), 11.5 (CH2, minor), 11.0 
(CH2, major); IR: νmax (cm
-1) 2951, 2938, 2888, 2845, 1645, 1599, 1483, 1461, 1447, 1343, 1161, 
1099, 757, 665; HRMS (ES) m/z calculated for C28H27NO3SNa (M+Na)
+ 480.1609, found 480.1601. 
3-Tosyl-1a,2,3,3a-tetrahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-4,2'-[1,3]dioxolane] 
519 
Prepared according to GP14 from ynamide 515 (76.7 mg, 0.2 mmol) stirring 
at 80 °C for 1 hour. Purification by flash column chromatography 
[hexane:EtOAc (80:20), 1% Et3N] then recrystallisation [CH2Cl2:hexane] gave 
tetracycle 519 (62.1 mg, 81%) as a white solid; mp: 168-170 °C; 1H-NMR (400 MHz, CDCl3): δ 
7.73 (d, J = 8.2 Hz, 2H), 7.38 – 7.35 (m, 1H), 7.33 (d, J = 8.2 Hz, 2H), 7.30 – 7.22 (m, 2H), 6.76 – 
6.73 (m, 1H), 4.57 – 4.50 (m, 1H), 4.45 – 4.38 (m, 1H), 4.37 (s, 1H), 4.25 (dd, J = 12.9, 6.3 Hz, 1H), 
4.24 – 4.17 (m, 1H), 4.07 (dd, J = 11.3, 4.4 Hz, 1H), 3.67 (d, J = 11.3 Hz, 1H), 2.44 (s, 3H), 1.46 – 
1.39 (m, 1H), 1.22 – 1.17 (m, 1H), -0.25 – -0.28 (m, 1H); 13C-NMR (101 MHz, CDCl3): δ 143.8 (C), 
141.2 (C), 140.1 (C), 136.3 (C), 130.4 (CH), 130.0 (2 × CH), 127.8 (CH), 127.2 (2 × CH), 123.9 (CH), 
119.3 (CH), 113.4 (C), 74.5 (CH), 66.7 (CH2), 66.1 (CH2), 54.1 (CH2), 37.6 (C), 26.4 (CH3), 21.7 (CH), 
348 
 
11.6 (CH2); IR: νmax (cm
-1) 2982, 2951, 2918, 2896, 1615, 1598, 1463, 1345, 1279, 1156, 754; 
HRMS (ES) m/z calculated for C21H22NO4S (M+H)
+ 384.1265, found 384.1276. 
Note: The reaction can also be conducted at room temperature over a 16 hour period to give 
the tetracycle 519 (71.3 mg, 93%) as a white solid. 
3-((4-Nitrophenyl)sulfonyl)-1a,2,3,3a-tetrahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-
4,2'-[1,3]dioxolane] 520 
Prepared according to GP14 from ynamide 516 (82.9 mg, 0.2 mmol), 
heating at 80 °C for 1 hour. Purification by flash column chromatography 
[hexane:EtOAc (9:1)] gave tetracycle 520 (50.2 mg, 61%) as a white solid; mp: 216-217 °C; 1H-
NMR (300 MHz, CDCl3): δ 8.40 (d, J = 8.9 Hz, 2H), 8.05 (d, J = 8.9 Hz, 2H), 7.39 – 7.23 (m, 3H), 
6.81 – 6.73 (m, 1H), 4.46 – 4.40 (m, 1H), 4.39 (s, 1H), 4.36 – 4.17 (m, 3H), 4.13 (dd, J = 11.2, 4.3 
Hz, 1H), 3.69 (d, J = 11.2 Hz, 1H), 1.54 – 1.45 (m, 1H), 1.32 (dd, J = 7.8, 6.4 Hz, 1H), -0.19 (dd, J = 
6.4, 5.1 Hz, 1H); 13C-NMR (101 MHz, CDCl3): δ 150.3 (C), 145.0 (C), 141.2 (C), 139.3 (C), 130.6 
(CH), 128.4 (2 × CH), 128.0 (CH), 124.7 (2 × CH) 123.9 (CH), 119.5 (CH), 113.4 (C), 74.4 (CH), 66.8 
(CH2), 65.9 (CH2), 54.3 (CH2), 37.5 (C), 26.0 (CH), 11.9 (CH2); IR: νmax (cm
-1) 3065, 3029, 3007, 
2972, 2912, 2941, 2840, 1636, 1355, 1165, 908, 859; HRMS (ES) m/z calculated for C20H19N2O6S 
(M+H)+ 415.4395, found 415.4389. 
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6,7-Dimethoxy-3-tosyl-1a,2,3,3a-tetrahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-4,2'-
[1,3]dioxolane] 521 
Prepared according to GP14 from ynamide 517 (88.7 mg, 0.2 mmol), 
heating at 80 °C for 1 hour. Purification by flash column chromatography 
[hexane:EtOAc (70:30), 1% Et3N] gave tetracycle 521 (86.8 mg, 98%) as a pale yellow solid; mp: 
168-170 °C; 1H-NMR (300 MHz, CDCl3): δ 7.72 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 6.86 (s, 
1H), 6.21 (s, 1H), 4.61 – 4.51 (m, 1H), 4.51 – 4.40 (m, 1H), 4.33 (s, 1H), 4.29 – 4.16 (m, 2H), 4.06 
(dd, J = 11.4, 4.3 Hz, 1H), 3.88 (s, 3H), 3.79 (s, 3H), 3.65 (d, J = 11.4 Hz, 1H), 2.44 (s, 3H), 1.40 – 
1.31 (m, 1H), 1.11 (dd, J = 8.0, 6.3 Hz, 1H), -0.35 (dd, J = 6.3, 5.1 Hz, 1H); 13C-NMR (101 MHz, 
CDCl3): δ 151.6 (C), 149.5 (C), 143.8 (C), 136.2 (C), 132.4 (C), 132.2 (C), 130.0 (2 × CH), 127.2 (2 × 
CH), 113.8 (C), 106.6 (CH), 102.3 (CH), 76.9 (CH), 66.5 (CH2), 66.0 (CH2), 56.3 (CH3), 56.2 (CH3), 
54.2 (CH2), 37.6 (C), 25.3 (CH), 21.7 (CH3), 11.3 (CH2); IR: νmax (cm
-1) 3004, 2961, 2923, 2890, 
2869, 1614, 1596, 1507, 1467, 1454, 1340, 1159, 1009, 663; HRMS (ES) m/z calculated for 
C23H26NO6S (M+H)
+ 444.1481, found 444.1501. 
6-Fluoro-3-tosyl-1a,2,3,3a-tetrahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-4,2'-
[1,3]dioxolane] 522 
Prepared according to GP14 from ynamide 518 (80.3 mg, 0.2 mmol), 
heating at 80 °C for 24 hours. Purification by flash column 
chromatography [hexane:EtOAc (85:15), 1% Et3N] gave tetracycle 522 (59.5 mg, 74%) as a white 
solid; mp: 176-178 °C; 1H-NMR (300 MHz, CDCl3): δ 7.73 (d, J = 8.2 Hz, 2H), 7.34 (d, J = 8.2 Hz, 
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2H), 7.05 (dd, J = 8.2, 2.4 Hz, 1H), 7.02 – 6.92 (m, 1H), 6.70 (dd, J = 8.2, 4.7 Hz, 1H), 4.55 – 4.48 
(m, 1H), 4.47 – 4.38 (m, 1H), 4.37 (s, 1H), 4.28 – 4.16 (m, 2H), 4.06 (dd, J = 11.4, 4.3 Hz, 1H), 3.66 
(d, J = 11.4 Hz, 1H), 2.45 (s, 3H), 1.44 – 1.38 (m, 1H), 1.17 (dd, J = 7.9, 6.6 Hz, 1H), -0.24 – -0.29 
(m, 1H); 13C-NMR (101 MHz, CDCl3): δ 162.4 (d, JC-F = 246.0 Hz, C), 143.9 (C), 143.3 (d, JC-F = 7.2 
Hz, C), 136.2 (C), 135.6 (C), 130.1 (2 × CH), 127.2 (2 × CH), 120.8 (d, JC-F = 8.2 Hz, CH), 117.6 (d, JC-
F = 23.0 Hz, CH), 112.9 (C), 111.2 (d, JC-F = 22.7 Hz, CH), 74.6 (CH), 66.8 (CH2), 66.2 (CH2), 54.1 
(CH2), 37.2 (C), 26.2 (CH), 21.7 (CH3), 11.6 (CH2); IR: νmax (cm
-1) 2996, 2972, 2948, 2893, 1494, 
1345, 1157, 732, 658; HRMS (ES) m/z calculated for C21H21NO4SF (M+H)
+ 402.1175, found 
404.1159. 
3-Tosyl-1a,2,3,3a,5,6,7,8-octahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-4,2'-
[1,3]dioxolane] 539 
Prepared according to GP14, from ynamide 535 (77.5 mg, 0.2 mmol), 
heating at 50 °C for 15 minutes. Purification by flash column 
chromatography [toluene:EtOAc (95:5), 1% Et3N] gave tetracycle 539 (62.3 mg, 80%) as a white 
solid. When the reaction was carried out on a 0.6 mmol scale, 99% of pure product was isolated 
following flash column chromatography; mp: 189-191 °C; 1H-NMR (300 MHz, CDCl3): δ 7.70 (d, J 
= 8.2 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 4.14 – 3.89 (m, 2H), 4.11 – 3.91 (m, 3H), 4.02 (s, 1H), 3.62 
(d, J = 11.5 Hz, 1H), 2.43 (s, 3H), 2.14 – 1.99 (m, 1H), 1.98 – 1.82 (m, 1H), 1.78 – 1.41 (m, 6H), 
1.22 – 1.16 (m, 1H), 0.74 (dd, J = 8.0, 6.2 Hz, 1H), -0.56 – -0.61 (m, 1H); 13C-NMR (101 MHz, 
CDCl3): δ 143.6 (C), 138.4 (C), 136.0 (C), 135.0 (C), 129.9 (2 × CH), 127.3 (2 × CH), 115.5 (C), 73.8 
(CH), 66.2 (CH2), 66.2 (CH2), 54.4 (CH2), 40.5 (C), 22.3 (CH2), 22.1 (CH2), 21.9 (CH2), 21.7 (CH3), 
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20.2 (CH2), 19.5 (CH), 10.8 (CH2); IR: νmax (cm
-1) 2934, 2880, 2855, 2836, 1344, 1158, 1001, 808, 
663; HRMS (ES) m/z calculated for C21H26NO4S (M+H)
+ 388.1583, found 388.1591. 
3-Tosyl-1a,2,3,3a,5,6,7,8-octahydrocyclopropa[c]indeno[2,1-b]pyrrol-4(1H)-one 540 
Tetracyclic acetal 539 (194 mg, 0.5 mmol, 1.0 equiv.) was dissolved in THF 
(2.5 m, 0.2 M). Aqueous HCl solution (2.0 M solution, 0.9 mL) was added 
and the mixture was heated to 50 °C for 1 hour. One cooled to room temperature, the mixture 
was neutralised by the dropwise addition NaOH solution (2.0 M). The aqueous phase was 
extracted with CH2Cl2 (3 × 20 mL), dried over NaSO4, filtered and the solvent removed under 
reduced pressure. No further purification was required and the enone 540 was isolated as a 
white solid (129 mg, 75%); mp: 158-160 °C; 1H-NMR (300 MHz, CDCl3): δ 7.85 (d, J = 8.2 Hz, 2H), 
7.31 (d, J = 8.2 Hz, 2H), 4.32 (s, 1H), 3.79 (d, J = 11.0 Hz, 1H), 3.69 (dd, J = 11.0, 4.3 Hz, 1H), 2.41 
(s, 3H), 2.16 – 2.01 (m, 3H), 1.91 – 1.59 (m, 5H), 1.47 – 1.32 (m, 2H), 0.66 (app. t, J = 5.0 Hz, 1H); 
13C-NMR (101 MHz, CDCl3): δ 203.2 (C), 167.4 (C), 143.7 (C), 136.9 (C), 136.8 (C), 129.8 (2 × CH), 
128.0 (2 × CH), 69.5 (CH), 53.6 (CH2), 39.8 (C), 29.9 (CH2), 23.7 (CH2), 21.8 (CH) 21.7 (CH2), 21.5 
(CH3), 20.3 (CH2), 14.5 (CH2); IR: νmax (cm
-1) 2928, 2891, 2864, 1701, 1619, 1345, 1161, 1091, 
1044, 663; HRMS (ES) m/z calculated for C19H22NO3S (M+H)
+ 344.1320, found 344.1325. 
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4'-Methyl-3-tosyl-1a,2,3,3a-tetrahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-4,2'-
[1,3]dioxolane] 547 
Prepared according to GP14 from ynamide 546 (79.5 mg, 0.2 mmol) 
heating at 50 °C for 45 minutes. Purification by flash column 
chromatography [hexane:EtOAc (90:10), 1% Et3N] gave tetracycle 547 (58.2 mg, 73%) as a 
mixture of four diastereoisomers as a white solid; mp: 72-74 °C; Note: Due to the complexity of 
the 1H-NMR spectrum, it was not possible to assign structures or a ratio of diastereoisomers due 
to overlapping resonances. Two major diastereoisomers were formed in a 1:1 ratio and two 
minor diastereoisomers were also formed in low levels. For simplicity, only the two major 
diastereoisomers are assigned as a mixture in the 1H- and 13C- spectra. It was not possible to 
fully assign the minor diastereoisomers. 1H-NMR (400 MHz, CDCl3): δ 7.74 and 7.73 (2 × d, J = 
8.3 Hz, 2H), 7.42 – 7.31 (m, 3H), 7.29 – 7.22 (m, 2H), 6.78 – 6.69 (m, 1H), 4.93 and 4.85 (app. dd, 
J = 12.4, 6.2 Hz and app. dt, J = 7.7, 6.1 Hz, 1H), 4.63 – 4.58 and 4.55 – 4.50 (2 × m, 1H), 4.36 and 
4.32 (2 × s, 1H), 4.16 – 4.01 (m, 1H), 3.76 – 3.61 (m, 2H), 2.44 (s, 3H), 1.47 and 1.38 (2 × d, J = 6.1 
Hz, 3H), 1.45 – 1.36 (m, 1H), 1.17 (dd, J = 8.2, 6.5 Hz, 1H), -0.29 – -0.38 (m, 1H); 13C-NMR (101 
MHz, CDCl3): δ 143.9 and 143.8 (C), 141.4 and 141.2 (C), 140.0 (C), 136.3 and 136.1 (C), 130.4 
(CH), 130.0 (2 × CH), 127.9 and 127.8 (CH), 127.3 and 127.2 (2 × CH), 124.1 and 124.0 (CH), 
119.3 (CH), 113.8 (C), 74.8 (CH), 73.8 and 73.5 (CH), 73.1 and 72.1 (CH2), 54.2 and 54.1 (CH2), 
37.7 and 37.5 (C), 26.4 (CH), 21.7 (CH3), 19.9 and 19.0 (CH3), 11.6 and 11.5 (CH2);.IR: νmax (cm
-1) 
2974, 2936, 2888, 1613, 1597, 1347, 1161, 1099, 1073, 1010, 729, 666, 661; HRMS (ES) m/z 
calculated for C22H23NO4SNa (M+Na)
+ 420.1245, found 420.1245. 
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4-Tosyl-1,1a,2,3,4,4a-hexahydrospiro[cyclopropa[c]indeno[2,1-b]pyridine-5,2'-[1,3]dioxolane] 
558-a and 558-b 
Prepared according to GP14 from ynamide 552 (79.5 mg, 0.2 mmol), heating at 80 °C for 2 
hours. Purification by flash column chromatography [hexane:EtOAc (90:10), 1% Et3N] allowed 
isolation of diastereoisomeric tetracycles 558-a and 558-b as white solids. 
558-a: (17.2 mg, 22%); mp: 193-195 °C; 1H-NMR (300 MHz, CDCl3): δ 7.75 (d, J 
= 8.3 Hz, 2H), 7.34 – 7.26 (m, 4H), 7.22 (app. td, J = 7.5, 1.1 Hz, 1H), 6.65 (d, J 
= 7.5 Hz, 1H), 4.72 (s, 1H), 4.29 – 4.06 (m, 4H), 3.81 (app. dd, J = 14.2, 4.7 Hz, 1H), 3.46 (app. td, J 
= 14.2, 3.8 Hz, 1H), 2.44 (s, 3H), 1.90 – 1.74 (m, 1H), 1.31 – 1.09 (m, 3H), 0.12 (app. t, J = 5.1 Hz, 
1H); 13C-NMR (101 MHz, CDCl3): δ 145.1 (C), 143.4 (C), 140.1 (C), 139.0 (C), 130.6 (CH), 129.8 (2 × 
CH), 127.3 (2 × CH), 127.0 (CH), 123.4 (CH), 118.9 (CH), 115.1 (C), 66.5 (CH2), 66.0 (CH2), 62.0 
(CH), 40.8 (CH2), 22.6 (C), 22.3 (CH2), 21.7 (CH3), 21.5 (CH), 18.6 (CH2); IR: νmax (cm
-1) 3060, 3026, 
2979, 2900, 1601,1578, 1485, 1466, 1245, 1179, 1166, 1088, 752; HRMS (ES) m/z calculated for 
C22H24NO4S (M+H)
+ 398.1426, found 398.1409. 
558-b: (27.5 mg, 35%) mp: 185-187 °C; 1H-NMR (400 MHz, CDCl3): δ 7.89 (d, J 
= 8.3 Hz, 2H), 7.31 – 7.27 (m, 3H), 7.22 (app. td, J = 6.8, 1.5 Hz, 2H), 6.72 (dd, 
J = 6.3, 1.5 Hz, 1H), 4.56 – 4.51 (m, 1H), 4.47 – 4.36 (m, 2H), 4.22 - 4.14 (m, 1H), 3.80 (s, 1H), 
3.59 (ddd, J = 13.9, 5.9, 3.1 Hz, 1H), 3.49 – 3.38 (m, 1H), 2.40 (s, 3H), 1.94 – 1.81 (m, 2H), 1.75 – 
1.62 (m, 2H), 0.59 (dd, J = 8.0, 5.6 Hz, 1H); 13C-NMR (101 MHz, CDCl3): δ 143.5 (C), 142.8 (C), 
142.5 (C), 134.2 (C), 129.7 (2 × CH), 129.6 (CH), 128.4 (2 × CH), 126.9 (CH), 122.8 (CH), 118.1 
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(CH), 114.3 (C), 66.7 (CH2), 64.9 (CH2), 61.7 (CH), 44.9 (CH2), 23.0 (C), 22.3 (CH2), 21.7 (CH3), 16.7 
(CH2), 14.1 (CH); IR: νmax (cm
-1) 3067, 2984, 2901, 1598, 1486, 1461, 1347, 1240, 1168, 1091, 
732, 664; HRMS (ES) m/z calculated for C22H24NO4S (M+H)
+ 398.1426, found 398.1415. 
2-Methyl-3-tosyl-1a,2,3,3a-tetrahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-4,2'-
[1,3]dioxolane] 570 
Prepared according to GP14 from ynamide 566 (79.5 mg, 0.2 mmol), heating 
at 80 °C for 1 hour. Purification by flash column chromatography 
[hexane:toluene:EtOAc (50:47:3), 1% Et3N] gave tetracycle 570 (54.3 mg, 68%) as a 1:4 mixture 
of diastereoisomers as a white solid; Recrystallisation [hexane:CH2Cl2] allowed isolation of one 
diastereoisomer (38.6 mg, 49% from ynamide 566); mp: 202-204 °C; 1H-NMR (300 MHz, CDCl3): 
δ 7.74 (d, J = 8.2 Hz, 2H), 7.40 – 7.36 (m, 1H), 7.33 (d, J = 8.2 Hz, 2H), 7.28 – 7.24 (m, 2H), 6.72 – 
6.67 (m, 1H), 4.60 – 4.47 (m, 2H), 4.32 (s, 1H), 4.28 – 4.20 (m, 2H), 3.98 (q, J = 6.6 Hz, 1H), 2.44 
(s, 3H), 1.58 (d, J = 6.6 Hz, 3H), 1.24 (dd, J = 8.3, 4.8 Hz, 1H), 1.10 (dd, J = 8.3, 6.0 Hz, 1H), -0.39 – 
-0.44 (m, 1H); 13C-NMR (101 MHz, CDCl3): δ 143.9 (C), 141.5 (C), 140.4 (C), 135.5 (C), 130.4 (CH), 
130.0 (2 × CH), 127.9 (CH), 127.4 (2 × CH), 124.3 (CH), 119.2 (CH), 112.6 (C), 75.5 (CH), 66.6 
(CH2), 66.0 (CH2), 64.6 (CH), 38.6 (C), 32.6 (CH), 23.1 (CH3), 21.7 (CH3), 12.8 (CH2); IR: νmax (cm
-1) 
3065, 2982, 2903, 1597, 1491, 1461, 1337, 1276, 1261, 1162, 763, 751; HRMS (ES) m/z 
calculated for C22H24NO4S (M+H)
+ 389.1426, found 398.1430. 
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5-(1-(2-(1,3-Dioxan-2-yl)phenyl)vinyl)-2-methyl-1-tosyl-2,3-dihydro-1H-pyrrole 571 
Prepared according to GP14, from ynamide 568 (85.1 mg, 0.2 mmol), heating at 
80 °C for 45 minutes. Purification by flash column chromatography 
[toluene:Et2O (97:3), 1% Et3N] gave 1,3-diene 571 (54.0 mg, 63%) as a white 
solid; mp: 54-56 °C; 1H-NMR (400 MHz, CDCl3): δ 7.78 (dd, J = 7.7, 1.1 Hz, 1H), 7.73 (d, J = 8.2 Hz, 
2H), 7.37 (app. td, J = 7.6, 1.2 Hz, 1H), 7.33 – 7.24 (m, 3H), 7.19 (dd, J = 7.6, 1.1 Hz, 1H), 5.98 (s, 
1H), 5.85 (s, 1H), 5.34 (s, 1H), 5.19 (dd, J = 3.5, 2.1 Hz, 1H), 4.28 – 4.15 (m, 3H), 4.04 – 3.89 (m, 
2H), 2.41 (s, 3H), 2.32 – 2.16 (m, 1H), 1.90 (dd, J = 17.2, 7.7 Hz, 1H), 1.62 (dd, J = 17.2, 3.5 Hz, 
1H), 1.39 (d, J = 13.4 Hz, 1H), 1.22 (d, J = 6.6 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.0 (C), 
143.9 (C), 139.2 (C), 138.4 (C), 137.1 (C), 135.1 (C), 129.6 (2 × CH), 129.1 (CH), 128.4 (CH), 128.2 
(CH), 128.1 (2 × CH), 127.0 (CH), 121.0 (CH), 120.2 (CH2), 99.8 (CH), 67.7 (CH2), 67.4 (CH2), 59.8 
(CH), 35.7 (CH2), 26.1 (CH2), 22.0 (CH3), 21.8 (CH3); IR: νmax (cm
-1) 3061, 2963, 2926, 2851, 1598, 
1347, 1163, 1096, 982, 755, 733, 684, 657; HRMS (ES) m/z calculated for C24H27NO4SNa (M+Na)
+ 
448.1559, found 448.1553. 
Formation of Isomeric Indenes from Ynamide 581 
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Prepared according to GP13 from ynamide 581 (96.3 mg, 0.2 mmol), stirring for 6 hours. 
Purification by flash column chromatography [hexane:EtOAc (95:5) then hexane:EtOAc (85:15)] 
gave the isomeric indenes 582-584.  
N-Benzyl-N-(2-methoxy-1-phenyl-1H-inden-3-yl)-4-methylbenzenesulfonamide 582: 
(46.9 mg, 49%); White solid; mp: 204-206 °C; 1H-NMR (400 MHz, DMSO, 110 °C): δ 7.80 (d, J = 
8.2 Hz, 2H), 7.40 (d, J = 8.2 Hz, 2H), 7.32 (dd, J = 7.4, 2.0 Hz, 2H), 7.29 – 7.15 (m, 6H), 7.04 (t, J = 
7.4 Hz, 1H), 6.96 – 6.81 (m, 5H), 4.81 (d, J = 14.0 Hz, 1H), 4.77 (s, 1H), 4.69 (d, J = 14.0 Hz, 1H), 
3.29 (s, 3H), 2.42 (s, 3H); Broadening and splitting of some signals due to restricted rotation, 
some nuclei therefore have 2 resonances assigned to them; 13C-NMR (101 MHz, CDCl3): δ 164.1 
and 163.4 (C), 143.4 (C), 141.0 (C), 139.6 (C), 138.0 and 137.6 (C), 136.8 (C), 136.4 and 136.1 (C), 
129.4 (2 × CH), 129.1 and 128.9 (4 × CH), 128.4 (2 × CH), 128.1 (2 × CH), 127.9 (2 × CH), 127.7 
(CH), 127.4 and 127.1 (CH), 127.0 (CH), 123.9 (CH), 123.0 (CH), 118.9 and 118.4 (CH), 115.5 (C), 
57.9 (CH), 52.8 and 52.5 (CH2), 51.8 and 51.5 (CH3), 21.7 (CH3); IR: νmax (cm
-1) 3065, 3033, 2953, 
2857, 1623, 1598, 1457, 1344, 1158, 1093, 1016, 750; HRMS (ES) m/z calculated for C30H27NO3S 
(M)+ 481.1712 found 481.1729. 
N-Benzyl-N-(3-methoxy-1-phenyl-1H-inden-2-yl)-4-methylbenzenesulfonamide 583:  
(14.0 mg, 15%); White solid; mp: 139-141 °C; 1H-NMR (400 MHz, CDCl3): δ 7.59 (d, J = 8.3 Hz, 
2H), 7.28 (d, J = 7.6 Hz, 1H), 7.21 (d, J = 8.1 Hz, 2H), 7.19 – 7.14 (m, 1H), 7.10 – 6.98 (m, 3H), 6.98 
– 6.88 (m, 5H), 6.84 – 6.79 (m, 2H), 6.54 (d, J = 7.1 Hz, 2H), 4.63 (s, 1H), 4.45 (d, J = 14.1 Hz, 1H), 
4.15 (d, J = 14.1 Hz, 1H), 3.42 (s, 3H), 2.36 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 153.2 (C), 145.3 
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(C), 143.5 (C), 138.7 (C), 138.1 (C), 137.3 (C), 135.9 (C), 129.7 (2 × CH), 129.2 (2 × CH), 129.0 (2 × 
CH), 128.5 (2 × CH), 128.2 (2 × CH), 128.0 (2 × CH), 127.5 (CH), 126.9 (CH), 126.8 (CH), 126.7 
(CH), 124.5 (CH), 124.0 (C), 119.3 (CH), 58.8 (CH), 53.4 (CH3), 52.9 (CH2), 21.7 (CH3); IR: νmax (cm
-
1) 3030, 2937, 2850, 1620, 1600, 1494, 1453, 1346, 1159, 908, 724, 697; HRMS (ES) m/z 
calculated for C30H28NO3S (M+H)
+ 482.1790 found 482.1804. 
N-Benzyl-N-(1-methoxy-1-phenyl-1H-inden-2-yl)-4-methylbenzenesulfonamide 584:  
(23.7 mg, 25%); White solid; mp: 60-62 °C; 1H-NMR (300 MHz, CDCl3): δ 7.59 (d, J = 8.3 Hz, 2H), 
7.30 (s, 1H), 7.31 – 7.28 (m, 2H), 7.22 – 7.06 (m, 8H), 7.00 – 6.85 (m, 5H), 6.73 – 6.69 (m, 1H), 
5.00 (d, J = 17.3 Hz, 1H), 4.84 (d, J = 17.3 Hz, 1H), 2.48 (s, 3H), 2.42 (s, 3H); 13C-NMR (101 MHz, 
CDCl3): δ 144.1 (C), 144.0 (C), 143.7 (C), 141.3 (C), 139.5 (C), 139.2 (C), 135.9 (C), 129.5 (2 × CH), 
128.8 (CH), 128.3 (6 × CH), 127.2 (CH), 126.8 (CH), 126.5 (2 × CH), 125.6 (CH), 125.2 (2 × CH), 
123.2 (CH), 121.2 (CH), 120.9 (CH), 90.9 (C), 51.8 (CH3), 51.1 (CH2), 21.7 (CH3); IR: νmax (cm
-1) 
3064, 3030, 2932, 2856, 2830, 1599, 1572, 1494, 1469, 1450, 1160, 1085, 1073, 749; HRMS (ES) 
m/z calculated for C30H28NO3S (M+H)
+ 482.1790 found 482.1771. 
Note: Indene 584 could also be prepared using GP14 from ynamide 581 (96.3 mg, 0.2 mmol), 
stirring for 5 hours at 80 °C. Purification by flash column chromatography [hexane:Et2O (95:5)] 
gave the indene 584 (25.9 mg, 27%). 
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4-Methoxy-4-phenyl-3-tosyl-1,1a,2,3,3a,4-hexahydrocyclopropa[c]indeno[2,1-b]pyrrole-3a-d 
d-498 
Prepared according to GP14 from ynamide d-494 (86.5 mg, 0.2 mmol) 
heating at 80 °C for 2 hours. Purification by flash column chromatography 
[hexane:EtOAc (9:1)] gave tetracycle d-498 (56.2 mg, 65%) as a 1:3.1 
mixture of diastereoisomers as a white solid; mp: 128-130 °C; 1H-NMR (400 MHz, CDCl3): δ 7.46 
(d, J = 8.3 Hz, 2H, minor), 7.33 (d, J = 8.3 Hz, 2H, major), 7.20 – 7.10 (m, 6H, major and 6H, 
minor), 7.10 – 7.00 (m, 3H, major and 3H, minor), 6.91 – 6.85 (m, 1H, major, 1H, minor) 6.76 (d, 
J = 7.4 Hz, 1H, major) 6.72 – 6.69 (m, 1H, minor), 3.92 (dd, J = 10.6, 4.1 Hz, 1H, major), 3.56 (d, J 
= 10.6 Hz, 1H, major), 3.34 (s, 3H, minor), 3.03 (d, J = 11.3 Hz, 1H, minor), 2.87 (s, 3H, major), 
2.26 (s, 3H, minor), 2.23 (s, 3H, major), 2.21 – 2.14 (m, 1H, minor), 1.40 – 1.33 (m, 1H, major), 
1.15 – 1.02 (m, 1H, major, 2H, minor), -0.03 (app. t, J = 5.4 Hz, 1H, major), -0.20 – -0.27 (m, 1H, 
minor); 13C-NMR (101 MHz, CDCl3): δ 143.4 (C, minor), 143.1 (C, major), 143.0 (C, minor), 142.7 
(C, major), 142.2 (C, major), 141.7 (C, minor), 141.1 (C, minor), 140.2 (C, major), 137.3 (C, 
major), 137.1 (C, minor), 129.8 (2 × CH, minor), 129.6 (2 × CH, major), 129.4 (CH, major), 129.2 
(CH, minor), 128.1 (2 × CH, minor), 127.9 (2 × CH, major), 127.8 (2 × CH, minor), 127.7 (2 × CH, 
major and CH, minor), 127.6 (2 × CH, minor), 127.2 (CH, major), 127.20 (2 × CH, major and CH, 
minor), 127.15 (CH, major), 126.1 (CH, major), 125.7 (CH, minor), 119.9 (CH, major), 119.4 (CH, 
minor), 91.8 (C, major), 88.9 (C, minor), 54.7 (CH2, major), 52.7 (CH2, minor), 52.0 (CH, minor), 
51.9 (CH, major), 38.5 (C, major), 37.7 (C, minor), 27.1 (CH3, minor), 26.7 (CH3, major), 21.6 (CH3, 
major and CH3 minor), 11.5 (CH2, minor), 11.0 (CH2, major), C-D carbon was not apparent in this 
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case; IR: νmax (cm
-1) 3050, 2996, 2947, 2929, 1598, 1492, 1462, 1447, 1349, 1161, 1079, 662; 
HRMS (ES) m/z calculated for C26H25NO3SD (M+H)
+ 433.1696, found 433.1687. 
3-Tosyl-1a,2,3,3a-tetrahydro-1H-spiro[cyclopropa[c]indeno[2,1-b]pyrrole-4,2'-[1,3]dioxolane]-
3a-d d-519 
Prepared according to GP14 from ynamide d-515 (38.4 mg, 0.1 mmol), 
stirring at 80 °C for 5.5 hours. Purification by flash column chromatography 
[toluene:Et2O (97:3), 1% Et3N] gave tetracycle d-519 (34.5 mg, 90%) as a 
white solid; mp: 132-134 °C; 1H-NMR (400 MHz, CDCl3): δ 7.73 (d, J = 8.3 Hz, 2H), 7.39 – 7.30 (m, 
3H), 7.30 – 7.22 (m, 2H), 6.78 – 6.71 (m, 1H), 4.56 – 4.48 (m, 1H), 4.42 (dd, J = 13.0, 6.4 Hz, 1H), 
4.32 – 4.16 (m, 2H), 4.07 (dd, J = 11.4, 4.3 Hz, 1H), 3.67 (d, J = 11.4 Hz, 1H), 2.44 (s, 3H), 1.46 – 
1.40 (m, 1H), 1.19 (dd, J = 7.8, 6.4 Hz, 1H), -0.23 – -0.28 (m, 1H); 13C-NMR (101 MHz, CDCl3): δ 
143.8 (C), 141.2 (C), 140.1 (C), 136.3 (C), 130.4 (CH), 130.0 (2 × CH), 127.8 (CH), 127.2 (2 × CH), 
123.9 (CH), 119.3 (CH), 113.4 (C), 77.1 (t, JC-D = 22.7 Hz, CD), 66.7 (CH2), 66.1 (CH2), 54.1 (CH2), 
37.6 (C), 26.4 (CH3), 21.7 (CH), 11.6 (CH2); IR: νmax (cm
-1) 2985, 2952, 2918, 2896, 1615, 1598, 
1463, 1345, 1337, 1277, 1255, 1017, 759, 666; HRMS (ES) m/z calculated for C21H20DNO4SNa 
(M+Na)+ 407.1152, found 407.1143. 
  
360 
 
Preparation of Functionalised Isoquinolines 
4-Allyl-1-phenylisoquinoline 651 
Prepared according to GP16 from ynamide 255 (71.1 mg, 0.2 mmol), stirring for 8 
hours. Purification by flash column chromatography [hexane:EtOAc (95:5)] gave the 
isoquinoline (46.2 mg, 65%) as a pale yellow oil; 1H-NMR (300 MHz, CDCl3): δ 8.49 (s, 
1H), 8.13 (d, J = 8.5 Hz, 1H), 8.06 (d, J = 8.5 Hz, 1H), 7.82 – 7.65 (m, 3H), 7.61 – 7.44 (m, 4H), 6.13 
(ddt, J = 16.5, 10.9, 6.2 Hz, 1H), 5.16 (app, dt, J = 16.5, 1.5 Hz, 1H), 5.17 (app. dt, J = 10.9, 1.5 Hz, 
1H), 3.84 (d, J = 6.2 Hz, 2H); 13C-NMR (101 MHz, CDCl3): δ 159.9 (C), 142.2 (CH), 139.7 (C), 136.2 
(CH), 135.8 (C), 130.1 (CH), 130.0 (2 × CH), 128.6 (CH), 128.4 (2 × CH), 128.4 (CH), 126.9 (CH), 
126.6 (C), 123.7 (CH), 117.0 (CH2 and C), 34.6 (CH2); IR: νmax (cm
-1) 3058, 2923, 2953, 1638, 1615, 
1580, 1550, 1383, 913, 776, 760, 697, 675; HRMS (ES) m/z calculated for C18H16N (M+H)
+ 
246.1283, found 246.1290. 
4-Allyl-1-methoxy-2-(methylsulfonyl)-1-phenyl-1,2-dihydroisoquinoline 654 
Prepared according to GP15 from ynamide 255 (71.1 mg, 0.2 mmol), stirring for 24 
hours. Purification by flash column chromatography [hexane:EtOAc (90:10), 1% 
Et3N] followed by recrystallisation [hexane:CH2Cl2] gave the isoquinoline 654 (60.4 
mg, 85%) as a white solid; mp: 64-66 °C; 1H-NMR (300 MHz, CDCl3): δ 7.54 – 7.45 (m, 2H), 7.37 – 
7.22 (m, 5H), 7.09 (ddd, J = 8.4, 5.4, 3.2 Hz, 1H), 6.97 (s, 1H), 6.96 – 6.92 (m, 1H), 6.00 (ddt, J = 
17.0, 10.1, 6.0 Hz, 1H), 5.19 (app. dq, J = 17.0, 1.5 Hz, 1H), 5.16 (app. ddd, J = 10.1, 3.0, 1.5 Hz, 
1H), 3.25 (ddd, J = 6.0, 3.0, 1.5 Hz, 2H), 3.18 (s, 3H), 2.49 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 
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145.0 (C), 136.0 (CH), 134.0 (C), 130.9 (C), 129.2 (CH), 128.5 (CH), 128.1 (CH), 127.8 (2 × CH), 
127.5 (2 × CH), 127.2 (CH), 124.0 (CH), 121.4 (CH), 117.0 (CH2), 110.6 (C), 93.5 (C), 51.0 (CH3), 
42.0 (CH3), 34.4 (CH2); IR: νmax (cm
-1) 3060, 2936, 2851, 1638, 1494, 1447, 1388, 1347, 1224, 
1166, 1041, 775; HRMS (ES) m/z calculated for C20H21NO3SNa (M+Na)
+ 378.1140, found 
378.1146. 
4-Allyl-1-methoxy-2-(methylsulfonyl)-1-phenyl-1,2-dihydroisoquinoline-3-d d-654 
Prepared according to GP15 from ynamide d-255 (71.3 mg, 0.2 mmol) stirring for 
48 hours. Purification by flash column chromatography [hexane:Et2O (90:10), 1 % 
Et3N] gave the isoquinoline d-654 (46.0 mg, 65%) as a white solid; mp: 66-68 °C; 
1H-NMR (300 MHz, CDCl3): δ 7.54 – 7.46 (m, 2H), 7.37 – 7.21 (m, 5H), 7.09 (ddd, J = 8.5, 5.2, 3.3 
Hz, 1H), 6.98 – 6.91 (m, 1H), 6.00 (ddt, J = 17.0, 10.1, 6.0 Hz, 1H), 5.19 (app. dq, J = 17.1, 1.5 Hz, 
1H), 5.16 (app. ddd, J = 10.1, 3.0, 1.5 Hz, 1H), 3.25 (ddd, J = 6.0, 3.0, 1.5 Hz, 2H), 3.18 (s, 3H), 
2.49 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.9 (C), 135.9 (CH), 134.0 (C), 130.9 (C), 129.2 (CH), 
128.5 (CH), 128.1 (CH), 127.8 (2 × CH), 127.5 (2 × CH), 127.2 (CH), 123.7 (t, JC-D = 27.5 Hz, CD), 
121.4 (CH), 117.0 (CH2), 110.4 (C), 93.4 (C), 51.0 (CH3), 42.0 (CH3), 34.3 (CH2); IR: νmax (cm
-1) 
3063, 3029, 3008, 2975, 2932, 2841, 1637, 1492, 1354, 1164, 908, 859, 749; HRMS (ES) m/z 
calculated for C20H20DNO3SNa (M+Na)
+ 379.1203, found 379.1195. 
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4-Allyl-1-(allyloxy)-2-(methylsulfonyl)-1-phenyl-1,2-dihydroisoquinoline 662 
Prepared according to GP15 from ynamide 323 (76.3 mg, 0.2 mmol) stirring for 48 
hours. Purification by flash column chromatography [hexane:Et2O (90:10), 1 % 
Et3N] gave the isoquinoline XX (47.5 mg, 62%) as a white solid; mp: 50-52 °C; 
1H-
NMR (300 MHz, CDCl3): δ 7.58 – 7.48 (m, 2H), 7.38 – 7.22 (m, 5H), 7.09 (ddd, J = 8.4, 5.1, 3.5 Hz, 
1H), 7.01 – 6.93 (m, 2H), 6.08 – 5.84 (m, 2H), 5.33 (app. dq, J = 17.2, 1.7 Hz, 1H), 5.24 – 5.14 (m, 
2H), 5.15 (ddd, J = 17.3, 3.1, 1.5 Hz, 1H), 4.04 (ddt, J = 12.5, 5.2, 1.6 Hz, 1H), 3.60 (ddt, J = 12.5, 
5.2, 1.6 Hz, 1H), 3.25 (d, J = 5.9 Hz, 2H), 2.49 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 145.0 (C), 
135.9 (CH), 134.3 (C), 134.1 (CH), 130.7 (C), 129.2 (CH), 128.6 (CH), 128.1 (CH), 127.8 (2 × CH), 
127.6 (2 × CH), 127.2 (CH), 123.9 (CH), 121.4 (CH), 117.0 (CH2), 116.5 (CH2), 110.7 (C), 92.8 (C), 
64.5 (CH2), 42.0 (CH3), 34.4 (CH2); IR: νmax (cm
-1) 3004, 2987, 2890, 1608, 1584, 1489, 1427, 
1393, 1272, 1160, 1113, 1063, 750; HRMS (ES) m/z calculated for C22H23NO3SNa (M+Na)
+ 
404.1296, found 404.1299. 
4'-Allyl-2'-(methylsulfonyl)-2'H-spiro[[1,3]dioxolane-2,1'-isoquinoline] 665 
Prepared according to GP16 from ynamide 255 (61.5 mg, 0.2 mmol), stirring for 24 
hours. Purification by flash column chromatography [hexane:Et2O (85:15), 1 % 
Et3N] gave the isoquinoline 665 (52.4 mg, 85%) as a white solid; mp: 72-74 °C; 
1H-
NMR (300 MHz, CDCl3): δ 7.54 – 7.48 (m, 1H), 7.48 – 7.39 (m, 1H), 7.39 – 7.31 (m, 2H), 6.88 (s, 
1H), 5.96 (ddt, J = 16.9, 10.1, 6.2 Hz, 1H), 5.15 (app. dq, J = 17.1, 1.4 Hz, 1H), 5.12 (app. ddd, J = 
10.1, 3.0, 1.4 Hz, 1H), 4.54 (m, 2H), 4.21 (m, 2H), 3.28 (ddd, J = 6.1, 3.0, 1.4 Hz, 2H), 3.06 (s, 3H); 
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13C-NMR (101 MHz, CDCl3): δ 135.6 (CH), 131.5 (C), 131.0 (C), 129.6 (CH), 127.3 (CH), 123.6 (CH), 
123.1 (CH), 122.5 (CH), 117.2 (CH2), 116.3 (C), 112.8 (C), 66.6 (2 × CH2), 43.3 (CH3), 34.0 (CH2); IR: 
νmax (cm
-1) 3080, 3007, 2974, 2898, 2848, 1641, 1343, 1268, 1167; HRMS (ES) m/z calculated for 
C15H18NO4S (M+H)
+ 308.0957, found 308.0951. 
4-Allyl-2-tosyl-2H-spiro[isoquinoline-1,2'-[1,3]dioxolane] 666 
Prepared according to GP16 from ynamide 515 (76.7 mg, 0.2 mmol) stirring 
for 48 hours. Purification by flash column chromatography [hexane:Et2O 
(93:7), 1 % Et3N] gave the isoquinoline 666 (53.2 mg, 69%) as a white solid; 
mp: 82-84 °C; 1H-NMR (300 MHz, CDCl3): δ 7.50 (d, J = 8.3 Hz, 2H), 7.29 – 7.17 (m, 3H), 7.16 – 
7.08 (m, 1H), 7.06 – 6.95 (m, 3H), 5.91 (ddt, J = 16.2, 10.1, 6.1 Hz, 1H), 5.10 (app. ddd, J = 17.1, 
3.3, 1.6 Hz, 1H), 5.04 (dd, J = 10.1, 1.6 Hz, 1H), 4.54 - 4.44 (m, 2H), 4.15 – 4.05 (m, 2H), 3.22 (app. 
dd, J = 6.1, 1.1 Hz, 2H), 2.22 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 143.4 (C), 139.1 (C), 135.8 
(CH), 131.3 (C), 130.9 (C), 129.3 (3 × CH), 127.2 (CH), 126.7 (2 × CH), 123.8 (CH), 123.6 (CH), 
122.3 (CH), 117.1 (C), 117.0 (CH2), 112.8 (C), 66.4 (2 × CH2), 34.1 (CH2), 21.6 (CH3); IR: νmax (cm
-1) 
3076, 2978, 2903, 1640, 1599, 1348, 1264, 1168, 1016, 981, 949, 670; HRMS (ES) m/z calculated 
for C21H22NO4S (M+H)
+ 387.1270, found 384.1265. 
4-Allyl-7-fluoro-2-(methylsulfonyl)-2H-spiro[isoquinoline-1,2'-[1,3]dioxolane] 672 
Prepared according to GP16 from ynamide 669 (65.1 mg, 0.2 mmol), stirring for 
24 hours. Purification by flash column chromatography [hexane:EtOAc (90:10), 
1% Et2N] gave the isoquinoline 672 (57.2 mg, 88%) as a white solid; mp: 86-88 °C; 
1H-NMR (300 
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MHz, CDCl3): δ 7.32 (dd, J = 8.5, 5.3 Hz, 1H), 7.20 (dd, J = 9.2, 2.7 Hz, 1H), 7.13 (td, J = 8.5, 2.7 Hz, 
1H), 6.84 (s, 1H), 5.93 (ddt, J = 17.2, 10.1, 6.1 Hz, 1H), 5.14 (dd, J = 17.2, 1.7 Hz, 1H), 5.12 (dd, J = 
10.1, 1.5 Hz, 1H), 4.60 – 4.46 (m, 2H), 4.27 – 4.14 (m, 2H), 3.25 (dd, J = 6.1, 1.2 Hz, 2H), 3.06 (s, 
3H); 13C-NMR (101 MHz, CDCl3): δ 162.0 (d, JC-F = 246.9 Hz, C), 135.4 (CH), 132.9 (d, J C-F = 6.8 Hz, 
C), 127.95 (d, J C-F = 2.1 Hz, C), 124.5 (d, J C-F = 7.7 Hz, CH), 122.4 (CH), 117.3 (CH2), 116.7 (d, J C-F = 
21.8 Hz, CH), 115.6 (C), 110.8 (d, J C-F = 23.8 Hz, CH), 66.7 (2 × CH2), 46.3 (C), 43.4 (CH3), 34.1 
(CH2); IR: νmax (cm
-1) 3090, 3024, 2981, 2907, 1643, 1612, 1582, 1501, 1345, 1262, 1160, 963, 
750; HRMS (ES) m/z calculated for C15H17NO4FS (M+Na)
+ 326.0862, found 326.0854. 
4'-Allyl-5'-methoxy-2'-(methylsulfonyl)-2'H-spiro[[1,3]dioxolane-2,1'-isoquinoline] 673 
Prepared according to GP16 from ynamide 670 (67.5 mg, 0.2 mmol), stirring for 13 
hours. Purification by flash column chromatography [hexane:EtOAc (85:15), 1% 
Et2N] gave the isoquinoline 673 (34.6 mg, 51%) as a white solid; mp: 91-93 °C; 
1H-NMR (300 
MHz, CDCl3): δ 7.25 (dd, J = 8.2, 7.7 Hz, 1H), 7.11 (dd, J = 7.7, 1.0 Hz, 1H), 6.91 (dd, J = 8.2, 1.0 
Hz, 1H), 6.66 (s, 1H), 5.92 (ddt, J = 16.8, 10.2, 6.1 Hz, 1H), 5.00 (app. dq, J = 16.8, 1.4 Hz, 1H), 
4.93 (ddd, J = 10.2, 3.2, 1.4 Hz, 1H), 4.57 – 4.46 (m, 2H), 4.25 – 4.13 (m, 2H), 3.80 (s, 3H), 3.45 
(dd, J = 6.1, 1.2 Hz, 2H), 2.96 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 155.7 (C), 137.6 (CH), 133.6 
(C), 128.3 (CH), 122.9 (CH), 120.9 (C), 118.5 (C), 115.9 (CH), 115.3 (CH2), 112.5 (CH), 66.4 (2 × 
CH2), 55.7 (CH3), 46.3 (C), 43.1 (CH3), 37.5 (CH2); IR: νmax (cm
-1) 3017, 2918, 2905, 2839, 1638, 
1597, 1570, 1470, 1342, 1263, 1167, 1141, 1052, 1022, 963, 951, 733; HRMS (ES) m/z calculated 
for C16H19NO5SNa (M+Na)
+ 360.0882, found 360.0885. 
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2-((4-Allyl-6,7-dimethoxyisoquinolin-1-yl)oxy)ethan-1-ol 675 
Prepared according to GP15 from ynamide 671 (73.5 mg, 0.2 mmol), stirring for 11 
hours. Purification by flash column chromatography [hexane:EtOAc (70:30), 1% 
Et2N] gave the isoquinoline 674 (42.0 mg, 57%) as a white solid. Several 
unsuccessful attempts at recrystallisation were then made [hexane:CH2Cl2]. The solvents were 
removed under reduced pressure, the residue was dissolved in CH2Cl2 (ca. 0.5 mL) and filtered in 
a pipette through a short pad (ca. 1 cm) of silica, eluting with CH2Cl2 (10 mL, 1 % Et3N. The 
solvents were removed under reduced pressure to give the alcohol 675 (29.4 mg, 70% from the 
acetal) as a white solid; mp: 102-104 °C; 1H-NMR (300 MHz, CDCl3): δ 7.61 (s, 1H), 7.47 (s, 1H), 
7.06 (s, 1H), 5.96 (ddt, J = 17.1, 10.3, 6.2 Hz, 1H), 5.04 (app. ddd, J = 17.1, 3.3, 1.6 Hz, 1H), 5.02 
(app. ddd, J = 10.3, 3.3, 1.6 Hz, 1H), 4.64 – 4.58 (m, 2H), 3.96 (s, 3H), 3.97 – 3.94 (m, 2H), 3.94 (s, 
3H), 3.54 (d, J = 6.2 Hz, 2H); 13C-NMR (101 MHz, CDCl3): δ 159.2 (C), 152.9 (C), 149.4 (C), 136.9 
(CH), 136.5 (CH), 133.6 (C), 122.7 (C), 116.4 (CH2), 114.3 (C), 103.4 (CH), 102.6 (CH), 70.1 (CH2), 
63.3 (CH2), 56.1 (CH3), 55.9 (CH3), 34.5 (CH2); IR: νmax (cm
-1) 3349, 3071, 2930, 2854, 1646, 1611, 
1504, 1424, 1212, 1169, 1040; HRMS (ES) m/z calculated for C16H20NO4 (M+H)
+ 290.1392, found 
290.1389. 
4'-Allyl-2'-(methylsulfonyl)-2'H-spiro[[1,3]dioxolane-2,1'-[2,6]naphthyridine] 678 
Prepared according to GP16 from ynamide 676 (59.9 mg, 0.2 mmol) stirring for 24 
hours. Purification by flash column chromatography [toluene:Et2O (90:10), 1 % 
Et3N] gave the isoquinoline 678 (39.3 mg, 67%) as a pale orange solid; mp: 112-114 °C; 
1H-NMR 
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(300 MHz, CDCl3): δ 8.66 (s, 1H), 8.59 (d, J = 5.1 Hz, 1H), 7.34 (d, J = 5.1 Hz, 1H), 6.97 (s, 1H), 5.94 
(ddt, J = 16.7, 10.2, 6.1 Hz, 1H), 5.17 (app. dq, J = 16.7, 1.5 Hz, 1H), 5.14 (app. dq, J = 10.2, 1.5 
Hz, 1H), 4.62 – 4.49 (m, 2H), 4.30 – 4.16 (m, 2H), 3.32 (ddd, J = 6.1, 2.6, 1.5 Hz, 2H), 3.09 (s, 3H); 
13C-NMR (101 MHz, CDCl3): δ 148.4 (CH), 144.5 (CH), 138.0 (C), 134.9 (CH), 126.6 (C), 124.5 (CH), 
117.7 (CH2), 117.6 (CH), 113.3 (C), 111.7 (C), 67.0 (2 × CH2), 43.7 (CH3), 33.4 (CH2); IR: νmax (cm
-1) 
3119, 3037, 3007, 2985, 2956, 2987, 1364, 1414, 1333, 1277, 1149, 1088, 1024, 967, 950, 751; 
HRMS (ES) m/z calculated for C14H17N2O4S (M+H)
+ 309.0909, found 309.0899. 
4-Allyl-6-(methylsulfonyl)-6H-spiro[thieno[2,3-c]pyridine-7,2'-[1,3]dioxolane] 679 
Prepared according to GP16 from ynamide 677 (62.7 mg, 0.2 mmol), stirring for 4 
hours. Purification by flash column chromatography [hexane:EtOAc (80:10), 1% 
Et2N] followed by recrystallisation [hexane:CH2Cl2] gave the isoquinoline 679 (15.7 mg, 25%) as 
a white solid; mp: 104-105 °C; 1H-NMR (300 MHz, CDCl3): δ 7.38 (d, J = 5.4 Hz, 1H), 7.24 (d, J = 
5.4 Hz, 1H), 6.65 (s, 1H), 5.67 (ddt, J = 16.9, 10.2, 6.4 Hz, 1H), 5.36 (dd, J = 16.9, 1.2 Hz, 1H), 5.27 
(dd, J = 10.1, 1.2 Hz, 1H), 4.22 – 4.13 (m, 1H), 4.13 – 4.01 (m, 3H), 3.30 (dd, J = 13.9, 6.4 Hz, 1H), 
3.22 (dd, J = 13.9, 6.4 Hz, 1H), 2.95 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.1 (C), 129.2 (CH), 
128.8 (CH), 126.3 (CH), 125.6 (C), 122.9 (CH2), 116.4 (2 × C), 97.9 (CH), 66.0 (CH2), 65.6 (CH2), 
37.9 (CH3), 37.2 (CH2); IR: νmax (cm
-1) 3112, 3012, 2985, 2931, 2894, 1445, 1321, 1146, 1074, 937, 
731; HRMS (ES) m/z calculated for C13H15NO4S2Na (M+Na)
+ 336.0340, found 336.0345. 
4'-(But-3-en-2-yl)-2'-(methylsulfonyl)-2'H-spiro[[1,3]dioxolane-2,1'-isoquinoline] 684 
367 
 
Prepared according to GP16 from ynamide 683 (64.3 mg, 0.2 mmol), stirring for 18 
hours. Purification by flash column chromatography [hexane:EtOAc (90:10), 1 % 
Et3N] gave the isoquinoline 684 (59.2 mg, 92%) as a white solid; mp: 68-70 °C; 
1H-
NMR (300 MHz, CDCl3): δ 7.52 (dt, J = 7.6, 1.0 Hz, 1H), 7.45 – 7.42 (m, 2H), 7.39 – 7.31 (m, 1H), 
6.86 (d, J = 0.9 Hz, 1H), 5.98 (ddd, J = 17.2, 10.3, 6.1 Hz, 1H), 5.12 (app. dt, J = 17.3, 1.5 Hz, 1H), 
5.09 (app. dt, J = 10.3, 1.4 Hz, 1H), 4.58 – 4.48 (m, 2H), 4.26 – 4.16 (m, 2H), 3.67 – 3.55 (m, 1H), 
3.06 (s, 3H), 1.36 (d, J = 6.9 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ 141.7 (CH), 131.4 (C), 131.2 
(C), 129.5 (CH), 127.2 (CH), 123.6 (CH), 122.5 (CH), 122.0 (CH), 121.2 (C), 114.7 (CH2), 112.6 (C), 
66.7 (CH2), 66.5 (CH2), 43.4 (CH), 36.3 (CH3), 19.1 (CH3); IR: νmax (cm
-1) 3104, 3013, 2973, 2937, 
2917, 2867, 1640, 1342, 1327, 1263, 1169, 944, 750; HRMS (ES) m/z calculated for C16H20NO4S 
(M+H)+ 322.1113, found 322.1121. 
Compounds from Chapter 5 
2-((Trimethylsilyl)ethynyl) aniline 762 
Trimethylsilylacetylene (35.5 mL, 0.25 mol, 1.1 equiv.), was added to a solution of 
2-iodoaniline (50 g, 0.22 mol) in diethylamine (500 mL, 0.45 M). Pd(PPh3)2Cl2 (1.6 
g, 1 mol%), and CuI (430 mg, 1 mol%) were added and mixture stirred for 18 hours at room 
temperature. The solvent was removed under reduced pressure and the crude residue was 
purified by flash column chromatography [hexane:EtOAc (96:4)] to give the protected alkyne 
762 (42.4 g, 98%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.29 (dd, J = 7.7, 1.4, Hz, 1H), 7.07 
- 7.15 (m, 1H), 6.62 - 6.71 (m, 2H), 4.22 (br. s, 2H), 0.26 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 
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148.3 (C), 132.8 (CH), 130.2 (CH), 118.1 (CH), 114.5 (CH), 107.9 (C), 102.4 (C), 99.9 (C), 0.2 (3 × 
CH3); MS (EI): m/z 189 (M
+, 58%), 174 (100), 146 (5). Data matches that reported in the 
literature.216 
N,N-Diallyl-2-((trimethylsilyl)ethynyl)aniline 763 
Allyl iodide (102 mL, 1.1 mol, 5.0 equiv.) was added to a solution of 2-
((trimethylsilyl)ethynyl) aniline 762 (42.3 g, 0.22 mol) and potassium carbonate 
(123.4 g, 0.89 mol, 4.0 equiv.) in acetone (1.1 L, 0.2 M). The mixture was heated at reflux for 16 
hours and then cooled and filtered through a plug of celite. Purification by flash column 
chromatography [hexane:CH2Cl2 (95:5)] gave the diallyl aniline deriviative 763 (55.7 g, 93%) as a 
yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.41 (dd, J = 7.6, 1.7 Hz, 1H), 7.17 (ddd, J = 8.3, 7.8, 1.7 
Hz, 1H), 6.77 - 6.88 (m, 2H), 5.88 (ddt, J = 16.9, 10.2, 5.5 Hz, 2H), 5.20 (dd, J = 16.9, 1.6, Hz, 2H), 
5.16 (dd, J = 10.2, 1.6 Hz, 2H), 3.93 (d, J = 5.5 Hz, 4H), 0.24 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ 
152.8 (C), 135.4 (CH), 135.0 (CH), 129.1 (2 × CH2), 120.1 (CH), 119.0 (CH), 117.0 (2 × CH2), 115.0 
(C), 104.6 (C), 99.1 (C), 54.0 (2 × CH2), 0.2 (3 × CH3); MS (EI): m/z 269 (M
+, 36%), 242 (100), 196 
(55), 73 (32). Data matches that reported in the literature.182 
N,N-Diallyl-2-ethynylaniline 764 
 Potassium carbonate (14.2 g, 0.10 mol, 0.5 equiv.) was added to a solution of N,N-
diallyl-2-((trimethylsilyl)ethynyl)aniline 763 (55.5 g, 0.21 mol, 1.0 equiv.) in 
methanol (1.0 L, 0.2 M) and the mixture was stirred for 2 hours at room temperature. Saturated 
NaHCO3 solution (500 mL) was added and the aqueous layer was extracted with EtOAc (2 × 200 
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mL). The combined organic layers were dried over Na2SO4, the solid filtered off and the solvent 
removed under reduced pressure to give the terminal alkyne 764 (40.5 g, >99%) as a yellow oil; 
1H-NMR (300 MHz, CDCl3): δ 7.45 (dd, J = 7.6, 1.7, 1H), 7.22 - 7.21 (m, 1H), 6.82 - 6.93 (m, 1H), 
6.82 - 6.93 (m, 1H), 5.86 (ddt, J = 17.1, 10.2, 6.0 Hz, 2H), 5.19 (dd, J = 17.1, 1.5 Hz, 2H), 5.15 (dd, 
J = 10.2, 1.5 Hz, 2H), 3.90 (d, J = 6.0 Hz, 4H), 3.38 (s, 1H); 13C-NMR (101 MHz, CDCl3): δ 153.3 (C), 
134.9 (CH), 134.5 (CH), 129.6 (2 × CH), 121.1 (CH), 119.9 (CH), 117.6 (2 × CH2), 115.1 (C), 83.4 
(C), 82.5 (CH), 54.8 (2 × CH2); MS (EI): m/z 197 (M
+, 100%), 170 (95), 154 (10), 128 (8); HRMS (ES) 
m/z calculated for C15H14N (M)
+ 197.1204, found 197.1208. Data matches that reported in the 
literature.182 
1,3-Diallyl-1H-indole 769 
Ph3PAuNTf2 (2:1 Ph3PAuNTf2:toluene, 3.9 mg, 5 mol%) was added to a solution of 
N,N-diallyl-2-ethynylaniline 764 (19.7 mg, 0.1 mmol, 1.0 equiv.) in CH2Cl2 (1.0 mL, 
0.1 M). The reaction was stirred for 16 hours at room temperature and filtered through a short 
(ca. 1 cm) plug of silica, eluting with CH2Cl2 (15 mL) and the solvent was removed under reduced 
pressure. Tetramethylbenzene (2.7 mg, 20 mol%) was added to the flask before being taken up 
in CDCl3 to carry out NMR and mass spectrometry analysis; 88% 
1H NMR yield; 1H-NMR (300 
MHz, CDCl3): δ 7.62 (d, J = 7.8 Hz, 1H), 7.31 (d, J = 7.8 Hz, 1H), 7.22 (app. t, J = 6.9 Hz, 1H), 7.12 
(app. t, J = 6.9 Hz, 1H), 6.93 (s, 1H), 6.17 - 5.93 (m, 2H), 5.06 - 5.23 (m, 4H), 4.71 (dd, J = 5.4, 1.6, 
2H), 3.54 (dd, J = 6.5, 1.3 Hz, 2H); 13C-NMR (101 MHz, CDCl3): δ 137.5 (CH), 136.6 (C), 133.7 (CH), 
128.1 (C), 125.5 (CH), 121.6 (CH), 119.3 (CH), 118.8 (CH), 117.2 (CH2), 115.1 (CH2), 113.4 (C), 
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109.5 (CH), 48.7 (CH2), 29.8 (CH2); MS (EI): m/z 197 (M
+, 100%), 170 (52), 156 (44), 128 (21). 
Data matches that reported in the literature.182  
2-Ethynylaniline 781 
Potassium carbonate (1.4 g, 10.4 mmol, 2.0 equiv.) was added to a solution of 2-
(trimethylsilyl)ethynyl) aniline 762 (0.8 g, 5.2 mmol, 1.0 equiv.) in methanol (8 mL, 0.7 
M) and the mixture was stirred for 30 minutes. Saturated NaHCO3 solution (20 mL) was added 
and the aqueous layer was extracted with EtOAc (3 × 20 mL). The combined organic layers were 
dried over Na2SO4, the solid filtered off and the solvent removed under reduced pressure to give 
the terminal alkyne 781 (390 mg, 65%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.33 (dd, J = 
8.2, 2.4, Hz, 1H), 7.15 (dd, J = 8.2, 7.1 Hz, 1H), 6.71 - 6.66 (m, 2H), 4.25 (s, 2H), 3.39 (s, 1H); MS 
(EI): m/z 117 (M+, 100%), 102 (34), 66 (21).Data matches that reported in the literature.217 
N-(2-Ethynylphenyl)-4-methylbenzenesulfonamide 782 
Pyridine (0.4 mL, 5.1 mmol, 5.0 equiv.), and DMAP (20 mg), were added to a 
solution of 2-ethynylaniline 781 (118 mg, 1.0 mmol, 1.0 equiv.) in CH2Cl2 (6 mL, 
0.2 M) at 0 °C and the mixture was stirred for 5 minutes at this temperature. p-
TsCl (1.9 g, 1.2 mmol, 1.2 equiv.) was added portionwise and mixture stirred at 0 °C for 30 
minutes before being allowed to warm to room temperature and stirred for 16 hours. The 
reaction was quenched with 1 M HCl solution (10 mL) and the aqueous layer extracted with 
CH2Cl2 (3 × 10 mL). The combined organic layers were washed with brine (10 mL), dried over 
Na2SO4, filtered, and the solvent removed under reduced pressure. Purification by flash column 
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chromatography [hexane:EtOAc (90:10)] gave the sulfonylamide 782 (201 mg, 75%) as a white 
solid; mp: 86-88 °C; 1H-NMR (300 MHz, CDCl3): δ 7.70 - 7.58 (m, 2H), 7.61 - 7.58 (m, 1H), 7.35 - 
7.20 (m, 5H), 7.04 - 6.99 (m, 1H), 3.37 (s, 1H), 2.37 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.5 
(C), 138.9 (CH), 136.3 (C), 132.9 (C), 130.9 (CH), 130.0 (CH), 127.2 (C), 124.6 (2 × CH), 119.8 (CH), 
112.7 (2 × CH), 84.9 (C), 78.8 (CH), 21.8 (CH3); IR: νmax (cm
-1) 3278, 2924, 2845, 1736, 1599, 1490, 
1344, 1169, 1091, 760; MS (EI): m/z 294 ([M+Na]+, 100%).Data matches that reported in 
literature.183  
N-Allyl-N-(2-ethynylphenyl)-4-methylbenzenesulfonamide 783 
Allyl bromide (0.13 mL, 1.4 mmol, 1.6 equiv.), and potassium carbonate (0.19 g, 
1.4 mmol, 1.5 equiv.) were added to a solution amide 782 (0.24 g, 0.9 mmol, 1.0 
equiv.) in acetone (0.2 M) and the resulting mixture was stirred at reflux for 5 
hours. The solvent was removed under reduced pressure and the residue dissolved in EtOAc (20 
mL). The organic layer was washed with water (3 × 15 mL), brine (3 × 15 mL), dried over Na2SO4 
and filtered. The solvent was removed under reduced pressure. Purification by flash column 
chromatography [hexane:EtOAc (90:10)] gave the N-allyl amine 783 (0.27 g, 83 %) as a clear oil; 
1H-NMR (300 MHz, CDCl3): δ 7.62 (d, J = 8.3 Hz, 2H), 7.49 (dd, J = 7.3, 2.0 Hz, 1H), 7.22 - 7.35 (m, 
4H), 7.13 (dd, J = 7.8, 2.0 Hz, 1H), 5.82 (ddt, J = 17.2, 10.1, 6.5 Hz, 1H), 5.05 (dd, J = 17.2, 1.2 Hz, 
1H), 5.02 (dd, J = 10.1, 1.2 Hz, 1H), 4.27 (d, J = 6.5 Hz, 2H), 2.96 (s, 1H), 2.43 (s, 3H); MS (EI): m/z 
334 ([M+Na]+, 100%), 284 (75), 101 (30). Data matches that reported in literature.218 
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Methyl 3-(2-(diallylamino)phenyl)propiolate 786 
Terminal alkyne 764 (40.5 g, 0.21 mol, 1.0 equiv.) was dissolved in THF (0.82 L, 
0.25 M) and cooled to -78 °C . n-BuLi (98.6 mL, 2.5 M in hexane, 0.25 mol, 1.2 
equiv.) was added dropwise and the resulting solution stirred for 1 hour. Methyl 
chloroformate (23.8 mL, 0.31 mol, 1.5 equiv.) was added slowly and the solution warmed to 
room temperature. After stirring for a further hour, aqueous NH4Cl solution (300 mL) was added 
and the aqueous layer was extracted with Et2O (3 × 300 mL). The combined organic layers were 
washed with brine, dried over MgSO4, filtered and the solvent removed under reduced 
pressure. Purification by flash column chromatography [hexane:EtOAc (97:3)] gave the 
substituted alkyne 786 (37.8 g, 72%) as a yellow oil; 1H-NMR (300 MHz, CDCl3): δ
 7.49 (dd, J = 
7.6, 1.7 Hz, 1H), 7.32 – 7.24 (m, 1H), 6.92 – 6.88 (m, 1H), 6.83 (td, J = 7.6, 1.0 Hz, 1H), 5.90 (ddt, J 
= 16.4, 10.5, 5.8 Hz, 2H), 5.20 (app. dt, J = 16.4, 1.5 Hz, 2H), 5.19 (app. dt, J = 10.5, 1.5 Hz, 2H), 
3.94 (d, J = 5.8 Hz, 4H), 3.82 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 155.0 (C), 154.4 (C), 136.3 
(CH), 134.7 (2 × CH), 131.5 (CH), 120.1 (CH), 119.0 (CH), 117.6 (2 × CH2), 110.4 (C), 87.2 (C), 85.6 
(C), 54.7 (2 × CH2), 52.7 (CH3); IR: νmax (cm
-1) 3078, 2952, 2841, 2212, 1705, 1487, 1417, 1299, 
1273, 1169, 746; HRMS (EI) m/z calculated for C16H17NO2 (M+H)
+ 255.1259, found 255.1256. 
2-(Methoxycarbonyl)pyridine 1-oxide O-1 
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Methyl picolinate (50.0 g, 0.4 mol, 1.0 equiv.) was dissolved in CH2Cl2 (1.5 L, 0.25 M) and m-
CPBA (77% pure, 84.6 g, 0.5 mol, 1.4 equiv.) was added in portions at room temperature. The 
resulting solution was heated to relux for 16 hours. Once cooled to room temperature, 
saturated NaHCO3 solution (500 mL) was added and the aqueous phase was extracted with 
CH2Cl2 (6 × 300 mL). The combined organic fractions were dried over Na2SO4, filtered and the 
solvent was removed under reduced pressure. Purification by flash column chromatography 
[EtOAc:MeOH (88:12)] gave the N-oxide O-1 (40.5 g, 73%) as a white solid; mp: 70-72 °C; 1H-
NMR (300 MHz, CDCl3): δ 8.76 – 8.73 (m, 1H), 8.14 (dd, J = 7.8, 0.7 Hz, 1H), 7.85 (td, J = 7.8, 1.7 
Hz, 1H), 7.48 (ddd, J = 7.8, 4.7, 1.7 Hz, 1H), 4.01 (s, 3H). Data matches that reported in literature. 
219 
4-(Methoxycarbonyl)pyridine 1-oxide O-2 
This N-oxide was donated by a collegue (Mickaël Dos Santos). 
 
8-Ethylquinoline 1-oxide O-3 
This N-oxide was donated by a collegue (Mickaël Dos Santos). 
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Products from oxidative gold catalysis of alkyne 786 
 
Methyl picolinate N-oxide O-1 (50.5 mg, 0.3 mmol, 1.1 equiv.) and alkyne 786 (76.6 mg, 0.3 
mmol, 1.0 equiv.) were dissolved in THF (3.0 mL, 0.1 M) at room temperature. Dichloro(2-
pyridinecarboxylato)gold(III) (5.8 mg, 5 mol%) was added and the solution stirred for 16 hours at 
room temperature. The reaction mixture was filtered through a pipette containing a short (ca. 
0.5 cm) pad of silica, eluting with CH2Cl2 (20 mL). The solvent was removed under reduced 
pressure and the crude residue was purified by flash column chromatography [hexane:EtOAc 
(92:8), then hexane:EtOAc (90:10)] to give the products 787-789. 
Methyl 1,2-diallyl-3-oxoindoline-2-carboxylate 787 
(29.9 mg, 39%), yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.58 (dd, J = 7.7, 0.6 Hz, 1H), 7.46 (ddd, J 
= 8.4, 7.1, 1.4 Hz, 1H), 6.85 – 6.74 (m, 2H), 5.88 (ddt, J = 17.0, 10.5, 5.6 Hz, 1H), 5.45 (ddt, J = 
17.0, 10.0, 7.2, 1H), 5.34 – 4.95 (m, 4H), 4.03 (dd, J = 16.8, 5.5 Hz, 1H), 3.93 (dd, J = 16.8, 5.5 Hz, 
1H), 3.68 (s, 3H), 3.02 (dd, J = 14.7, 6.8 Hz, 1H), 2.93 (dd, J = 14.7, 7.2 Hz, 1H); 13C-NMR (101 
MHz, CDCl3): δ 195.7 (C), 168.2 (C), 161.5 (C), 137.9 (CH), 133.5 (CH), 130.7 (CH), 125.2 (CH), 
120.1 (CH2), 119.7 (C), 118.2 (CH), 117.6 (CH2), 109.7 (CH), 53.1 (CH3), 47.3 (CH2), 37.0 (CH2), 
29.9 (C); IR: νmax (cm
-1) 2958, 2924, 2854, 1744, 1705; HRMS (EI) m/z calculated for C16H17NO3Na 
(M+Na)+ 294.1106, found 294.1101. 
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Methyl 1,3-diallyl-1H-indole-2-carboxylate 788 
(31.4 mg, 41%), yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.70 (app. dt, J = 8.1, 0.9 Hz, 1H), 7.34 
(d, J = 4.3, 1H), 7.35 (d, J = 4.3 Hz, 1H), 7.18 – 7.12 (m, 1H), 6.08 – 5.93 (m, 2H), 5.16 (dt, J = 4.9, 
1.7 Hz, 2H), 5.12 – 4.85 (m, 4H), 3.93 (s, 3H), 3.87 (dt, J = 6.2, 1.6 Hz, 2H); 13C-NMR (101 MHz, 
CDCl3): δ 163.2 (C), 138.6 (C), 137.3 (CH), 134.4 (CH), 126.9 (C), 125.6 (CH), 124.4 (C), 122.9 (C), 
121.1 (CH), 120.3 (CH), 116.0 (CH2), 114.8 (CH2), 110.7 (CH), 51.6 (CH3), 47.3 (CH2), 30.1 (CH2); 
IR: νmax (cm
-1) 3085, 2951, 1706; HRMS (EI) m/z calculated for C16H17NO2Na (M+Na)
+ 278.1157, 
found 278.1151. 
Methyl 3-(2-(diallylamino)phenyl)-2,3-dioxopropanoate 789 
(5.4 mg, 7%), yellow oil; 1H-NMR (300 MHz, CDCl3): δ 7.96 (dd, J = 7.8, 1.7 Hz, 1H), 7.63 (ddd, J = 
8.0, 7.4, 1.7 Hz, 1H), 7.36 (m, 1H), 7.25 (d, J = 8.0 Hz, 1H), 5.73 (ddt, J = 17.0, 10.2, 6.9 Hz, 2H), 
5.19 (dd, J = 10.2, 1.5 Hz, 2H), 5.13 (dd, J = 17.0, 1.5 Hz, 2H), 3.84 (s, 3H), 3.42 (d, J = 6.9 Hz, 4H); 
13C-NMR (101 MHz, CDCl3): δ 193.7 (C), 177.3 (C), 160.4 (C), 152.5 (C), 135.3 (CH), 132.7 (C), 
131.2 (2 × CH), 129.7 (CH), 126.9 (CH), 124.8 (CH), 120.8 (2 × CH2), 57.1 (2 × CH2), 53.0 (CH3); IR: 
νmax (cm
-1) 2954, 2924, 2851, 1756, 1731, 1707, 1671; HRMS (EI) m/z calculated for C16H17NO4Na 
(M+Na)+ 310.3048, found 310.3051. 
N,N’-(Ethane-1,2-diyl)bis(4-methylbenzenesulfonamide) 798 
p-TsCl (9.6 g, 59.8 mmol, 2.0 equiv.) was suspended in diethyl ether (24 mL) and 
cooled to 0 °C. A mixture of sodium hydroxide (2.4 g, 59.8 mmol, 2.0 equiv.) and 
ethylene diamine (2.0 mL, 29.9 mmol, 1.0 equiv.) dissolved in water (24 mL) was 
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added dropwise. The white suspension was then stirred for 16 hours at room temperature. The 
solvent was removed under reduced pressure and the aqueous layer extracted with 
dichloromethane (3 × 15 mL). Recrystallisation [methanol] gave the sulfonamide 798 (9.6 g, 88 
%) as a white solid; mp: 160-161 °C; 1H-NMR (300 MHz, d6-DMSO): δ 7.61 (d, J = 8.2, 4H), 7.37 
(d, J = 8.2 Hz, 4H), 2.70 (s, 4H), 2.38 (s, 6H); 13C-NMR (101 MHz, d6-DMSO): δ 142.7 (2 × C), 137.3 
(2 × C), 129.6 (4 × CH), 126.4 (4 × CH), 42.1 (2 × CH2), 20.9 (2 × CH3); MS (EI): m/z 391 
([M+Na]+,100%). Data matches that reported in literature.187  
N-Allyl-N,N’-(ethane-1,2-diyl)bis(4-methylbenzenesulfonamide) 799 
N,N-Ditosyl-1,2-ethanediamine 789 (750 mg, 2.0 mmol, 1.2 equiv.) was dissolved 
in acetone (12.5 mL, 0.1 M) and the mixture was cooled to 0 °C. Potassium 
carbonate (203 mg, 1.5 mmol, 0.9 equiv.) and allyl bromide (0.4 mL, 1.6 mmol, 
1.0 equiv.) were then added and the mixture was heated at reflux for 16 hours. 
The solvent was removed under reduced pressure and the residue dissolved in ethyl acetate 
and washed with water (3 × 20 mL) and brine (3 × 20 mL). The organic layer was dried over 
Na2SO4, filtered and concentrated under reduced pressure. Purification by flash column 
chromatography [hexane:CH2Cl2:EtOAc (50:50:10)] N-allulsulfonamide 799 (421 mg, 50%) as a 
white solid; mp 53-55°C; 1H-NMR (300 MHz, CDCl3): δ 7.89 (d, J = 8.30 Hz, 2H), 7.64 (d, J = 8.31 
Hz, 2H), 7.31 - 7.37 (m, 4H), 5.43 - 5.57 (m, 1H), 5.09 - 5.15 (m, 2H), 5.03 (br. s, 1H), 3.71 (d, J = 
6.6 Hz, 2H), 3.13 - 3.15 (m, 4H), 2.47 (s, 3H), 2.45 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.3 (C), 
144.1 (C), 132.6 (2 × CH), 129.9 (2 × CH), 129.7 (2 × CH), 127.2 (2 × CH), 119.8 (2 × C), 52.2 (CH2), 
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47.1 (CH2), 42.2 (CH2), 21.5 (2 × CH3); IR: νmax (cm
-1) 3311, 3072, 2962, 2898, 1415, 1334, 1150; 
HRMS (EI) m/z calculated for C19H24N2O4NaS2 (M+Na)
+ 431.1075, found 431.1069. 
N-Allyl-N-phenylacetylene-N,N’-(ethane-1,2-diyl)bis(4-methylbenzenesulfonamide) 800  
Prepared according to GP11 using freshly prepared (bromoethynyl)benzene 
(452 mg, 2.5 mmol, GP9) and N-allyl-N,N-ditosyl-1,2-ethanediamine (850 
mg, 2.1 mmol). Purification by flash column chromatography [hexane:EtOAc 
(80:20)] gave the ynamide 800 (920 mg, 88%) as a white solid; mp: 94-96 °C; 
1H-NMR (300 MHz, CDCl3): δ 7.86 (d, J = 8.8 Hz, 2H), 7.73 (d, J = 8.3 Hz, 2H), 7.28 - 7.48 (m, 9H), 
5.67 (ddt, J = 16.6, 10.0, 6.6 Hz, 1H), 5.19 - 5.25 (m, 2H), 3.83 (d, J = 6.6 Hz, 2H), 3.62 (app. t, J = 
7.2 Hz, 2H), 3.41 (t, J = 7.2 Hz, 2H), 2.49 (s, 3H), 2.43 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.9 
(C), 143.6 (C), 136.1 (C), 134.3 (C), 132.6 (2 × CH), 131.3 (CH), 129.9 (2 × CH), 129.8 (CH), 129.4 (2 
x CH), 128.6 (CH), 128.3 (2 × CH), 127.9 (CH), 127.7 (CH), 127.4 (CH), 122.6 (C), 120.0 (CH2), 82.1 
(C), 70.7 (C), 52.0 (CH2), 50.9 (CH2), 45.2 (CH2), 21.7 (CH3), 21.5 (CH3); IR: νmax (cm
-1) 3075, 2950, 
2929, 2862, 2240, 1597, 1367, 1341, 1160; HRMS (EI) m/z calculated for C27H28N2O4NaS2 (M+H)
+ 
531.1382, found 531.1388. 
Benzene-1,2-diamine 808 
2-Nitroaniline (6.0 g, 36.4 mmol) and tin granules (12.0 g, 101.4 mmol, 2.8 equiv.) and 
hydrochloric acid (130 mL, 6 M) were heated at 80°C until the tin had completely 
dissolved. The flask was cooled using an ice bath and sodium hydroxide solution (10 M) was 
added dropwise with stirring until a pH of 10 was achieved. The precipitate was removed by hot 
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filtration and the solids washed with boiling water (100 mL). Once cooled, the precipitate 
formed from the filtrate was collected by suction filtration to give the diamine 808 (3.3 g, 60 %) 
as a yellow solid; mp: 100-101°C; 1H-NMR (300 MHz, CDCl3): δ 6.72 (s, 4H), 3.38 (br. s, 4H); 
13C-
NMR (101 MHz, CDCl3): δ 134.7 (2 × C), 120.3 (2 × CH), 116.3 (2 × CH); IR: νmax (cm
-1) 3384, 3362, 
3181, 1590, 1499, 1458; MS (EI): m/z 108 (100 %), 80 (34). Data matches that reported in 
literature.220 
N,N’-(1,2-Phenylene)bis(4-methylbenzenesulfonamide) 809 
p-TsCl (4.9 g, 30.6 mmol, 2.2 equiv.) was added portion-wise to a solution of 
benzene-1,2-diamine 808 (1.5 g, 13.9 mmol) in pyridine (28 mL, 0.5 M) at room 
temperature and stirred for 6 hours. The mixture was diluted with CH2Cl2 (100 ml) 
and washed with 1 M HCl solution (3 × 30 mL). The organic layer was dried ober 
Na2SO4, filtered, and concentrated under reduced pressure. Recrystallisation [methanol] gave 
sulfonamide 809 (2.5 g, 43 %) as an off-white solid; mp: 204-206 °C; 1H-NMR (300 MHz, d6-
DMSO): δ 9.29 (br. s, 2H) 7.60 (d, J = 8.2 Hz, 4H), 7.34 (d, J = 8.2 Hz, 4H), 6.99 (m, 4H), 2.35 (s, 
6H); 13C-NMR (101 MHz, d6-DMSO): δ 143.6 (2 × C), 136.0 (2 × C), 130.4 (2 × C), 129.7 (4 × CH), 
126.9 (4 × CH), 125.8 (2 × CH), 123.3 (2 × CH), 21.0 (2 × CH3); MS (EI): m/z 439 ([M+Na
+], 100 %). 
Data matches that reported in literature.221 
N-Allyl-4-methyl-N-(2-(4-methylphenylsulfonamido)phenyl)benzenesulfonamide 810 
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Sulfonamide 809 (1.0 g, 2.4 mmol, 1.2 equiv.) was dissolved in acetone (15 mL, 
0.2 M) and cooled to 0 °C. Potassium carbonate (240 mg, 1.7 mmol, 0.9 equiv.), 
and allyl bromide (0.2 mL, 1.9 mmol, 1.0 equiv.) were added at 0°C and the 
mixture was heated at reflux for 16 hours. The solvent was removed under 
reduced pressure and the residue dissolved in EtOAc (20 mL), and washed with water (3 × 20 
mL) and brine (3 × 20 mL) before drying over Na2SO4 and concentrating under reduced pressure. 
Purification by flash column chromatography [hexane:EtOAc (70:30)] gave the N-allyl 
sulfonamide 810 (284 mg, 32%) as a white solid; mp: 181-183 °C; 1H-NMR (300 MHz, CDCl3): δ 
7.85 (d, J = 8.3 Hz, 2H), 7.64 (dd, J = 8.3, 1.4 Hz, 2H), 7.47 (d, J = 8.3 Hz, 2H), 7.26-7.31 (m, 4H), 
7.21 (ddd, J = 8.3, 7.5, 1.4, 1H), 6.83 (dd, J = 8.0, 1.4 Hz, 1H), 6.29 (dd, J = 8.0, 1.4 Hz, 1H), 5.22-
5.39 (m, 1H), 4.81-4.90 (m, 2H), 4.21 (dd, J = 13.7, 5.4 Hz, 1H), 3.64 (dd, J = 13.7, 7.9 Hz, 1H), 
2.45 (s, 3H), 2.40 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 144.4 (C), 143.9 (C), 137.1 (C), 136.9 (C), 
133.6 (C), 131.2 (CH), 129.6 (2 × CH), 129.4 (2 × CH), 128.5 (C), 128.3 (2 × CH), 128.2 (CH), 127.6 
(2 × CH), 123.6 (2 × CH), 120.2 (CH2), 119.9 (CH), 54.9 (CH2), 21.6 (CH3), 21.5 (CH3); IR: νmax (cm
-1) 
3274, 3073, 2860, 1643, 1596, 1494, 1404, 1338, 1165; HRMS (EI) m/z calculated for 
C23H24N2O4NaS2 (M+Na)
+ 479.1075, found 479.1084. 
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Spectral Analysis of Compounds 265 and 266 
HSQC of Compound 265 
 
HMBC of Compound 265 
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Spectral Analysis of Compound 265 
Key correlations observed in HSQC and HMBC NMR 
spectroscopy are detailed below for structure 2g. Chemical 
shifts in ppm are shown in black (quaternary C), blue (C) and 
red (H). 
 Hi is coupled to quaternary carbons: Ca, Ch, Cj (2J-
couplings) as well as Cb, Cc (3J-couplings). 
 Hi coupled to Ca (2J-coupling) which is in turn coupled 
to methoxy protons Hn (3J-coupling). 
 Quaternary carbon Cb is coupled to the allylic protons 
Hp as well as the aryl proton Hd (3J-couplings).  
 
  
Hp 
Hi 
Hn 
Ca 
Hr H
q
 
Hd 
Cc 
Ch 
Cj 
Cq 
Cb 
Ck 
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HSQC of Compound 266 
 
HMBC of Compound 266 
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Spectral Analysis of Compound 266 
Key correlations observed in HSQC and HMBC NMR 
spectroscopy are detailed below for structure 3g. Chemical 
shifts in ppm are shown in black (quaternary C), blue (C) 
and red (H). 
 Hi is coupled to quaternary carbons: Ca, Ch, Cj (2J-
couplings) as well as Cb, Cc (3J-couplings). 
 Hi coupled to Ca (2J-coupling) which is in turn 
coupled to allylic protons Hp (3J-coupling). 
 Quaternary carbon Cb is coupled to the methoxy 
protons Hn as well as the aryl proton Hd (3J-couplings). Cc is 
also coupled to Hd (2J-coupling). 
Hr Hq 
Hp H
i
 
Hn 
Cb 
Cc 
Cj 
Ch Cq 
Cl 
Ck 
Cd 
Ca 
Cr 
Hd 
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1H- and 13C- NMR spectra of ynamide 255
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1H- and 13C- NMR spectra of ynamide d-255
 
13C enriched carbon 
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1H-NMR Spectrum of Tetracycle 519
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1H-NMR Spectrum of Tetracycle d-519 
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1H-NMR Spectrum of Isoquinoline 651 
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1H-NMR Spectrum of Isoquinoline d-651 
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Crystal data and structure refinement for 235 
Empirical formula  C29H25NO3S 
Formula weight  467.56 
Temperature  120(2) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 10.19700(10) Å = 81.7780(10)°. 
 b = 10.29440(10) Å = 79.5540(10)°. 
 c = 11.15720(10) Å  = 88.0600(10)°. 
Volume 1139.906(19) Å3 
Z 2 
Density (calculated) 1.362 Mg/m3 
Absorption coefficient 1.523 mm-1 
F(000) 492 
Crystal size 0.20 x 0.18 x 0.17 mm3 
Theta range for data collection 6.36 to 66.60°. 
Index ranges -11<=h<=12, -12<=k<=12, -13<=l<=13 
Reflections collected 11629 
Independent reflections 3947 [R(int) = 0.0253] 
Completeness to theta = 66.60° 97.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7818 and 0.7505 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3947 / 0 / 309 
Goodness-of-fit on F2 1.093 
Final R indices [I>2sigma(I)] R1 = 0.0387, wR2 = 0.1067 
R indices (all data) R1 = 0.0399, wR2 = 0.1088 
Largest diff. peak and hole 0.328 and -0.331 e.Å-3 
 
Notes: 
 
The hydrogen atoms have been fixed as riding models. Table 2.  Atomic coordinates ( x 104) and 
equivalent isotropic displacement parameters (Å2x 103) 
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for 235.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________
__ 
 x y z U(eq) 
______________________________________________________________________________
__ 
C(1) 3661(2) 5240(2) 4160(2) 42(1) 
C(2) 3015(2) 5881(2) 5258(2) 28(1) 
C(3) 2619(2) 5132(2) 6400(2) 28(1) 
C(4) 1998(2) 5711(2) 7407(1) 24(1) 
C(5) 1752(1) 7053(1) 7257(1) 20(1) 
C(6) 2148(2) 7821(2) 6134(1) 26(1) 
C(7) 2792(2) 7229(2) 5141(2) 30(1) 
C(8) 1490(1) 7327(1) 10748(1) 20(1) 
C(9) 1338(2) 5999(2) 11185(2) 26(1) 
C(10) 922(2) 5606(2) 12434(2) 32(1) 
C(11) 673(2) 6532(2) 13244(2) 32(1) 
C(12) 843(2) 7854(2) 12800(2) 29(1) 
C(13) 1244(1) 8257(2) 11549(1) 23(1) 
C(14) 4341(1) 7898(1) 8808(1) 18(1) 
C(15) 3126(1) 8466(1) 9027(1) 18(1) 
C(16) 3275(1) 9900(1) 8841(1) 19(1) 
C(17) 2346(2) 10910(1) 8992(1) 21(1) 
C(18) 2798(2) 12197(2) 8767(1) 24(1) 
C(19) 4152(2) 12476(1) 8398(1) 24(1) 
C(20) 5086(2) 11458(2) 8253(1) 22(1) 
C(21) 4639(1) 10179(1) 8477(1) 19(1) 
C(22) 5440(1) 8910(1) 8405(1) 18(1) 
C(23) 5876(2) 6088(2) 8757(1) 25(1) 
C(24) 6251(1) 8812(1) 7129(1) 19(1) 
C(25) 5600(2) 8718(2) 6148(1) 25(1) 
C(26) 6323(2) 8606(2) 4987(1) 28(1) 
C(27) 7705(2) 8592(2) 4788(1) 29(1) 
C(28) 8355(2) 8691(2) 5756(2) 29(1) 
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C(29) 7635(2) 8801(2) 6923(1) 24(1) 
N(1) 1918(1) 7748(1) 9450(1) 21(1) 
O(1) -222(1) 6926(1) 9131(1) 28(1) 
O(2) 540(1) 9091(1) 8026(1) 30(1) 
O(3) 4531(1) 6586(1) 8952(1) 25(1) 
S(1) 851(1) 7767(1) 8501(1) 21(1) 
Table 3.   Bond lengths [Å] and angles [°] for 235 
_____________________________________________________ 
C(1)-C(2)  1.510(2) 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(2)-C(3)  1.390(2) 
C(2)-C(7)  1.390(2) 
C(3)-C(4)  1.388(2) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.387(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.384(2) 
C(5)-S(1)  1.7588(15) 
C(6)-C(7)  1.390(2) 
C(6)-H(6)  0.9500 
C(7)-H(7)  0.9500 
C(8)-C(13)  1.388(2) 
C(8)-C(9)  1.389(2) 
C(8)-N(1)  1.4414(19) 
C(9)-C(10)  1.386(2) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.392(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.385(2) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.387(2) 
C(12)-H(12)  0.9500 
C(13)-H(13)  0.9500 
C(14)-O(3)  1.3483(18) 
C(14)-C(15)  1.349(2) 
C(14)-C(22)  1.5185(19) 
C(15)-N(1)  1.4277(18) 
C(15)-C(16)  1.4700(19) 
C(16)-C(17)  1.390(2) 
C(16)-C(21)  1.404(2) 
C(17)-C(18)  1.391(2) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.395(2) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.398(2) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.382(2) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.5218(19) 
C(22)-C(24)  1.5257(19) 
C(22)-H(22)  1.0000 
C(23)-O(3)  1.4379(18) 
C(23)-H(23A)  0.9800 
C(23)-H(23B)  0.9800 
C(23)-H(23C)  0.9800 
C(24)-C(29)  1.388(2) 
C(24)-C(25)  1.395(2) 
C(25)-C(26)  1.388(2) 
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C(25)-H(25)  0.9500 
C(26)-C(27)  1.386(2) 
C(26)-H(26)  0.9500 
C(27)-C(28)  1.383(2) 
C(27)-H(27)  0.9500 
C(28)-C(29)  1.392(2) 
C(28)-H(28)  0.9500 
C(29)-H(29)  0.9500 
N(1)-S(1)  1.6481(12) 
O(1)-S(1)  1.4327(11) 
O(2)-S(1)  1.4363(11) 
C(2)-C(1)-H(1A) 109.5 
C(2)-C(1)-H(1B) 109.5 
H(1A)-C(1)-H(1B) 109.5 
C(2)-C(1)-H(1C) 109.5 
H(1A)-C(1)-H(1C) 109.5 
H(1B)-C(1)-H(1C) 109.5 
C(3)-C(2)-C(7) 118.84(15) 
C(3)-C(2)-C(1) 120.67(16) 
C(7)-C(2)-C(1) 120.49(16) 
C(4)-C(3)-C(2) 120.95(15) 
C(4)-C(3)-H(3) 119.5 
C(2)-C(3)-H(3) 119.5 
C(5)-C(4)-C(3) 119.07(14) 
C(5)-C(4)-H(4) 120.5 
C(3)-C(4)-H(4) 120.5 
C(6)-C(5)-C(4) 121.07(14) 
C(6)-C(5)-S(1) 119.73(12) 
C(4)-C(5)-S(1) 119.12(12) 
C(5)-C(6)-C(7) 119.06(15) 
C(5)-C(6)-H(6) 120.5 
C(7)-C(6)-H(6) 120.5 
C(6)-C(7)-C(2) 120.96(15) 
C(6)-C(7)-H(7) 119.5 
C(2)-C(7)-H(7) 119.5 
C(13)-C(8)-C(9) 120.62(14) 
C(13)-C(8)-N(1) 119.50(13) 
C(9)-C(8)-N(1) 119.88(13) 
C(10)-C(9)-C(8) 119.38(15) 
C(10)-C(9)-H(9) 120.3 
C(8)-C(9)-H(9) 120.3 
C(9)-C(10)-C(11) 120.36(15) 
C(9)-C(10)-H(10) 119.8 
C(11)-C(10)-H(10) 119.8 
C(12)-C(11)-C(10) 119.79(15) 
C(12)-C(11)-H(11) 120.1 
C(10)-C(11)-H(11) 120.1 
C(11)-C(12)-C(13) 120.23(15) 
C(11)-C(12)-H(12) 119.9 
C(13)-C(12)-H(12) 119.9 
C(12)-C(13)-C(8) 119.61(14) 
C(12)-C(13)-H(13) 120.2 
C(8)-C(13)-H(13) 120.2 
O(3)-C(14)-C(15) 123.04(13) 
O(3)-C(14)-C(22) 125.17(12) 
C(15)-C(14)-C(22) 111.78(12) 
C(14)-C(15)-N(1) 123.71(13) 
C(14)-C(15)-C(16) 109.25(12) 
N(1)-C(15)-C(16) 126.92(12) 
C(17)-C(16)-C(21) 120.42(13) 
C(17)-C(16)-C(15) 131.70(13) 
C(21)-C(16)-C(15) 107.86(12) 
C(16)-C(17)-C(18) 118.60(14) 
C(16)-C(17)-H(17) 120.7 
C(18)-C(17)-H(17) 120.7 
C(17)-C(18)-C(19) 121.00(14) 
C(17)-C(18)-H(18) 119.5 
C(19)-C(18)-H(18) 119.5 
C(18)-C(19)-C(20) 120.35(14) 
C(18)-C(19)-H(19) 119.8 
C(20)-C(19)-H(19) 119.8 
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C(21)-C(20)-C(19) 118.70(14) 
C(21)-C(20)-H(20) 120.7 
C(19)-C(20)-H(20) 120.7 
C(20)-C(21)-C(16) 120.93(14) 
C(20)-C(21)-C(22) 129.02(14) 
C(16)-C(21)-C(22) 110.05(12) 
C(14)-C(22)-C(21) 101.02(11) 
C(14)-C(22)-C(24) 113.49(11) 
C(21)-C(22)-C(24) 113.48(11) 
C(14)-C(22)-H(22) 109.5 
C(21)-C(22)-H(22) 109.5 
C(24)-C(22)-H(22) 109.5 
O(3)-C(23)-H(23A) 109.5 
O(3)-C(23)-H(23B) 109.5 
H(23A)-C(23)-H(23B) 109.5 
O(3)-C(23)-H(23C) 109.5 
H(23A)-C(23)-H(23C) 109.5 
H(23B)-C(23)-H(23C) 109.5 
C(29)-C(24)-C(25) 118.86(13) 
C(29)-C(24)-C(22) 121.21(13) 
C(25)-C(24)-C(22) 119.92(13) 
C(26)-C(25)-C(24) 120.61(14) 
C(26)-C(25)-H(25) 119.7 
C(24)-C(25)-H(25) 119.7 
C(27)-C(26)-C(25) 120.22(15) 
C(27)-C(26)-H(26) 119.9 
C(25)-C(26)-H(26) 119.9 
C(28)-C(27)-C(26) 119.40(14) 
C(28)-C(27)-H(27) 120.3 
C(26)-C(27)-H(27) 120.3 
C(27)-C(28)-C(29) 120.59(15) 
C(27)-C(28)-H(28) 119.7 
C(29)-C(28)-H(28) 119.7 
C(24)-C(29)-C(28) 120.31(14) 
C(24)-C(29)-H(29) 119.8 
C(28)-C(29)-H(29) 119.8 
C(15)-N(1)-C(8) 119.91(11) 
C(15)-N(1)-S(1) 118.11(10) 
C(8)-N(1)-S(1) 119.92(10) 
C(14)-O(3)-C(23) 118.31(11) 
O(1)-S(1)-O(2) 118.46(7) 
O(1)-S(1)-N(1) 106.29(7) 
O(2)-S(1)-N(1) 110.77(6) 
O(1)-S(1)-C(5) 109.79(7) 
O(2)-S(1)-C(5) 106.84(7) 
N(1)-S(1)-C(5) 103.74(7) 
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_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
Table 4.   Anisotropic displacement parameters (Å2x 103)for 235.  The anisotropic 
displacement factor exponent takes the form: -2 2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 36(1)  63(1) 27(1)  -17(1) -5(1)  12(1) 
C(2) 19(1)  43(1) 24(1)  -11(1) -6(1)  2(1) 
C(3) 27(1)  27(1) 30(1)  -9(1) -6(1)  6(1) 
C(4) 25(1)  24(1) 24(1)  -4(1) -3(1)  2(1) 
C(5) 17(1)  23(1) 24(1)  -8(1) -6(1)  0(1) 
C(6) 28(1)  25(1) 27(1)  -3(1) -12(1)  -4(1) 
C(7) 29(1)  40(1) 22(1)  -1(1) -7(1)  -7(1) 
C(8) 13(1)  23(1) 24(1)  -5(1) -3(1)  0(1) 
C(9) 22(1)  23(1) 34(1)  -6(1) -6(1)  -1(1) 
C(10) 28(1)  29(1) 39(1)  5(1) -9(1)  -7(1) 
C(11) 24(1)  46(1) 26(1)  1(1) -4(1)  -7(1) 
C(12) 23(1)  39(1) 26(1)  -10(1) -1(1)  -1(1) 
C(13) 19(1)  23(1) 27(1)  -7(1) -3(1)  1(1) 
C(14) 19(1)  20(1) 16(1)  -4(1) -4(1)  0(1) 
C(15) 18(1)  20(1) 17(1)  -5(1) -4(1)  -2(1) 
C(16) 21(1)  21(1) 16(1)  -5(1) -5(1)  -1(1) 
C(17) 19(1)  23(1) 21(1)  -5(1) -4(1)  0(1) 
C(18) 28(1)  22(1) 22(1)  -5(1) -4(1)  4(1) 
C(19) 32(1)  20(1) 19(1)  -3(1) -3(1)  -4(1) 
C(20) 23(1)  26(1) 16(1)  -4(1) -2(1)  -5(1) 
C(21) 21(1)  22(1) 13(1)  -5(1) -4(1)  0(1) 
C(22) 17(1)  21(1) 17(1)  -3(1) -4(1)  0(1) 
C(23) 23(1)  24(1) 26(1)  -5(1) -1(1)  6(1) 
C(24) 20(1)  18(1) 19(1)  -2(1) -2(1)  1(1) 
C(25) 20(1)  32(1) 22(1)  -5(1) -5(1)  2(1) 
C(26) 32(1)  33(1) 20(1)  -6(1) -6(1)  3(1) 
C(27) 32(1)  27(1) 23(1)  -5(1) 5(1)  3(1) 
C(28) 20(1)  34(1) 32(1)  -6(1) 3(1)  2(1) 
C(29) 20(1)  28(1) 25(1)  -5(1) -5(1)  0(1) 
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N(1) 16(1)  24(1) 22(1)  -7(1) -3(1)  -3(1) 
O(1) 16(1)  35(1) 34(1)  -16(1) -3(1)  -3(1) 
O(2) 30(1)  23(1) 43(1)  -12(1) -18(1)  7(1) 
O(3) 19(1)  20(1) 34(1)  -3(1) -3(1)  2(1) 
S(1) 17(1)  21(1) 28(1)  -10(1) -6(1)  2(1) 
Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for 235. 
______________________________________________________________________________
__ 
 x  y  z  U(eq) 
______________________________________________________________________________
__ 
 
H(1A) 3235 5567 3454 62 
H(1B) 3554 4286 4354 62 
H(1C) 4612 5452 3959 62 
H(3) 2776 4212 6492 33 
H(4) 1744 5195 8187 29 
H(6) 1982 8740 6042 31 
H(7) 3083 7753 4372 36 
H(9) 1518 5366 10634 31 
H(10) 806 4700 12738 39 
H(11) 389 6259 14100 39 
H(12) 683 8486 13353 35 
H(13) 1350 9164 11244 27 
H(17) 1423 10726 9245 25 
H(18) 2174 12898 8865 29 
H(19) 4442 13361 8246 29 
H(20) 6010 11643 8006 26 
H(22) 6049 8821 9022 22 
H(23A) 6263 6263 7879 37 
H(23B) 5874 5139 9028 37 
H(23C) 6409 6522 9229 37 
H(25) 4653 8731 6276 29 
H(26) 5869 8538 4326 34 
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H(27) 8201 8516 3993 34 
H(28) 9302 8683 5624 35 
H(29) 8092 8870 7581 29 
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Table 6.  Torsion angles [°] for 235 
________________________________________________________________ 
C(7)-C(2)-C(3)-C(4) 0.7(2) 
C(1)-C(2)-C(3)-C(4) -178.52(15) 
C(2)-C(3)-C(4)-C(5) 1.1(2) 
C(3)-C(4)-C(5)-C(6) -1.7(2) 
C(3)-C(4)-C(5)-S(1) 175.15(12) 
C(4)-C(5)-C(6)-C(7) 0.5(2) 
S(1)-C(5)-C(6)-C(7) -176.34(11) 
C(5)-C(6)-C(7)-C(2) 1.4(2) 
C(3)-C(2)-C(7)-C(6) -2.0(2) 
C(1)-C(2)-C(7)-C(6) 177.28(15) 
C(13)-C(8)-C(9)-C(10) 0.7(2) 
N(1)-C(8)-C(9)-C(10) -179.75(14) 
C(8)-C(9)-C(10)-C(11) -0.8(2) 
C(9)-C(10)-C(11)-C(12) 0.0(3) 
C(10)-C(11)-C(12)-C(13) 0.7(2) 
C(11)-C(12)-C(13)-C(8) -0.8(2) 
C(9)-C(8)-C(13)-C(12) 0.0(2) 
N(1)-C(8)-C(13)-C(12) -179.50(13) 
O(3)-C(14)-C(15)-N(1) 0.9(2) 
C(22)-C(14)-C(15)-N(1) -178.22(12) 
O(3)-C(14)-C(15)-C(16) 177.24(12) 
C(22)-C(14)-C(15)-C(16) -1.89(16) 
C(14)-C(15)-C(16)-C(17) -177.26(15) 
N(1)-C(15)-C(16)-C(17) -1.1(2) 
C(14)-C(15)-C(16)-C(21) 0.98(16) 
N(1)-C(15)-C(16)-C(21) 177.16(13) 
C(21)-C(16)-C(17)-C(18) 0.5(2) 
C(15)-C(16)-C(17)-C(18) 178.52(14) 
C(16)-C(17)-C(18)-C(19) -0.1(2) 
C(17)-C(18)-C(19)-C(20) -0.2(2) 
C(18)-C(19)-C(20)-C(21) 0.3(2) 
C(19)-C(20)-C(21)-C(16) 0.1(2) 
C(19)-C(20)-C(21)-C(22) -178.99(13) 
C(17)-C(16)-C(21)-C(20) -0.4(2) 
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C(15)-C(16)-C(21)-C(20) -178.92(12) 
C(17)-C(16)-C(21)-C(22) 178.78(12) 
C(15)-C(16)-C(21)-C(22) 0.31(15) 
O(3)-C(14)-C(22)-C(21) -177.16(13) 
C(15)-C(14)-C(22)-C(21) 1.95(15) 
O(3)-C(14)-C(22)-C(24) 61.02(17) 
C(15)-C(14)-C(22)-C(24) -119.87(13) 
C(20)-C(21)-C(22)-C(14) 177.85(14) 
C(16)-C(21)-C(22)-C(14) -1.30(14) 
C(20)-C(21)-C(22)-C(24) -60.33(19) 
C(16)-C(21)-C(22)-C(24) 120.53(13) 
C(14)-C(22)-C(24)-C(29) -131.34(14) 
C(21)-C(22)-C(24)-C(29) 114.07(15) 
C(14)-C(22)-C(24)-C(25) 48.02(18) 
C(21)-C(22)-C(24)-C(25) -66.57(17) 
C(29)-C(24)-C(25)-C(26) 0.5(2) 
C(22)-C(24)-C(25)-C(26) -178.88(14) 
C(24)-C(25)-C(26)-C(27) -0.3(2) 
C(25)-C(26)-C(27)-C(28) 0.0(2) 
C(26)-C(27)-C(28)-C(29) 0.1(2) 
C(25)-C(24)-C(29)-C(28) -0.4(2) 
C(22)-C(24)-C(29)-C(28) 178.98(14) 
C(27)-C(28)-C(29)-C(24) 0.1(2) 
C(14)-C(15)-N(1)-C(8) 84.83(17) 
C(16)-C(15)-N(1)-C(8) -90.84(17) 
C(14)-C(15)-N(1)-S(1) -111.47(14) 
C(16)-C(15)-N(1)-S(1) 72.87(16) 
C(13)-C(8)-N(1)-C(15) 60.00(18) 
C(9)-C(8)-N(1)-C(15) -119.53(15) 
C(13)-C(8)-N(1)-S(1) -103.41(14) 
C(9)-C(8)-N(1)-S(1) 77.06(16) 
C(15)-C(14)-O(3)-C(23) -176.62(13) 
C(22)-C(14)-O(3)-C(23) 2.4(2) 
C(15)-N(1)-S(1)-O(1) 177.14(10) 
C(8)-N(1)-S(1)-O(1) -19.16(12) 
C(15)-N(1)-S(1)-O(2) -52.93(12) 
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C(8)-N(1)-S(1)-O(2) 110.77(12) 
C(15)-N(1)-S(1)-C(5) 61.38(12) 
C(8)-N(1)-S(1)-C(5) -134.92(11) 
C(6)-C(5)-S(1)-O(1) 136.87(12) 
C(4)-C(5)-S(1)-O(1) -40.05(14) 
C(6)-C(5)-S(1)-O(2) 7.23(14) 
C(4)-C(5)-S(1)-O(2) -169.70(12) 
C(6)-C(5)-S(1)-N(1) -109.87(13) 
C(4)-C(5)-S(1)-N(1) 73.21(13) 
________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  
Crystal data and structure refinement for 265 
Empirical formula  C20H21NO3S 
Formula weight  355.44 
Temperature  120(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 21/n 
Unit cell dimensions a = 10.65260(10) Å = 90°. 
 b = 14.6878(2) Å = 97.7890(10)°. 
 c = 10.79310(10) Å  = 90°. 
Volume 1673.14(3) Å3 
Z 4 
Density (calculated) 1.411 Mg/m3 
Absorption coefficient 1.881 mm-1 
F(000) 752 
Crystal size 0.24 x 0.18 x 0.16 mm3 
Theta range for data collection 6.97 to 70.85°. 
Index ranges -12<=h<=12, -17<=k<=17, -12<=l<=13 
Reflections collected 16957 
Independent reflections 3152 [R(int) = 0.0415] 
Completeness to theta = 70.85° 98.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7529 and 0.6610 
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Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3152 / 0 / 228 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0439, wR2 = 0.1179 
R indices (all data) R1 = 0.0446, wR2 = 0.1196 
Largest diff. peak and hole 0.371 and -0.480 e.Å-3 
 
Notes: 
 
The hydrogen atoms have been fixed as riding models. 
The structure is in a centrosymmetric space group and, as such in 50 % of molecules C(2) and 
C(13) are R and C(5) and C(6) are S and in the other 50 % C(2) and C(13) are S and C(5) and C(6) 
are R.  
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103) 
for 265  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________
__ 
 x y z U(eq) 
______________________________________________________________________________
__ 
C(1) 1572(2) 3863(1) 5321(1) 19(1) 
C(2) 1715(1) 2888(1) 4917(1) 18(1) 
C(3) 841(1) 2542(1) 3786(1) 18(1) 
C(4) -246(2) 3730(1) 549(1) 24(1) 
C(5) 2121(1) 3745(1) 3078(1) 13(1) 
C(6) 2533(1) 3636(1) 4471(1) 14(1) 
C(7) 3930(1) 3718(1) 4647(1) 14(1) 
C(8) 4778(2) 3873(1) 5725(1) 17(1) 
C(9) 6060(1) 3958(1) 5618(1) 19(1) 
C(10) 6493(1) 3898(1) 4454(2) 18(1) 
C(11) 5643(1) 3728(1) 3376(1) 16(1) 
C(12) 4365(1) 3637(1) 3480(1) 14(1) 
C(13) 3276(1) 3379(1) 2470(1) 13(1) 
C(14) 4231(1) 1911(1) 2190(1) 20(1) 
C(15) 3292(1) 3789(1) 1180(1) 13(1) 
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C(16) 2893(1) 3285(1) 108(1) 17(1) 
C(17) 2784(1) 3687(1) -1070(1) 19(1) 
C(18) 3065(1) 4602(1) -1187(1) 18(1) 
C(19) 3465(1) 5112(1) -124(1) 19(1) 
C(20) 3587(1) 4709(1) 1054(1) 17(1) 
N(1) 934(1) 3236(1) 2793(1) 15(1) 
O(1) -248(1) 4732(1) 2511(1) 32(1) 
O(2) -1422(1) 3281(1) 2413(1) 25(1) 
O(3) 3130(1) 2408(1) 2418(1) 16(1) 
S(1) -332(1) 3790(1) 2160(1) 17(1) 
______________________________________________________________________________
Table 3.   Bond lengths [Å] and angles [°] for 265 
_____________________________________________________ 
C(1)-C(6)  1.502(2) 
C(1)-C(2)  1.511(2) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-C(3)  1.519(2) 
C(2)-C(6)  1.5201(19) 
C(2)-H(2)  1.0000 
C(3)-N(1)  1.4914(17) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-S(1)  1.7557(16) 
C(4)-H(4A)  0.9800 
C(4)-H(4B)  0.9800 
C(4)-H(4C)  0.9800 
C(5)-N(1)  1.4649(17) 
C(5)-C(6)  1.5162(19) 
C(5)-C(13)  1.5654(18) 
C(5)-H(5)  1.0000 
C(6)-C(7)  1.479(2) 
C(7)-C(8)  1.391(2) 
C(7)-C(12)  1.405(2) 
C(8)-C(9)  1.392(2) 
C(8)-H(8)  0.9500 
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C(9)-C(10)  1.398(2) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.397(2) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.387(2) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.5282(18) 
C(13)-O(3)  1.4344(16) 
C(13)-C(15)  1.5199(18) 
C(14)-O(3)  1.4317(17) 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-C(16)  1.391(2) 
C(15)-C(20)  1.3979(19) 
C(16)-C(17)  1.391(2) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.386(2) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.389(2) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.392(2) 
C(19)-H(19)  0.9500 
C(20)-H(20)  0.9500 
N(1)-S(1)  1.6420(12) 
O(1)-S(1)  1.4351(12) 
O(2)-S(1)  1.4379(11) 
C(6)-C(1)-C(2) 60.60(9) 
C(6)-C(1)-H(1A) 117.7 
C(2)-C(1)-H(1A) 117.7 
C(6)-C(1)-H(1B) 117.7 
C(2)-C(1)-H(1B) 117.7 
H(1A)-C(1)-H(1B) 114.8 
C(1)-C(2)-C(3) 118.29(13) 
C(1)-C(2)-C(6) 59.42(9) 
C(3)-C(2)-C(6) 107.57(11) 
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C(1)-C(2)-H(2) 118.8 
C(3)-C(2)-H(2) 118.8 
C(6)-C(2)-H(2) 118.8 
N(1)-C(3)-C(2) 104.81(11) 
N(1)-C(3)-H(3A) 110.8 
C(2)-C(3)-H(3A) 110.8 
N(1)-C(3)-H(3B) 110.8 
C(2)-C(3)-H(3B) 110.8 
H(3A)-C(3)-H(3B) 108.9 
S(1)-C(4)-H(4A) 109.5 
S(1)-C(4)-H(4B) 109.5 
H(4A)-C(4)-H(4B) 109.5 
S(1)-C(4)-H(4C) 109.5 
H(4A)-C(4)-H(4C) 109.5 
H(4B)-C(4)-H(4C) 109.5 
N(1)-C(5)-C(6) 106.26(11) 
N(1)-C(5)-C(13) 116.24(11) 
C(6)-C(5)-C(13) 103.92(11) 
N(1)-C(5)-H(5) 110.0 
C(6)-C(5)-H(5) 110.0 
C(13)-C(5)-H(5) 110.0 
C(7)-C(6)-C(1) 131.34(13) 
C(7)-C(6)-C(5) 105.66(12) 
C(1)-C(6)-C(5) 116.87(12) 
C(7)-C(6)-C(2) 128.92(12) 
C(1)-C(6)-C(2) 59.97(10) 
C(5)-C(6)-C(2) 106.80(11) 
C(8)-C(7)-C(12) 120.54(14) 
C(8)-C(7)-C(6) 130.40(13) 
C(12)-C(7)-C(6) 109.04(12) 
C(7)-C(8)-C(9) 118.56(14) 
C(7)-C(8)-H(8) 120.7 
C(9)-C(8)-H(8) 120.7 
C(8)-C(9)-C(10) 121.03(14) 
C(8)-C(9)-H(9) 119.5 
C(10)-C(9)-H(9) 119.5 
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C(9)-C(10)-C(11) 120.30(14) 
C(9)-C(10)-H(10) 119.8 
C(11)-C(10)-H(10) 119.8 
C(12)-C(11)-C(10) 118.82(14) 
C(12)-C(11)-H(11) 120.6 
C(10)-C(11)-H(11) 120.6 
C(11)-C(12)-C(7) 120.72(13) 
C(11)-C(12)-C(13) 128.68(13) 
C(7)-C(12)-C(13) 110.44(12) 
O(3)-C(13)-C(15) 111.86(11) 
O(3)-C(13)-C(12) 110.07(11) 
C(15)-C(13)-C(12) 116.93(12) 
O(3)-C(13)-C(5) 105.68(10) 
C(15)-C(13)-C(5) 110.81(11) 
C(12)-C(13)-C(5) 100.37(10) 
O(3)-C(14)-H(14A) 109.5 
O(3)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
O(3)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
C(16)-C(15)-C(20) 118.72(13) 
C(16)-C(15)-C(13) 120.76(12) 
C(20)-C(15)-C(13) 120.21(12) 
C(15)-C(16)-C(17) 120.83(13) 
C(15)-C(16)-H(16) 119.6 
C(17)-C(16)-H(16) 119.6 
C(18)-C(17)-C(16) 120.16(13) 
C(18)-C(17)-H(17) 119.9 
C(16)-C(17)-H(17) 119.9 
C(17)-C(18)-C(19) 119.55(13) 
C(17)-C(18)-H(18) 120.2 
C(19)-C(18)-H(18) 120.2 
C(18)-C(19)-C(20) 120.37(13) 
C(18)-C(19)-H(19) 119.8 
C(20)-C(19)-H(19) 119.8 
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C(19)-C(20)-C(15) 120.38(13) 
C(19)-C(20)-H(20) 119.8 
C(15)-C(20)-H(20) 119.8 
C(5)-N(1)-C(3) 109.69(11) 
C(5)-N(1)-S(1) 118.14(9) 
C(3)-N(1)-S(1) 120.45(9) 
C(14)-O(3)-C(13) 115.27(10) 
O(1)-S(1)-O(2) 118.32(7) 
O(1)-S(1)-N(1) 110.47(7) 
O(2)-S(1)-N(1) 107.59(6) 
O(1)-S(1)-C(4) 107.41(8) 
O(2)-S(1)-C(4) 108.30(7) 
N(1)-S(1)-C(4) 103.76(7) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
Table 4.   Anisotropic displacement parameters (Å2x 103)for HVA/357  The anisotropic 
displacement factor exponent takes the form: -2 2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 19(1)  24(1) 14(1)  -2(1) 6(1)  0(1) 
C(2) 17(1)  21(1) 17(1)  4(1) 4(1)  -1(1) 
C(3) 18(1)  18(1) 19(1)  4(1) 3(1)  -2(1) 
C(4) 22(1)  30(1) 19(1)  6(1) 3(1)  4(1) 
C(5) 12(1)  14(1) 12(1)  -1(1) 2(1)  0(1) 
C(6) 15(1)  16(1) 12(1)  0(1) 2(1)  1(1) 
C(7) 15(1)  12(1) 16(1)  1(1) 2(1)  1(1) 
C(8) 21(1)  17(1) 14(1)  0(1) 1(1)  2(1) 
C(9) 19(1)  15(1) 20(1)  -1(1) -3(1)  1(1) 
C(10) 13(1)  16(1) 26(1)  2(1) 0(1)  1(1) 
C(11) 16(1)  14(1) 18(1)  2(1) 4(1)  1(1) 
C(12) 16(1)  11(1) 14(1)  1(1) 2(1)  1(1) 
C(13) 13(1)  13(1) 15(1)  0(1) 3(1)  0(1) 
C(14) 21(1)  17(1) 24(1)  -1(1) 4(1)  5(1) 
C(15) 11(1)  17(1) 14(1)  1(1) 4(1)  2(1) 
C(16) 17(1)  16(1) 17(1)  -1(1) 2(1)  0(1) 
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C(17) 18(1)  23(1) 14(1)  -3(1) 1(1)  1(1) 
C(18) 17(1)  22(1) 15(1)  4(1) 3(1)  4(1) 
C(19) 20(1)  15(1) 21(1)  3(1) 5(1)  1(1) 
C(20) 17(1)  17(1) 17(1)  -2(1) 3(1)  0(1) 
N(1) 12(1)  17(1) 17(1)  2(1) 2(1)  -1(1) 
O(1) 23(1)  22(1) 47(1)  -12(1) -7(1)  8(1) 
O(2) 14(1)  36(1) 27(1)  3(1) 3(1)  -2(1) 
O(3) 17(1)  12(1) 19(1)  0(1) 5(1)  1(1) 
S(1) 12(1)  18(1) 20(1)  -2(1) 1(1)  1(1) 
______________________________________________________________________________
Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for 265 
______________________________________________________________________________
__ 
 x  y  z  U(eq) 
______________________________________________________________________________
__ 
 
H(1A) 801 4196 4957 23 
H(1B) 1889 4022 6199 23 
H(2) 2116 2438 5545 22 
H(3A) 1121 1938 3522 22 
H(3B) -40 2492 3973 22 
H(4A) -973 4049 90 35 
H(4B) -258 3091 286 35 
H(4C) 540 4018 371 35 
H(5) 1976 4403 2868 15 
H(8) 4487 3920 6517 21 
H(9) 6651 4058 6347 22 
H(10) 7369 3974 4397 22 
H(11) 5935 3675 2586 19 
H(14A) 4560 2166 1459 30 
H(14B) 4007 1270 2033 30 
H(14C) 4881 1956 2922 30 
H(16) 2691 2659 180 20 
H(17) 2518 3333 -1795 22 
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H(18) 2983 4878 -1990 22 
H(19) 3657 5739 -200 22 
H(20) 3872 5061 1775 20 
___________________________________________________________________________Tab
le 6.  Torsion angles [°] for 265 
________________________________________________________________ 
C(6)-C(1)-C(2)-C(3) -94.59(14) 
C(1)-C(2)-C(3)-N(1) 50.35(16) 
C(6)-C(2)-C(3)-N(1) -13.83(15) 
C(2)-C(1)-C(6)-C(7) -117.26(17) 
C(2)-C(1)-C(6)-C(5) 94.67(13) 
N(1)-C(5)-C(6)-C(7) 152.21(11) 
C(13)-C(5)-C(6)-C(7) 29.06(13) 
N(1)-C(5)-C(6)-C(1) -52.15(16) 
C(13)-C(5)-C(6)-C(1) -175.30(12) 
N(1)-C(5)-C(6)-C(2) 12.19(15) 
C(13)-C(5)-C(6)-C(2) -110.96(12) 
C(1)-C(2)-C(6)-C(7) 120.92(17) 
C(3)-C(2)-C(6)-C(7) -126.10(15) 
C(3)-C(2)-C(6)-C(1) 112.98(13) 
C(1)-C(2)-C(6)-C(5) -111.76(13) 
C(3)-C(2)-C(6)-C(5) 1.22(15) 
C(1)-C(6)-C(7)-C(8) 13.3(2) 
C(5)-C(6)-C(7)-C(8) 163.94(14) 
C(2)-C(6)-C(7)-C(8) -68.3(2) 
C(1)-C(6)-C(7)-C(12) -165.06(14) 
C(5)-C(6)-C(7)-C(12) -14.40(15) 
C(2)-C(6)-C(7)-C(12) 113.35(16) 
C(12)-C(7)-C(8)-C(9) 0.8(2) 
C(6)-C(7)-C(8)-C(9) -177.39(14) 
C(7)-C(8)-C(9)-C(10) 0.6(2) 
C(8)-C(9)-C(10)-C(11) -1.6(2) 
C(9)-C(10)-C(11)-C(12) 1.2(2) 
C(10)-C(11)-C(12)-C(7) 0.2(2) 
C(10)-C(11)-C(12)-C(13) -174.72(13) 
C(8)-C(7)-C(12)-C(11) -1.2(2) 
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C(6)-C(7)-C(12)-C(11) 177.35(12) 
C(8)-C(7)-C(12)-C(13) 174.55(12) 
C(6)-C(7)-C(12)-C(13) -6.91(15) 
C(11)-C(12)-C(13)-O(3) 88.43(16) 
C(7)-C(12)-C(13)-O(3) -86.88(13) 
C(11)-C(12)-C(13)-C(15) -40.63(19) 
C(7)-C(12)-C(13)-C(15) 144.06(12) 
C(11)-C(12)-C(13)-C(5) -160.51(13) 
C(7)-C(12)-C(13)-C(5) 24.18(14) 
N(1)-C(5)-C(13)-O(3) -33.45(15) 
C(6)-C(5)-C(13)-O(3) 82.90(12) 
N(1)-C(5)-C(13)-C(15) 87.91(14) 
C(6)-C(5)-C(13)-C(15) -155.74(11) 
N(1)-C(5)-C(13)-C(12) -147.88(12) 
C(6)-C(5)-C(13)-C(12) -31.53(13) 
O(3)-C(13)-C(15)-C(16) 14.69(18) 
C(12)-C(13)-C(15)-C(16) 142.89(13) 
C(5)-C(13)-C(15)-C(16) -102.96(14) 
O(3)-C(13)-C(15)-C(20) -171.87(12) 
C(12)-C(13)-C(15)-C(20) -43.67(18) 
C(5)-C(13)-C(15)-C(20) 70.48(16) 
C(20)-C(15)-C(16)-C(17) -0.1(2) 
C(13)-C(15)-C(16)-C(17) 173.41(13) 
C(15)-C(16)-C(17)-C(18) -0.6(2) 
C(16)-C(17)-C(18)-C(19) 0.6(2) 
C(17)-C(18)-C(19)-C(20) 0.1(2) 
C(18)-C(19)-C(20)-C(15) -0.8(2) 
C(16)-C(15)-C(20)-C(19) 0.8(2) 
C(13)-C(15)-C(20)-C(19) -172.76(13) 
C(6)-C(5)-N(1)-C(3) -21.67(14) 
C(13)-C(5)-N(1)-C(3) 93.37(14) 
C(6)-C(5)-N(1)-S(1) 121.65(10) 
C(13)-C(5)-N(1)-S(1) -123.31(11) 
C(2)-C(3)-N(1)-C(5) 22.19(15) 
C(2)-C(3)-N(1)-S(1) -120.14(11) 
C(15)-C(13)-O(3)-C(14) 74.41(14) 
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C(12)-C(13)-O(3)-C(14) -57.35(14) 
C(5)-C(13)-O(3)-C(14) -164.91(11) 
C(5)-N(1)-S(1)-O(1) -27.42(13) 
C(3)-N(1)-S(1)-O(1) 111.86(12) 
C(5)-N(1)-S(1)-O(2) -157.93(10) 
C(3)-N(1)-S(1)-O(2) -18.65(12) 
C(5)-N(1)-S(1)-C(4) 87.44(11) 
C(3)-N(1)-S(1)-C(4) -133.29(11) 
________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  
Crystal data and structure refinement for 357 
Empirical formula  C20H21NO3S 
Formula weight  355.44 
Temperature  120(2) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 8.53990(10) Å = 83.5660(10)°. 
 b = 8.68330(10) Å = 85.8150(10)°. 
 c = 12.1209(2) Å  = 84.8840(10)°. 
Volume 887.80(2) Å3 
Z 2 
Density (calculated) 1.330 Mg/m3 
Absorption coefficient 1.772 mm-1 
F(000) 376 
Crystal size 0.24 x 0.16 x 0.13 mm3 
Theta range for data collection 6.57 to 66.59°. 
Index ranges -9<=h<=10, -10<=k<=10, -14<=l<=14 
Reflections collected 8609 
Independent reflections 3049 [R(int) = 0.0223] 
Completeness to theta = 66.59° 97.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8023 and 0.6757 
Refinement method Full-matrix least-squares on F2 
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Data / restraints / parameters 3049 / 0 / 228 
Goodness-of-fit on F2 1.068 
Final R indices [I>2sigma(I)] R1 = 0.0394, wR2 = 0.1075 
R indices (all data) R1 = 0.0414, wR2 = 0.1101 
Largest diff. peak and hole 0.455 and -0.393 e.Å-3 
 
Notes: 
The hydrogen atoms have been fixed as riding models.  
The space group is centrosymmetric which means that there will be an equal number of molecules where C(13) is 
R and where C(13) is S in the structure.  
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 357.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 7455(2) 7646(2) 5670(2) 36(1) 
C(2) 6195(2) 7021(2) 6151(1) 28(1) 
C(3) 4558(2) 7796(2) 6123(1) 26(1) 
C(4) 861(2) 9253(2) 7426(2) 31(1) 
C(5) 4692(2) 10523(2) 7714(1) 21(1) 
C(6) 4729(2) 8959(2) 7878(1) 21(1) 
C(7) 5875(2) 8369(2) 8696(1) 21(1) 
C(8) 6342(2) 6867(2) 9138(1) 25(1) 
C(9) 7537(2) 6655(2) 9879(1) 28(1) 
C(10) 8234(2) 7924(2) 10179(1) 27(1) 
C(11) 7742(2) 9436(2) 9759(1) 24(1) 
C(12) 6563(2) 9645(2) 9020(1) 20(1) 
C(13) 5847(2) 11143(2) 8410(1) 20(1) 
C(14) 3574(2) 13048(2) 7023(2) 28(1) 
C(15) 7083(2) 12075(2) 7729(1) 20(1) 
C(16) 7491(2) 11861(2) 6624(1) 25(1) 
C(17) 8630(2) 12717(2) 6017(1) 28(1) 
C(18) 9377(2) 13786(2) 6521(1) 27(1) 
C(19) 8987(2) 13997(2) 7626(2) 27(1) 
C(20) 7837(2) 13151(2) 8230(1) 23(1) 
N(1) 3924(2) 7988(2) 7271(1) 22(1) 
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O(1) 1730(1) 6421(1) 7039(1) 32(1) 
O(2) 2129(1) 7218(1) 8886(1) 31(1) 
O(3) 3807(1) 11393(1) 6959(1) 26(1) 
S(1) 2142(1) 7566(1) 7706(1) 23(1) 
Table 3.   Bond lengths [Å] and angles [°] for 357. 
_____________________________________________________ 
C(1)-C(2)  1.317(3) 
C(1)-H(1A)  0.9500 
C(1)-H(1B)  0.9500 
C(2)-C(3)  1.497(2) 
C(2)-H(2)  0.9500 
C(3)-N(1)  1.477(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-S(1)  1.7657(18) 
C(4)-H(4A)  0.9800 
C(4)-H(4B)  0.9800 
C(4)-H(4C)  0.9800 
C(5)-C(6)  1.348(2) 
C(5)-O(3)  1.350(2) 
C(5)-C(13)  1.515(2) 
C(6)-N(1)  1.4290(19) 
C(6)-C(7)  1.464(2) 
C(7)-C(8)  1.388(2) 
C(7)-C(12)  1.405(2) 
C(8)-C(9)  1.396(2) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.393(2) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.394(2) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.382(2) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.523(2) 
C(13)-C(15)  1.525(2) 
C(13)-H(13)  1.0000 
C(14)-O(3)  1.4439(19) 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-C(16)  1.389(2) 
C(15)-C(20)  1.395(2) 
C(16)-C(17)  1.393(2) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.390(2) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.385(2) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.394(2) 
C(19)-H(19)  0.9500 
C(20)-H(20)  0.9500 
N(1)-S(1)  1.6328(13) 
O(1)-S(1)  1.4321(12) 
O(2)-S(1)  1.4274(13) 
C(2)-C(1)-H(1A) 120.0 
C(2)-C(1)-H(1B) 120.0 
H(1A)-C(1)-H(1B) 120.0 
C(1)-C(2)-C(3) 124.32(17) 
C(1)-C(2)-H(2) 117.8 
C(3)-C(2)-H(2) 117.8 
N(1)-C(3)-C(2) 109.34(13) 
N(1)-C(3)-H(3A) 109.8 
C(2)-C(3)-H(3A) 109.8 
N(1)-C(3)-H(3B) 109.8 
C(2)-C(3)-H(3B) 109.8 
H(3A)-C(3)-H(3B) 108.3 
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S(1)-C(4)-H(4A) 109.5 
S(1)-C(4)-H(4B) 109.5 
H(4A)-C(4)-H(4B) 109.5 
S(1)-C(4)-H(4C) 109.5 
H(4A)-C(4)-H(4C) 109.5 
H(4B)-C(4)-H(4C) 109.5 
C(6)-C(5)-O(3) 123.15(14) 
C(6)-C(5)-C(13) 111.54(14) 
O(3)-C(5)-C(13) 125.15(13) 
C(5)-C(6)-N(1) 126.25(14) 
C(5)-C(6)-C(7) 109.50(14) 
N(1)-C(6)-C(7) 123.91(13) 
C(8)-C(7)-C(12) 120.38(15) 
C(8)-C(7)-C(6) 131.57(15) 
C(12)-C(7)-C(6) 108.05(13) 
C(7)-C(8)-C(9) 118.60(15) 
C(7)-C(8)-H(8) 120.7 
C(9)-C(8)-H(8) 120.7 
C(10)-C(9)-C(8) 120.65(15) 
C(10)-C(9)-H(9) 119.7 
C(8)-C(9)-H(9) 119.7 
C(9)-C(10)-C(11) 120.90(16) 
C(9)-C(10)-H(10) 119.6 
C(11)-C(10)-H(10) 119.6 
C(12)-C(11)-C(10) 118.40(15) 
C(12)-C(11)-H(11) 120.8 
C(10)-C(11)-H(11) 120.8 
C(11)-C(12)-C(7) 121.05(15) 
C(11)-C(12)-C(13) 129.33(14) 
C(7)-C(12)-C(13) 109.59(13) 
C(5)-C(13)-C(12) 101.32(12) 
C(5)-C(13)-C(15) 113.87(13) 
C(12)-C(13)-C(15) 112.48(12) 
C(5)-C(13)-H(13) 109.6 
C(12)-C(13)-H(13) 109.6 
C(15)-C(13)-H(13) 109.6 
O(3)-C(14)-H(14A) 109.5 
O(3)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
O(3)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
C(16)-C(15)-C(20) 119.18(14) 
C(16)-C(15)-C(13) 121.36(14) 
C(20)-C(15)-C(13) 119.45(14) 
C(15)-C(16)-C(17) 120.51(15) 
C(15)-C(16)-H(16) 119.7 
C(17)-C(16)-H(16) 119.7 
C(18)-C(17)-C(16) 120.01(15) 
C(18)-C(17)-H(17) 120.0 
C(16)-C(17)-H(17) 120.0 
C(19)-C(18)-C(17) 119.81(15) 
C(19)-C(18)-H(18) 120.1 
C(17)-C(18)-H(18) 120.1 
C(18)-C(19)-C(20) 120.18(15) 
C(18)-C(19)-H(19) 119.9 
C(20)-C(19)-H(19) 119.9 
C(19)-C(20)-C(15) 120.29(15) 
C(19)-C(20)-H(20) 119.9 
C(15)-C(20)-H(20) 119.9 
C(6)-N(1)-C(3) 116.69(12) 
C(6)-N(1)-S(1) 119.22(10) 
C(3)-N(1)-S(1) 121.74(11) 
C(5)-O(3)-C(14) 118.26(12) 
O(2)-S(1)-O(1) 119.59(7) 
O(2)-S(1)-N(1) 107.18(7) 
O(1)-S(1)-N(1) 106.67(7) 
O(2)-S(1)-C(4) 107.45(8) 
O(1)-S(1)-C(4) 107.65(8) 
N(1)-S(1)-C(4) 107.81(8) 
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_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters (Å2x 103)for 357.  The anisotropic 
displacement factor exponent takes the form: -2 2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 29(1)  38(1) 40(1)  -8(1) 6(1)  -2(1) 
C(2) 29(1)  27(1) 28(1)  -6(1) 1(1)  -1(1) 
C(3) 26(1)  28(1) 23(1)  -4(1) -2(1)  -5(1) 
C(4) 22(1)  31(1) 40(1)  -3(1) -2(1)  0(1) 
C(5) 17(1)  22(1) 23(1)  -2(1) 0(1)  -3(1) 
C(6) 18(1)  22(1) 22(1)  -4(1) 0(1)  -4(1) 
C(7) 19(1)  23(1) 21(1)  -3(1) 2(1)  -2(1) 
C(8) 27(1)  21(1) 27(1)  -4(1) 0(1)  -3(1) 
C(9) 30(1)  24(1) 28(1)  -1(1) -2(1)  3(1) 
C(10) 23(1)  33(1) 26(1)  -2(1) -5(1)  1(1) 
C(11) 22(1)  27(1) 23(1)  -3(1) -1(1)  -5(1) 
C(12) 18(1)  22(1) 21(1)  -2(1) 2(1)  -3(1) 
C(13) 18(1)  20(1) 23(1)  -3(1) -1(1)  -4(1) 
C(14) 27(1)  21(1) 35(1)  0(1) -4(1)  0(1) 
C(15) 16(1)  19(1) 25(1)  0(1) -2(1)  -1(1) 
C(16) 22(1)  28(1) 27(1)  -6(1) -2(1)  -6(1) 
C(17) 21(1)  37(1) 25(1)  -1(1) 1(1)  -3(1) 
C(18) 18(1)  28(1) 33(1)  5(1) -1(1)  -5(1) 
C(19) 22(1)  24(1) 36(1)  -1(1) -6(1)  -5(1) 
C(20) 23(1)  21(1) 25(1)  -2(1) -2(1)  -3(1) 
N(1) 19(1)  24(1) 25(1)  -5(1) -1(1)  -5(1) 
O(1) 28(1)  30(1) 42(1)  -10(1) -1(1)  -12(1) 
O(2) 29(1)  32(1) 31(1)  1(1) 2(1)  -9(1) 
O(3) 25(1)  20(1) 35(1)  1(1) -10(1)  -3(1) 
S(1) 20(1)  21(1) 29(1)  -3(1) -1(1)  -6(1) 
______________________________________________________________________________
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Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for 357 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1A) 7358 8653 5273 43 
H(1B) 8461 7089 5720 43 
H(2) 6333 6012 6542 34 
H(3A) 4572 8825 5680 31 
H(3B) 3877 7155 5768 31 
H(4A) -221 9029 7675 47 
H(4B) 917 9579 6624 47 
H(4C) 1175 10089 7822 47 
H(8) 5858 6003 8939 30 
H(9) 7879 5634 10183 33 
H(10) 9056 7757 10677 33 
H(11) 8205 10302 9974 29 
H(13) 5260 11797 8959 24 
H(14A) 3113 13245 7764 42 
H(14B) 2860 13520 6459 42 
H(14C) 4589 13504 6890 42 
H(16) 6990 11124 6278 30 
H(17) 8896 12569 5259 34 
H(18) 10153 14371 6108 32 
H(19) 9504 14720 7973 32 
H(20) 7566 13308 8985 28 
________________________________________________________________________________
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Table 6.  Torsion angles [°] for 357 
________________________________________________________________ 
C(1)-C(2)-C(3)-N(1) -119.40(18) 
O(3)-C(5)-C(6)-N(1) 2.9(2) 
C(13)-C(5)-C(6)-N(1) -172.72(13) 
O(3)-C(5)-C(6)-C(7) 176.26(13) 
C(13)-C(5)-C(6)-C(7) 0.64(18) 
C(5)-C(6)-C(7)-C(8) -179.79(16) 
N(1)-C(6)-C(7)-C(8) -6.2(3) 
C(5)-C(6)-C(7)-C(12) -0.75(18) 
N(1)-C(6)-C(7)-C(12) 172.80(13) 
C(12)-C(7)-C(8)-C(9) -1.9(2) 
C(6)-C(7)-C(8)-C(9) 177.00(16) 
C(7)-C(8)-C(9)-C(10) 0.7(2) 
C(8)-C(9)-C(10)-C(11) 0.9(3) 
C(9)-C(10)-C(11)-C(12) -1.2(2) 
C(10)-C(11)-C(12)-C(7) -0.1(2) 
C(10)-C(11)-C(12)-C(13) -177.73(14) 
C(8)-C(7)-C(12)-C(11) 1.7(2) 
C(6)-C(7)-C(12)-C(11) -177.49(14) 
C(8)-C(7)-C(12)-C(13) 179.72(13) 
C(6)-C(7)-C(12)-C(13) 0.56(17) 
C(6)-C(5)-C(13)-C(12) -0.29(16) 
O(3)-C(5)-C(13)-C(12) -175.80(14) 
C(6)-C(5)-C(13)-C(15) 120.72(15) 
O(3)-C(5)-C(13)-C(15) -54.8(2) 
C(11)-C(12)-C(13)-C(5) 177.65(16) 
C(7)-C(12)-C(13)-C(5) -0.19(16) 
C(11)-C(12)-C(13)-C(15) 55.7(2) 
C(7)-C(12)-C(13)-C(15) -122.16(14) 
C(5)-C(13)-C(15)-C(16) -23.7(2) 
C(12)-C(13)-C(15)-C(16) 90.87(18) 
C(5)-C(13)-C(15)-C(20) 157.20(14) 
C(12)-C(13)-C(15)-C(20) -88.25(17) 
C(20)-C(15)-C(16)-C(17) -0.5(2) 
C(13)-C(15)-C(16)-C(17) -179.63(15) 
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C(15)-C(16)-C(17)-C(18) 0.5(3) 
C(16)-C(17)-C(18)-C(19) 0.0(3) 
C(17)-C(18)-C(19)-C(20) -0.6(3) 
C(18)-C(19)-C(20)-C(15) 0.7(2) 
C(16)-C(15)-C(20)-C(19) -0.1(2) 
C(13)-C(15)-C(20)-C(19) 179.05(15) 
C(5)-C(6)-N(1)-C(3) 73.1(2) 
C(7)-C(6)-N(1)-C(3) -99.32(17) 
C(5)-C(6)-N(1)-S(1) -89.77(18) 
C(7)-C(6)-N(1)-S(1) 97.77(16) 
C(2)-C(3)-N(1)-C(6) 62.79(18) 
C(2)-C(3)-N(1)-S(1) -134.77(13) 
C(6)-C(5)-O(3)-C(14) 166.09(14) 
C(13)-C(5)-O(3)-C(14) -18.9(2) 
C(6)-N(1)-S(1)-O(2) -42.90(13) 
C(3)-N(1)-S(1)-O(2) 155.09(12) 
C(6)-N(1)-S(1)-O(1) -172.11(12) 
C(3)-N(1)-S(1)-O(1) 25.88(14) 
C(6)-N(1)-S(1)-C(4) 72.50(14) 
C(3)-N(1)-S(1)-C(4) -89.51(14) 
________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Factorial Experimental Design (Chapter 5) 
Exp 
No 
Exp 
Name 
Run 
Order Temperature Concentration Oxidant Catalyst 
5 N5 1 10 0.05 5 2.5 
15 N15 2 10 0.2 5 7.5 
16 N16 3 40 0.2 5 7.5 
6 N6 4 40 0.05 5 2.5 
7 N7 5 10 0.2 5 2.5 
14 N14 6 40 0.05 5 7.5 
2 N2 7 40 0.05 1 2.5 
8 N8 8 40 0.2 5 2.5 
19 N19 9 25 0.125 3 5 
12 N12 10 40 0.2 1 7.5 
4 N4 11 40 0.2 1 2.5 
10 N10 12 40 0.05 1 7.5 
11 N11 13 10 0.2 1 7.5 
17 N17 14 25 0.125 3 5 
9 N9 15 10 0.05 1 7.5 
3 N3 16 10 0.2 1 2.5 
13 N13 17 10 0.05 5 7.5 
1 N1 18 10 0.05 1 2.5 
18 N18 19 25 0.125 3 5 
 
Note: reaction number refers to run order: 
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